# BugSigDB 2023-12-28_23:59_UTC, License: Creative Commons Attribution 4.0 International, URL: https://bugsigdb.org
bsdb:1/1/1_colorectal-adenoma:conventional-adenoma-cases_vs_controls_UP	NA	1654	1716	1301	162289	189330	33024	40544	1386
bsdb:1/1/2_colorectal-adenoma:conventional-adenoma-cases_vs_controls_DOWN	NA	100883
bsdb:1/2/1_Hyperplastic-Polyp:hyperplastic-polyp-cases_vs_controls_UP	NA	207244
bsdb:1/2/2_Hyperplastic-Polyp:hyperplastic-polyp-cases_vs_controls_DOWN	NA	100883
bsdb:1/4/1_colorectal-adenoma:Proximal-conventional-adenoma-cases_vs_controls_UP	NA	1654	1716	1485	836	162289	1301	165779	283168	207244	189330	40544	33024
bsdb:1/4/2_colorectal-adenoma:Proximal-conventional-adenoma-cases_vs_controls_DOWN	NA	100883
bsdb:1/5/1_colorectal-adenoma:Distal-conventional-adenoma-cases_vs_controls_DOWN	NA	1485	1350
bsdb:1/6/1_colorectal-adenoma:Non-advanced-conventional-adenoma-cases_vs_controls_UP	NA	1654	283168	1301	189330	40544	33024
bsdb:1/7/1_colorectal-adenoma:advanced-conventional-adenoma-cases_vs_controls_UP	NA	1654	1716	836	165779	150022	162289	724
bsdb:1/7/2_colorectal-adenoma:advanced-conventional-adenoma-cases_vs_controls_DOWN	NA	140625	28050
bsdb:2/1/1_head-and-neck-squamous-cell-carcinoma:squamous-cell-carcinoma-tissues_vs_normal-adjacent-tissues_UP	NA	543311
bsdb:2/1/2_head-and-neck-squamous-cell-carcinoma:squamous-cell-carcinoma-tissues_vs_normal-adjacent-tissues_DOWN	NA	1654
bsdb:2/2/1_head-and-neck-squamous-cell-carcinoma:T3-T4-high-tumor-stages-patients_vs_T0-T2-low-tumor-stages-patients_UP	NA	543311
bsdb:2/2/2_head-and-neck-squamous-cell-carcinoma:T3-T4-high-tumor-stages-patients_vs_T0-T2-low-tumor-stages-patients_DOWN	NA	1654
bsdb:3/1/1_colorectal-cancer:adenocarcinoma-of-colon-and-rectum-patients_vs_controls_UP	NA	848	836
bsdb:4/1/1_Hepatitis:HCV-stage-4-male-patients_vs_male-healthy-controls_UP	NA	469	838	29465	33024
bsdb:4/1/2_Hepatitis:HCV-stage-4-male-patients_vs_male-healthy-controls_DOWN	NA	375288	1263	574697	1678	53246	39948
bsdb:5/1/1_chronic-obstructive-pulmonary-disease:Chronic-obstructive-pulmonary-disease_vs_controls_UP	NA	46123	1654	642	653683	1380	1678	118747	830	194	1016	43996	82202	84162	893	39948	156973	1730	848	52228	32067	186650	1839	133925	265975	543311	1257	838	32207	970	613	123375	1301	195950	29465
bsdb:5/1/2_chronic-obstructive-pulmonary-disease:Chronic-obstructive-pulmonary-disease_vs_controls_DOWN	NA	1485	88138	2023	544	1663
bsdb:5/2/1_chronic-obstructive-pulmonary-disease:Severe_vs_moderate-Chronic-obstructive-pulmonary-disease_UP	NA	1839	289201	1485	186650	642
bsdb:7/1/1_autism:severely-autistic_vs_non-sibling-control_UP	NA	191303	816	286729	872	258514	375288
bsdb:7/1/2_autism:severely-autistic_vs_non-sibling-control_DOWN	NA	114627	52784	109326	1678	1485	102106	39948	253238	31983	1578	1243	113286	1263	1301	46255
bsdb:10/1/1_cervical-glandular-intraepithelial-neoplasia:Cervical-Intraepithelial-Lesion-HIV-patients_vs_Normal-tissue-HIV-patients_UP	NA	437755
bsdb:10/2/1_cervical-glandular-intraepithelial-neoplasia:Cervical-Intraepithelial-Lesion-HIV-patients_vs_Normal-tissue-HIV-patients_UP	NA	1375
bsdb:14/1/1_halitosis:Oral-Halitosis_vs_Control_UP	NA	194	195950	39948	1257	970	32067	2740	543311	157	1016	416916	838
bsdb:14/1/2_halitosis:Oral-Halitosis_vs_Control_DOWN	NA	416916	724	437755	265975	838	1301	2740	32067
bsdb:15/1/1_gestational-diabetes:Gestational-diabetes-mellitus_vs_controls_UP	NA	33057
bsdb:15/1/2_gestational-diabetes:Gestational-diabetes-mellitus_vs_controls_DOWN	NA	55080	935200	1578	231454	44675
bsdb:16/1/1_obesity:high-fat-diet_vs_normal-chow-diet_UP	NA	31980	1263	248744	239759	572511
bsdb:16/1/2_obesity:high-fat-diet_vs_normal-chow-diet_DOWN	NA	816	283168	109326	574697	209	990721	35832	459786
bsdb:16/2/1_obesity:high-fat-diet-+-melatonin_vs_high-fat-diet_UP	NA	583	283168	209	109326	872	574697	239934	1920251
bsdb:16/2/2_obesity:high-fat-diet-+-melatonin_vs_high-fat-diet_DOWN	NA	239759	244127
bsdb:17/1/1_anxiety-disorder:treatment-active-Generalized-Anxiety-disorder_vs_healthy-controls_UP	NA	848	816	946234	1432051	1505663
bsdb:17/1/2_anxiety-disorder:treatment-active-Generalized-Anxiety-disorder_vs_healthy-controls_DOWN	NA	35832	580596	39948	216851	28050	46205	841	292632	40544
bsdb:17/2/1_anxiety-disorder:treatment-naiive-Generalized-Anxiety-disorder_vs_healthy-controls_UP	NA	1578	848	816	561	620	375288	1505663	946234
bsdb:17/2/2_anxiety-disorder:treatment-naiive-Generalized-Anxiety-disorder_vs_healthy-controls_DOWN	NA	244127	397864	580596	574697	102106	216851	1407607	28050	437755	846	577310	2740	841	292632
bsdb:18/1/1_obesity:Sv129--Low-Fat_vs_BL6--Low-Fat_UP	NA	244127	816	572511	830	1485	189330	1730	216851	1578	459786	1017280	841	1263	292632
bsdb:18/1/2_obesity:Sv129--Low-Fat_vs_BL6--Low-Fat_DOWN	NA	239934	239759	283168	375288	838	195950
bsdb:18/2/1_obesity:Sv129-High-Fat-without-enomithacin_vs_BL6-High-Fat-without-enomithacin_UP	NA	1485	841
bsdb:18/2/2_obesity:Sv129-High-Fat-without-enomithacin_vs_BL6-High-Fat-without-enomithacin_DOWN	NA	239934
bsdb:18/3/1_obesity:Sv129-High-Fat-with-enomithacin_vs_BL6-High-Fat-with-enomithacin_UP	NA	816
bsdb:18/3/2_obesity:Sv129-High-Fat-with-enomithacin_vs_BL6-High-Fat-with-enomithacin_DOWN	NA	239934	244127
bsdb:19/1/1_schizophrenia:Schizophrenia_vs_Healthy-controls_UP	NA	838	83770	848	906	1578	544	33024	904	872
bsdb:19/1/2_schizophrenia:Schizophrenia_vs_Healthy-controls_DOWN	NA	1301	33042	841	572511
bsdb:20/1/1_non-alcoholic-fatty-liver-disease:NASH_vs_Non-NASH_UP	NA	816
bsdb:20/1/2_non-alcoholic-fatty-liver-disease:NASH_vs_Non-NASH_DOWN	NA	838
bsdb:20/2/1_non-alcoholic-fatty-liver-disease:significant-fibrosis-(F>2)_vs_mild-fibrosis-(F-0-1)_UP	NA	1263	816
bsdb:20/2/2_non-alcoholic-fatty-liver-disease:significant-fibrosis-(F>2)_vs_mild-fibrosis-(F-0-1)_DOWN	NA	838
bsdb:21/1/1_obesity:Cameron-County-Hispanic-Cohort-samples_vs_Human-Microbiome-Project-samples_UP	NA	838	102106	841	1301	39948
bsdb:21/1/2_obesity:Cameron-County-Hispanic-Cohort-samples_vs_Human-Microbiome-Project-samples_DOWN	NA	816	375288	239759
bsdb:22/1/1_Parkinson's-disease:Parkinson's_vs_Healthy-controls_UP	NA	1578	990721	270497	119852	1678
bsdb:22/1/2_Parkinson's-disease:Parkinson's_vs_Healthy-controls_DOWN	NA	189330	816	838	216851
bsdb:23/1/1_Alzheimer's-disease:Alzheimer's_vs_Healhty-controls_UP	NA	239759	816	572511	1378	33024	35832
bsdb:23/1/2_Alzheimer's-disease:Alzheimer's_vs_Healhty-controls_DOWN	NA	447020	1678	1485	39948	86331
bsdb:24/1/1_chronic-fatigue-syndrome:Chronic-Fatigue-patients_vs_Healthy-controls_UP	NA	331654	816	194	848	1378
bsdb:24/1/2_chronic-fatigue-syndrome:Chronic-Fatigue-patients_vs_Healthy-controls_DOWN	NA	29465	724	836	475	286
bsdb:25/1/1_psoriasis:Psoriasis-Male_vs_Female_UP	NA	1301	150022	165779	29465	360541	1716	43668	32207	33882	57495	1016	469	36739	171412
bsdb:25/1/2_psoriasis:Psoriasis-Male_vs_Female_DOWN	NA	1578	1743	2701	212791	1696
bsdb:26/1/1_sex-design:female_vs_male_UP	NA	35832
bsdb:26/2/1_obesity:BMI->33-female_vs_male_UP	NA	816
bsdb:27/1/1_obesity:foster-mother-wild-type-pre-HFD_vs_foster-mother-fat1-pre-HFD_UP	NA	1485	191303	2740	946234	574697	580596	375288
bsdb:27/1/2_obesity:foster-mother-wild-type-pre-HFD_vs_foster-mother-fat1-pre-HFD_DOWN	NA	816	239759	397864	209	283168	872	174708	28138	1331051
bsdb:27/2/1_obesity:foster-mother-wild-type-post-HFD_vs_foster-mother-fat1-post-HFD_UP	NA	172900	256846	1485	28138	244127	459786	946234	1578	2740	574697	375288
bsdb:27/2/2_obesity:foster-mother-wild-type-post-HFD_vs_foster-mother-fat1-post-HFD_DOWN	NA	209	816	283168	1331051
bsdb:28/1/1_chronic-fatigue-syndrome:CFS-cases_vs_Healthy-controls_UP	NA	119852	84111	1357	244127	100883
bsdb:28/1/2_chronic-fatigue-syndrome:CFS-cases_vs_Healthy-controls_DOWN	NA	2740	724	1380	1485	216851	1263	416916	1678	102106	40544
bsdb:29/1/1_unipolar-depression:Active-Major-Depressive-Disorder_vs_Healthy-Controls_UP	NA	946234	574697	375288	239759
bsdb:29/1/2_unipolar-depression:Active-Major-Depressive-Disorder_vs_Healthy-Controls_DOWN	NA	216851	39948	1263	724	561	620
bsdb:29/2/1_unipolar-depression:Responded-Major-Depressive-Disorder_vs_Healthy-Controls_UP	NA	574697
bsdb:29/2/2_unipolar-depression:Responded-Major-Depressive-Disorder_vs_Healthy-Controls_DOWN	NA	1263	724	1485
bsdb:30/1/1_chronic-fatigue-syndrome:Norweigan-controls_vs_Belgian-controls_UP	NA	841	61170
bsdb:30/1/2_chronic-fatigue-syndrome:Norweigan-controls_vs_Belgian-controls_DOWN	NA	816	239759	397864	838	375288
bsdb:30/2/1_chronic-fatigue-syndrome:Norweigan-CFS/ME-patients_vs_Norweigan-controls_UP	NA	239759	420345
bsdb:30/2/2_chronic-fatigue-syndrome:Norweigan-CFS/ME-patients_vs_Norweigan-controls_DOWN	NA	841	61170	39948	84036
bsdb:30/3/1_chronic-fatigue-syndrome:Belgian-CFS/ME-patients_vs_Belgian-controls_UP	NA	420345
bsdb:30/3/2_chronic-fatigue-syndrome:Belgian-CFS/ME-patients_vs_Belgian-controls_DOWN	NA	553372
bsdb:31/1/1_chronic-fatigue-syndrome:CFS/ME-patients_vs_controls_UP	NA	207244	1485	100883	1017280
bsdb:31/1/2_chronic-fatigue-syndrome:CFS/ME-patients_vs_controls_DOWN	NA	33042	189330	216851	1378	724	841
bsdb:31/2/1_chronic-fatigue-syndrome:CFS/ME-patients-with-IBS_vs_controls_UP	NA	1485	207244
bsdb:31/2/2_chronic-fatigue-syndrome:CFS/ME-patients-with-IBS_vs_controls_DOWN	NA	33042	189330	216851	841
bsdb:31/3/1_chronic-fatigue-syndrome:CFS/ME-patients-without-IBS_vs_controls_UP	NA	1485	100883	84111	1017280	286
bsdb:31/3/2_chronic-fatigue-syndrome:CFS/ME-patients-without-IBS_vs_controls_DOWN	NA	189330
bsdb:32/1/2_anorexia-nervosa:Aonerxia-Nervosa-patients_vs_Controls_DOWN	NA	1263	841	1485
bsdb:34/1/2_bipolar-disorder:Bipolar-disorder_vs_Controls_DOWN	NA	216851
bsdb:34/2/1_bipolar-disorder:Bipolar-patients-with-high-IL-6_vs_low-IL-6_UP	NA	1578	1301
bsdb:34/4/1_bipolar-disorder:Bipolar-patients-with-high-LDL_vs_low-LDL_DOWN	NA	838
bsdb:34/5/1_bipolar-disorder:Bipolar-patients-with-high-TRP_vs_low-TRP_UP	NA	1578
bsdb:34/6/1_bipolar-disorder:Bipolar-patients-with-high-TBARS-level_vs_low-TBARS-level_UP	NA	1730
bsdb:34/7/1_bipolar-disorder:Bipolar-patients-with-high-MDA-level_vs_low-MDA-level_DOWN	NA	216851
bsdb:34/8/1_bipolar-disorder:Bipolar-patients-with-high-BMI_vs_low-BMI_UP	NA	1578
bsdb:34/9/1_bipolar-disorder:Bipolar-patients-with-metabolic-syndrome_vs_no-metabolic-syndrome_UP	NA	1578
bsdb:34/10/2_bipolar-disorder:Bipolar-patients-with-depressive-syndrome_vs_healthier-bipolar-patients_DOWN	NA	841
bsdb:34/11/2_bipolar-disorder:Bipolar-disorder_vs_Controls_DOWN	NA	216851
bsdb:35/1/1_Sjogren-syndrome:PSS_vs_Controls_UP	NA	29465
bsdb:35/1/2_Sjogren-syndrome:PSS_vs_Controls_DOWN	NA	1654	724	482	32207	836	1257
bsdb:36/1/1_obesity:obese-adolescent_vs_control-adult_UP	NA	1654
bsdb:36/1/2_obesity:obese-adolescent_vs_control-adult_DOWN	NA	119852
bsdb:36/2/1_obesity:obese-adult_vs_contorl-adolescent_UP	NA	1301
bsdb:36/2/2_obesity:obese-adult_vs_contorl-adolescent_DOWN	NA	119852
bsdb:36/3/1_obesity:control-adolescent_vs_control-adult_UP	NA	119852
bsdb:36/3/2_obesity:control-adolescent_vs_control-adult_DOWN	NA	1301
bsdb:36/4/1_obesity:obese-adolescent_vs_obese-adult_UP	NA	1654	447020
bsdb:36/5/1_obesity:obese-adolescent_vs_control-adolescent_UP	NA	1654	447020	1301
bsdb:36/5/2_obesity:obese-adolescent_vs_control-adolescent_DOWN	NA	119852
bsdb:37/1/1_colorectal-cancer:CRC-patients_vs_Healthy-controls_UP	NA	165779	194	1730	236752	848	1378	61170	32257	32067	283168	459786	375288	543311	1257	836	123375
bsdb:37/1/2_colorectal-cancer:CRC-patients_vs_Healthy-controls_DOWN	NA	1243	1301
bsdb:38/1/1_body-odor-measurement:head-of-teen-ager_vs_head-of-child_UP	NA	1912216
bsdb:38/1/2_body-odor-measurement:head-of-teen-ager_vs_head-of-child_DOWN	NA	55193	1279
bsdb:38/2/1_body-odor-measurement:teen-neck_vs_child-neck_UP	NA	1912216	55193
bsdb:38/2/2_body-odor-measurement:teen-neck_vs_child-neck_DOWN	NA	1279
bsdb:39/1/2_body-odor-measurement:youth-underarm-after-exercise_vs_youth-underarm-before_DOWN	NA	265
bsdb:39/2/1_body-odor-measurement:youth-Neck-before_vs_after-excercise_DOWN	NA	469
bsdb:39/3/1_body-odor-measurement:Children-underarm-before_vs_after-excercise_DOWN	NA	265
bsdb:39/4/1_body-odor-measurement:Children-Neck-before_vs_after-excercise_UP	NA	1279
bsdb:39/4/2_body-odor-measurement:Children-Neck-before_vs_after-excercise_DOWN	NA	1912216
bsdb:39/5/1_body-odor-measurement:teen-underarm-before_vs_after-excercise_DOWN	NA	265
bsdb:39/6/1_body-odor-measurement:teen-Neck-before_vs_after-excercise_DOWN	NA	469
bsdb:40/1/1_attention-deficit-hyperactivity-disorder:ADHD_vs_Controls_UP	NA	1678	84111	283168	375288	239759
bsdb:40/1/2_attention-deficit-hyperactivity-disorder:ADHD_vs_Controls_DOWN	NA	292632	1263	35829	33042
bsdb:41/1/1_psychosis:FIrst-episode-Psychosis_vs_Controls_UP	NA	2038	528	316625	56688	1578	53572	109262
bsdb:41/1/2_psychosis:FIrst-episode-Psychosis_vs_Controls_DOWN	NA	1163	96	35798
bsdb:42/1/1_extrahepatic-cholestasis:cholestasis-infants_vs_healthy-infants_UP	NA	1301	1350	1279	906	28100	158846
bsdb:42/1/2_extrahepatic-cholestasis:cholestasis-infants_vs_healthy-infants_DOWN	NA	1678	816	572511	216851	841	207244	102106
bsdb:43/1/1_Behcet's-syndrome:behcet's-disease_vs_controls_UP	NA	1283313
bsdb:43/2/1_Behcet's-syndrome:immunosuppressant-users_vs_non-immunosuppressent-users-among-behcet's-patients_UP	NA	59735	838
bsdb:44/1/2_obesity:pediatric-obese_vs_controls_DOWN	NA	816
bsdb:45/1/1_obesity:Rats-fed--HFHS_vs_control-rats_UP	NA	572511	1678	33024	174708
bsdb:46/1/1_obesity:pediatric-obese_vs_controls_DOWN	NA	816	838
bsdb:46/1/2_obesity:pediatric-obese_vs_controls_DOWN	NA	838
bsdb:47/1/1_obesity:low_vs_high-dietary-fiber_UP	NA	1263
bsdb:47/2/2_obesity:low_vs_hight-moderate-to-vigrous-physical-activity_DOWN	NA	189330	28050	577309
bsdb:48/1/1_obesity:obese-adolescent_vs_control-adolescent_UP	NA	838
bsdb:48/1/2_obesity:obese-adolescent_vs_control-adolescent_DOWN	NA	816	239759	216851	459786
bsdb:48/2/1_obesity:high-BMI-zscore_vs_low-BMI-zscores_UP	NA	838
bsdb:48/2/2_obesity:high-BMI-zscore_vs_low-BMI-zscores_DOWN	NA	816	239759
bsdb:48/3/1_obesity:high-triglycerides_vs_low-triglycerides_UP	NA	838
bsdb:48/3/2_obesity:high-triglycerides_vs_low-triglycerides_DOWN	NA	816
bsdb:48/4/1_obesity:high-total-cholesterol_vs_low-total-cholesterol_DOWN	NA	816
bsdb:48/5/1_obesity:high-HDL-C_vs_low-HDL-C_UP	NA	816
bsdb:48/6/1_obesity:high-senstive-C-reactive-protein_vs_low-sensetive-C-reactive-protein_UP	NA	838
bsdb:48/6/2_obesity:high-senstive-C-reactive-protein_vs_low-sensetive-C-reactive-protein_DOWN	NA	816	459786
bsdb:49/1/1_obesity:Obesity-group_vs_controls_UP	NA	43996	117563	86331	1257	838	123375
bsdb:49/1/2_obesity:Obesity-group_vs_controls_DOWN	NA	724	2717	1016	47670	1716	1279	40323
bsdb:50/1/1_colorectal-cancer:Colrectal-cancer-patients_vs_healthy-controls_UP	NA	836	561	620	1350	1301	1257
bsdb:50/1/2_colorectal-cancer:Colrectal-cancer-patients_vs_healthy-controls_DOWN	NA	816	841	239759	1730	577310
bsdb:51/1/1_colorectal-cancer:Carcinoma-patients_vs_postoperation-patients_UP	NA	1578	838	150022	48736	1380	404402	1283313	1716	135858	1573535	543311	286	1378	1257	836	46255	117563	1654
bsdb:51/1/2_colorectal-cancer:Carcinoma-patients_vs_postoperation-patients_DOWN	NA	32067	196082	1678	33882	1847725	1573534	40544	28050	1506577	570
bsdb:51/2/1_colorectal-cancer:NDA(new-dev.-adenoma)_vs_CIT(cleain-intestine)_UP	NA	46123	1380	581	838	123375
bsdb:51/2/2_colorectal-cancer:NDA(new-dev.-adenoma)_vs_CIT(cleain-intestine)_DOWN	NA	574697	1263	1485	33042	150022	437755	459786	872	244127
bsdb:52/1/1_substance-related-disorder:Substance-use-disorder-patients_vs_Healthy-controls_UP	NA	838	265	1485	33057
bsdb:52/1/2_substance-related-disorder:Substance-use-disorder-patients_vs_Healthy-controls_DOWN	NA	35832	189330	375288	1301	207244	906	1407607	239759	204475	816	1263
bsdb:52/2/1_substance-related-disorder:Substance-use-disorder-patients_vs_adjusted-Healthy-controls_UP	NA	33057	265	838
bsdb:52/2/2_substance-related-disorder:Substance-use-disorder-patients_vs_adjusted-Healthy-controls_DOWN	NA	207244	375288	204475	35832	1301	906	1407607
bsdb:55/1/1_stimulus-or-stress-design:grid-floor-induced-stress_vs_control_UP	NA	283168	239759
bsdb:56/1/1_type-ii-diabetes-mellitus:Healthy-baby-meconium_vs_adult-stool_UP	NA	283	561	570	583	620
bsdb:56/2/1_gestational-diabetes:Baby-meconium-with-GDM-mothers_vs_Healthy-baby-meconium_DOWN	NA	507	106589	283	80865	40323
bsdb:56/3/1_type-ii-diabetes-mellitus:Baby-meconium-with-DM-mothers_vs_Healthy-baby-meconium_UP	NA	904	267408	1380	1678	574697	135858	102106	33042	39948	189330	156973	1730	1378	2053	61170	57493	33882	88138	459786	375288	162291	836	838	841	125216	1263	191303
bsdb:57/1/1_irritable-bowel-syndrome:irritable-bowel-syndrome_vs_control_UP	NA	838	1485	79206	1257	507	32008	482
bsdb:57/1/2_irritable-bowel-syndrome:irritable-bowel-syndrome_vs_control_DOWN	NA	1716	1743	1301	13687	286
bsdb:57/2/1_irritable-bowel-syndrome:overweight-irritable-bowel-syndrome_vs_control_UP	NA	1716	1678	1380	133925	1386	162291	1578	113286	265975	177971	39948	906	970	92793	80865	194	286	157	838	1279
bsdb:57/2/2_irritable-bowel-syndrome:overweight-irritable-bowel-syndrome_vs_control_DOWN	NA	396388	59732	109244	670486	1378	1301	482	724	838	1279
bsdb:58/1/1_high-fat-diet:newborns-of-maternal-high-fat-diet_vs_nebowrns-of-maternal-control_UP	NA	1357	117563	1350
bsdb:58/1/2_high-fat-diet:newborns-of-maternal-high-fat-diet_vs_nebowrns-of-maternal-control_DOWN	NA	40544	375288	816	283
bsdb:58/2/1_high-fat-diet:6-months-babies-of-maternal-high-fat-diet_vs_6-months-babies-control_UP	NA	1301	561
bsdb:58/2/2_high-fat-diet:6-months-babies-of-maternal-high-fat-diet_vs_6-months-babies-control_DOWN	NA	816
bsdb:60/1/1_type-ii-diabetes-mellitus:Type-2-DM-cases_vs_controls_UP	NA	458839	111142	504481	255204
bsdb:60/1/2_type-ii-diabetes-mellitus:Type-2-DM-cases_vs_controls_DOWN	NA	92793	338	1847
bsdb:60/2/1_type-ii-diabetes-mellitus:Type-2-DM-cariers-of-pathogens_vs_carier-of-pathogens-controls_UP	NA	504481
bsdb:60/2/2_type-ii-diabetes-mellitus:Type-2-DM-cariers-of-pathogens_vs_carier-of-pathogens-controls_DOWN	NA	816
bsdb:61/1/1_obesity:infants-of-overweight-mothers_vs_infants-of-normal-weight-mother-at-age-1-month_DOWN	NA	816	838
bsdb:61/3/1_obesity:infants-of-excessive-maternal-weight-gain-mothers_vs_infants-of-normal-maternal-weight-gain-mothers-at-age-1-month_DOWN	NA	816	838
bsdb:62/1/1_cesarean-section:C-section_vs_vaginal-delivery_DOWN	NA	1578
bsdb:63/2/1_cesarean-section:C-section-delivery_vs_vaginal-delivery-after-3-months-of-delivery_DOWN	NA	1578
bsdb:64/1/2_periodontitis:periodontitis_vs_No-Periodontitis-within-negative-diabetic-background-only_DOWN	NA	416916	32067
bsdb:64/4/1_periodontitis:periodontitis_vs_No-Periodontitis-within-positive-diabetic-background-only_UP	NA	32067
bsdb:64/4/2_periodontitis:periodontitis_vs_No-Periodontitis-within-positive-diabetic-background-only_DOWN	NA	29465	482
bsdb:65/1/1_type-ii-diabetes-mellitus:Diabetic_vs_Non-diabetic_UP	NA	416916	482	1378	538	1654	1016	848	29465	1301	970
bsdb:65/1/2_type-ii-diabetes-mellitus:Diabetic_vs_Non-diabetic_DOWN	NA	1730	44259	836	195950	157
bsdb:66/1/1_neonatal-jaundice:cesarean-infants-with-jaundice_vs_control_UP	NA	106589
bsdb:66/2/2_neonatal-jaundice:infants-with-jaundice_vs_control_DOWN	NA	1301
bsdb:67/2/1_autism:autistic_vs_neurotypical_UP	NA	1578	102106	1716	189330
bsdb:67/2/2_autism:autistic_vs_neurotypical_DOWN	NA	239759	39948	375288	29465	35832
bsdb:67/3/1_autism:constipated-autistic_vs_non-constipated-autistic_UP	NA	561	620	1485
bsdb:67/4/1_autism:constipated-neurotypical_vs_non-constipated-neurotypical_DOWN	NA	204475
bsdb:68/1/1_obesity:obese_vs_normal-weight_UP	NA	35832	572511	1485	33042	140625	1578	1263	1301
bsdb:68/1/2_obesity:obese_vs_normal-weight_DOWN	NA	1485	33042	51514	189330	119852	375288
bsdb:68/2/1_obesity:overweight_vs_normal-weight_UP	NA	816	1578	1301	1485	572511	140625	1263	35832
bsdb:68/2/2_obesity:overweight_vs_normal-weight_DOWN	NA	51514	119852	375288
bsdb:68/3/1_obesity:obese-men_vs_normal-weight-men_UP	NA	1578	1301	572511
bsdb:68/3/2_obesity:obese-men_vs_normal-weight-men_DOWN	NA	1716	51514	1263
bsdb:68/4/1_obesity:overweight-men_vs_normal-weight-men_UP	NA	816	1578	1301	572511	33042	140625
bsdb:68/4/2_obesity:overweight-men_vs_normal-weight-men_DOWN	NA	1716	51514	150022	906	1263
bsdb:68/5/1_obesity:obese-women_vs_normal-weight-women_UP	NA	1301	140625	1263
bsdb:68/5/2_obesity:obese-women_vs_normal-weight-women_DOWN	NA	51514
bsdb:68/6/1_obesity:overweight-women_vs_normal-weight-women_UP	NA	1301	1263	140625
bsdb:69/1/1_sex-design:female_vs_male_UP	NA	1263
bsdb:69/2/1_obesity:female-obese_vs_female-normal-weight_DOWN	NA	33024
bsdb:69/3/1_obesity:male-obese_vs_male-normal-weight_UP	NA	574697	848
bsdb:69/4/1_obesity:obese_vs_normal-weight_UP	NA	848
bsdb:70/1/1_obesity:pediatric-obese_vs_pediatric-normal-weight_UP	NA	39948	816	838
bsdb:70/1/2_obesity:pediatric-obese_vs_pediatric-normal-weight_DOWN	NA	207244	40544	816
bsdb:70/2/2_obesity:female-pediatric-obese_vs_female-pediatric-normal-weight_DOWN	NA	283168
bsdb:71/1/1_cesarean-section:C-section_vs_vaginal-delivery_UP	NA	1243	909928	2737	830
bsdb:71/2/1_premature-birth:infants-<33-weeks-gestational-age_vs_>/=33-weeks_UP	NA	1386	1279	1350	2737	1578	1243	1485	29465	909928	1678	547	544	551	570	160674	53335	29487	195950
bsdb:71/2/2_premature-birth:infants-<33-weeks-gestational-age_vs_>/=33-weeks_DOWN	NA	223927
bsdb:72/1/2_autism:autism_vs_typically-developing-controls_DOWN	NA	1301	29465	561	1654	543311	118747	162289
bsdb:73/1/1_obesity:obese_vs_normal-weight_UP	NA	216851	841	28050	33042
bsdb:73/1/2_obesity:obese_vs_normal-weight_DOWN	NA	816
bsdb:73/2/1_obesity:obese-+-metabolic-syndrome_vs_normal-weight_UP	NA	216851	841	28050	33042
bsdb:73/2/2_obesity:obese-+-metabolic-syndrome_vs_normal-weight_DOWN	NA	816
bsdb:74/1/2_obesity:obese_vs_non-obese_DOWN	NA	239759	195950
bsdb:74/2/2_obesity:obese_vs_Nonobese-microbiota-cluster_DOWN	NA	239759
bsdb:74/3/1_obesity:high-BMI_vs_low-BMI_UP	NA	55079	1678	662	629
bsdb:74/3/2_obesity:high-BMI_vs_low-BMI_DOWN	NA	239759	195950
bsdb:74/4/1_obesity:high-C-Reactive-Protein_vs_low-C-Reactive-Protein_UP	NA	55079
bsdb:74/4/2_obesity:high-C-Reactive-Protein_vs_low-C-Reactive-Protein_DOWN	NA	239759	195950
bsdb:75/1/1_smoking-behavior:right-oropharynx-of-smokers_vs_right-oropharynx-of-nonsmokers_UP	NA	1016	1257	848	12916	724	482
bsdb:75/1/2_smoking-behavior:right-oropharynx-of-smokers_vs_right-oropharynx-of-nonsmokers_DOWN	NA	906	29465	52228	1301
bsdb:75/2/1_smoking-behavior:left-oropharynx-of-smokers_vs_left-oropharynx-of-nonsmokers_UP	NA	1016	848	482	416916
bsdb:75/2/2_smoking-behavior:left-oropharynx-of-smokers_vs_left-oropharynx-of-nonsmokers_DOWN	NA	1654	84111	906	29465	34104
bsdb:75/3/1_smoking-behavior:right-nasopharynx-of-smokers_vs_right-nasopharynx-of-nonsmokers_UP	NA	1654	1243	469	407217	620	349
bsdb:75/3/2_smoking-behavior:right-nasopharynx-of-smokers_vs_right-nasopharynx-of-nonsmokers_DOWN	NA	84111	189330	1730	46123	174708	109326	33042	150022	1378	84036	52784
bsdb:75/4/1_smoking-behavior:left-nasopharynx-of-smokers_vs_left-nasopharynx-of-nonsmokers_UP	NA	237	1647	1378	620	40544
bsdb:75/4/2_smoking-behavior:left-nasopharynx-of-smokers_vs_left-nasopharynx-of-nonsmokers_DOWN	NA	84111	836	46123	52784	109326	189330	1730	841	84036	194	724	40323
bsdb:76/1/1_type-I-diabetes-mellitus:type-I-diabetes-mellitus-children_vs_controls_UP	NA	572511	904
bsdb:76/1/2_type-I-diabetes-mellitus:type-I-diabetes-mellitus-children_vs_controls_DOWN	NA	39948	724	1392389
bsdb:77/1/2_bipolar-disorder:atypical-antipsychotic-users_vs_non-users_DOWN	NA	239934
bsdb:78/1/1_stimulus-or-stress-design:limited-nesting-stress_vs_controls_UP	NA	1350	1301	2740	1375	227979	66831	1485	1716	872	117563	32207	583	100883	1357	191303	2316
bsdb:78/1/2_stimulus-or-stress-design:limited-nesting-stress_vs_controls_DOWN	NA	1263	841	33042	1573535	1279	375288	28050	244127	724	283168
bsdb:79/1/1_obesity:Laparoscopic-sleeve-gastrectomy-baseline_vs_Laparoscopic-sleeve-gastrectomy-after-3-months-and-6-Months-combined_UP	NA	33042	189330	1263
bsdb:79/2/1_obesity:Very-low-calorie-diet-baseline_vs_very-low-calorie-diet-after-3-months-and-6-months_DOWN	NA	100883	1350	61170	1578	265975	1263
bsdb:80/1/1_type-I-diabetes-mellitus:Type-I-diabetic-children-at-onset_vs_controls_UP	NA	816
bsdb:80/1/2_type-I-diabetes-mellitus:Type-I-diabetic-children-at-onset_vs_controls_DOWN	NA	838	904	158846
bsdb:83/1/1_obesity:before-surgery_vs_after-surgery_UP	NA	207244	33042	216851	209	5782	40637
bsdb:83/1/2_obesity:before-surgery_vs_after-surgery_DOWN	NA	544	547	590	29465	5140
bsdb:85/1/1_cesarean-section:two-day-aged-babies-c-section_vs_vaginal-delivery_UP	NA	570	1266
bsdb:85/2/1_cesarean-section:two-day-aged-babies-c-section_vs_vaginal-delivery_DOWN	NA	816
bsdb:85/3/1_cesarean-section:seven-day-aged-babies-c-section_vs_vaginal-delivery_UP	NA	570	1266
bsdb:85/4/1_cesarean-section:seven-day-aged-babies-c-section_vs_vaginal-delivery_DOWN	NA	816	102106
bsdb:86/1/1_cesarean-section:c-section_vs_vaginal-delivery-at-day-3_UP	NA	1279	1578
bsdb:86/3/1_cesarean-section:c-section_vs_vaginal-delivery-at-day-28_DOWN	NA	816
bsdb:86/4/1_cesarean-section:c-section_vs_vaginal-delivery-at-day-150_DOWN	NA	816
bsdb:86/7/1_cesarean-section:overall-time-point-infants-samples-of-c-section_vs_vaginal-delivery_UP	NA	239934	207244	1485	39948	547	1350	946234	1378	724	1578	1743	32207	1279	1301
bsdb:86/7/2_cesarean-section:overall-time-point-infants-samples-of-c-section_vs_vaginal-delivery_DOWN	NA	375288	816	239759
bsdb:87/1/1_type-I-diabetes-mellitus:Type-I-Diabetics_vs_maturity-onset-diabetes-of-the-young-2-(MODY2)-and-healthy-Controls_UP	NA	572511	816	29465	1263	1301	547	40544
bsdb:87/2/1_type-I-diabetes-mellitus:Type-I-Diabetics-and-maturity-onset-diabetes-of-the-young-2-(MODY2)_vs_healthy-Controls_DOWN	NA	28050	841	207244	216851
bsdb:88/1/1_schizophrenia:schizophrenia_vs_non-psychiatric-controls_UP	NA	165779	906	572511
bsdb:88/1/2_schizophrenia:schizophrenia_vs_non-psychiatric-controls_DOWN	NA	724	40544	1485
bsdb:89/1/1_Crohn's-disease:CD-patients_vs_Healthy-controls_UP	NA	1654	1678
bsdb:89/1/2_Crohn's-disease:CD-patients_vs_Healthy-controls_DOWN	NA	698776	1730	61170	375288	841	1017280	292632
bsdb:90/1/1_cesarean-section:transitional-stool_vs_mecomium-in-vaginal-delivery_UP	NA	209
bsdb:90/1/2_cesarean-section:transitional-stool_vs_mecomium-in-vaginal-delivery_DOWN	NA	469	70774	1301	13687	1716	42255	165695	129337	482	165779	407	29465	1269	1357	357	212791	29580	80865
bsdb:90/2/1_cesarean-section:transitional-stool_vs_mecomium-in-C-section-delivery_UP	NA	29465	1350
bsdb:90/2/2_cesarean-section:transitional-stool_vs_mecomium-in-C-section-delivery_DOWN	NA	286	400634	1716	1301	106589	32067	1654	848	13687	42255	2745	157	724	41275	2717	165695
bsdb:91/1/1_cesarean-section:C-section_vs_vaginal-delivery_UP	NA	1386	1298	1730	216851	40323
bsdb:91/1/2_cesarean-section:C-section_vs_vaginal-delivery_DOWN	NA	1743	283	286
bsdb:92/2/1_non-alcoholic-fatty-liver-disease:non-alcoholic-fatty-liver-disease-patients_vs_healthy-controls_UP	NA	838
bsdb:92/3/1_non-alcoholic-fatty-liver-disease:non-alcoholic-fatty-liver-disease-patients_vs_obese-without-non-alcoholic-fatty-liver-disease_UP	NA	838
bsdb:93/1/1_cesarean-section:C-section_vs_vaginal-delivery_DOWN	NA	1279
bsdb:93/2/1_cesarean-section:Antimicrobials-use-during-delivery-yes_vs_no_UP	NA	1678
bsdb:93/3/1_cesarean-section:Maternal-consumption-of-probiotics-yes_vs_no_UP	NA	1578
bsdb:93/4/1_cesarean-section:Furry-pets-at-home-yes_vs_no_UP	NA	216851
bsdb:93/4/2_cesarean-section:Furry-pets-at-home-yes_vs_no_DOWN	NA	1279
bsdb:95/1/1_obesity:overweight/obese-babies_vs_control-babies-at-the-age-of-3_UP	NA	189330	841
bsdb:95/1/2_obesity:overweight/obese-babies_vs_control-babies-at-the-age-of-3_DOWN	NA	375288
bsdb:96/1/1_obesity:obese_vs_controls_UP	NA	239759	165779	33042	848	543311
bsdb:96/1/2_obesity:obese_vs_controls_DOWN	NA	816	872	216851	150022	1164882	133925	292632
bsdb:97/2/1_obesity:Roux-en-Y-gastric-bypass-(RYGB)_vs_healthy-controls_UP	NA	1678	906
bsdb:97/3/1_obesity:obese-patients-three-months-after-Sleeve-gastrectomy-SG3_vs_obese-patients-prior-to-Sleeve-gastrectomy-SG0_DOWN	NA	239759	1301
bsdb:97/4/1_obesity:obese-patients-3-moths-after-Roux-en-Y-gastric-bypass-RYGB3_vs_patients-prior-to-Roux-en-Y-gastric-bypass-RYGB0_UP	NA	216851
bsdb:97/4/2_obesity:obese-patients-3-moths-after-Roux-en-Y-gastric-bypass-RYGB3_vs_patients-prior-to-Roux-en-Y-gastric-bypass-RYGB0_DOWN	NA	1301
bsdb:98/1/1_chronic-kidney-disease:CKD_vs_controls_UP	NA	469	1386	81	445	68	1664383	286	504481	613	629
bsdb:98/1/2_chronic-kidney-disease:CKD_vs_controls_DOWN	NA	1705353	911113	1716	1210119	265	13687	40323	1506577
bsdb:99/1/2_obesity:obese_vs_controls_DOWN	NA	816	239759
bsdb:100/1/1_obesity:High-BMI_vs_low-BMI_UP	NA	613	838
bsdb:100/2/1_obesity:Abdominal-obesity_vs_non-abdominal-obesity_UP	NA	613	838
bsdb:100/2/2_obesity:Abdominal-obesity_vs_non-abdominal-obesity_DOWN	NA	119852
bsdb:101/1/1_obesity:obese_vs_lean-controls_UP	NA	1578
bsdb:102/1/1_type-ii-diabetes-mellitus:Women-with-gestational-DM_vs_normoglycemic-controls_UP	NA	838	1263
bsdb:102/1/2_type-ii-diabetes-mellitus:Women-with-gestational-DM_vs_normoglycemic-controls_DOWN	NA	572511	239759
bsdb:103/1/1_unipolar-depression:depressed-female_vs_Healthy-Controls_UP	NA	572511	1654	1678	553372	1380	84111	644652	133925	1730	207244	841	216851	872
bsdb:103/1/2_unipolar-depression:depressed-female_vs_Healthy-Controls_DOWN	NA	404402	40544	638847
bsdb:103/2/1_unipolar-depression:depressed-male_vs_Healthy-Controls_UP	NA	1380	816	29465
bsdb:103/2/2_unipolar-depression:depressed-male_vs_Healthy-Controls_DOWN	NA	644652	109326	638847
bsdb:104/1/1_unipolar-depression:major-depressive-disoreder-(visit-1)_vs_healthy-controls_UP	NA	838	570	1301
bsdb:104/2/1_unipolar-depression:major-depressive-disoreder-(visit-2)_vs_healthy-controls_UP	NA	838	1301
bsdb:105/1/1_unipolar-depression:bipolar_vs_healthy-controls_DOWN	NA	216851
bsdb:106/1/1_bipolar-disorder:bipolar_vs_healthy-controls_UP	NA	946234
bsdb:107/1/2_anorexia-nervosa:anorexia_vs_healthy-controls_DOWN	NA	207244	216851
bsdb:107/2/1_anorexia-nervosa:anorexia_vs_healthy-controls_UP	NA	375288
bsdb:108/1/1_anorexia-nervosa:anorexia-nervosa-patients_vs_healthy-controls_DOWN	NA	1301
bsdb:109/1/1_anorexia-nervosa:anorexia-patients-before-weight-gain_vs_normal-weight-participants_UP	NA	207244	244127	1678	1485
bsdb:109/1/2_anorexia-nervosa:anorexia-patients-before-weight-gain_vs_normal-weight-participants_DOWN	NA	204475	841
bsdb:109/2/1_anorexia-nervosa:anorexia-patients-after-weight-gain_vs_HC_UP	NA	207244	1678	1578	1357	1017280	1263	44748	1485
bsdb:109/2/2_anorexia-nervosa:anorexia-patients-after-weight-gain_vs_HC_DOWN	NA	816	1485
bsdb:110/1/1_schizophrenia:schizophrenia_vs_healthy-controls_DOWN	NA	1678	1578
bsdb:111/1/1_attention-deficit-hyperactivity-disorder:ADHD_vs_healthy-control_UP	NA	40323	469	1473205	100883	990721	1573534	1505652
bsdb:111/1/2_attention-deficit-hyperactivity-disorder:ADHD_vs_healthy-control_DOWN	NA	1506553	39948
bsdb:112/1/1_attention-deficit-hyperactivity-disorder:ADHD-males_vs_controls_UP	NA	482	816
bsdb:112/1/2_attention-deficit-hyperactivity-disorder:ADHD-males_vs_controls_DOWN	NA	838	375288
bsdb:113/1/1_unipolar-depression:MDD_vs_controls_DOWN	NA	1678
bsdb:114/1/1_unipolar-depression:MDD_vs_controls_UP	NA	846	543311	118747	286	1257	1378
bsdb:114/1/2_unipolar-depression:MDD_vs_controls_DOWN	NA	216851	33042	572511	189330
bsdb:115/1/1_unipolar-depression:MDD_vs_controls_UP	NA	1485	1678	459786	1301	970	906	904	838
bsdb:115/1/2_unipolar-depression:MDD_vs_controls_DOWN	NA	816	283168	195950
bsdb:115/2/1_bipolar-disorder:bipolar_vs_healthy-controls_DOWN	NA	816	283168	195950
bsdb:116/1/1_type-I-diabetes-mellitus:children-with-type-1-diabetes_vs_healthy-controls_UP	NA	1485	816	29465
bsdb:116/1/2_type-I-diabetes-mellitus:children-with-type-1-diabetes_vs_healthy-controls_DOWN	NA	838	1678	1578
bsdb:117/1/1_pneumonia:elderly-pneumonia-patients_vs_elderly-controls_UP	NA	1578	32207
bsdb:117/1/2_pneumonia:elderly-pneumonia-patients_vs_elderly-controls_DOWN	NA	32067	196082
bsdb:117/2/1_pneumonia:adult-pneumonia-patients_vs_adult-controls_UP	NA	1578	32207
bsdb:117/2/2_pneumonia:adult-pneumonia-patients_vs_adult-controls_DOWN	NA	724	32067	482
bsdb:118/1/1_cesarean-section:cesarean-born_vs_vaginal-born-children_UP	NA	1578
bsdb:118/1/2_cesarean-section:cesarean-born_vs_vaginal-born-children_DOWN	NA	1678
bsdb:118/2/1_cesarean-section:cesarean-born-and-mixed-fed_vs_cesarean-born-and-breastfed_UP	NA	29465	1350
bsdb:118/2/2_cesarean-section:cesarean-born-and-mixed-fed_vs_cesarean-born-and-breastfed_DOWN	NA	1506577	838	216851
bsdb:119/1/1_type-ii-diabetes-mellitus:Metaformin-positive_vs_Metaformin-negative-among-Opoid-negative_UP	NA	1678
bsdb:119/2/1_type-ii-diabetes-mellitus:Metaformin-positive_vs_Metaformin-negative-among-Opoid-positive_UP	NA	838
bsdb:119/2/2_type-ii-diabetes-mellitus:Metaformin-positive_vs_Metaformin-negative-among-Opoid-positive_DOWN	NA	1678
bsdb:119/3/1_type-ii-diabetes-mellitus:Opoid-positive_vs_opoid-negative-among-Metaformin-negative_UP	NA	1678
bsdb:119/3/2_type-ii-diabetes-mellitus:Opoid-positive_vs_opoid-negative-among-Metaformin-negative_DOWN	NA	838
bsdb:120/1/1_physical-activity:Activity-Based-Anorexia-group_vs_exercise-group_UP	NA	838	1485	1350	816
bsdb:120/1/2_physical-activity:Activity-Based-Anorexia-group_vs_exercise-group_DOWN	NA	816	1678	1578
bsdb:120/2/1_physical-activity:Ad-libitum-group_vs_exercise-group_UP	NA	816	838	1350	1485
bsdb:120/2/2_physical-activity:Ad-libitum-group_vs_exercise-group_DOWN	NA	1678	1578
bsdb:121/1/1_gingivitis:gingivitis_vs_healthy-controls_UP	NA	836	195950	157
bsdb:121/1/2_gingivitis:gingivitis_vs_healthy-controls_DOWN	NA	1016
bsdb:122/1/1_breast-carcinoma:tumor-tissue_vs_normal-tissue_UP	NA	237	407
bsdb:122/1/2_breast-carcinoma:tumor-tissue_vs_normal-tissue_DOWN	NA	13687	914	374
bsdb:123/1/1_diet:high-fat-diet_vs_low-fat-diet_UP	NA	1357	117563	1486725	109326	1485	33042	1730	216851	946234	119852	100175	1017280	44748	1506577	1505663	61170	32207	447020	102106
bsdb:123/1/2_diet:high-fat-diet_vs_low-fat-diet_DOWN	NA	544	397864	816	588605
bsdb:124/1/2_diet:body-builders-(high-protein)_vs_distance-runners-(high-carb)_DOWN	NA	1678	561	1357
bsdb:124/2/1_diet:body-builders-(high-protein)_vs_control_UP	NA	40544	216851	1485	724	1432051
bsdb:124/2/2_diet:body-builders-(high-protein)_vs_control_DOWN	NA	1678	577310	1243
bsdb:124/3/1_diet:distance-runners-(high-carb)_vs_control_UP	NA	40544
bsdb:124/3/2_diet:distance-runners-(high-carb)_vs_control_DOWN	NA	572511	547	46255	1243
bsdb:125/1/1_squamous-cell-carcinoma:Oral-Squamous-Cell-Cancer-patients_vs_noncancer-individuals_UP	NA	1257	848	1283313	1016
bsdb:125/1/2_squamous-cell-carcinoma:Oral-Squamous-Cell-Cancer-patients_vs_noncancer-individuals_DOWN	NA	32207	724
bsdb:126/1/1_Oral-leukoplakia:Oral-leukoplakia_vs_healthy-controls_UP	NA	724	1386
bsdb:126/1/2_Oral-leukoplakia:Oral-leukoplakia_vs_healthy-controls_DOWN	NA	1301	46123
bsdb:126/2/1_oral-squamous-cell-carcinoma:Oral-Squamous-Cell-Cancer-patients_vs_healthy-controls_UP	NA	724	1386
bsdb:126/2/2_oral-squamous-cell-carcinoma:Oral-Squamous-Cell-Cancer-patients_vs_healthy-controls_DOWN	NA	1301	46123
bsdb:126/3/1_Oral-leukoplakia:Oral-leukoplakia_vs_Oral-Squamous-Cell-Cancer-patients_UP	NA	724	1301
bsdb:126/3/2_Oral-leukoplakia:Oral-leukoplakia_vs_Oral-Squamous-Cell-Cancer-patients_DOWN	NA	1386
bsdb:127/1/1_alcohol-drinking:alcohol-overconsumers_vs_controls_UP	NA	1485	61170	40544
bsdb:127/1/2_alcohol-drinking:alcohol-overconsumers_vs_controls_DOWN	NA	216851
bsdb:127/2/1_alcohol-drinking:alcohol-overconsumers_vs_controls_UP	NA	904	118747	1485	2383	561	61170	570	158846	581	32207	40544
bsdb:127/2/2_alcohol-drinking:alcohol-overconsumers_vs_controls_DOWN	NA	447020	102106	216851	52225	283168	265975	838	1279	674963
bsdb:128/1/1_gastric-cancer:gastric-cancer_vs_intestinal-metaplasia_UP	NA	1283313	43996	39948	848	543311	1578	437755	2740	1257	838	84108	1301
bsdb:128/1/2_gastric-cancer:gastric-cancer_vs_intestinal-metaplasia_DOWN	NA	469	57739	378210	235572
bsdb:128/2/1_gastric-cancer:gastric-cancer_vs_atrophic-gastric_UP	NA	1301	1257	1378	848	543311	1578	1730	1283313	838	39948	84108	2740	43996	437755
bsdb:128/2/2_gastric-cancer:gastric-cancer_vs_atrophic-gastric_DOWN	NA	57739	235572
bsdb:128/3/1_gastric-cancer:gastric-cancer_vs_superficial-gastric_UP	NA	1283313	43996	39948	1730	848	1378	1578	437755	543311	2740	1257	838	84108	1301
bsdb:128/3/2_gastric-cancer:gastric-cancer_vs_superficial-gastric_DOWN	NA	47420	469	57739	378210	235572
bsdb:129/1/1_multiple-sclerosis:multiple-sclerosis_vs_healthy-controls_UP	NA	237	84567	572511	189330	13159	286
bsdb:129/1/2_multiple-sclerosis:multiple-sclerosis_vs_healthy-controls_DOWN	NA	102106	375288	100883	1578	724
bsdb:130/1/1_diet:high-Southern-European-Atlantic-Diet_vs_low-Southern-European-Atlantic-Diet_UP	NA	1678
bsdb:130/2/1_diet:intermediate-Southern-European-Atlantic-Diet_vs_low-Southern-European-Atlantic-Diet_UP	NA	1678
bsdb:130/5/1_diet:>-30-years-participants_vs_20-30-years-participants_UP	NA	1578
bsdb:130/6/2_diet:BMI->25_vs_BMI-<-20_DOWN	NA	1678
bsdb:130/7/1_diet:BMI-20-25_vs_BMI-<20_DOWN	NA	1678
bsdb:131/1/1_diet:Time-7-days_vs_Time-0-days-controls_DOWN	NA	119852
bsdb:131/2/2_diet:Time-7-days_vs_Time-0-days-Cara-Cara_DOWN	NA	283168
bsdb:131/4/1_diet:Cara-Cara_vs_controls-at-time-7_UP	NA	375288	189330	244127	574697
bsdb:131/5/1_diet:Bahia_vs_controls-at-time-7_UP	NA	447020	1350	1485	244127
bsdb:132/1/1_diet:Meat_vs_mushroom_UP	NA	189330
bsdb:132/1/2_diet:Meat_vs_mushroom_DOWN	NA	816	375288	33042	207244	40544
bsdb:134/1/1_diet:6-months-after-Average-Danish-Diet_vs_before-Average-Danish-Diet_UP	NA	872
bsdb:134/2/1_diet:6-months-after--New-Nordic-Diet_vs_before--New-Nordic-Diet_UP	NA	1485	872
bsdb:134/2/2_diet:6-months-after--New-Nordic-Diet_vs_before--New-Nordic-Diet_DOWN	NA	239759
bsdb:135/1/1_diet:High-animal-protein_vs_low-animal-protein_UP	NA	816
bsdb:136/1/2_diet:Low-vegetable,-fruit,-grains,_vs_high-vegetable,-fruit,-grain_DOWN	NA	1485	1730	459786
bsdb:136/2/1_diet:two-weeks-after-a-dietry-intervention_vs_before-dietary-intervention_UP	NA	84111	1357	1301	1350	1730	102106	1485	1678	572511
bsdb:136/2/2_diet:two-weeks-after-a-dietry-intervention_vs_before-dietary-intervention_DOWN	NA	872	39948	216851	1263	84108	29465
bsdb:137/1/1_colorectal-cancer:CRC_vs_controls_UP	NA	642	848
bsdb:137/1/2_colorectal-cancer:CRC_vs_controls_DOWN	NA	816	35832	544	413496	189330	1730	841
bsdb:138/1/1_lung-cancer:lung-cancer_vs_controls_UP	NA	1654	1380	1350	1505663	1573535	1392389	69965	160674
bsdb:138/1/2_lung-cancer:lung-cancer_vs_controls_DOWN	NA	447020	226	1678	102106	1348911	189330	28050	175304	437755	162289	1257	46205	1508657	40544
bsdb:139/1/2_head-and-neck-squamous-cell-carcinoma:HNSCC_vs_controls_DOWN	NA	1716	32257
bsdb:139/2/1_squamous-cell-carcinoma:Larynx-cancer-cases_vs_controls_DOWN	NA	46123	1016	1716	32257	482
bsdb:139/3/1_squamous-cell-carcinoma:Pharynx-cancer-cases_vs_controls_DOWN	NA	1716	32257
bsdb:139/4/1_squamous-cell-carcinoma:Oral-cavity-cancer-cases_vs_controls_UP	NA	1654
bsdb:140/1/1_multiple-sclerosis:multiple-sclerosis_vs_healthy-controls_UP	NA	2172	239934	84593
bsdb:140/1/2_multiple-sclerosis:multiple-sclerosis_vs_healthy-controls_DOWN	NA	574697
bsdb:140/2/1_multiple-sclerosis:multiple-sclerosis-patients_vs_controls_UP	NA	84593	2172	239934
bsdb:140/2/2_multiple-sclerosis:multiple-sclerosis-patients_vs_controls_DOWN	NA	574697
bsdb:140/3/1_multiple-sclerosis:untreated-multiple-sclerosis_vs_controls_UP	NA	239934	2735
bsdb:140/3/2_multiple-sclerosis:untreated-multiple-sclerosis_vs_controls_DOWN	NA	574697	838	40544
bsdb:140/4/1_multiple-sclerosis:untreated-multiple-sclerosis_vs_controls_UP	NA	239934	2172	2735
bsdb:140/4/2_multiple-sclerosis:untreated-multiple-sclerosis_vs_controls_DOWN	NA	574697	838	40544
bsdb:140/5/1_multiple-sclerosis:treated-multiple-sclerosis_vs_untreated-multiple-sclerosis_UP	NA	838	40544
bsdb:140/5/2_multiple-sclerosis:treated-multiple-sclerosis_vs_untreated-multiple-sclerosis_DOWN	NA	1266
bsdb:140/6/1_multiple-sclerosis:treated-multiple-sclerosis_vs_untreated-multiple-sclerosis_UP	NA	838
bsdb:140/6/2_multiple-sclerosis:treated-multiple-sclerosis_vs_untreated-multiple-sclerosis_DOWN	NA	1266
bsdb:141/1/1_preterm-premature-rupture-of-the-membranes:PPROM_vs_controls_UP	NA	165779	39948	162289	543311	43996	838	1301
bsdb:141/1/2_preterm-premature-rupture-of-the-membranes:PPROM_vs_controls_DOWN	NA	1578
bsdb:142/1/1_oral-squamous-cell-carcinoma:HNSCC_vs_Controls_UP	NA	1578	543311	1257	1279	1301	195950	29465
bsdb:142/1/2_oral-squamous-cell-carcinoma:HNSCC_vs_Controls_DOWN	NA	416916	47670	724	482	32067
bsdb:142/2/1_oral-squamous-cell-carcinoma:HPV-+_vs_HPV--_UP	NA	1578	1013
bsdb:142/2/2_oral-squamous-cell-carcinoma:HPV-+_vs_HPV--_DOWN	NA	538	482	32067
bsdb:142/3/1_oral-squamous-cell-carcinoma:chemotherapy-radiation-and-surgery_vs_surgery_UP	NA	1578
bsdb:142/3/2_oral-squamous-cell-carcinoma:chemotherapy-radiation-and-surgery_vs_surgery_DOWN	NA	724	416916	32067
bsdb:144/1/1_air-pollution:moderately-polluted-region-(B)_vs_lightly-poluuted-region-(A)_UP	NA	32207	265975	482	1654
bsdb:144/1/2_air-pollution:moderately-polluted-region-(B)_vs_lightly-poluuted-region-(A)_DOWN	NA	848	475	1257	836	838	29465
bsdb:144/2/2_air-pollution:heavily-polluted-region-(C)_vs_lightly-poluuted-region-(A)_DOWN	NA	194	1016	848	475	1257	836	838	29465
bsdb:144/3/2_air-pollution:heavily-polluted-region-(C)_vs_moderately-poluuted-region-(B)_DOWN	NA	32207	848	265975	1654	194	482
bsdb:146/1/1_oral-squamous-cell-carcinoma:oral-squamous-cell-carcinoma-(OSCC)_vs_Controls_UP	NA	2093	157	194	538	82202	1283313	848	970	39948	1257	44259	2740	43996	543311	1016
bsdb:146/1/2_oral-squamous-cell-carcinoma:oral-squamous-cell-carcinoma-(OSCC)_vs_Controls_DOWN	NA	906	1213720	117563	47670	29465	1301	196081	32207	1654
bsdb:147/1/1_squamous-cell-carcinoma:laryngeal-squamous-cell-carcinoma-(LSCC)_vs_controls_UP	NA	848	838	543311	1257	39948	43996	970	157	32008
bsdb:147/1/2_squamous-cell-carcinoma:laryngeal-squamous-cell-carcinoma-(LSCC)_vs_controls_DOWN	NA	1301	32207
bsdb:147/2/1_squamous-cell-carcinoma:Site-1-(upper-portion-of-throat-near-the-epiglottis)_vs_Site-2-(site-below-the-epiglottis-in-the-throat)_UP	NA	29465	32067	1654	32207	117563	906	265975	1380	437755
bsdb:147/2/2_squamous-cell-carcinoma:Site-1-(upper-portion-of-throat-near-the-epiglottis)_vs_Site-2-(site-below-the-epiglottis-in-the-throat)_DOWN	NA	848	838	543311	1257	836	39948	2093	44259	43996	538	157	416916
bsdb:148/1/1_polycystic-ovary-syndrome:NIR-PCOS_vs_HC_UP	NA	816	28050
bsdb:148/1/2_polycystic-ovary-syndrome:NIR-PCOS_vs_HC_DOWN	NA	838
bsdb:148/2/1_polycystic-ovary-syndrome:IR-PCOS_vs_HC_UP	NA	28050	816
bsdb:148/2/2_polycystic-ovary-syndrome:IR-PCOS_vs_HC_DOWN	NA	838
bsdb:148/3/1_polycystic-ovary-syndrome:NIR-PCOS_vs_IR-PCOS_UP	NA	816
bsdb:148/3/2_polycystic-ovary-syndrome:NIR-PCOS_vs_IR-PCOS_DOWN	NA	216851
bsdb:149/1/1_obesity:Obese_vs_controls_UP	NA	158846
bsdb:149/1/2_obesity:Obese_vs_controls_DOWN	NA	207244	459786	61170	816
bsdb:150/1/1_head-and-neck-carcinoma:Throat-cancer_vs_Healthy-controls_UP	NA	286	416916	216851	1508657	47670	909656	816
bsdb:150/1/2_head-and-neck-carcinoma:Throat-cancer_vs_Healthy-controls_DOWN	NA	713	109326	59735	194	1716	1730	848	724	1506553	32067	475	482	543311	1257	836	838	841	32207	970	157	29465
bsdb:150/2/1_head-and-neck-carcinoma:Cancer_vs_Vocal-cord-polyp_UP	NA	547	416916	286
bsdb:150/2/2_head-and-neck-carcinoma:Cancer_vs_Vocal-cord-polyp_DOWN	NA	848	838	44259	713	209	1730	841	109326	872	43994
bsdb:152/1/1_cervical-cancer:cervical-cancer_vs_healthy-controls_UP	NA	189330	581	583	1263	22	83770
bsdb:152/1/2_cervical-cancer:cervical-cancer_vs_healthy-controls_DOWN	NA	2745	33024
bsdb:152/2/1_cervical-cancer:cervical-cancer-patients_vs_healthy-controls_UP	NA	375288	841
bsdb:152/2/2_cervical-cancer:cervical-cancer-patients_vs_healthy-controls_DOWN	NA	33024
bsdb:153/1/1_prostate-cancer:prostate-cancer_vs_non-prostate-cancer_UP	NA	1357	2747	1301	129337	547
bsdb:153/1/2_prostate-cancer:prostate-cancer_vs_non-prostate-cancer_DOWN	NA	413496	114627	44249
bsdb:154/1/1_colorectal-cancer:colorectal-cancer_vs_healthy-controls_UP	NA	46913	44249	59732
bsdb:154/1/2_colorectal-cancer:colorectal-cancer_vs_healthy-controls_DOWN	NA	838	1730	570	32067	33024	86331	613
bsdb:155/1/1_esophageal-cancer:Esophageal-Adenocarcinoma-(EAC)_vs_controls_UP	NA	29465	970
bsdb:155/1/2_esophageal-cancer:Esophageal-Adenocarcinoma-(EAC)_vs_controls_DOWN	NA	1283313	265975	123375	482	724
bsdb:155/2/1_esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_controls_UP	NA	59735
bsdb:155/2/2_esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_controls_DOWN	NA	838
bsdb:156/1/1_gastric-adenocarcinoma:Gastric-cancer_vs_healthy-controls_UP	NA	838	561	620	570	1578	1301	239759	29465	1678	990721	375288
bsdb:156/1/2_gastric-adenocarcinoma:Gastric-cancer_vs_healthy-controls_DOWN	NA	216851	841	28050	1506553
bsdb:156/2/1_gastric-adenocarcinoma:Gastric-cancer_vs_healthy-controls_UP	NA	1729679	838	561	620	570	1301	1578	239759	1678	29465
bsdb:156/2/2_gastric-adenocarcinoma:Gastric-cancer_vs_healthy-controls_DOWN	NA	841	28050	1506553
bsdb:157/1/1_esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_Dysplasia_UP	NA	838	1301	836	1578
bsdb:157/1/2_esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_Dysplasia_DOWN	NA	29465	482	848	724	32207	32067	194	416916	265975	1380	47670	118747	43996	1716	2740	2717	963
bsdb:157/2/1_esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_controls_UP	NA	838	1301	836	1016	308865	816
bsdb:157/2/2_esophageal-cancer:Esophageal-Squamous-cell-carcinoma-(ESCC)_vs_controls_DOWN	NA	29465	482	724	32207	157	906	194	970	416916	1257	265975	1654	1380	47670	118747	43996	44259	1716	2147	830	39948	2740	2717
bsdb:158/1/1_lung-cancer:lung-cancer-patients_vs_healthy-volunteers_UP	NA	816	29465	848	33024
bsdb:158/1/2_lung-cancer:lung-cancer-patients_vs_healthy-volunteers_DOWN	NA	579	216851	547	39948	561	620
bsdb:158/2/1_lung-cancer:lung-cancer-patients_vs_healthy-volunteers_UP	NA	848	570	816
bsdb:158/2/2_lung-cancer:lung-cancer-patients_vs_healthy-volunteers_DOWN	NA	39948	547	561	216851	620
bsdb:159/1/1_gingival-disease:1-month-after-the-placement-of-the-brackets_vs_before_UP	NA	713	1016
bsdb:159/2/1_gingival-disease:3-months-after-the-placement-of-the-brackets_vs_before_UP	NA	1016
bsdb:159/2/2_gingival-disease:3-months-after-the-placement-of-the-brackets_vs_before_DOWN	NA	117563
bsdb:160/1/1_head-and-neck-carcinoma:OCC-&-OPC_vs_High-risk-individuals_DOWN	NA	346096	1716	836	1654	713	1016	848	416916	47670
bsdb:160/2/1_head-and-neck-carcinoma:OCC-&-OPC_vs_Normal-Healthy-Controls_UP	NA	265975
bsdb:160/2/2_head-and-neck-carcinoma:OCC-&-OPC_vs_Normal-Healthy-Controls_DOWN	NA	32207	724	1716	346096	836	1016
bsdb:161/1/1_lung-cancer:NSCLC_vs_healthy-controls_UP	NA	416916	32207	32067	47670	1301	29465
bsdb:161/1/2_lung-cancer:NSCLC_vs_healthy-controls_DOWN	NA	216851	816	838	1283313	836
bsdb:161/2/1_lung-cancer:NSCLC_vs_healthy-controls_UP	NA	1301	47670
bsdb:161/2/2_lung-cancer:NSCLC_vs_healthy-controls_DOWN	NA	838
bsdb:163/1/1_squamous-cell-carcinoma:Oropharyngeal-Squamous-Cell-Carcinoma_vs_Healthy-Controls_UP	NA	872	55506	437755	157	1678	1654	970
bsdb:163/1/2_squamous-cell-carcinoma:Oropharyngeal-Squamous-Cell-Carcinoma_vs_Healthy-Controls_DOWN	NA	43996	29465	482	1301	838	724
bsdb:163/2/1_squamous-cell-carcinoma:Oropharyngeal-Squamous-Cell-Carcinoma_vs_Healthy-Controls_UP	NA	146	29465
bsdb:163/2/2_squamous-cell-carcinoma:Oropharyngeal-Squamous-Cell-Carcinoma_vs_Healthy-Controls_DOWN	NA	1213720
bsdb:164/1/1_gastric-cancer:gastric-cancer_vs_controls_UP	NA	838	1301	29465	1654	32067
bsdb:164/1/2_gastric-cancer:gastric-cancer_vs_controls_DOWN	NA	482	848	724	836	1301
bsdb:165/1/1_chronic-kidney-disease:chronic-kidney-disease-patients_vs_healthy-controls_UP	NA	1283313	1485	872	407	577309
bsdb:165/1/2_chronic-kidney-disease:chronic-kidney-disease-patients_vs_healthy-controls_DOWN	NA	239934	174708	580024	1730	209	1578	1357	1243	248038	133925	265975	577310	1427376	638847	32207	2753
bsdb:166/1/1_chronic-kidney-disease:chronic-kidney-disease_vs_healthy-controls_UP	NA	816	84111	1505663	561	946234	375288	1508657	1769710	620	46255
bsdb:166/1/2_chronic-kidney-disease:chronic-kidney-disease_vs_healthy-controls_DOWN	NA	1506577	102106	580596	1501226	1263	841	33042	292632	28050	2747	39948
bsdb:167/1/1_squamous-cell-carcinoma:Stage-4_vs_healthy-controls_UP	NA	82202
bsdb:167/3/1_squamous-cell-carcinoma:Stage-2-&-3_vs_healthy-controls_UP	NA	1730
bsdb:168/1/1_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-yellow-tongue-coating-patients_vs_healthy-controls_UP	NA	283	47670	482
bsdb:168/1/2_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-yellow-tongue-coating-patients_vs_healthy-controls_DOWN	NA	194	1331051	543311	1481960	196081
bsdb:168/2/1_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-yellow-tongue-coating-patients_vs_chronic-hepatitis-B-white-tongue-coating-patients_UP	NA	2093	482
bsdb:168/2/2_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-yellow-tongue-coating-patients_vs_chronic-hepatitis-B-white-tongue-coating-patients_DOWN	NA	43996	838
bsdb:168/3/1_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-white-tongue-coating-patients_vs_healthy-controls_UP	NA	59735	118747	82202	836
bsdb:168/3/2_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-white-tongue-coating-patients_vs_healthy-controls_DOWN	NA	1654	194195	113286	196081
bsdb:169/1/1_gastric-cancer:white-thin-tongue-coating-GC-patient_vs_other-coatings_UP	NA	47670	50729
bsdb:169/1/2_gastric-cancer:white-thin-tongue-coating-GC-patient_vs_other-coatings_DOWN	NA	1213720
bsdb:169/3/1_gastric-cancer:yellow-thick-tongue-coating-GC-patient_vs_other-coatings_DOWN	NA	47670	482	1257
bsdb:169/4/1_gastric-cancer:yellow-thin-coating-GC-patient_vs_other-coatings_DOWN	NA	5543
bsdb:170/1/1_lung-cancer:cancerous-site_vs_controls_UP	NA	1301
bsdb:170/1/2_lung-cancer:cancerous-site_vs_controls_DOWN	NA	1279
bsdb:170/2/1_lung-cancer:paired-contralateral-non-cancerous-site-in-lung-cancer-patients_vs_controls_UP	NA	1016	237	724	32067	482	970	1301
bsdb:170/2/2_lung-cancer:paired-contralateral-non-cancerous-site-in-lung-cancer-patients_vs_controls_DOWN	NA	469
bsdb:170/3/1_lung-cancer:cancerous-site_vs_paired-contralateral-non-cancerous-site_UP	NA	39948
bsdb:170/4/1_lung-cancer:cancerous-site-with-no-antibiotics_vs_control-group-with-no-antibiotics_UP	NA	1016
bsdb:170/4/2_lung-cancer:cancerous-site-with-no-antibiotics_vs_control-group-with-no-antibiotics_DOWN	NA	265	1279	1004300
bsdb:171/1/1_digestive-system-cancer:digestive-tract-cancer-patients_vs_controls_UP	NA	1716	848	482	29465
bsdb:171/1/2_digestive-system-cancer:digestive-tract-cancer-patients_vs_controls_DOWN	NA	836	838	32207
bsdb:171/2/1_tongue-neoplasm:tongue/pharyngeal-cancer-patients_vs_controls_UP	NA	1716	32067	482	838
bsdb:171/2/2_tongue-neoplasm:tongue/pharyngeal-cancer-patients_vs_controls_DOWN	NA	1301
bsdb:171/3/1_esophageal-cancer:esophageal-cancer-patients_vs_controls_UP	NA	1716
bsdb:171/3/2_esophageal-cancer:esophageal-cancer-patients_vs_controls_DOWN	NA	1654	1301	482
bsdb:171/4/1_colorectal-cancer:colorectal-cancer-patients_vs_controls_UP	NA	1716	482
bsdb:171/4/2_colorectal-cancer:colorectal-cancer-patients_vs_controls_DOWN	NA	838	1301
bsdb:171/5/1_gastric-cancer:gastric-cancer-patients_vs_controls_UP	NA	482	1301
bsdb:171/5/2_gastric-cancer:gastric-cancer-patients_vs_controls_DOWN	NA	838	32207	1301
bsdb:172/1/1_Cannabis-use:marijuana-usage-group_vs_controls-(lateral-border-of-tongue)_UP	NA	80865	32207	85413	88	86331
bsdb:172/1/2_Cannabis-use:marijuana-usage-group_vs_controls-(lateral-border-of-tongue)_DOWN	NA	1016	848	59735	836
bsdb:172/2/1_Cannabis-use:marijuana-usage-group_vs_controls-(oral-pharynx)_UP	NA	29465	970	86331
bsdb:172/2/2_Cannabis-use:marijuana-usage-group_vs_controls-(oral-pharynx)_DOWN	NA	59735	1301
bsdb:172/3/1_Cannabis-use:marijuana-usage-group_vs_controls-(lateral-border-of-tongue)_UP	NA	80865	88	286	85413	47670	32207
bsdb:172/3/2_Cannabis-use:marijuana-usage-group_vs_controls-(lateral-border-of-tongue)_DOWN	NA	59735
bsdb:172/4/1_Cannabis-use:marijuana-usage-group_vs_controls-(oral-pharynx)_UP	NA	29465	86331	838
bsdb:172/4/2_Cannabis-use:marijuana-usage-group_vs_controls-(oral-pharynx)_DOWN	NA	400634	59735
bsdb:173/1/1_pancreatic-carcinoma:pancreatic-cancer_vs_healthy-controls_UP	NA	904	416916	194	135858	82202	413496	547	52228	570	1578	32067	200903	838	970	29465
bsdb:173/1/2_pancreatic-carcinoma:pancreatic-cancer_vs_healthy-controls_DOWN	NA	239934	239759	207244	244127	1678	35832	572511	41275	580596	1485	33042	189330	84111	946234	204475	158846	906	86331	651554	577310	583	379	44748
bsdb:173/2/1_pancreatic-carcinoma:pancreatic-head-cancer-with-obstruction_vs_pancreatic-head-cancer-without-obstruction_UP	NA	283	117563	140625	32067	115543	46205	1200657	1301
bsdb:173/2/2_pancreatic-carcinoma:pancreatic-head-cancer-with-obstruction_vs_pancreatic-head-cancer-without-obstruction_DOWN	NA	118966	561	620
bsdb:174/1/1_gastric-cancer:cancer-tissue_vs_adjacent-normal-tissue_UP	NA	970	838	1164882	1301	1257	13687	469	1386
bsdb:174/1/2_gastric-cancer:cancer-tissue_vs_adjacent-normal-tissue_DOWN	NA	613	209	1543704	1357
bsdb:175/1/1_pancreatic-carcinoma:pancreatic-cancer-cases_vs_controls_UP	NA	1283313
bsdb:175/1/2_pancreatic-carcinoma:pancreatic-cancer-cases_vs_controls_DOWN	NA	32067
bsdb:175/2/1_pancreatic-carcinoma:pancreatic-cancer-cases_vs_controls_DOWN	NA	1283313	32067
bsdb:175/3/1_pancreatic-carcinoma:pancreatic-cancer-cases_vs_controls_DOWN	NA	32067
bsdb:176/1/1_leukemia:survivors-of-acute-lymphoblastic-leukemia_vs_controls_UP	NA	1716	162289	150022	1279	1654
bsdb:176/1/2_leukemia:survivors-of-acute-lymphoblastic-leukemia_vs_controls_DOWN	NA	216851	1263	28050
bsdb:177/1/1_colorectal-cancer:colon-cancer-patients_vs_control_UP	NA	35832	1485	39948	848	2172	119852	1257
bsdb:177/1/2_colorectal-cancer:colon-cancer-patients_vs_control_DOWN	NA	1301
bsdb:177/2/1_colorectal-cancer:colon-cancer-patients-(tumor-samples)_vs_control_UP	NA	2172	1257	970
bsdb:177/3/1_colorectal-cancer:colon-cancer-patients-(fecal-samples)_vs_control_UP	NA	189330	1257
bsdb:177/3/2_colorectal-cancer:colon-cancer-patients-(fecal-samples)_vs_control_DOWN	NA	841
bsdb:178/1/1_gastric-cancer:gastric-cancer-peritumor-group_vs_normal_UP	NA	2745	22	1350	41275	1663	1763
bsdb:178/1/2_gastric-cancer:gastric-cancer-peritumor-group_vs_normal_DOWN	NA	106589	445
bsdb:178/2/1_gastric-cancer:gastric-cancer-tumor-group_vs_peritumor_UP	NA	1350	970	2745	1678	239759	1263	39948	459786	33042	841	906	1279	572511
bsdb:178/2/2_gastric-cancer:gastric-cancer-tumor-group_vs_peritumor_DOWN	NA	379	158846	22	1763	1578
bsdb:178/3/1_gastric-cancer:gastric-cancer-tumor-group_vs_normal_UP	NA	92793	1678	572511	33042	39948	1378	204475	117563	70774	1578	149698	407	482	1257	1743	841	42255	1263	22	1301	29465
bsdb:178/3/2_gastric-cancer:gastric-cancer-tumor-group_vs_normal_DOWN	NA	1716	106589	1654	1279
bsdb:179/1/1_esophageal-squamous-cell-carcinoma:Oesophageal-cancer_vs_Healthy-controls_UP	NA	1654	1380	2717
bsdb:179/1/2_esophageal-squamous-cell-carcinoma:Oesophageal-cancer_vs_Healthy-controls_DOWN	NA	848	836
bsdb:179/2/1_esophageal-squamous-cell-carcinoma:Oesophageal-cancer_vs_Healthy-controls_UP	NA	1380	1654
bsdb:179/2/2_esophageal-squamous-cell-carcinoma:Oesophageal-cancer_vs_Healthy-controls_DOWN	NA	848	836
bsdb:181/1/1_irritable-bowel-syndrome:IBS_vs_Healthy-control_UP	NA	239934	572511	946234	283168	459786	375288	29465
bsdb:181/1/2_irritable-bowel-syndrome:IBS_vs_Healthy-control_DOWN	NA	838
bsdb:184/1/1_prostate-cancer:prostate-cancer-patients_vs_controls_UP	NA	816
bsdb:184/1/2_prostate-cancer:prostate-cancer-patients_vs_controls_DOWN	NA	216851	28050	258514
bsdb:185/1/1_gastric-cancer:gastric-cancer_vs_controls_UP	NA	561	620	1485	29465
bsdb:185/1/2_gastric-cancer:gastric-cancer_vs_controls_DOWN	NA	816
bsdb:185/2/1_gastric-cancer:gastric-cancer_vs_healthy-gastric-cancer-(post-surgery)_UP	NA	570
bsdb:185/2/2_gastric-cancer:gastric-cancer_vs_healthy-gastric-cancer-(post-surgery)_DOWN	NA	239934	620	1578	39948
bsdb:187/1/1_medroxyprogesterone-acetate:naive-black-participants-(baseline-visit)_vs_depot-medroxyprogesterone-acetate-vaginal-microbiome-(visit-2)-among-black-participants_UP	NA	838
bsdb:187/2/1_medroxyprogesterone-acetate:white-naiive-vaginal-microbiome-(baseline)_vs_black-naive-vaginal-microbiome-(baseline-visit-)_UP	NA	150022
bsdb:187/2/2_medroxyprogesterone-acetate:white-naiive-vaginal-microbiome-(baseline)_vs_black-naive-vaginal-microbiome-(baseline-visit-)_DOWN	NA	1485	177971
bsdb:187/3/1_medroxyprogesterone-acetate:white-participants-after-using-depot-medroxyprogesterone-(visit-2)_vs_black-participants-after-using-depot-medroxyprogesterone-(visit-2)_UP	NA	1578
bsdb:187/3/2_medroxyprogesterone-acetate:white-participants-after-using-depot-medroxyprogesterone-(visit-2)_vs_black-participants-after-using-depot-medroxyprogesterone-(visit-2)_DOWN	NA	1485	848	1378	838	168808
bsdb:187/4/1_medroxyprogesterone-acetate:white-participants-after-using-depot-medroxyprogesterone-(visit-3)_vs_black-participants-after-using-depot-medroxyprogesterone-(visit-3)_UP	NA	150022
bsdb:187/4/2_medroxyprogesterone-acetate:white-participants-after-using-depot-medroxyprogesterone-(visit-3)_vs_black-participants-after-using-depot-medroxyprogesterone-(visit-3)_DOWN	NA	1375	906	838
bsdb:188/1/1_cervical-cerclage:Vaginal-microbiome-of-symptomatic-women-prior-ro-cerclage_vs_Vaginal-microbiome-of-asymptomatic-women-prior-to-cerclage_UP	NA	2701
bsdb:189/1/1_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-patients_vs_healthy-controls_UP	NA	158846	1654
bsdb:189/1/2_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B-patients_vs_healthy-controls_DOWN	NA	816	574697	375288	553372	239759	1263
bsdb:190/1/1_Environmental-exposure-measurement:one-month-age-infants-exposed-to-high-chemical-breast-milk_vs_one-month-age-infants-exposed-to-low-chemical-breast-milk-(<20th-percentile)_UP	NA	1485	1350
bsdb:190/1/2_Environmental-exposure-measurement:one-month-age-infants-exposed-to-high-chemical-breast-milk_vs_one-month-age-infants-exposed-to-low-chemical-breast-milk-(<20th-percentile)_DOWN	NA	1578	29465
bsdb:192/1/2_irritable-bowel-syndrome:diarrhea-predominant-irritable-bowel-syndrome_vs_healthy-controls_DOWN	NA	216851
bsdb:192/2/1_irritable-bowel-syndrome:diarrhea-predominant-irritable-bowel-syndrome_vs_healthy-controls_UP	NA	253238
bsdb:194/1/1_ovarian-cancer:ovarian-cancer_vs_normal-tissue_UP	NA	236752	1357
bsdb:194/1/2_ovarian-cancer:ovarian-cancer_vs_normal-tissue_DOWN	NA	212791	283	1279	165695	407	106589	586	215579	504481	12916	13687	469
bsdb:195/1/1_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B_vs_healthy-controls_UP	NA	629	44259
bsdb:195/1/2_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B_vs_healthy-controls_DOWN	NA	32067	1016
bsdb:195/2/1_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B_vs_liver-cirrhosis_UP	NA	44259	157
bsdb:195/2/2_chronic-hepatitis-B-virus-infection:chronic-hepatitis-B_vs_liver-cirrhosis_DOWN	NA	482
bsdb:196/1/1_Henoch-Schoenlein-purpura:Henoch-Schnlein-Purpura_vs_controls_UP	NA	29465	1350	158846	375288
bsdb:196/1/2_Henoch-Schoenlein-purpura:Henoch-Schnlein-Purpura_vs_controls_DOWN	NA	39948	724	570	28050	577310	841	1508657	1263	1301
bsdb:197/1/1_asthma:severe-asthma_vs_non-asthma_UP	NA	239759	207244	816	1016	1432051	1730	216851	946234	5277	283168	459786	375288	4753	5533	1501226	841	1263
bsdb:197/1/2_asthma:severe-asthma_vs_non-asthma_DOWN	NA	5206	237557	583	5615
bsdb:198/1/1_Henoch-Schoenlein-purpura:Henoch-Schnlein-Purpura_vs_controls_UP	NA	482	29465	838
bsdb:198/1/2_Henoch-Schoenlein-purpura:Henoch-Schnlein-Purpura_vs_controls_DOWN	NA	724	469
bsdb:199/1/2_ovarian-cancer:ovarian-cancer_vs_controls_DOWN	NA	44249	2251
bsdb:200/1/2_endometrial-cancer:post_vs_pre_DOWN	NA	39948	162289	836	194	1654	72763	1380	2740	816	285105	1485	33983	162290	572511	216851	184869
bsdb:200/2/1_endometrial-cancer:endometrial-cancer_vs_benign_UP	NA	165779	1578
bsdb:200/2/2_endometrial-cancer:endometrial-cancer_vs_benign_DOWN	NA	1578	836	838	150022	162289	848	194	1654	2740	162290	184869	28263
bsdb:201/1/1_leukemia:induction_vs_repeat-therapy_UP	NA	816	216851	459786	375288	1263
bsdb:201/1/2_leukemia:induction_vs_repeat-therapy_DOWN	NA	1654	84111	1350	1573536	1578	292632	29465
bsdb:202/1/1_autism:children-with-autism-mental-regression-(AMR)_vs_children-with-autism-non-mental-regression-(ANMR)_UP	NA	1350
bsdb:202/2/1_autism:children-with-autism-non-mental-regression-(ANMR)_vs_healthy-controls_UP	NA	1678	1350
bsdb:202/3/1_autism:children-with-autism-mental-regression-(AMR)_vs_healthy-controls_UP	NA	1678	1350
bsdb:204/1/1_premature-birth:mothers-whose-newborns-were-delivered-at-<34-gestational-week_vs_mothers-whose-newborns-were-delivered-at-37-getastional-weeks_DOWN	NA	1678
bsdb:207/1/1_vulvovaginitis:Women-with-BV_vs_Normal-controls_UP	NA	1380	118747	39948	2701	2050	836	168808
bsdb:207/1/2_vulvovaginitis:Women-with-BV_vs_Normal-controls_DOWN	NA	1578
bsdb:207/2/1_vulvovaginitis:Women-with-BV-and-VVC_vs_Normal-controls_UP	NA	838
bsdb:208/1/1_food-allergy:infants-with-food-allergies_vs_healthy-controls_UP	NA	207244	1485	1350	216851	946234	1578	838	1279
bsdb:208/1/2_food-allergy:infants-with-food-allergies_vs_healthy-controls_DOWN	NA	816	572511	158846	906	1301	29465
bsdb:208/2/1_food-allergy:infants-with-food-allergies_vs_healthy-controls_UP	NA	580596	1485
bsdb:208/2/2_food-allergy:infants-with-food-allergies_vs_healthy-controls_DOWN	NA	906	68287	222	84111	237	40323	86331	59732	283
bsdb:208/3/1_food-allergy:infants-IgE-mediated_vs_infants-non-IgE-mediated_UP	NA	1485
bsdb:208/3/2_food-allergy:infants-IgE-mediated_vs_infants-non-IgE-mediated_DOWN	NA	816
bsdb:208/4/1_food-allergy:infants-IgE-mediated_vs_infants-non-IgE-mediated_UP	NA	1485
bsdb:208/4/2_food-allergy:infants-IgE-mediated_vs_infants-non-IgE-mediated_DOWN	NA	816
bsdb:209/1/1_cesarean-section:C-section_vs_vaginal-delivery_UP	NA	29465	407	544	1279	1716	1301	12916	1743	117563	469	374	80865	1302778	1578	222	65551	28209	40323	114248	724	88	283	28067	504481	1357	547	150247	357
bsdb:209/1/2_cesarean-section:C-section_vs_vaginal-delivery_DOWN	NA	561	816	1485	1678	1350	544	570	158851	620	1279	1716	1301
bsdb:210/1/1_food-allergy:children-with-food-sensitization_vs_healthy-controls_UP	NA	239934	1678	102106	1350	216851	1578	841	1263	13687	292632	40544
bsdb:210/1/2_food-allergy:children-with-food-sensitization_vs_healthy-controls_DOWN	NA	239759	816	375288	838	1301	29465
bsdb:210/2/1_food-allergy:children-with-food-sensitization_vs_healthy-controls_UP	NA	292632
bsdb:210/2/2_food-allergy:children-with-food-sensitization_vs_healthy-controls_DOWN	NA	816	29465
bsdb:211/1/1_Anemia:gestational-anemia-(GA1-group)_vs_healthy-controls(HC1-group)_UP	NA	244127	265975	543311	191303
bsdb:211/2/1_Anemia:gestational-anemia-(GA3-group)_vs_healthy-controls(HC3-group)_UP	NA	1380	135858	84111
bsdb:212/1/1_diet:Higher-quartile-of-TOTAL-fiber-intake_vs_low-quartile-of-TOTAL-fiber-intake_DOWN	NA	1654	283168	119852
bsdb:212/1/2_diet:Higher-quartile-of-TOTAL-fiber-intake_vs_low-quartile-of-TOTAL-fiber-intake_DOWN	NA	216851	28050
bsdb:212/2/1_diet:Higher-fiber-intake-from-FRUITS/-VEGETABLES_vs_low-fiber-intake-from-FRUITS/-VEGETABLES_DOWN	NA	1654	283168
bsdb:212/3/1_diet:Higher-fiber-intake-from-BEANS_vs_low-fiber-intake-from-BEANS_UP	NA	816	33042	216851	283168	375288	1263
bsdb:212/3/2_diet:Higher-fiber-intake-from-BEANS_vs_low-fiber-intake-from-BEANS_DOWN	NA	283168
bsdb:212/4/1_diet:Higher-fiber-intake-from-GRAINS_vs_low-fiber-intake-from-GRAINS_DOWN	NA	572511
bsdb:213/4/1_Gut-microbiome-measurement:2-month-old-infants_vs_Neonates_UP	NA	29465	1485	1578	838	1678
bsdb:213/5/1_Delivery-method:Vaginally-delivered-neonates_vs_Cesarean-delivered-neonates_UP	NA	816	158846	375288
bsdb:213/5/2_Delivery-method:Vaginally-delivered-neonates_vs_Cesarean-delivered-neonates_DOWN	NA	1301	158851
bsdb:213/6/1_Delivery-method:Vaginally-delivered-2-month-olds_vs_Cesarean-delivered-2-month-olds_UP	NA	816	158846
bsdb:213/6/2_Delivery-method:Vaginally-delivered-2-month-olds_vs_Cesarean-delivered-2-month-olds_DOWN	NA	1485	838
bsdb:214/1/1_milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_UP	NA	547	590	158851
bsdb:214/1/2_milk-allergic-reaction:children-with-milk-allergy-persistence_vs_milk-allergy-resolution_DOWN	NA	572511	1730	1263
bsdb:215/1/1_Eczema:infants-with-eczema_vs_healthy-control-infants_UP	NA	239934	207244	35832	33042	872	547	216851	946234	204475	44249	375288	577309	33024	836	379	841	29465	561	620	1485
bsdb:215/1/2_Eczema:infants-with-eczema_vs_healthy-control-infants_DOWN	NA	904	209879	156454	244127	1678	43668	1696	580596	1485	102106	1716	39948	189330	538	117563	724	570	1578	906	459786	838	1263	1301	40544	191303
bsdb:216/1/1_cesarean-section:C-section_vs_vaginal-delivery_DOWN	NA	1380	1350
bsdb:217/2/1_age:infant-at-18-months_vs_infant-at-6-months_UP	NA	1485
bsdb:217/3/1_age:infant-at-18-months_vs_infant-at-6-months_UP	NA	848	583
bsdb:217/3/2_age:infant-at-18-months_vs_infant-at-6-months_DOWN	NA	1678
bsdb:218/1/1_hepatocellular-carcinoma:non-HBV-non-HCV-related-HCC_vs_healthy-controls_UP	NA	244127
bsdb:218/1/2_hepatocellular-carcinoma:non-HBV-non-HCV-related-HCC_vs_healthy-controls_DOWN	NA	28050	158846
bsdb:218/2/1_hepatocellular-carcinoma:HBV-related-HCC-patients_vs_healthy-controls_UP	NA	244127	33024	838
bsdb:218/3/1_hepatocellular-carcinoma:non-HBV-non-HCV-patients_vs_HBV-related-HCC-patients_DOWN	NA	32199	28050	33024
bsdb:219/2/1_diet:lower-fiber-(cracker)---8-wk-after-intervention_vs_higher-fiber-(almonds)---8-wk-after-intervention_UP	NA	28050
bsdb:219/2/2_diet:lower-fiber-(cracker)---8-wk-after-intervention_vs_higher-fiber-(almonds)---8-wk-after-intervention_DOWN	NA	239759	574697	283168
bsdb:219/3/1_diet:lower-fiber-(cracker)_vs_higher-fiber-(almonds)_DOWN	NA	40544
bsdb:220/1/1_age:older-age-European-women_vs_younger-age_UP	NA	1663	168808	1716	2745
bsdb:220/1/2_age:older-age-European-women_vs_younger-age_DOWN	NA	1743
bsdb:221/1/1_urinary-tract-infection:urinary-tract-infection_vs_healthy-controls_UP	NA	547
bsdb:221/1/2_urinary-tract-infection:urinary-tract-infection_vs_healthy-controls_DOWN	NA	39948	150022	724	149698
bsdb:223/1/1_HIV-infection:HIV-infected-patients_vs_healthy-controls_UP	NA	1578	1506553	1301	1350
bsdb:223/1/2_HIV-infection:HIV-infected-patients_vs_healthy-controls_DOWN	NA	816	838	158846	292632	216851	39948	33024
bsdb:223/2/1_HIV-infection:HIV-infected-patients-who-are-homosexual_vs_healthy-controls_UP	NA	1350	1505663
bsdb:223/2/2_HIV-infection:HIV-infected-patients-who-are-homosexual_vs_healthy-controls_DOWN	NA	39948	216851	33024	838
bsdb:223/3/1_HIV-infection:Intravenous-drug-abuse-HIV-patients_vs_healthy-controls_UP	NA	1578	1301
bsdb:223/4/1_HIV-infection:homosexual-subjects-with-HIV_vs_heterosexual-subjects-with-HIV_DOWN	NA	838	1506553	33024	375288
bsdb:223/5/1_HIV-infection:HAART-treated-HIV+-patients_vs_healthy-control_UP	NA	561	1506553	620	1301
bsdb:223/5/2_HIV-infection:HAART-treated-HIV+-patients_vs_healthy-control_DOWN	NA	816	39948	216851	158846	33024	838	292632
bsdb:223/6/1_HIV-infection:HAART-untreated_vs_healthy-control_UP	NA	1350	1578
bsdb:224/1/1_diet:barley-(WGB)_vs_baseline_UP	NA	572511
bsdb:224/1/2_diet:barley-(WGB)_vs_baseline_DOWN	NA	283168	841	39948
bsdb:224/3/1_diet:brown-rice-+-barley-(BR-+-WGB)_vs_baseline_UP	NA	572511
bsdb:224/3/2_diet:brown-rice-+-barley-(BR-+-WGB)_vs_baseline_DOWN	NA	816
bsdb:225/1/1_atopic-eczema:infant-with-atopic-eczema_vs_healthy-infant_UP	NA	1350
bsdb:226/1/1_HIV-infection:HIV-1-infected-patients_vs_healthy-controls_UP	NA	580596	135858	189330	547	1350	216851	158846	577310	838
bsdb:226/1/2_HIV-infection:HIV-1-infected-patients_vs_healthy-controls_DOWN	NA	33042	397864	39948	816
bsdb:226/2/1_HIV-infection:HAART-treated-HIV-1-patients_vs_HAART-naive-HIV-1-patients_UP	NA	1654	572511	1350	158846	29465
bsdb:226/2/2_HIV-infection:HAART-treated-HIV-1-patients_vs_HAART-naive-HIV-1-patients_DOWN	NA	239759	397864	39948	216851	283168	459786	838	638847
bsdb:227/1/2_atopic-eczema:infant-with-transient-atopic-dermatitis_vs_healthy-control_UP	NA	1678	239934
bsdb:227/2/1_atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_healthy-controls_UP	NA	1301
bsdb:227/2/2_atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_healthy-controls_DOWN	NA	1485
bsdb:227/3/1_atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_transient-atopic-dermatitis_UP	NA	1301
bsdb:227/3/2_atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_transient-atopic-dermatitis_DOWN	NA	239934
bsdb:227/4/1_atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_healthy-controls_UP	NA	1301	1505657	216851	375288	1505652	1501226	117563	100883
bsdb:227/4/2_atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_healthy-controls_DOWN	NA	1654	544	100883	84111	547	1330547	1504576	160674	1485
bsdb:227/5/1_atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_transient-atopic-dermatitis_UP	NA	100883	189330	216851	375288	1501226	34104	1301
bsdb:227/5/2_atopic-eczema:infants-with-persistent-atopic-dermatitis_vs_transient-atopic-dermatitis_DOWN	NA	239934	547	1330547	160674	2735
bsdb:227/6/1_atopic-eczema:infant-with-transient-atopic-dermatitis_vs_healthy-control_UP	NA	1678
bsdb:227/6/2_atopic-eczema:infant-with-transient-atopic-dermatitis_vs_healthy-control_DOWN	NA	32207
bsdb:228/1/1_diet:day-3-of-PECTIN-spike-in_vs_day-6-of-PECTIN-spike-in_DOWN	NA	841	816	44748
bsdb:229/1/1_diet:early_vs_late-pectin-incubation-time_UP	NA	1678	100883	846	283168	33042	574697	1263	207244	572511	375288	33024	841	816
bsdb:229/1/2_diet:early_vs_late-pectin-incubation-time_DOWN	NA	28050	40544	189330	1485
bsdb:230/1/1_food-allergy:infant-with-food-allergy_vs_non-allergy_DOWN	NA	1243	46255	29465
bsdb:230/1/2_food-allergy:infant-with-food-allergy_vs_non-allergy_UP	NA	1485
bsdb:232/1/1_HIV-infection:HIV-infected-cART-negative_vs_Healthy-controls_UP	NA	165779	848	1257	836
bsdb:232/1/2_HIV-infection:HIV-infected-cART-negative_vs_Healthy-controls_DOWN	NA	239759	33042	1730	28050	841	1263
bsdb:233/1/1_HIV-infection:HIV-infected-subjects_vs_uninfected-controls_UP	NA	469	838
bsdb:233/1/2_HIV-infection:HIV-infected-subjects_vs_uninfected-controls_DOWN	NA	816	572511	33042
bsdb:236/1/1_diet:before-walnut-diet_vs_after-walnut-diet_UP	NA	207244
bsdb:236/1/2_diet:before-walnut-diet_vs_after-walnut-diet_DOWN	NA	1678	572511
bsdb:236/2/1_diet:carbohydrate-replacement-(with-walnuts)_vs_replace-both_DOWN	NA	204475	1407607	816
bsdb:236/3/1_diet:replace-both_vs_fat-replacement-(with-walnuts)_UP	NA	204475	1407607	816
bsdb:237/1/1_chronic-hepatitis-C-virus-infection:cirrhosis-patients_vs_healthy-controls_UP	NA	1283313	1578	1301	29465	239934	561	620	724	1269	46255	169133	1253
bsdb:237/1/2_chronic-hepatitis-C-virus-infection:cirrhosis-patients_vs_healthy-controls_DOWN	NA	35832	574697	52225	213484	172900	1485	1017280	35829
bsdb:237/2/1_chronic-hepatitis-C-virus-infection:cirrhosis-patients_vs_no-cirrhosis_UP	NA	1578	29465	1678	239934	724	1269	46255
bsdb:237/2/2_chronic-hepatitis-C-virus-infection:cirrhosis-patients_vs_no-cirrhosis_DOWN	NA	213484
bsdb:237/3/1_chronic-hepatitis-C-virus-infection:hepatitis-C-patients_vs_healthy-controls_DOWN	NA	946234	906	1017280	35829
bsdb:238/1/1_cervical-cancer:cervical-cancer-patient_vs_healthy-controls_UP	NA	838	836	39948	1506553	40544	1505663	437755	946234	459786	1301
bsdb:238/1/2_cervical-cancer:cervical-cancer-patient_vs_healthy-controls_DOWN	NA	239759	207244	816	572511	547	561	1407607	1505657	375288	1501226	620	574697
bsdb:238/2/1_cervical-cancer:cervical-cancer-patient_vs_healthy-controls_UP	NA	838	836	39948	1506553	1505663	946234	437755
bsdb:238/2/2_cervical-cancer:cervical-cancer-patient_vs_healthy-controls_DOWN	NA	1501226	207244	572511	239759
bsdb:238/3/1_cervical-cancer:cervical-cancer-patient_vs_healthy-controls_UP	NA	838	836	39948	1506553	1301	1505663	437755
bsdb:238/3/2_cervical-cancer:cervical-cancer-patient_vs_healthy-controls_DOWN	NA	1505657	1501226	1407607	207244	547	239759
bsdb:239/1/1_egg-allergy:children-with-egg-allergy_vs_healthy-control_UP	NA	1263	1357
bsdb:239/1/2_egg-allergy:children-with-egg-allergy_vs_healthy-control_DOWN	NA	1243
bsdb:239/2/1_egg-allergy:children-with-egg-sensitization_vs_healthy-control_UP	NA	216851	841
bsdb:241/1/2_Iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_DOWN	NA	39948
bsdb:242/1/1_Iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_UP	NA	475	1357	286	1350	57493	1578
bsdb:242/1/2_Iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_DOWN	NA	1716	482	416916	2717
bsdb:242/2/1_Iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_UP	NA	1350	57493	1357	475	286
bsdb:242/2/2_Iron-deficiency-anemia:iron-deficiency-anemia_vs_healthy-control_DOWN	NA	194	2717	32207	416916	215579	1016	482	1716
bsdb:242/3/1_Iron-deficiency-anemia:iron-deficiency-anemia-severe_vs_iron-deficiency-anemia-moderate_UP	NA	57493	1111	1279	475	1350	286	1357
bsdb:243/1/1_gastric-cancer:current-H.pylori-infection_vs_non-current-H.pylori-infection_UP	NA	1378
bsdb:243/1/2_gastric-cancer:current-H.pylori-infection_vs_non-current-H.pylori-infection_DOWN	NA	12916	1827
bsdb:243/2/1_gastric-cancer:current-H.pylori-infection-patients_vs_past-H.pylori-infection_UP	NA	838	40544
bsdb:243/3/1_gastric-cancer:past-H.pylori-infection_vs_H.pylori-negative_DOWN	NA	375288
bsdb:243/4/1_gastric-cancer:gastritis-cases_vs_normal_UP	NA	244127	189330	561	216851	620	1301	191303
bsdb:243/5/1_gastric-cancer:subjects-with-metaplasia_vs_normal_UP	NA	39948	189330	1506553	1501226	191303
bsdb:244/1/1_age:18-62-years_vs_2-12-years_UP	NA	1743	1716	1279	1578	150022	165779
bsdb:244/1/2_age:18-62-years_vs_2-12-years_DOWN	NA	32207	1301	117563	1378	724
bsdb:244/2/1_atopic-eczema:lesional-skin_vs_non-lesional-skin_UP	NA	1279
bsdb:244/2/2_atopic-eczema:lesional-skin_vs_non-lesional-skin_DOWN	NA	1301	1743
bsdb:244/3/1_age:13-62-years_vs_2-12-years_UP	NA	1743	1716	1578
bsdb:244/3/2_age:13-62-years_vs_2-12-years_DOWN	NA	1301	117563	1378	482	724	32207	29465
bsdb:245/1/1_nephrolithiasis,urolithiasis:kidney-stone-group_vs_healthy-control_UP	NA	469	1283313	85413	561	1730	1573534	1506553	158846	620
bsdb:245/1/2_nephrolithiasis,urolithiasis:kidney-stone-group_vs_healthy-control_DOWN	NA	1508657	39948	61170	168934	638847	1678	841	577310	547
bsdb:245/2/1_nephrolithiasis,urolithiasis:kidney-stone-group_vs_healthy-control_UP	NA	1283313	1505663	33024	158846	469	561	620	40544
bsdb:245/2/2_nephrolithiasis,urolithiasis:kidney-stone-group_vs_healthy-control_DOWN	NA	189330	1508657	207244	1407607	292632	1573535	39948	1263	577310	35832
bsdb:246/1/1_asthma:maternal-asthma_vs_no-asthma_UP	NA	1654	1357	158846
bsdb:246/1/2_asthma:maternal-asthma_vs_no-asthma_DOWN	NA	158851
bsdb:246/2/1_asthma:maternal-asthma_vs_no-asthma_UP	NA	816	286
bsdb:246/2/2_asthma:maternal-asthma_vs_no-asthma_DOWN	NA	906	1578
bsdb:246/3/1_asthma:maternal-asthma_vs_no-asthma_DOWN	NA	1578
bsdb:246/4/1_asthma:maternal-asthma_vs_no-asthma_DOWN	NA	1578
bsdb:246/5/1_asthma:maternal-asthma_vs_no-asthma_UP	NA	816	189330
bsdb:246/6/1_asthma:maternal-asthma_vs_no-asthma_DOWN	NA	1578	906
bsdb:246/7/1_asthma:maternal-asthma_vs_no-asthma_UP	NA	239934
bsdb:246/7/2_asthma:maternal-asthma_vs_no-asthma_DOWN	NA	1654
bsdb:247/1/1_diet:placebo_vs_prebiotic-(inulin-type-fructan)_UP	NA	33042	189330	119852
bsdb:247/1/2_diet:placebo_vs_prebiotic-(inulin-type-fructan)_DOWN	NA	1678
bsdb:247/2/1_diet:placebo_vs_prebiotic-(inulin-type-fructan)---in-participants-with-low-dietary-fiber_DOWN	NA	1678
bsdb:247/3/1_diet:placebo_vs_prebiotic-(inulin-type-fructan)---in-participants-with-high-dietary-fiber_UP	NA	572511	33042	189330
bsdb:247/3/2_diet:placebo_vs_prebiotic-(inulin-type-fructan)---in-participants-with-high-dietary-fiber_DOWN	NA	1678
bsdb:247/4/1_diet:low-dietary-fiber_vs_high-dietary-fiber_DOWN	NA	216851
bsdb:248/1/1_human-papilloma-virus-infection:high-risk-hpv_vs_low-risk-hpv_UP	NA	33870
bsdb:248/1/2_human-papilloma-virus-infection:high-risk-hpv_vs_low-risk-hpv_DOWN	NA	724	28100
bsdb:248/2/1_human-papilloma-virus-infection:HPV_vs_no-HPV_UP	NA	2701
bsdb:248/2/2_human-papilloma-virus-infection:HPV_vs_no-HPV_DOWN	NA	286	28100
bsdb:249/1/1_Hepatitis,-Alcoholic:alcoholics_vs_NAC_UP	NA	374	33882	1843210	1716
bsdb:249/1/2_Hepatitis,-Alcoholic:alcoholics_vs_NAC_DOWN	NA	2053	1839	53387	1678	816	397864	577309	838	239759	237	182709	94008	572511	1263	186650	265	780	114248	12916	47420	215579	29580	70774	642
bsdb:249/2/1_Hepatitis,-Alcoholic:HDC_vs_NAC_UP	NA	469	165779	374	59732	57493	33882	482	20	1883	1060
bsdb:249/2/2_Hepatitis,-Alcoholic:HDC_vs_NAC_DOWN	NA	2053	1839	1678	816	397864	838	237	1301	1485	114248	12916	70774
bsdb:249/3/1_Hepatitis,-Alcoholic:MAH_vs_NAC_UP	NA	469	1654	165779	374	501783	1716	281915	117563	407
bsdb:249/3/2_Hepatitis,-Alcoholic:MAH_vs_NAC_DOWN	NA	1839	53387	838	237	1386	1485	29580	70774
bsdb:249/4/1_Hepatitis,-Alcoholic:SAH_vs_NAC_UP	NA	1654	1651	43668	1716	244698	33882
bsdb:249/4/2_Hepatitis,-Alcoholic:SAH_vs_NAC_DOWN	NA	1839	1678	397864	239759	237
bsdb:250/2/1_severe-aplastic-anemia:hematopoietic-stem-cell-transplantation-engraftment_vs_baseline_DOWN	NA	482
bsdb:251/1/1_milk-allergic-reaction:cows-milk-allergy_vs_healthy-control_UP	NA	1350	1263	100883	572511	375288
bsdb:251/1/2_milk-allergic-reaction:cows-milk-allergy_vs_healthy-control_DOWN	NA	1301	590
bsdb:252/1/1_pemphigus-vulgaris:pemphigus-vulgaris_vs_healthy-control_UP	NA	46123	100883	946234	117563
bsdb:252/1/2_pemphigus-vulgaris:pemphigus-vulgaris_vs_healthy-control_DOWN	NA	102106	33042
bsdb:253/1/1_asthma:asthma_vs_healthy-control_UP	NA	1279	838
bsdb:253/1/2_asthma:asthma_vs_healthy-control_DOWN	NA	724
bsdb:253/2/1_asthma:asthma-remission_vs_healthy-control_UP	NA	848	838	543311
bsdb:253/2/2_asthma:asthma-remission_vs_healthy-control_DOWN	NA	724
bsdb:254/1/1_nephrolithiasis,urolithiasis:kidney-stone-patient_vs_healthy-control_UP	NA	239759	816	375288
bsdb:254/1/2_nephrolithiasis,urolithiasis:kidney-stone-patient_vs_healthy-control_DOWN	NA	150022	162289	838	184869
bsdb:255/1/1_human-papilloma-virus-infection:high-grade-squamous-intraepithelial-lesions_vs_negative-for-intraepithelial-lesion-or-malignancy_UP	NA	1279
bsdb:255/1/2_human-papilloma-virus-infection:high-grade-squamous-intraepithelial-lesions_vs_negative-for-intraepithelial-lesion-or-malignancy_DOWN	NA	150022
bsdb:255/2/1_human-papilloma-virus-infection:high-grade-squamous-intraepithelial-lesions_vs_negative-for-intraepithelial-lesion-or-malignancy_UP	NA	1301	543311
bsdb:255/2/2_human-papilloma-virus-infection:high-grade-squamous-intraepithelial-lesions_vs_negative-for-intraepithelial-lesion-or-malignancy_DOWN	NA	150022
bsdb:255/3/1_HIV-infection:HIV+_vs_HIV-_UP	NA	1375	1378	117563	437755	1257	1279	1301
bsdb:255/3/2_HIV-infection:HIV+_vs_HIV-_DOWN	NA	28263	2129	1678
bsdb:256/1/1_gastric-cancer:peritumoral-tissues_vs_normal-tissues_UP	NA	209	2745	1301	22	1578	29465	407	1257	970	45402
bsdb:256/1/2_gastric-cancer:peritumoral-tissues_vs_normal-tissues_DOWN	NA	838	13687	216851	286	816	1386	848	1743	1716	33024
bsdb:256/2/1_gastric-cancer:tumoral-tissues_vs_peritumoral-tissues_UP	NA	838	286	1386	1743
bsdb:256/2/2_gastric-cancer:tumoral-tissues_vs_peritumoral-tissues_DOWN	NA	2745	22	13687	216851	33024
bsdb:256/3/1_gastric-cancer:tumoral-tissues_vs_normal-tissues_UP	NA	2745	1301	22	1578	1386	970	848	1743	1716
bsdb:256/3/2_gastric-cancer:tumoral-tissues_vs_normal-tissues_DOWN	NA	209	13687	286	816
bsdb:256/9/1_gastric-cancer:normal-HP+_vs_normal-HP-_UP	NA	149698	1678	1716	1654	407	13687	1301	209
bsdb:256/9/2_gastric-cancer:normal-HP+_vs_normal-HP-_DOWN	NA	572511	39948	216851	204475	2745	33024	838	841	1263	22
bsdb:256/10/1_gastric-cancer:peritumor-HP+_vs_peritumor-HP-_UP	NA	1386	1378	209	1301
bsdb:256/10/2_gastric-cancer:peritumor-HP+_vs_peritumor-HP-_DOWN	NA	33024	841	216851	239759	39948	204475	158846	1386	375288
bsdb:256/11/1_gastric-cancer:tumor-HP+_vs_tumor-HP-_UP	NA	1279	816	41275	572511	149698	165696	209
bsdb:256/11/2_gastric-cancer:tumor-HP+_vs_tumor-HP-_DOWN	NA	469	1263	286	13687	1678
bsdb:257/1/1_colorectal-cancer:colorectal-cancer_vs_healthy-control_UP	NA	239934	35832	574697	990721	1485	51514	848	283168	119852	846	375288	1257	836	1263	970	1730
bsdb:257/1/2_colorectal-cancer:colorectal-cancer_vs_healthy-control_DOWN	NA	158846	52225
bsdb:258/1/1_colorectal-cancer:carcinoma_vs_healthy-control_UP	NA	848	836
bsdb:258/1/2_colorectal-cancer:carcinoma_vs_healthy-control_DOWN	NA	816
bsdb:260/1/2_food-allergy:allergic_vs_nonallergic_DOWN	NA	816
bsdb:262/1/1_atopic-asthma:nasal-brush-speciments_vs_bronchial-brush-specimens_UP	NA	1651	1716	475	1279
bsdb:262/1/2_atopic-asthma:nasal-brush-speciments_vs_bronchial-brush-specimens_DOWN	NA	1654	32067	836	838	1301
bsdb:262/2/1_atopic-asthma:oral-wash-specimens_vs_bronchial-brush-specimens_UP	NA	1654	32067	1301
bsdb:262/2/2_atopic-asthma:oral-wash-specimens_vs_bronchial-brush-specimens_DOWN	NA	1716	475	838	1279
bsdb:262/3/1_atopic-asthma:induced-sputum-specimens_vs_nasal-brush-specimens_UP	NA	1654	32067	836	838	1301
bsdb:262/3/2_atopic-asthma:induced-sputum-specimens_vs_nasal-brush-specimens_DOWN	NA	1651	1716	475	1279
bsdb:262/4/1_atopic-asthma:oral-wash-specimens_vs_nasal-brush-specimens_UP	NA	1654	32067	836	838	1301
bsdb:262/4/2_atopic-asthma:oral-wash-specimens_vs_nasal-brush-specimens_DOWN	NA	1651	1716	475	1279
bsdb:262/5/1_atopic-asthma:oral-wash-specimens_vs_induced-sputum-specimens_UP	NA	1654
bsdb:262/5/2_atopic-asthma:oral-wash-specimens_vs_induced-sputum-specimens_DOWN	NA	1716	838	1279
bsdb:262/6/1_atopic-asthma:induced-sputum-specimens_vs_bronchial-brush-specimens_UP	NA	32067	1301
bsdb:262/7/1_atopic-asthma:atopic-asthma-subjects_vs_healthy-controls_UP	NA	1279	1716	47420
bsdb:263/1/1_Crohn's-disease:chron's-disease_vs_healthy-controls_UP	NA	1654	572511	84111	1573536	1378	1505657	32207	1301
bsdb:263/1/2_Crohn's-disease:chron's-disease_vs_healthy-controls_DOWN	NA	553372	1485	33042	216851	1407607	204475	28050	86331	459786	1501226	1263	44748	292632	191303
bsdb:263/2/1_ulcerative-colitis:ulcerative-colitis_vs_healthy-controls_UP	NA	1654	264995	1678	84111	1573536	1378	1301
bsdb:263/2/2_ulcerative-colitis:ulcerative-colitis_vs_healthy-controls_DOWN	NA	644652	204475	28050	86331	1263	44748
bsdb:263/3/1_multiple-sclerosis:multiple-sceloris_vs_healthy-controls_UP	NA	1654	264995	1485	84111	1573536	1301	191303
bsdb:263/3/2_multiple-sclerosis:multiple-sceloris_vs_healthy-controls_DOWN	NA	580596	39948	216851	1407607	204475	28050	100132	292632
bsdb:263/4/1_rheumatoid-arthritis:arthiritis_vs_healthy-controls_UP	NA	1654	84111	1573536	1378	32207	1301
bsdb:263/4/2_rheumatoid-arthritis:arthiritis_vs_healthy-controls_DOWN	NA	264995	580596	1485	216851	1407607	204475	28050	1501226	841	44748	292632
bsdb:264/1/1_human-papilloma-virus-infection:HPV+/HIV-_vs_HPV-/HIV-_UP	NA	28263	39948	906	162289	1257	838	168808
bsdb:264/1/2_human-papilloma-virus-infection:HPV+/HIV-_vs_HPV-/HIV-_DOWN	NA	56688	1578
bsdb:265/1/1_human-papilloma-virus-infection,Age:two-months_vs_at-birth_UP	NA	32207	1301	29465	724	150022
bsdb:265/1/2_human-papilloma-virus-infection,Age:two-months_vs_at-birth_DOWN	NA	357	816	80865	1578	906	1743	286	1279
bsdb:265/2/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	400634	2129
bsdb:265/2/2_human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	29465
bsdb:266/1/1_diet:healthy-vegetarian_vs_healthy-non-vegetarian_UP	NA	838	570
bsdb:266/1/2_diet:healthy-vegetarian_vs_healthy-non-vegetarian_DOWN	NA	375288	816	239759	239934
bsdb:267/1/1_atopic-asthma:atopic-asthma_vs_healthy-control_UP	NA	1654	109326	194	848	724	32257	482	836	838	165697	157	29465
bsdb:267/1/2_atopic-asthma:atopic-asthma_vs_healthy-control_DOWN	NA	713	1578	32067	407	1257
bsdb:267/2/1_atopic-asthma:atopic-no-asthma_vs_healthy-control_UP	NA	1654	416916	1716	2353	848	117563	724	475	970	519427	165697	29465
bsdb:267/2/2_atopic-asthma:atopic-no-asthma_vs_healthy-control_DOWN	NA	209	1578	32067	543311	836	838	286	1301
bsdb:267/3/1_atopic-asthma:atopic-asthma_vs_atopic-no-asthma_UP	NA	39948	848	724	32067	2093	838	970
bsdb:267/3/2_atopic-asthma:atopic-asthma_vs_atopic-no-asthma_DOWN	NA	416916	174708	1716	2353	1578	836	519427	165697	1301
bsdb:267/4/1_atopic-asthma:inhaled-corticosteroid-responder_vs_nonresponder_UP	NA	86331	1301
bsdb:267/4/2_atopic-asthma:inhaled-corticosteroid-responder_vs_nonresponder_DOWN	NA	1378
bsdb:267/5/1_atopic-asthma:post-inhaled-corticosteroid-treatment_vs_baseline-(corticosteroid-treatment-group)_UP	NA	482	475
bsdb:267/5/2_atopic-asthma:post-inhaled-corticosteroid-treatment_vs_baseline-(corticosteroid-treatment-group)_DOWN	NA	848	39948
bsdb:267/6/1_atopic-asthma:post-placebo-treatment_vs_baseline-(placebo-group)_UP	NA	538
bsdb:267/6/2_atopic-asthma:post-placebo-treatment_vs_baseline-(placebo-group)_DOWN	NA	469
bsdb:268/1/1_cervical-glandular-intraepithelial-neoplasia:before_vs_after-loop-electrosurgical-excision-procedure_UP	NA	1485	102106	1716	168808	29465
bsdb:268/1/2_cervical-glandular-intraepithelial-neoplasia:before_vs_after-loop-electrosurgical-excision-procedure_DOWN	NA	1279	48736
bsdb:269/1/1_leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_UP	NA	816
bsdb:269/1/2_leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_DOWN	NA	194	1716	1678	1380	162289	1279	838	165779	836
bsdb:269/1/3_leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_UP	NA	1678
bsdb:269/1/4_leukemia:Acute-Lymphoblastic-Leukemia-diagnosis-and-Pre--Chemotherapy-treatment_vs_healthy-control_DOWN	NA	1380	816	838	848	1716
bsdb:270/1/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	168808	906	1253	1696	286
bsdb:270/1/2_human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	83618	1654	213484	222991
bsdb:270/2/1_human-papilloma-virus-infection:HPV+-(persistance)_vs_HPV+-(clearance)_UP	NA	1380	216851
bsdb:270/2/2_human-papilloma-virus-infection:HPV+-(persistance)_vs_HPV+-(clearance)_DOWN	NA	28065
bsdb:271/1/1_acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease+-(positivity)-with-Allogenic-Stem-Cell-Transplant_UP	NA	216851	253238	44748
bsdb:271/1/2_acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease+-(positivity)-with-Allogenic-Stem-Cell-Transplant_DOWN	NA	32207
bsdb:271/2/1_acute-lymphoblastic-leukemia:Minimal-Residual-Disease--(negativity)-with-Allogenic-Stem-Cell-Transplant_vs_Minimal-Residual-Disease+-(positivity)-with-Allogenic-Stem-Cell-Transplant_UP	NA	1730	216851
bsdb:272/1/1_pneumonia:S.pneumoniae-positive_vs_negative_UP	NA	475	1301
bsdb:272/1/2_pneumonia:S.pneumoniae-positive_vs_negative_DOWN	NA	1716	1279
bsdb:273/1/1_acute-lymphoblastic-leukemia:Infectious-complications-(IC)_vs_non-infectious-complications-(NIC)_DOWN	NA	1678	816	838	239759	189330	216851
bsdb:273/1/2_acute-lymphoblastic-leukemia:Infectious-complications-(IC)_vs_non-infectious-complications-(NIC)_UP	NA	357	507	41275	517
bsdb:274/1/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	838
bsdb:274/1/2_human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	2701	1678	1578	39948	1654
bsdb:274/2/1_cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_UP	NA	543311
bsdb:274/2/2_cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_DOWN	NA	1578	1301	561	71655	620	162289
bsdb:274/3/1_cervical-glandular-intraepithelial-neoplasia:high-grade-dysplasia_vs_HPV-_UP	NA	2701	1485	543311	168808	1380	906	177971
bsdb:274/3/2_cervical-glandular-intraepithelial-neoplasia:high-grade-dysplasia_vs_HPV-_DOWN	NA	1678	1301	2129	39948	836	1578
bsdb:274/4/2_cervical-cancer:invasive-cervical-carcinoma_vs_HPV-_DOWN	NA	1578	1301	2129	561	71655	620	404402	1678	39948	1716
bsdb:274/5/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	133925	177971	1578	838	906
bsdb:274/5/2_human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	1375	165779	2701	1678
bsdb:274/6/1_cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_UP	NA	168808	836	838	1678	1485	1578	39948
bsdb:274/6/2_cervical-glandular-intraepithelial-neoplasia:low-grade-dysplasia_vs_HPV-_DOWN	NA	1578
bsdb:274/7/1_cervical-glandular-intraepithelial-neoplasia:high-grade-dysplasia_vs_HPV-_UP	NA	1485	2701	906	543311	168808	177971
bsdb:274/7/2_cervical-glandular-intraepithelial-neoplasia:high-grade-dysplasia_vs_HPV-_DOWN	NA	1375	165779	1678	39948	162290	2701	404402	836
bsdb:274/8/1_cervical-cancer:invasive-cervical-carcinoma_vs_HPV-_DOWN	NA	165779	1678	2701	1578	437755
bsdb:274/9/1_human-papilloma-virus-infection,cervical-cancer:normal-pH_vs_abnormal-pH_UP	NA	838	1301	29465	1380	1485	1257	1350	543311	1279	168808	1378	2701	437755	906	177971	1678
bsdb:274/9/2_human-papilloma-virus-infection,cervical-cancer:normal-pH_vs_abnormal-pH_DOWN	NA	1578	561	71655	620	1485
bsdb:274/10/1_human-papilloma-virus-infection:Hispanic_vs_non-Hispanic_UP	NA	29465	1301	1375	2701	1350	437755	906	168808	1380	177971	836
bsdb:274/10/2_human-papilloma-virus-infection:Hispanic_vs_non-Hispanic_DOWN	NA	1578
bsdb:275/1/1_acute-lymphoblastic-leukemia:adolescent-ALL-patient_vs_healthy-sibling-control_UP	NA	816
bsdb:275/1/2_acute-lymphoblastic-leukemia:adolescent-ALL-patient_vs_healthy-sibling-control_DOWN	NA	841
bsdb:276/2/1_multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-control_UP	NA	816	191303	413496
bsdb:276/2/2_multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-control_DOWN	NA	1508657	1730	207244	84108	135858	904
bsdb:276/3/1_multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-control_UP	NA	816	216851	841	29465	904	1472649	830	174708
bsdb:276/3/2_multiple-myeloma:Multiple-Myeloma-patient_vs_healthy-control_DOWN	NA	1481960
bsdb:277/1/1_Crohn's-disease:crohn's-disease_vs_healthy-control_DOWN	NA	216851	1263	841	239759	1730	46239	206664	836	28138	375288	830
bsdb:278/1/1_non-alcoholic-fatty-liver-disease:non-alcoholic-fatty-liver-disease_vs_healthy-control_UP	NA	1578
bsdb:278/1/2_non-alcoholic-fatty-liver-disease:non-alcoholic-fatty-liver-disease_vs_healthy-control_DOWN	NA	239759	207244	816	572511	189330	216851
bsdb:279/1/2_acute-myeloid-leukemia:High-Intensity-Chemotherapy_vs_Low-Intensity-Chemotherapy_DOWN	NA	55193
bsdb:279/2/1_acute-myeloid-leukemia:bacterial-infections-at-T3_vs_No-bacterial-infections-at-T3_UP	NA	1535326
bsdb:279/3/1_acute-myeloid-leukemia:bacterial-infections-at-T6_vs_No-bacterial-infections-at-T6_DOWN	NA	5506
bsdb:279/4/1_acute-myeloid-leukemia:Amphotericin-B-use_vs_No-Amphotericin-B-use_UP	NA	5506
bsdb:280/1/1_cervical-glandular-intraepithelial-neoplasia:high-grade-squamus-intraepithelial-lesion_vs_low-grade-squamus-intraepithelial-lesion_UP	NA	165779	168808
bsdb:281/1/1_acute-lymphoblastic-leukemia:Fecal-bacterial-composition-in-small-intestines-of-leukemia-mice_vs_Fecal-bacterial-composition-in-small-intestines-of-control-mice_UP	NA	119852	2086	830	189330	1263	1485	33042	207244	239934	572511
bsdb:281/1/2_acute-lymphoblastic-leukemia:Fecal-bacterial-composition-in-small-intestines-of-leukemia-mice_vs_Fecal-bacterial-composition-in-small-intestines-of-control-mice_DOWN	NA	1578	447020	191303	207244	239934	572511
bsdb:282/1/2_graft-versus-host-disease:Grades-II-IV-(acute-graft-host-disease)_vs_Grades-0-I-(non-acute-graft-host-disease)_DOWN	NA	1506553	572511
bsdb:283/1/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	84111	1378
bsdb:284/1/1_chronic-kidney-disease:Chronic-kidney-disease_vs_healthy-controls_UP	NA	1654	59735	1716	32207	1301	1578
bsdb:284/1/2_chronic-kidney-disease:Chronic-kidney-disease_vs_healthy-controls_DOWN	NA	848	836
bsdb:285/1/1_multiple-sclerosis:pediatric-multiple-sclerosis_vs_healthy-controls_UP	NA	35832	1678	872	135858	33024
bsdb:285/1/2_multiple-sclerosis:pediatric-multiple-sclerosis_vs_healthy-controls_DOWN	NA	28050	577309	816	119852
bsdb:285/3/1_multiple-sclerosis:IMD-naive-cases-multiple-sclerosis_vs_healthy-controls_UP	NA	904	1380	1678	35832	135858	33042	872	189330	1730	158846	906	2172	119852	33024	113286	1263	40544
bsdb:285/3/2_multiple-sclerosis:IMD-naive-cases-multiple-sclerosis_vs_healthy-controls_DOWN	NA	577309	816	1263	574697	33042	207244	40544	135858	39948	189330
bsdb:286/1/2_Graves-ophthalmopathy:graves-orbitopathy_vs_Healthy-controls_DOWN	NA	207244	572511	574697	102106	1407607	1263
bsdb:288/1/1_Phenylketonuria:phenylketonuric-with-Phe-restricted-diet_vs_mild-hyperphenylalaninemic-with-unrestricted-diet_DOWN	NA	841	1578
bsdb:289/1/1_health-trait:suboptimal-health-status_vs_healthy-controls_UP	NA	59732	119852	841	1263
bsdb:289/1/2_health-trait:suboptimal-health-status_vs_healthy-controls_DOWN	NA	581	48736	40544
bsdb:290/1/1_oral-mucositis:ulcerative-oral-mucositis_vs_no-ulcerative-oral-mucositis_UP	NA	29465	1350	1301	1279	848	838
bsdb:290/1/2_oral-mucositis:ulcerative-oral-mucositis_vs_no-ulcerative-oral-mucositis_DOWN	NA	1301	1654
bsdb:290/2/1_oral-mucositis:pre--and-three-month-after-auto-stem-cell-transplant_vs_one-and-two-weeks-after-stem-cell-transplant_UP	NA	838	32067
bsdb:290/2/2_oral-mucositis:pre--and-three-month-after-auto-stem-cell-transplant_vs_one-and-two-weeks-after-stem-cell-transplant_DOWN	NA	1578
bsdb:290/3/1_oral-mucositis:pre--and-three-month-after-auto-stem-cell-transplant_vs_one-and-two-weeks-after-stem-cell-transplant_UP	NA	1654
bsdb:290/4/1_oral-mucositis:0.1%-or-higher-fungi-load_vs_low-or-no-fungi-load_UP	NA	196081	1279	1578
bsdb:290/4/2_oral-mucositis:0.1%-or-higher-fungi-load_vs_low-or-no-fungi-load_DOWN	NA	29465	1654	838	32067	906	1301
bsdb:291/1/1_Graves-disease:graves-disease_vs_healthy-controls_UP	NA	838	724
bsdb:291/1/2_Graves-disease:graves-disease_vs_healthy-controls_DOWN	NA	239759	216851
bsdb:292/1/2_response-to-allogeneic-hematopoietic-stem-cell-transplant:allogeneic-hematopoietic-stem-cell-transplant_vs_community-dwelling-controls_DOWN	NA	1283313	724	32067	482	265975	838	1301
bsdb:293/1/1_human-papilloma-virus-infection:Baseline-HPV+_vs_Baseline-HPV-_UP	NA	2129
bsdb:293/1/2_human-papilloma-virus-infection:Baseline-HPV+_vs_Baseline-HPV-_DOWN	NA	1582879	216851	848	873565
bsdb:293/2/1_human-papilloma-virus-infection:new-acquisition-of-HPV-within-a-year_vs_no-new-acquisition-of-HPV-within-a-year_DOWN	NA	1654
bsdb:295/1/1_human-papilloma-virus-infection:low-risk-HPV_vs_negative-control_UP	NA	1654	239759	1678	35832	572511	574697	1485	1348911	33042	39948	1407607	204475	70774	906	745	1257	33024	841	1263	1200657	168808	40544
bsdb:295/1/2_human-papilloma-virus-infection:low-risk-HPV_vs_negative-control_DOWN	NA	209	68	497726
bsdb:297/1/1_human-papilloma-virus-infection:non-pregnant-high-risk-HPV_vs_non-pregnant-no-HPV_UP	NA	1678	1386
bsdb:297/1/2_human-papilloma-virus-infection:non-pregnant-high-risk-HPV_vs_non-pregnant-no-HPV_DOWN	NA	1578
bsdb:297/2/1_human-papilloma-virus-infection:pregnant-high-risk-HPV_vs_pregnant-no-HPV_UP	NA	12916
bsdb:297/2/2_human-papilloma-virus-infection:pregnant-high-risk-HPV_vs_pregnant-no-HPV_DOWN	NA	1301
bsdb:298/2/1_acute-myeloid-leukemia:infection_vs_no-infection_UP	NA	40323
bsdb:298/2/2_acute-myeloid-leukemia:infection_vs_no-infection_DOWN	NA	1301
bsdb:298/3/1_acute-myeloid-leukemia:infection_vs_no-infection_UP	NA	40323
bsdb:300/1/2_graft-versus-host-disease:acute-graft--versus--host-disease_vs_non--graft--versus--host-disease_DOWN	NA	1470353
bsdb:301/1/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	39948	906	168808	848
bsdb:301/1/2_human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	1578
bsdb:301/2/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	168808
bsdb:301/3/1_human-papilloma-virus-infection:HR-HPV+_vs_HPV-_UP	NA	168808
bsdb:302/3/1_asthma:exacerbated-asthma_vs_non-exacerbated-asthma_UP	NA	838	222991	2701
bsdb:302/3/2_asthma:exacerbated-asthma_vs_non-exacerbated-asthma_DOWN	NA	39948
bsdb:303/1/1_non-Hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_UP	NA	544	1350	375288	1380	570
bsdb:303/1/2_non-Hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_DOWN	NA	447020	165779	1380	1678	572511	1485	102106	33042	189330	570	28050	119852	841	1263
bsdb:304/1/1_antimicrobial-agent:oral-intake-of-vancomycin-(directed-against-Gram-positive-bacteria)_vs_or-placebo-(microcrystalline-cellulose)_UP	NA	1380	1678	102106
bsdb:305/1/1_Genital-neoplasm,-female:women-with-gynecological-cancer_vs_healthy-controls_UP	NA	165779	39948	1582879	848	2050	437755	2093	543311	162289	1257	836	838	168808
bsdb:305/1/2_Genital-neoplasm,-female:women-with-gynecological-cancer_vs_healthy-controls_DOWN	NA	1678	1578	177971
bsdb:306/1/1_graft-versus-host-disease:post--allogeneic-hematopoietic-stem-cell-transplant_vs_pre--allogeneic-hematopoietic-stem-cell-transplant_UP	NA	160674	416916	838	1578
bsdb:306/1/2_graft-versus-host-disease:post--allogeneic-hematopoietic-stem-cell-transplant_vs_pre--allogeneic-hematopoietic-stem-cell-transplant_DOWN	NA	413496	160674	416916	838	1578
bsdb:307/1/1_antimicrobial-agent:moxifloxacin-treated-group-(MXF)_vs_Negative-control-group-(CLT)_UP	NA	572511
bsdb:307/1/2_antimicrobial-agent:moxifloxacin-treated-group-(MXF)_vs_Negative-control-group-(CLT)_DOWN	NA	239759	572511	574697	135858	1485	100883	1730	216851	459786
bsdb:307/2/1_antimicrobial-agent:DAV132+moxifloxacin-treated-group-(MXF+DAV132)_vs_moxifloxacin-treated-group-(MXF)_UP	NA	239759	216851	572511	459786	100883	1730	574697	135858
bsdb:307/2/2_antimicrobial-agent:DAV132+moxifloxacin-treated-group-(MXF+DAV132)_vs_moxifloxacin-treated-group-(MXF)_DOWN	NA	572511
bsdb:307/3/2_antimicrobial-agent:DAV132+moxifloxacin-treated-group-(MXF+DAV132)_vs_Negative-control-group-(CLT)_DOWN	NA	135858
bsdb:308/1/1_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_UP	NA	1578
bsdb:308/1/2_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	1578	1279
bsdb:308/2/1_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_UP	NA	28050	816
bsdb:308/2/2_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	816	1279	1578	191303
bsdb:308/3/2_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	816	119852	1263	1279	191303
bsdb:308/4/2_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	1578
bsdb:308/5/1_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_UP	NA	375288
bsdb:308/5/2_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	2086	1485	191303
bsdb:308/6/1_air-pollution:PM-2.5-air-exposed-group_vs_Filtered-air-group_DOWN	NA	1578	1279
bsdb:309/1/1_cervical-glandular-intraepithelial-neoplasia:CIN2+_vs_CIN1_UP	NA	1578	816	375288	59195	574697
bsdb:309/2/1_cervical-glandular-intraepithelial-neoplasia:>38.8%-8-OHdG-positive-cervical-cells_vs_<=38.8%-8-OHdG-positive-cervical-cells_UP	NA	286	357	665874	20
bsdb:310/1/1_non-Hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_UP	NA	816	561
bsdb:310/1/2_non-Hodgkins-lymphoma:post-chemotherapy_vs_pre-chemotherapy_DOWN	NA	572511	216851	841	1678
bsdb:311/1/1_graft-versus-host-disease:post--engraftment_vs_pre--engraftment_DOWN	NA	572511	189330	841	216851	119852
bsdb:311/2/1_graft-versus-host-disease:post--engraftment_vs_pre--engraftment_DOWN	NA	1678	33042	189330	28050	841	1263	119852
bsdb:312/2/1_antimicrobial-agent:Infants-born-by-mothers-positive-to-GBS-and-received-IAP_vs_infants-born-by-mothers-negative-to-GBS_DOWN	NA	1678
bsdb:313/1/1_non-Hodgkins-lymphoma:bloodstream-infection_vs_non-bloodstream-infection_UP	NA	29465
bsdb:313/1/2_non-Hodgkins-lymphoma:bloodstream-infection_vs_non-bloodstream-infection_DOWN	NA	574697	51514	216851	119852	40544
bsdb:314/1/1_cervical-glandular-intraepithelial-neoplasia:CIN-non-regression_vs_CIN-regression_UP	NA	1380	168808	906	543311	838
bsdb:314/1/2_cervical-glandular-intraepithelial-neoplasia:CIN-non-regression_vs_CIN-regression_DOWN	NA	1578
bsdb:316/4/1_Delivery-method:10-day-old-vaginally-delivered-pre-term-neonates_vs_10-day-old-cesarean-delivered-pre-term-neontes_UP	NA	816
bsdb:316/11/1_antimicrobial-agent:90-day-old-pre-tem-neonates-exposed-to-antibiotics-(IAP/postnatal)_vs_90-day-old-pre-term-neonates-not-exposed-to-antibiotics-(IAP/postnatal)_DOWN	NA	1678
bsdb:317/1/1_obsessive-compulsive-disorder:OCD-T0-(Baseline)_vs_Control-(healthy-group)_UP	NA	239759	207244	1348911	946234	1649459	459786
bsdb:317/1/2_obsessive-compulsive-disorder:OCD-T0-(Baseline)_vs_Control-(healthy-group)_DOWN	NA	1766253	580596	135858	1485	33042	39948	404402	28050	577309	1501226
bsdb:317/2/1_obsessive-compulsive-disorder:OCD-T0_vs_Control-(healthy-group)_UP	NA	265975	1654	1380	1164882	86331
bsdb:317/3/1_obsessive-compulsive-disorder:OCD-T3_vs_Control-(healthy-group)_UP	NA	239759	207244	244127	35832	1348911	1432051	946234	61170	1649459	459786	1929305	1508657
bsdb:317/3/2_obsessive-compulsive-disorder:OCD-T3_vs_Control-(healthy-group)_DOWN	NA	135858	33042	1505657	577309	1501226
bsdb:317/4/1_obsessive-compulsive-disorder:OCD-T3_vs_Control-(healthy-group)_UP	NA	1654	1380	43996	86331
bsdb:317/4/2_obsessive-compulsive-disorder:OCD-T3_vs_Control-(healthy-group)_DOWN	NA	830	1716	43994
bsdb:318/2/1_graft-versus-host-disease:acute-graft-versus-host-disease_vs_non-acute-graft-versus-host-disease_UP	NA	216851	1730
bsdb:319/1/1_air-pollution:mice-exposed-to-filtered-air-(FA)_vs_mice-exposed-to-PM-2.5-(CAP)_UP	NA	248744	2093
bsdb:319/1/2_air-pollution:mice-exposed-to-filtered-air-(FA)_vs_mice-exposed-to-PM-2.5-(CAP)_DOWN	NA	209	1501226	100175	174708	191303
bsdb:320/1/1_antimicrobial-agent:infants(6-weeks)-to-mothers-exposed-to-intrapartum-antibiotic_vs_infants-(6-weeks)-to-mothers-unexposed-to--intrapartum-antibiotic_UP	NA	119852	113286	184869
bsdb:320/1/2_antimicrobial-agent:infants(6-weeks)-to-mothers-exposed-to-intrapartum-antibiotic_vs_infants-(6-weeks)-to-mothers-unexposed-to--intrapartum-antibiotic_DOWN	NA	816	1678	572511	841	1263
bsdb:320/2/1_antimicrobial-agent:infants(1-year)-to-mothers-exposed-to-intrapartum-antibiotic_vs_infants-(1-year)-to-mothers-unexposed-to--intrapartum-antibiotic_UP	NA	119852	113286	184869
bsdb:320/2/2_antimicrobial-agent:infants(1-year)-to-mothers-exposed-to-intrapartum-antibiotic_vs_infants-(1-year)-to-mothers-unexposed-to--intrapartum-antibiotic_DOWN	NA	816	1678	572511	841
bsdb:320/3/1_antimicrobial-agent:infants(6-weeks)-to-mothers-exposed-to--antibiotic-penicillin_vs_infants-(6-weeks)-to-mothers-unexposed-to--antibiotic_DOWN	NA	816	1678
bsdb:320/4/1_antimicrobial-agent:infants(1-year)-to-mothers-exposed-to-the-penicillin-group_vs_infants-(1-year)-to-mothers-unexposed-to--antibiotic_UP	NA	33042
bsdb:320/4/2_antimicrobial-agent:infants(1-year)-to-mothers-exposed-to-the-penicillin-group_vs_infants-(1-year)-to-mothers-unexposed-to--antibiotic_DOWN	NA	816	1485	158846	1301
bsdb:320/6/1_antimicrobial-agent:infants-to-mothers-exposed-to-cephalosporins_vs_infants-to-mothers-unexposed-to-intrapartum-antibiotic_DOWN	NA	1678
bsdb:321/1/1_antimicrobial-agent:10-d-old-7-10-day-treatment-infants_vs_10-d-old-2-day-treatment-infants_DOWN	NA	1357	816
bsdb:322/1/1_oral-mucositis:patients-with-newly-diagnosed-malignancies_vs_reference_UP	NA	46123	1357	203697
bsdb:322/1/2_oral-mucositis:patients-with-newly-diagnosed-malignancies_vs_reference_DOWN	NA	1716	346096	1378	848	22	2745	713
bsdb:322/2/1_oral-mucositis:oral-mucositis_vs_no-oral-mucositis_UP	NA	1016	1357	146
bsdb:322/3/1_oral-mucositis:during-chemotherapy_vs_at-malignancy-diagnosis_UP	NA	1279
bsdb:322/3/2_oral-mucositis:during-chemotherapy_vs_at-malignancy-diagnosis_DOWN	NA	203697
bsdb:322/4/1_oral-mucositis:during-chemotherapy_vs_at-malignancy-diagnosis_UP	NA	338
bsdb:322/5/1_oral-mucositis:mucositis-lesions_vs_all-samples_UP	NA	46123	1654	1386	1357	196081	1279	1578	1257	40323	2093
bsdb:322/5/2_oral-mucositis:mucositis-lesions_vs_all-samples_DOWN	NA	713	416916	724
bsdb:323/1/1_necrotizing-enterocolitis:NEC_vs_non-NEC_UP	NA	1485	1279
bsdb:323/1/2_necrotizing-enterocolitis:NEC_vs_non-NEC_DOWN	NA	28196	150022	29330	1654	286	59732	283	1301	1716
bsdb:323/3/1_necrotizing-enterocolitis:NEC_vs_non-NEC_UP	NA	1279
bsdb:324/1/1_thyroid-carcinoma:patients-with-thyroid-carcinoma_vs_healthy-controls_UP	NA	207244	33042	561	1505657	570	1578	620	1301	292632	191303	1357	239759
bsdb:324/1/2_thyroid-carcinoma:patients-with-thyroid-carcinoma_vs_healthy-controls_DOWN	NA	1283313	816	1506553	158846	33024	838	841
bsdb:325/1/1_psoriasis:psoriasis_vs_healthy-controls_UP	NA	572511	1263	216851	1678	33042	86331	189330	990721	1654	102106
bsdb:325/1/2_psoriasis:psoriasis_vs_healthy-controls_DOWN	NA	574697	35832	283168	375288	838	40544	28050	577309
bsdb:326/1/1_non-small-cell-lung-carcinoma,renal-cell-carcinoma:Responders_vs_Non-Responders_UP	NA	1392389	838
bsdb:326/1/2_non-small-cell-lung-carcinoma,renal-cell-carcinoma:Responders_vs_Non-Responders_DOWN	NA	572511	838
bsdb:326/2/1_non-small-cell-lung-carcinoma,renal-cell-carcinoma:Progressive--Free--Survival-more-than-30-days_vs_Progressive--Free--Survival-more-less-than-30-days_UP	NA	239759	572511	1392389	1263
bsdb:327/1/1_antimicrobial-agent:infants-who-received-short-term-or-long-term-antibiotic-treatment---week-1_vs_control-(no-treatment)---week-1_UP	NA	1578
bsdb:327/1/2_antimicrobial-agent:infants-who-received-short-term-or-long-term-antibiotic-treatment---week-1_vs_control-(no-treatment)---week-1_DOWN	NA	561	1301
bsdb:327/2/1_antimicrobial-agent:infants-received-long-term(>5days)-antibiotic-treatment---week-2_vs_control(no-treatment)---week-2_UP	NA	1350
bsdb:327/3/2_antimicrobial-agent:infants-received-long-term-(>5days)-antibiotic-treatment---week-1_vs_infants-received-short-term-(<3days)-antibiotic-treatment---week-1_UP	NA	29465
bsdb:328/1/1_psoriatic-arthritis:psoriatic-arthiritis_vs_healthy-controls_DOWN	NA	239934	33042	46205	1263
bsdb:328/2/1_psoriatic-arthritis:skin-psoriasis_vs_healthy-controls_DOWN	NA	375288	100883	33042
bsdb:328/3/1_psoriatic-arthritis:psoriatic-arthiritis_vs_skin-psoriasis_UP	NA	100883
bsdb:329/1/1_antimicrobial-agent:Postnatal-antibiotic-group-(2-day-old-infant)_vs_control-group_UP	NA	1578
bsdb:329/1/2_antimicrobial-agent:Postnatal-antibiotic-group-(2-day-old-infant)_vs_control-group_DOWN	NA	816
bsdb:329/2/1_antimicrobial-agent:IAP-group-(4-day-old-infant)_vs_control-group_DOWN	NA	816
bsdb:329/3/1_antimicrobial-agent:IAP-group-(6-month-old-infant)_vs_control-group_UP	NA	1485
bsdb:329/4/1_antimicrobial-agent:IAP+postnatal-antibiotic-group-(2-day-old-infant)_vs_control-group_UP	NA	1578
bsdb:329/4/2_antimicrobial-agent:IAP+postnatal-antibiotic-group-(2-day-old-infant)_vs_control-group_DOWN	NA	816
bsdb:329/5/1_antimicrobial-agent:IAP+postnatal-antibiotic-group-(4-day-old-infant)_vs_control-group_DOWN	NA	816
bsdb:329/6/1_antimicrobial-agent:IAP+postnatal-antibiotic-group-(6-month-old-infant)_vs_control-group_UP	NA	1485
bsdb:330/1/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	1578	2129
bsdb:330/2/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	1578	2129
bsdb:330/2/2_human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	724	1257
bsdb:330/3/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	150022
bsdb:330/3/2_human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	724
bsdb:331/1/1_Hashimoto's-thyroiditis:hashimoto's-thyroiditis-patients_vs_healthy-controls_UP	NA	207244	572511	580596	33042	189330	1407607	724	1501226	841	1301	292632	1485
bsdb:331/1/2_Hashimoto's-thyroiditis:hashimoto's-thyroiditis-patients_vs_healthy-controls_DOWN	NA	816	216851	838	1283313	33024	1506553	375288	577309	1154586
bsdb:333/1/1_antimicrobial-agent:infants-with-(Abx)_vs_without-(non-Abx)-use-of-maternal-antimicrobial-agents-at-delivery_DOWN	NA	1678
bsdb:334/1/1_antimicrobial-agent:infants(14-d-old)-exposed-to-prenatal-antibiotic-therapy-(PAT-group)_vs_prenatal-antibiotic-free-group-(PAF-group)_UP	NA	1618113
bsdb:334/1/2_antimicrobial-agent:infants(14-d-old)-exposed-to-prenatal-antibiotic-therapy-(PAT-group)_vs_prenatal-antibiotic-free-group-(PAF-group)_DOWN	NA	1678
bsdb:334/2/2_antimicrobial-agent:infants-exposed-to-antibiotic->7day-(H-group)_vs_infants-exposed-to-antibiotic-<=7day-(L-group)_DOWN	NA	1678
bsdb:336/1/1_antimicrobial-agent:combination-of-penicillin-and-moxalactam-group-(postnatal-day-3)_vs_Antibiotic-free-group-(postnatal-day-3)_UP	NA	816	1578	13687
bsdb:336/1/2_antimicrobial-agent:combination-of-penicillin-and-moxalactam-group-(postnatal-day-3)_vs_Antibiotic-free-group-(postnatal-day-3)_DOWN	NA	1485
bsdb:336/4/1_antimicrobial-agent:piperacillin-tazobactam-group-(postnatal-day-7)_vs_Antibiotic-free-group-(postnatal-day-7)_UP	NA	816	1350
bsdb:336/4/2_antimicrobial-agent:piperacillin-tazobactam-group-(postnatal-day-7)_vs_Antibiotic-free-group-(postnatal-day-7)_DOWN	NA	570
bsdb:336/5/1_antimicrobial-agent:combination-of-penicillin-and-moxalactam-group-(postnatal-day-3)_vs_piperacillin-tazobactam-group-(postnatal-day-3)_DOWN	NA	1350
bsdb:336/6/1_antimicrobial-agent:combination-of-penicillin-and-moxalactam-group-(postnatal-day-7)_vs_piperacillin-tazobactam-group-(postnatal-day-7)_DOWN	NA	1485
bsdb:337/1/1_antimicrobial-agent:3-month-old-infants-exposed-to-antibiotics-in-the-second-trimester_vs_3-month-old-infants-not-exposed-to-antibiotics-during-the-second-trimester_UP	NA	1407607	1350
bsdb:337/1/2_antimicrobial-agent:3-month-old-infants-exposed-to-antibiotics-in-the-second-trimester_vs_3-month-old-infants-not-exposed-to-antibiotics-during-the-second-trimester_DOWN	NA	816	1279	1301	29465
bsdb:337/3/1_antimicrobial-agent:12-month-old-infants-exposed-to-antibiotics-during-the-second-trimester_vs_12-month-old-infants-not-exposed-to-antibiotics-during-the-second-trimester_UP	NA	1485	29465
bsdb:337/3/2_antimicrobial-agent:12-month-old-infants-exposed-to-antibiotics-during-the-second-trimester_vs_12-month-old-infants-not-exposed-to-antibiotics-during-the-second-trimester_DOWN	NA	239934	239759	816	572511	1485	204475	1506553	29465
bsdb:338/1/1_obesity:obese-children_vs_normal-weight-children_UP	NA	216851	724	28050	158846	33024
bsdb:338/1/2_obesity:obese-children_vs_normal-weight-children_DOWN	NA	39948	119852
bsdb:338/2/1_obesity:obese-children_vs_normal-weight-children_UP	NA	713	416916	194	848	117563	724	28050	158846	33024	32207	1301	40544	191303	29465
bsdb:338/2/2_obesity:obese-children_vs_normal-weight-children_DOWN	NA	447020	239759	244127	1678	35832	990721	1485	102106	1185408	872	1730	1769729	61170	119852	846	838	1263	44748
bsdb:341/1/1_smoking-behavior:patients-with-FD,-ID,or-CD-who-currently-smoked_vs_never-smoked_UP	NA	32207	1301	29465
bsdb:341/2/1_smoking-behavior:patients-with-FD,-ID,or-CD-who-currently-smokes_vs_never-smoked_DOWN	NA	482	838
bsdb:342/1/1_asthma:Children-who-experienced-exacerbation_vs_children-who-did-not-experience-asthma-exacerbation_DOWN	NA	724
bsdb:342/2/1_asthma:Samples-with-any-rhinovirus-infection_vs_Samples-with-no-rhinovirus-infection_UP	NA	1301
bsdb:342/2/2_asthma:Samples-with-any-rhinovirus-infection_vs_Samples-with-no-rhinovirus-infection_DOWN	NA	1279
bsdb:342/3/1_asthma:Samples-with-rhinovirus-A-(RV-A)_vs_Samples-that-were-RV-A-negative-_UP	NA	724	1301
bsdb:342/3/2_asthma:Samples-with-rhinovirus-A-(RV-A)_vs_Samples-that-were-RV-A-negative-_DOWN	NA	1279
bsdb:342/5/1_asthma:Children-who-experienced-exacerbation_vs_children-who-did-not-experience-exacerbation_UP	NA	475
bsdb:342/5/2_asthma:Children-who-experienced-exacerbation_vs_children-who-did-not-experience-exacerbation_DOWN	NA	1651	1716	724	1279
bsdb:342/7/1_asthma:samples-with-any-rhinovirus-infection_vs_samples-with-no-rhinovirus-infection_UP	NA	1301
bsdb:342/7/2_asthma:samples-with-any-rhinovirus-infection_vs_samples-with-no-rhinovirus-infection_DOWN	NA	1279
bsdb:342/8/1_asthma:Samples-with-rhinovirus-A_vs_Rhinovirus-negative-samples_UP	NA	724	1301
bsdb:342/8/2_asthma:Samples-with-rhinovirus-A_vs_Rhinovirus-negative-samples_DOWN	NA	1279
bsdb:343/1/1_leukemia:Acute-anti-leukemia-treatment_vs_Allogeneic-Hematopoetic-Stem-Cell-Transplant_UP	NA	816	239934	216851
bsdb:343/1/2_leukemia:Acute-anti-leukemia-treatment_vs_Allogeneic-Hematopoetic-Stem-Cell-Transplant_DOWN	NA	1485
bsdb:344/1/1_air-pollution:mice-exposed-to-Pm-2.5-suspension_vs_mice-exposed-suspension-from-extracts-of-blank-filter_UP	NA	946234	848	459786
bsdb:344/1/2_air-pollution:mice-exposed-to-Pm-2.5-suspension_vs_mice-exposed-suspension-from-extracts-of-blank-filter_DOWN	NA	1386	80865	173479	55968	248038	283168	286	970	13687	1301
bsdb:345/1/1_obesity:obese_vs_normal_UP	NA	158846
bsdb:345/1/2_obesity:obese_vs_normal_DOWN	NA	207244	816	61170	459786
bsdb:346/1/1_unipolar-depression:severe-depression_vs_mild-depression_UP	NA	1263
bsdb:346/2/1_unipolar-depression:moderate-depression_vs_mild-depression_UP	NA	946234
bsdb:346/3/2_anxiety-disorder:severe-anxiety_vs_mild-anxiety_DOWN	NA	1847725	1654
bsdb:350/1/1_obesity:obese_vs_normal-weight_UP	NA	836	216851
bsdb:350/1/2_obesity:obese_vs_normal-weight_DOWN	NA	33024
bsdb:350/2/1_obesity:obesity-with-metabolic-syndrome_vs_normal-weight_UP	NA	102106	33042	135858
bsdb:351/1/1_obesity:overweight/obesity_vs_normal_UP	NA	1578
bsdb:351/1/2_obesity:overweight/obesity_vs_normal_DOWN	NA	1678
bsdb:352/1/1_cervical-glandular-intraepithelial-neoplasia,human-papilloma-virus-infection:Low-Grade-Squamous-Intraepithelial-Lesion_vs_Atypical-Squamous-Cells-of-Undetermined-Significance_DOWN	NA	4930
bsdb:352/2/1_cervical-glandular-intraepithelial-neoplasia,human-papilloma-virus-infection:High-risk-HPV_vs_Low-risk-HPV_UP	NA	55193
bsdb:352/4/1_cervical-glandular-intraepithelial-neoplasia,human-papilloma-virus-infection:High-risk-HPV_vs_Low-risk-HPV_UP	NA	55193
bsdb:354/1/2_obesity:overweight/obese_vs_control-(BMI-at-normal-range)_DOWN	NA	872
bsdb:356/1/1_air-pollution:ICR-male-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-3_UP	NA	841	239759
bsdb:356/1/2_air-pollution:ICR-male-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-3_DOWN	NA	66831	482
bsdb:356/2/1_air-pollution:ICR-male-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-10_UP	NA	583
bsdb:356/3/1_air-pollution:ICR-male-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-21_UP	NA	1378	459786	841	1485
bsdb:356/4/1_air-pollution:ICR-male-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-35_UP	NA	1301
bsdb:356/4/2_air-pollution:ICR-male-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-35_DOWN	NA	816	872	244127
bsdb:356/5/2_air-pollution:ICR-female-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-10_DOWN	NA	580024	838
bsdb:356/6/2_air-pollution:ICR-female-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-21_DOWN	NA	1578
bsdb:356/7/2_air-pollution:ICR-female-mice-exposed-to-PM-2.5_vs_mice-dams-exposed-to-filtered-blanks-PND-35_DOWN	NA	1485
bsdb:357/1/1_air-pollution:post-smog-swabs_vs_pre-smog-swabs_UP	NA	32067
bsdb:357/1/2_air-pollution:post-smog-swabs_vs_pre-smog-swabs_DOWN	NA	838
bsdb:358/1/1_cervical-glandular-intraepithelial-neoplasia,cervical-cancer:CIN2/3-CC_vs_Healthy-controls_UP	NA	1301	212791	46255	1279	1912216	1269
bsdb:360/1/1_air-pollution:mice-exposed-to-MVE_vs_mice-exposed-to-Filtered-Air_UP	NA	191303	1485
bsdb:360/1/2_air-pollution:mice-exposed-to-MVE_vs_mice-exposed-to-Filtered-Air_DOWN	NA	1578	119852
bsdb:360/2/2_air-pollution:mice-exposed-to-WS_vs_mice-exposed-to-Filtered-Air_DOWN	NA	1485	1578	119852
bsdb:361/1/1_air-pollution:male-mice-exposed-to-cigarette-smoke_vs_all-other-mice_UP	NA	239934
bsdb:361/2/1_air-pollution:female-mice-exposed-to-cigarette-smoke_vs_all-other-mice_UP	NA	816
bsdb:361/3/1_air-pollution:ovariectomized-female-mice-exposed-to-cigarette-smoke_vs_all-other-mice_UP	NA	830	28138	838
bsdb:361/4/1_air-pollution:mice-exposed-to-smoke_vs_control_UP	NA	239934	816	459786
bsdb:361/4/2_air-pollution:mice-exposed-to-smoke_vs_control_DOWN	NA	239759	28050
bsdb:363/1/1_smoking-behavior:current-smokers_vs_never-smokers_UP	NA	32207	1301	1380	906	1716	346096	109326	195950	44259	2093
bsdb:363/1/2_smoking-behavior:current-smokers_vs_never-smokers_DOWN	NA	2740	1016	482	2717	47670	1257	43996	848	1283313	836	1164882	32067	265975	1730	194	123375	724	1213720	1378
bsdb:364/1/1_smoking-behavior:smokers_vs_non-smokers_UP	NA	1654	29465
bsdb:365/1/1_methionine-measurement:mice-fed-American-Diet_vs_mice-fed-control-rodent-diet._UP	NA	33042	119852	1263	1386	1357
bsdb:365/1/2_methionine-measurement:mice-fed-American-Diet_vs_mice-fed-control-rodent-diet._DOWN	NA	1485	838
bsdb:366/1/1_non-alcoholic-fatty-liver-disease:nonalcoholic-fatty-liver-disease_vs_healthy-controls_UP	NA	1578	588605	841	189330
bsdb:366/1/2_non-alcoholic-fatty-liver-disease:nonalcoholic-fatty-liver-disease_vs_healthy-controls_DOWN	NA	459786
bsdb:367/1/2_obesity:obese_vs_normal-weight_DOWN	NA	119852
bsdb:368/1/1_smoking-behavior:shammah-users_vs_non-shammah-users_UP	NA	1301	32207	1578	419014
bsdb:368/1/2_smoking-behavior:shammah-users_vs_non-shammah-users_DOWN	NA	538	1257	265975	47
bsdb:369/1/1_obesity:obese_vs_normal-weight_UP	NA	816	28050	841
bsdb:369/1/2_obesity:obese_vs_normal-weight_DOWN	NA	84108	838	119852
bsdb:369/2/1_obesity:after-onset-of-obesity_vs_before-onset-of-obesity_UP	NA	135858	40544
bsdb:369/2/2_obesity:after-onset-of-obesity_vs_before-onset-of-obesity_DOWN	NA	1263
bsdb:370/1/1_air-pollution:Spring/Summer-individuals_vs_Winter-individuals_DOWN	NA	1378	117563	724	2745	1301
bsdb:372/1/1_air-pollution:Diesel-exhaust-particle-(DEP)-exposed-mice_vs_mice-exposed-to-FRA_UP	NA	1578
bsdb:372/1/2_air-pollution:Diesel-exhaust-particle-(DEP)-exposed-mice_vs_mice-exposed-to-FRA_DOWN	NA	816	1485
bsdb:373/1/1_obesity:overweight_vs_normal-weight-children_UP	NA	1350	1301
bsdb:373/2/1_obesity:overweight_vs_normal-weight-adult_UP	NA	1506553
bsdb:374/1/1_cervical-glandular-intraepithelial-neoplasia:cervical-intraepithelial-neoplasia-cases_vs_normal-controls_UP	NA	114627	1643951	953
bsdb:374/1/2_cervical-glandular-intraepithelial-neoplasia:cervical-intraepithelial-neoplasia-cases_vs_normal-controls_DOWN	NA	53246	497
bsdb:374/2/1_cervical-cancer:cervical-cancer_vs_normal-control_UP	NA	114627	1643951	953
bsdb:374/2/2_cervical-cancer:cervical-cancer_vs_normal-control_DOWN	NA	1578	1279	1263978
bsdb:375/1/1_obesity:obese_vs_normal-weight_UP	NA	1578
bsdb:375/1/2_obesity:obese_vs_normal-weight_DOWN	NA	838
bsdb:376/1/1_antimicrobial-agent:patients-that-took-amoxiclav_vs_before-antibiotic-exposure_UP	NA	816
bsdb:376/2/1_antimicrobial-agent:patients-that-took-levofloxacin/Metronidazole_vs_before-antibiotic-exposure_UP	NA	816
bsdb:376/3/1_antimicrobial-agent:patients-that-took-Piperacilin/Tazobactam_vs_before-antibiotic-exposure_UP	NA	816
bsdb:376/4/1_antimicrobial-agent:patients-that-took-Ceftriaxone/Azithromycin_vs_before-antibiotic-exposure_UP	NA	816
bsdb:376/5/1_antimicrobial-agent:patients-that-took-Ciprofloxacin_vs_before-antibiotic-exposure_UP	NA	816
bsdb:378/1/1_graft-versus-host-disease:Severe-acute-graft-versus-host-disease_vs_controls_UP	NA	1357	47670	40323
bsdb:378/1/2_graft-versus-host-disease:Severe-acute-graft-versus-host-disease_vs_controls_DOWN	NA	207244	572511	1505663	946234	1378	1392389	1506553	459786	1508657	1769710
bsdb:378/2/1_graft-versus-host-disease:Severe-acute-graft-versus-host-disease_vs_controls_UP	NA	40323	838
bsdb:378/2/2_graft-versus-host-disease:Severe-acute-graft-versus-host-disease_vs_controls_DOWN	NA	572511	946234	1506553	1769710
bsdb:379/1/1_obesity:non-obese_vs_obese_UP	NA	1678	1578
bsdb:379/2/1_obesity:obese_vs_non-obese_UP	NA	1378	117563
bsdb:379/2/2_obesity:obese_vs_non-obese_UP	NA	419014	156454
bsdb:381/1/1_response-to-allogeneic-hematopoietic-stem-cell-transplant:hematopoietic-stem-cell-transplant-recipients_vs_healthy-volunteers_UP	NA	1350
bsdb:381/1/2_response-to-allogeneic-hematopoietic-stem-cell-transplant:hematopoietic-stem-cell-transplant-recipients_vs_healthy-volunteers_DOWN	NA	46205	292632
bsdb:381/2/1_response-to-allogeneic-hematopoietic-stem-cell-transplant:high-fecal-butyrate-levels_vs_low-fecal-butyrate-levels_UP	NA	84111	1508657	1506553	572511	46205	1505663
bsdb:381/2/2_response-to-allogeneic-hematopoietic-stem-cell-transplant:high-fecal-butyrate-levels_vs_low-fecal-butyrate-levels_DOWN	NA	1578	1350
bsdb:382/1/1_Chlamydia-trachomatis-infectious-disease:patient-with-chlamydia-infection_vs_healthy-control_UP	NA	1375
bsdb:382/1/2_Chlamydia-trachomatis-infectious-disease:patient-with-chlamydia-infection_vs_healthy-control_DOWN	NA	1578
bsdb:382/2/1_human-papilloma-virus-infection,Chlamydophila-infectious-disease:patient-with-chlamydia-infection_vs_HPV-positive-women_UP	NA	810
bsdb:382/2/2_human-papilloma-virus-infection,Chlamydophila-infectious-disease:patient-with-chlamydia-infection_vs_HPV-positive-women_DOWN	NA	1578
bsdb:383/1/1_food-allergy:child-with-food-sensitization_vs_no-food-sensitization_DOWN	NA	724	39948	189330	1485
bsdb:383/2/1_food-allergy:child-with-food-allergy_vs_no-food-allergy_DOWN	NA	544	119852	1357	189330
bsdb:384/1/1_schizophrenia:FSCZ_vs_healthy-controls_UP	NA	561	620	29465	1350
bsdb:384/1/2_schizophrenia:FSCZ_vs_healthy-controls_DOWN	NA	848	906	713
bsdb:384/2/1_schizophrenia:TSCZ_vs_healthy-controls_UP	NA	561	1350	1578	620	1301	29465
bsdb:384/2/2_schizophrenia:TSCZ_vs_healthy-controls_DOWN	NA	713	906
bsdb:384/3/1_schizophrenia:TSCZ_vs_FSCZ_UP	NA	561	848	906	1350	1578	620	1301
bsdb:384/3/2_schizophrenia:TSCZ_vs_FSCZ_DOWN	NA	29465
bsdb:385/1/1_gastric-adenocarcinoma:gastric-adenocarcinoma-(GC)_vs_superficial-gastritis-(SG)_UP	NA	416916	482	1283313
bsdb:385/1/2_gastric-adenocarcinoma:gastric-adenocarcinoma-(GC)_vs_superficial-gastritis-(SG)_DOWN	NA	165695	150203	1654	561
bsdb:387/1/1_antimicrobial-agent:after-ciprofloxacin-exposure_vs_before-ciprofloxacin-exposure_UP	NA	816
bsdb:387/1/2_antimicrobial-agent:after-ciprofloxacin-exposure_vs_before-ciprofloxacin-exposure_DOWN	NA	239759	216851
bsdb:387/2/1_antimicrobial-agent:after-clindamycin-exposure_vs_Before-clindamycin-exposure_DOWN	NA	33042	189330	28050	841	1263
bsdb:388/1/1_oral-squamous-cell-carcinoma:cancerous--lesions_vs_paracancerous-tissues_UP	NA	44259	195950	543311	2747	1257	1301	157	848
bsdb:388/1/2_oral-squamous-cell-carcinoma:cancerous--lesions_vs_paracancerous-tissues_DOWN	NA	1663	41275	872	33882	248038	44249
bsdb:389/1/1_schizophrenia:schizophrenia_vs_healthy-controls_UP	NA	1301
bsdb:389/1/2_schizophrenia:schizophrenia_vs_healthy-controls_DOWN	NA	838
bsdb:389/2/1_schizophrenia:mania_vs_healthy-controls_UP	NA	1301	215579
bsdb:389/2/2_schizophrenia:mania_vs_healthy-controls_DOWN	NA	838
bsdb:390/1/1_schizophrenia:acute-schizphrenia_vs_healthy-controls_UP	NA	258514	1654	244127	35832	946234	1505657	1508657
bsdb:390/1/2_schizophrenia:acute-schizphrenia_vs_healthy-controls_DOWN	NA	1432051	1392389	1774107
bsdb:390/2/1_schizophrenia:scizophrenia-during-remission_vs_healthy-controls_UP	NA	1485	1505657	375288	191303
bsdb:390/2/2_schizophrenia:scizophrenia-during-remission_vs_healthy-controls_DOWN	NA	580596	577309	1432051
bsdb:390/3/1_schizophrenia:acute-schizphrenia_vs_symptomatic-remission_DOWN	NA	1485
bsdb:391/1/1_neuromyelitis-optica:neuromyelitis-optica-spectrum-disorder_vs_healthy-controls_UP	NA	561	620	265975	1486725	156454	946234	1301
bsdb:391/1/2_neuromyelitis-optica:neuromyelitis-optica-spectrum-disorder_vs_healthy-controls_DOWN	NA	40544	1407607	33042	1501226	572511	841	216851	838
bsdb:392/1/1_milk-allergic-reaction:non-IgE-mediated-cow's-milk-allergy_vs_healthy-controls_UP	NA	239759	816	1266
bsdb:392/2/1_milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy-treated-with-EHCF_vs_infant-with-non-IgE-mediated-cow's-milk-allergy-at-diagnosis_DOWN	NA	816	239759
bsdb:392/3/1_milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy-treated-with-EHCF+LGG_vs_infant-with-non-IgE-mediated-cow's-milk-allergy-at-diagnosis_DOWN	NA	239759	816
bsdb:392/3/2_milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy-treated-with-EHCF+LGG_vs_infant-with-non-IgE-mediated-cow's-milk-allergy-at-diagnosis_UP	NA	1883
bsdb:392/4/1_milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy-treated-with-EHCF+LGG_vs_infant-with-non-IgE-mediated-cow's-milk-allergy-treated-with-EHCF_UP	NA	28050	1578	119852	1263
bsdb:392/4/2_milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy-treated-with-EHCF+LGG_vs_infant-with-non-IgE-mediated-cow's-milk-allergy-treated-with-EHCF_DOWN	NA	239759	816	39948
bsdb:393/1/1_milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy-tolerant-to-cow's-milk-protein_vs_infant-with-non-IgE-mediated-cow's-milk-allergy-non-tolerant-to-cow's-milk-protein_UP	NA	1678
bsdb:393/2/2_milk-allergic-reaction:infant-with-non-IgE-mediated-cow's-milk-allergy_vs_healthy-control_DOWN	NA	816
bsdb:394/1/1_asthma:child-with-asthma-at-age-6_vs_healthy-control_UP	NA	838	29465
bsdb:396/1/1_atopic-eczema:atopic-dermatitis_vs_healthy-control_UP	NA	1279
bsdb:396/1/2_atopic-eczema:atopic-dermatitis_vs_healthy-control_DOWN	NA	47670	106589
bsdb:396/2/1_atopic-eczema:atopic-dermatitis-after-treatment-with-TCS-+-Bleach_vs_baseline_UP	NA	469	1716	838
bsdb:396/2/2_atopic-eczema:atopic-dermatitis-after-treatment-with-TCS-+-Bleach_vs_baseline_DOWN	NA	1279
bsdb:396/3/1_atopic-eczema:atopic-dermatitis-after-treatment-with-TCS-only_vs_baseline_UP	NA	469	1716	838
bsdb:396/3/2_atopic-eczema:atopic-dermatitis-after-treatment-with-TCS-only_vs_baseline_DOWN	NA	1279
bsdb:397/1/1_atopic-eczema:severe-atopic-dermatitis_vs_healthy-control_UP	NA	1279	1827	1651	114248
bsdb:397/1/2_atopic-eczema:severe-atopic-dermatitis_vs_healthy-control_DOWN	NA	1301	32207	29465	838	836	131079	32067	357	1380
bsdb:398/1/1_atopic-eczema:atopic-dermatitis_vs_healthy-control_DOWN	NA	1279
bsdb:399/1/1_age:non-healthy-aging-(NHA)_vs_healthy-aging-(HA)_UP	NA	32207	1301	29465	1578	1678
bsdb:399/1/2_age:non-healthy-aging-(NHA)_vs_healthy-aging-(HA)_DOWN	NA	1016	848	724	482	195950	157	538	47670	43994	2717	283	44259	1743	1716	836	1481960
bsdb:399/2/1_age:non-healthy-aging-(NHA)_vs_healthy-aging-(HA)_UP	NA	561	1578	620	1301	244127	46205	1508657
bsdb:399/2/2_age:non-healthy-aging-(NHA)_vs_healthy-aging-(HA)_DOWN	NA	239934	816	84108
bsdb:400/1/1_asthma:asthma_vs_healthy-control_UP	NA	561	1350	1485	1578	1730
bsdb:400/1/2_asthma:asthma_vs_healthy-control_DOWN	NA	216851	841	39948
bsdb:400/2/1_allergic-rhinitis:allergic-rhinitis_vs_healthy-control_UP	NA	447020
bsdb:400/2/2_allergic-rhinitis:allergic-rhinitis_vs_healthy-control_DOWN	NA	189330	39948
bsdb:401/1/1_asthma:asthma_vs_healthy-control_UP	NA	970
bsdb:401/1/2_asthma:asthma_vs_healthy-control_DOWN	NA	830	543311
bsdb:401/2/1_allergic-rhinitis:allergic-rhinitis_vs_healthy-control_UP	NA	475	482	724	848	836
bsdb:401/2/2_allergic-rhinitis:allergic-rhinitis_vs_healthy-control_DOWN	NA	830	416916	437755
bsdb:402/2/1_atopic-eczema:Mothers-whose-infants-developed-IgE-associated-eczema_vs_mothers-whose-infants-remained-non-allergic_UP	NA	1301
bsdb:403/1/1_Eczema:child-with-eczema_vs_healthy-control_UP	NA	841	551
bsdb:403/1/2_Eczema:child-with-eczema_vs_healthy-control_DOWN	NA	1678	547
bsdb:403/2/2_Eczema:child-with-eczema_vs_healthy-control_DOWN	NA	1678
bsdb:403/3/1_Eczema:child-with-eczema_vs_healthy-control_UP	NA	551
bsdb:403/3/2_Eczema:child-with-eczema_vs_healthy-control_DOWN	NA	216851	28050
bsdb:403/5/1_Eczema:child-with-eczema_vs_healthy-control_UP	NA	551
bsdb:403/5/2_Eczema:child-with-eczema_vs_healthy-control_DOWN	NA	1678	1301	194
bsdb:403/6/1_Eczema:child-with-eczema_vs_healthy-control_DOWN	NA	216851	1678	547
bsdb:403/7/1_Eczema:child-with-eczema_vs_healthy-control_DOWN	NA	1678	547	570	1301	29465
bsdb:403/9/1_Eczema:child-with-eczema_vs_healthy-control_DOWN	NA	1678	40544	1485	102106	35832
bsdb:403/10/1_Eczema:child-with-eczema_vs_healthy-control_DOWN	NA	1678
bsdb:404/1/1_atopic-eczema:patient-with-atopic-dermatitis_vs_healthy-control_UP	NA	1263	375288	216851	292632	140625	158846	207244	239759
bsdb:404/1/2_atopic-eczema:patient-with-atopic-dermatitis_vs_healthy-control_DOWN	NA	561	620
bsdb:404/2/1_atopic-eczema:patient-with-atopic-dermatitis_vs_healthy-control_UP	NA	1263
bsdb:404/2/2_atopic-eczema:patient-with-atopic-dermatitis_vs_healthy-control_DOWN	NA	191303	100883
bsdb:404/3/1_atopic-eczema:patient-with-atopic-dermatitis_vs_healthy-control_UP	NA	588605
bsdb:404/3/2_atopic-eczema:patient-with-atopic-dermatitis_vs_healthy-control_DOWN	NA	244127	574697	102106	33042	61170	577309
bsdb:405/1/1_asthma:child-with-asthma-at-5-years-old_vs_no-asthma-at-5-years-old_UP	NA	29465	1301
bsdb:405/1/2_asthma:child-with-asthma-at-5-years-old_vs_no-asthma-at-5-years-old_DOWN	NA	841	239759	946234	216851	1678	572511	375288	207244	1263	39948	838
bsdb:405/2/1_asthma:child-with-asthma-at-5-years-old-among-mothers-with-asthma_vs_no-asthma-at-5-years-old_UP	NA	29465
bsdb:405/2/2_asthma:child-with-asthma-at-5-years-old-among-mothers-with-asthma_vs_no-asthma-at-5-years-old_DOWN	NA	239759	1678	39948	216851	841	1263	572511	375288	1301	838	946234	239934
bsdb:405/3/1_asthma:child-with-asthma-at-5-years-old-among-mothers-without-asthma_vs_no-asthma-at-5-years-old_UP	NA	29465	838	1301	1263	239934
bsdb:405/3/2_asthma:child-with-asthma-at-5-years-old-among-mothers-without-asthma_vs_no-asthma-at-5-years-old_DOWN	NA	216851	1678	572511	207244	239759	946234
bsdb:406/1/1_lung-cancer:non-smoking-female-lung-cancer-patients_vs_healthy-controls_UP	NA	150203	963	13687
bsdb:406/1/2_lung-cancer:non-smoking-female-lung-cancer-patients_vs_healthy-controls_DOWN	NA	469	59732	283	1301
bsdb:407/1/1_peptic-esophagitis:reflux-esophagus-patients_vs_healthy-controls_UP	NA	1380	1730	1164882	906	265975	1257	838	123375	29465	356797
bsdb:407/1/2_peptic-esophagitis:reflux-esophagus-patients_vs_healthy-controls_DOWN	NA	416916	194	1716	538	44259	2701	1378	940557	52228	43994	1508421	482	113286	32207	1301	157	843
bsdb:408/2/1_asthma:asthma-at-1-year_vs_healthy-controls_UP	NA	32207
bsdb:409/1/1_milk-allergic-reaction:IgE-mediated-cow's-milk-allergy_vs_healthy-controls_UP	NA	1263	216851
bsdb:409/1/2_milk-allergic-reaction:IgE-mediated-cow's-milk-allergy_vs_healthy-controls_DOWN	NA	1678	561
bsdb:410/1/1_HIV-infection:ART-treated-HIV-infected-MSM_vs_HIV-uninfected-MSM_UP	NA	162289	150022	165779	194
bsdb:410/1/2_HIV-infection:ART-treated-HIV-infected-MSM_vs_HIV-uninfected-MSM_DOWN	NA	838
bsdb:410/2/1_gonorrhea:MSM-with-gonorrhea_vs_MSM-with-no-gonorrhea_UP	NA	838
bsdb:411/1/1_HIV/AIDS-pre-exposure-prophylaxis:HIV-negative-MSM-on-PrEP_vs_HIV-negative-MSM-not-on-PrEP_UP	NA	1301	848	52225
bsdb:411/1/2_HIV/AIDS-pre-exposure-prophylaxis:HIV-negative-MSM-on-PrEP_vs_HIV-negative-MSM-not-on-PrEP_DOWN	NA	561	620
bsdb:411/2/1_HIV/AIDS-pre-exposure-prophylaxis:HIV-negative-MSM-on-PrEP_vs_HIV-negative-MSM-not-on-PrEP_UP	NA	1301
bsdb:412/1/1_HIV-infection,methamphetamine-dependence:HIV-positive-MA-users_vs_HIV-positive-non-MA-users_UP	NA	1654	75984	909928	34104
bsdb:412/2/1_methamphetamine-dependence:Methamphetamine-users_vs_non-users_UP	NA	1161127	724	1730	29465	37914	1301	543311	150022	1716	848	162289	836	1257	165779	86331
bsdb:412/2/2_methamphetamine-dependence:Methamphetamine-users_vs_non-users_DOWN	NA	580596	216851	1283313
bsdb:412/3/1_methamphetamine-dependence:MSM-who-tested-positive-on-MA-urine-drug-screening_vs_MSM-who-did-not-test-positive-on-MA-urine-drug-screening_UP	NA	1161127	37914	1730	150022	162289	836	848	86331	1257	1716	165779
bsdb:412/3/2_methamphetamine-dependence:MSM-who-tested-positive-on-MA-urine-drug-screening_vs_MSM-who-did-not-test-positive-on-MA-urine-drug-screening_DOWN	NA	216851	1485	1578	1313210	83770
bsdb:412/4/1_methamphetamine-dependence:HIV-positive-men-who-have-sex-with-men-who-tested-positive-in-a-methamphetamine-drug-screening_vs_HIV-positive-men-who-have-sex-with-men-who-did-not-test-positive-in-a-methamphetamine-drug-screening_UP	NA	34104
bsdb:412/4/2_methamphetamine-dependence:HIV-positive-men-who-have-sex-with-men-who-tested-positive-in-a-methamphetamine-drug-screening_vs_HIV-positive-men-who-have-sex-with-men-who-did-not-test-positive-in-a-methamphetamine-drug-screening_DOWN	NA	846
bsdb:412/5/1_methamphetamine-dependence:HIV-negative-MSM-who-tested-positive-in-a-MA-drug-screening_vs_HIV-negative-MSM-who-did-not-test-positive-in-a-MA-drug-screening_UP	NA	1485
bsdb:412/5/2_methamphetamine-dependence:HIV-negative-MSM-who-tested-positive-in-a-MA-drug-screening_vs_HIV-negative-MSM-who-did-not-test-positive-in-a-MA-drug-screening_DOWN	NA	397864	117563	168808	34104	292632
bsdb:413/1/1_obsessive-compulsive-disorder:OCD_vs_healthy-controls_DOWN	NA	119852	283168	207244
bsdb:414/1/1_epilepsy:before-keto-diet_vs_after-keto-diet_UP	NA	1678	39948
bsdb:414/1/2_epilepsy:before-keto-diet_vs_after-keto-diet_DOWN	NA	561
bsdb:415/1/1_HIV-infection:HIV-positive-women-who-have-been-taking-ART-for-more-than-1-year_vs_Age-matched-HIV-uninfected-women_UP	NA	265975	437755
bsdb:415/2/1_HIV-infection,oral-candidiasis:HIV-positive-women-with-oral-candidiasis_vs_Age-matched-HIV-uninfected-womenn_UP	NA	29465
bsdb:415/3/1_age:HIV-uninfected-women-who-are-50-years-of-age-or-older_vs_HIV-uninfected-women-who-are-less-than-35-years-of-age_UP	NA	265975	437755
bsdb:417/1/1_HIV-infection,diabetes-mellitus:Women-with-diabetes_vs_Women-without-diabetes_DOWN	NA	165779	150022	168808	447020
bsdb:418/1/1_HIV-infection:immunological-non-responders-assigned-to-treatment-for-12-weeks_vs_baseline_UP	NA	158846	872
bsdb:418/1/2_HIV-infection:immunological-non-responders-assigned-to-treatment-for-12-weeks_vs_baseline_DOWN	NA	135858
bsdb:418/2/1_HIV-infection:immunological-responders-assigned-to-treatment-for-12-weeks_vs_baseline_UP	NA	158846	872
bsdb:418/2/2_HIV-infection:immunological-responders-assigned-to-treatment-for-12-weeks_vs_baseline_DOWN	NA	135858
bsdb:419/1/1_HIV-infection:combination-antiretroviral-therapy-treated-individuals-after-taking-LGG-probiotic-for-8-weeks_vs_baseline_UP	NA	1508657
bsdb:420/1/1_HIV-infection:HIV-infected-on-antiretroviral-therapy-allocated-to-probiotic-intervention_vs_baseline_UP	NA	1678
bsdb:420/1/2_HIV-infection:HIV-infected-on-antiretroviral-therapy-allocated-to-probiotic-intervention_vs_baseline_DOWN	NA	816
bsdb:420/2/1_HIV-infection:HIV-infected-on-antiretroviral-therapy-allocated-to-probiotic-intervention_vs_nonprobiotic-intervention_UP	NA	1578
bsdb:421/1/1_HIV-infection:Vertically-HIV-infected-children_vs_HIV-uninfected-siblings-or-children-born-to-HIV-infected-mothers_UP	NA	239934	100883	561	848	838
bsdb:421/1/2_HIV-infection:Vertically-HIV-infected-children_vs_HIV-uninfected-siblings-or-children-born-to-HIV-infected-mothers_DOWN	NA	244127	207244	51514	1357	189330	33042	28050	216851	1678
bsdb:422/1/1_HIV-infection:Perinatally-HIV-infected-children_vs_uninfected-age-matched-controls_UP	NA	838	906	970	1485	32067	53335
bsdb:422/1/2_HIV-infection:Perinatally-HIV-infected-children_vs_uninfected-age-matched-controls_DOWN	NA	816	51514	216851	724	475961	48463	1263
bsdb:423/1/2_amyotrophic-lateral-sclerosis:ALS-patients_vs_Healthy-controls_DOWN	NA	158846
bsdb:424/1/1_pancreatic-carcinoma:Pancreatic-cancer-patients_vs_Healthy-control_UP	NA	239934	906	283168
bsdb:424/1/2_pancreatic-carcinoma:Pancreatic-cancer-patients_vs_Healthy-control_DOWN	NA	207244	216851	292632
bsdb:424/3/1_pancreatic-carcinoma:BO-PC_vs_NBO-PC_DOWN	NA	572511
bsdb:424/3/2_pancreatic-carcinoma:BO-PC_vs_NBO-PC_UP	NA	838
bsdb:424/4/1_pancreatic-carcinoma:NBO-PC_vs_Healthy-control_DOWN	NA	216851
bsdb:424/4/2_pancreatic-carcinoma:NBO-PC_vs_Healthy-control_UP	NA	239934
bsdb:426/1/1_Autoimmune-Hepatitis:autoimmune-hepatits-cases_vs_healthy-controls_UP	NA	570	1578	1301	29465
bsdb:426/1/2_Autoimmune-Hepatitis:autoimmune-hepatits-cases_vs_healthy-controls_DOWN	NA	33042	119852	375288
bsdb:427/1/1_diet:omnivores_vs_vegetarians_DOWN	NA	28050
bsdb:427/1/2_diet:omnivores_vs_vegetarians_UP	NA	1263
bsdb:427/2/1_diet:omnivores_vs_vegans_DOWN	NA	841	28050	838
bsdb:427/2/2_diet:omnivores_vs_vegans_UP	NA	1263	119852
bsdb:427/3/1_diet:vegetarians_vs_vegans_UP	NA	119852
bsdb:428/1/2_COVID-19:COVID-19-cases_vs_Healthy-controls_DOWN	NA	292632
bsdb:428/2/2_COVID-19:Recovered-COVID-19-cases_vs_Healthy-controls_DOWN	NA	292632
bsdb:428/3/1_COVID-19:Recovered-COVID-19-cases_vs_Healthy-controls_UP	NA	375288
bsdb:428/3/2_COVID-19:Recovered-COVID-19-cases_vs_Healthy-controls_DOWN	NA	292632
bsdb:428/4/2_COVID-19:COVID-19-patients-treated-with-antibiotics_vs_Healthy-controls_UP	NA	100883
bsdb:429/1/1_gastric-cancer:gastric-cancer-patients_vs_healthy-controls_UP	NA	1301
bsdb:429/1/2_gastric-cancer:gastric-cancer-patients_vs_healthy-controls_DOWN	NA	1301
bsdb:431/1/1_cervical-glandular-intraepithelial-neoplasia:persistent-HPV+-with-HSIL_vs_persistent-HPV+-with-LSIL_DOWN	NA	222	283	1079922	162290	2745	1357	1243	68	149698	407	1839	265	33024	1522432	286	207599	152161	84036	270
bsdb:431/3/1_cervical-glandular-intraepithelial-neoplasia:transient-HPV+-with-LSIL_vs_HPV-_DOWN	NA	168808	177971	29465	906	46913	2701
bsdb:431/4/1_cervical-glandular-intraepithelial-neoplasia:persistent-HPV+-with-HSIL_vs_HPV-_DOWN	NA	906	1257	177971	168808
bsdb:431/5/2_cervical-glandular-intraepithelial-neoplasia:persistent-HPV+-with-HSIL_vs_persistent-HPV+-with-LSIL_DOWN	NA	216851	1847725	162289	165779	39948	838	2701	1243	404402	150022	1279	1350
bsdb:431/6/2_cervical-glandular-intraepithelial-neoplasia:persistent-HPV+-with-LSIL_vs_transient-HPV+-with-HSIL_DOWN	NA	836	1567	1506577	73029
bsdb:431/7/1_cervical-glandular-intraepithelial-neoplasia:transient-HPV+-with-HSIL_vs_transient-HPV+-with-LSIL_UP	NA	501783	1578	231454
bsdb:431/8/1_cervical-glandular-intraepithelial-neoplasia:transient-HPV+-with-LSIL_vs_HPV-_DOWN	NA	168808	1578	286	177971
bsdb:431/9/1_cervical-glandular-intraepithelial-neoplasia:persistent-HPV+-with-HSIL_vs_HPV-_UP	NA	581
bsdb:431/9/2_cervical-glandular-intraepithelial-neoplasia:persistent-HPV+-with-HSIL_vs_HPV-_DOWN	NA	39948	838	40544	1257	286
bsdb:432/1/1_human-papilloma-virus-infection:HPV+_vs_HPV-_UP	NA	2093
bsdb:432/1/2_human-papilloma-virus-infection:HPV+_vs_HPV-_DOWN	NA	2077
bsdb:433/1/1_cervical-glandular-intraepithelial-neoplasia:CIN-2+_vs_healthy-controls_UP	NA	2701
bsdb:433/1/2_cervical-glandular-intraepithelial-neoplasia:CIN-2+_vs_healthy-controls_DOWN	NA	1578
bsdb:433/2/1_cervical-cancer:cervical-cancer_vs_healthy-controls_UP	NA	1301	162289	150022	165779	838
bsdb:433/2/2_cervical-cancer:cervical-cancer_vs_healthy-controls_DOWN	NA	1578
bsdb:434/1/1_human-papilloma-virus-infection:HPV-+_vs_healthy-control_UP	NA	906
bsdb:434/3/1_cervical-glandular-intraepithelial-neoplasia:HSIL_vs_healthy-control_UP	NA	838	177971
bsdb:434/4/1_cervical-cancer:cervical-cancer_vs_healthy-control_UP	NA	1386	168808	12916	848	182709	836	165779
bsdb:434/5/1_human-papilloma-virus-infection:HPV+_vs_Healthy-control_UP	NA	838	1386	168808	906	1301	165779
bsdb:434/5/2_human-papilloma-virus-infection:HPV+_vs_Healthy-control_DOWN	NA	1380
bsdb:435/1/1_human-papilloma-virus-infection:HPV+-persistence_vs_HPV-_UP	NA	28100	13687	165779	838	836	39948	162289
bsdb:435/1/2_human-papilloma-virus-infection:HPV+-persistence_vs_HPV-_DOWN	NA	1578
bsdb:435/2/2_human-papilloma-virus-infection:HPV+-transient_vs_HPV-_DOWN	NA	1578
bsdb:438/1/2_antimicrobial-agent:Antibiotic-treated-(week-4)_vs_Untreated-controls-(week-4)_DOWN	NA	1678	1578
bsdb:438/3/1_antimicrobial-agent:Week-8-(treated)_vs_Week-4-(treated)_UP	NA	1678
bsdb:439/1/2_type-ii-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	838
bsdb:441/1/1_COVID-19:COVID-19-cases_vs_Healthy-controls_UP	NA	1301	32207	29465	1505663	1654
bsdb:441/1/2_COVID-19:COVID-19-cases_vs_Healthy-controls_DOWN	NA	1766253	207244	189330	216851	1407607	1505657	570	1501226	191303	1485
bsdb:441/2/1_influenza-A-(H1N1):H1N1-cases_vs_Healthy-controls_DOWN	NA	572511	1501226	102106	1678	1766253	1407607	207244	189330
bsdb:441/2/2_influenza-A-(H1N1):H1N1-cases_vs_Healthy-controls_UP	NA	1350	838	150022	162289
bsdb:441/3/1_COVID-19:COVID-19-patients_vs_H1N1-patients_UP	NA	1766253	207244	1678	572511	102106	189330	1407607	32207	1263	1301	1485
bsdb:441/3/2_COVID-19:COVID-19-patients_vs_H1N1-patients_DOWN	NA	838	1582879	239934	1161127	836
bsdb:441/4/1_COVID-19:COVID-19-cases_vs_Healthy-controls_UP	NA	1301
bsdb:442/1/1_type-ii-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	5598	5498	5453	41254	95729	5644
bsdb:443/1/1_irritable-bowel-syndrome:IBS_vs_Healthy-Control_UP	NA	816	29465
bsdb:443/1/2_irritable-bowel-syndrome:IBS_vs_Healthy-Control_DOWN	NA	1678
bsdb:443/2/1_irritable-bowel-syndrome:IBS-C_vs_Health-Control_UP	NA	816	1578	29465
bsdb:443/3/1_irritable-bowel-syndrome:IBS-D_vs_Health-Control_UP	NA	816
bsdb:443/3/2_irritable-bowel-syndrome:IBS-D_vs_Health-Control_DOWN	NA	1578
bsdb:443/5/1_irritable-bowel-syndrome:Irritable-Bowel-Syndrome,-constipation-predominant-(IBS-C)_vs_Irritable-Bowel-Syndrome,-diarrhea-predominant-(IBS-D)_UP	NA	1578	816
bsdb:444/7/1_Colorectal-cancer,Body-mass-index,Physical-activity:Overweight/Obese/inactive-patients_vs_Overweight/Obese/active-patients_UP	NA	244448
bsdb:447/1/1_gestational-diabetes:Individuals-with-gestational-diabetes_vs_Healthy-controls_UP	NA	724
bsdb:447/1/2_gestational-diabetes:Individuals-with-gestational-diabetes_vs_Healthy-controls_DOWN	NA	239759	33024
bsdb:447/2/1_gestational-diabetes:Individuals-with-gestational-diabetes_vs_Healthy-controls_UP	NA	1678	970
bsdb:447/2/2_gestational-diabetes:Individuals-with-gestational-diabetes_vs_Healthy-controls_DOWN	NA	1164882	32067	1243
bsdb:448/1/1_influenza-A-(H1N1):Pneumonia-patients-with-pH1N1-infection_vs_Pneumonia-patients-without-any-influenza-A-infection_UP	NA	469	286	1386
bsdb:448/1/2_influenza-A-(H1N1):Pneumonia-patients-with-pH1N1-infection_vs_Pneumonia-patients-without-any-influenza-A-infection_DOWN	NA	482	838	29465
bsdb:448/1/5_influenza-A-(H1N1):Pneumonia-patients-with-pH1N1-infection_vs_Pneumonia-patients-without-any-influenza-A-infection_UP	NA	469	1386	286
bsdb:448/1/6_influenza-A-(H1N1):Pneumonia-patients-with-pH1N1-infection_vs_Pneumonia-patients-without-any-influenza-A-infection_DOWN	NA	482	838	29465
bsdb:452/1/1_gestational-diabetes:Pregnant-women-with-Gestational-Diabetes-Mellitus_vs_euglycemic-(control)-singleton-pregnant-women_UP	NA	244127	33042	189330	577309	838	1263
bsdb:452/1/2_gestational-diabetes:Pregnant-women-with-Gestational-Diabetes-Mellitus_vs_euglycemic-(control)-singleton-pregnant-women_DOWN	NA	29465
bsdb:453/1/1_COVID-19:SARS-CoV-2-infected-patients_vs_Non-infected-patients-with-unrelated-respiratory-medical-conditions_UP	NA	1716	194	150022	2050	165779	1582879	836	838	1161127	236752	66831	162290	1279	1380	990721	39948	577310	1649459	1392389
bsdb:453/1/2_COVID-19:SARS-CoV-2-infected-patients_vs_Non-infected-patients-with-unrelated-respiratory-medical-conditions_DOWN	NA	1578	1505657	189330	572511	32207	216851	561	2039302	292632	1301	29465	841	1407607	1766253	570
bsdb:453/2/1_COVID-19:SARS-CoV-2-recovered-individuals_vs_SARS-CoV-2-infected-patients_DOWN	NA	194	1716	2050	1686313	1582879	1161127	236752	66831	1279	162290	1847725	150022	40544	162289	836	1380	255204	508459	1769710	191303	31983	165779	36739	872
bsdb:453/2/2_COVID-19:SARS-CoV-2-recovered-individuals_vs_SARS-CoV-2-infected-patients_UP	NA	1357	207244	1926663	216851	561	1505657	135858	570	292632	117563	572511	1766253
bsdb:453/3/1_COVID-19:Recovered-COVID-19-patients_vs_Non-infected-patients-with-unrelated-respiratory-medical-conditions_UP	NA	207244	1926663
bsdb:453/3/2_COVID-19:Recovered-COVID-19-patients_vs_Non-infected-patients-with-unrelated-respiratory-medical-conditions_DOWN	NA	248744	1470349	35832	577309	39948	40544	1263
bsdb:453/4/1_COVID-19:Positive-for-COVID-19-viral-RNA-in-feces_vs_Negative-for-COVID-19-viral-RNA-in-feces_UP	NA	283	399320	2753	158846	588605	1505657	570	577309	171413	1870884	583	848	1505663	1573535	1769710	2129	1766253
bsdb:453/4/2_COVID-19:Positive-for-COVID-19-viral-RNA-in-feces_vs_Negative-for-COVID-19-viral-RNA-in-feces_DOWN	NA	171412	53456	447020	72763	1269	1357	944321	1926663	156973	168808	36739	1501226	547	1505652	1213720	1273095	1696	1912216	255204
bsdb:454/1/1_colorectal-cancer:colorectal-cancer-(CRC)_vs_healthy-controls_UP	NA	165779	816	397864	135858	39948	848	1378	117563	404402	459786	543311	1257	836	286	841	1263	123375
bsdb:455/1/1_pregnancy:pregnant-women-without-gingivitis_vs_non-pregnant-women-without-gingivitis_UP	NA	816	848	157
bsdb:455/1/2_pregnancy:pregnant-women-without-gingivitis_vs_non-pregnant-women-without-gingivitis_DOWN	NA	59735	1378	724	1301	217201
bsdb:455/2/1_gingivitis:pregnant-women-with-gingivitis_vs_pregnant-women-without-gingivitis_UP	NA	816	194	44259	1434006	195950	157
bsdb:455/3/1_gingivitis:pregnant-women-with-gingivitis_vs_pregnant-women-without-gingivitis_UP	NA	32067
bsdb:455/4/1_pregnancy:pregnant-women_vs_non-pregnant-women_UP	NA	59735	194	265975	1257
bsdb:456/1/1_type-ii-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	207244	816	35832	572511	1485	33042	216851	28050	248744	283168	577310	33024	46205	841	1263	13687	40544
bsdb:456/1/2_type-ii-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	1654	239934	244127	1678	544	102106	84111	1350	570	1578	906	375288	160674	1301	292632	46255
bsdb:457/1/1_periodontitis:Individuals-diagnosed-with-Periodontitis-group_vs_Healthy-controls-group_UP	NA	40544
bsdb:458/1/1_COVID-19:COVID-19-patients_vs_Non-intubated-patients-with-non-incubation-viral-pneumonia-or-non-incubation-non-infectious-diseases_UP	NA	469	570	48736	13687
bsdb:458/1/2_COVID-19:COVID-19-patients_vs_Non-intubated-patients-with-non-incubation-viral-pneumonia-or-non-incubation-non-infectious-diseases_DOWN	NA	1654	724	482	838	1301	29465
bsdb:459/1/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-controls_DOWN	NA	1283313	165779	38501	580596	194	1016	59732	150022	237	1378	57493	1269	475	162289	836	838	32207	970	29465	662
bsdb:459/1/2_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-controls_UP	NA	432330	397456
bsdb:462/1/1_type-I-diabetes-mellitus:Individuals-diagnosed-with-Type-1-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	165440	4930
bsdb:462/1/2_type-I-diabetes-mellitus:Individuals-diagnosed-with-Type-1-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	4855	42658	1124675
bsdb:462/2/1_type-ii-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	4970	5314	1851509	5605	148959
bsdb:462/2/2_type-ii-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	1500560	42658	1891946
bsdb:462/3/1_diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Individuals-diagnosed-with-Type-1-Diabetes-Mellitus_DOWN	NA	4970	5314	1851509	42658
bsdb:462/3/2_diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Individuals-diagnosed-with-Type-1-Diabetes-Mellitus_UP	NA	4930	1500560
bsdb:464/1/1_COVID-19:Confirmed-COVID-19-patients_vs_Healthy-controls_DOWN	NA	1331051	2717	43996	1716	44259	848	1378	724	86331	265975	543311	1257	836	123375	1301
bsdb:464/1/2_COVID-19:Confirmed-COVID-19-patients_vs_Healthy-controls_UP	NA	194	117563	32067	906	970	146	195950
bsdb:464/2/1_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_DOWN	NA	1331051	724	543311	836
bsdb:464/2/2_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_UP	NA	82202	32067	906	970
bsdb:464/3/1_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	239759	816	35832	572511	1485	102106	33042	39948	189330	216851	724	61170	1392389	570	28050	283168	375288	577310	46205	841	1263	13687	40544	191303
bsdb:464/3/2_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	239934	1678	1350	1301	32207	2745	207244	265975	29465	123375	1380	946234	1082930	1378	117563
bsdb:465/1/1_diabetic-neuropathy:Individuals-diagnosed-with-peripheral-neuropathy-associated-with-type-2-diabetes_vs_Healthy-controls_UP	NA	572511	561	1506553	906
bsdb:465/1/2_diabetic-neuropathy:Individuals-diagnosed-with-peripheral-neuropathy-associated-with-type-2-diabetes_vs_Healthy-controls_DOWN	NA	816	216851
bsdb:466/1/1_Chewing-tobacco-behavior:smokeless-tobacco-users_vs_age-matched-controls_UP	NA	43996	1434006
bsdb:466/2/1_smoking-behavior:Smokers-who-were-using-either-bidis-or-cigarettes_vs_age-matched-controls_UP	NA	848	177971
bsdb:466/3/1_smoking-behavior:Smokers_vs_Smokeless-tobacco-users_DOWN	NA	848	194
bsdb:467/1/1_HER2-Positive-Breast-Carcinoma:Her2-positive-tumor_vs_Her2-negative-tumor_UP	NA	904
bsdb:467/1/2_HER2-Positive-Breast-Carcinoma:Her2-positive-tumor_vs_Her2-negative-tumor_DOWN	NA	872	1263
bsdb:467/2/1_age-at-menarche:later-age-at-menarche-(12)_vs_early-age-at-menarche-(11)_UP	NA	561
bsdb:467/2/2_age-at-menarche:later-age-at-menarche-(12)_vs_early-age-at-menarche-(11)_DOWN	NA	2172	1263
bsdb:467/3/1_estrogen-receptor-status:ER-_vs_ER+_DOWN	NA	724	29465
bsdb:467/5/1_breast-cancer:Grade-High-(III)_vs_Grade-Low-(I/II)_UP	NA	84111
bsdb:467/5/2_breast-cancer:Grade-High-(III)_vs_Grade-Low-(I/II)_DOWN	NA	207244
bsdb:467/6/1_breast-cancer-stage:Stage-High-(III)_vs_Stage-Low-(I/II)_UP	NA	1485	29465	724
bsdb:467/6/2_breast-cancer-stage:Stage-High-(III)_vs_Stage-Low-(I/II)_DOWN	NA	904	135858
bsdb:467/7/1_age:Age-50_vs_Age-50+_UP	NA	1485	1357
bsdb:467/8/1_parous:Nulliparous_vs_Parous_DOWN	NA	135858
bsdb:467/9/1_body-mass-index:BMI25_vs_BMI<25_UP	NA	239934
bsdb:468/1/1_endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_DOWN	NA	1380	1378
bsdb:468/2/1_endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_DOWN	NA	1380	168808
bsdb:468/2/2_endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_UP	NA	1283313
bsdb:468/3/1_endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_DOWN	NA	2701	168808	397864
bsdb:468/4/1_endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_UP	NA	2701
bsdb:468/5/1_endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_UP	NA	2701	1301	2129
bsdb:468/5/2_endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_DOWN	NA	838	39948	906
bsdb:470/1/1_colorectal-cancer:colorectal-cancer_vs_controls_UP	NA	165779	1730	848	1378	1649459	1506553	32067	543311	1257	836	123375	292632
bsdb:470/1/2_colorectal-cancer:colorectal-cancer_vs_controls_UP	NA	165779	1730	848	1378	1649459	1506553	32067	543311	1257	836	123375	292632
bsdb:472/1/2_gestational-diabetes:Pregnant-individuals-with-gestational-diabetes_vs_Pregnant-individuals-who-are-normal-glucose-tolerance-(NGT)]_DOWN	NA	140625
bsdb:473/1/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-controls_DOWN	NA	32067	848	724
bsdb:476/1/1_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_UP	NA	343821	41949	32207	1505663
bsdb:476/1/2_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_DOWN	NA	102106	216851	119852	1263
bsdb:477/1/1_COVID-19:Severe-COVID-19-patients_vs_COVID-19-negative-controls_UP	NA	1283313	43996	1164882	265975	838
bsdb:477/2/1_COVID-19:Severe-COVID-19-patients-requiring-ICU_vs_COVID-19-negative-controls_UP	NA	157
bsdb:477/3/1_COVID-19:Severe-COVID-19-patients_vs_Mild-COVID-19-patients_UP	NA	838
bsdb:478/1/1_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	2801844	2050	265975	32207	84108
bsdb:478/1/2_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	29465
bsdb:478/2/1_COVID-19:COVID-19-patients_vs_Flu-patients_DOWN	NA	2801844	265975	32207	84108
bsdb:478/3/1_COVID-19:Flu-patients_vs_Healthy-controls_UP	NA	29465
bsdb:478/3/2_COVID-19:Flu-patients_vs_Healthy-controls_DOWN	NA	265975	2801844	32207	2050
bsdb:478/4/1_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	76833	1678	118747	1707	1716	84162	44259	57499	1164882	86331	543311	1743	2529408	970	1301	1654	32207	265975	186188	2801844	2717	184869	2050
bsdb:478/4/2_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	906	29465	46123
bsdb:478/5/1_COVID-19:Flu-patients_vs_Healthy-controls_DOWN	NA	1301	1654	32207	265975	186188	2801844	2717	184869
bsdb:478/5/2_COVID-19:Flu-patients_vs_Healthy-controls_UP	NA	906	29465
bsdb:479/1/1_COVID-19:ICU-COVID-19-patients_vs_Healthy-controls_DOWN	NA	469	642	1663	59735	1678	32008	830	1485	1298	44259	397456	43994	33882	745	335058	48736	42255	1193515	203470	1754	28895	261684	34072
bsdb:479/1/2_COVID-19:ICU-COVID-19-patients_vs_Healthy-controls_UP	NA	547	561	570	1506553	1847725	1269	133925	44249	53335	1827	590	196081	613	40323
bsdb:479/2/1_COVID-19:Mild-moderate-COVID-19-patients_vs_Healthy-controls_DOWN	NA	1663	118747	32008	1298	397456	43994	57493	1357	948104	335058	48736	42255	1193515	203470	1754	28895	261684	34072
bsdb:479/2/2_COVID-19:Mild-moderate-COVID-19-patients_vs_Healthy-controls_UP	NA	2330	407	34104
bsdb:479/3/1_COVID-19:ICU-COVID-19-patients_vs_Mild-Moderate-COVID-19-patients_DOWN	NA	469	642	59735	1678	118747	830	1485	44259	2330	407	745
bsdb:479/3/2_COVID-19:ICU-COVID-19-patients_vs_Mild-Moderate-COVID-19-patients_UP	NA	547	561	570	57493	1506553	1357	1847725	1269	948104	133925	44249	53335	1827	590	196081	613	40323	286
bsdb:479/4/1_COVID-19:ICU-COVID-19-patients_vs_Patients-infected-with-other-human-coronaviruses_DOWN	NA	469	642	239759	207244	637	1663	59735	1678	38501	572511	1696	41275	32008	1715793	75	59732	1485	106589	189330	66831	44259	1573535	53457	149698	407	33882	1763	909928	1839	283168	375288	265	84567	335058	48736	841	42255	1508657	1263	1835	1193515	13687	1506577	338
bsdb:479/4/2_COVID-19:ICU-COVID-19-patients_vs_Patients-infected-with-other-human-coronaviruses_UP	NA	1357	590	196081	613
bsdb:480/1/1_endometriosis:Vaginal-Fluid_vs_Control-group_UP	NA	1378	1301
bsdb:480/1/2_endometriosis:Vaginal-Fluid_vs_Control-group_DOWN	NA	1375	1380
bsdb:480/2/1_endometriosis:Eutopic-Endometrium-Samples_vs_Control-group_UP	NA	1678
bsdb:480/2/2_endometriosis:Eutopic-Endometrium-Samples_vs_Control-group_DOWN	NA	59753	1380	194	42054	2050
bsdb:480/3/1_endometriosis:endometriotic-lesion-samples_vs_Controls-group_UP	NA	1375	1279	13687	111142	286	1350
bsdb:480/3/2_endometriosis:endometriotic-lesion-samples_vs_Controls-group_DOWN	NA	838	1380	1033	2050	194	66831
bsdb:481/1/1_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	84111	100883
bsdb:481/2/1_COVID-19:Antibiotic-treated-COVID-19-patients_vs_Antibiotic-naive-COVID-19-patients_UP	NA	100883
bsdb:481/3/1_COVID-19:Severe-COVID-19-patients_vs_Mild-COVID-19-patients_UP	NA	80865
bsdb:482/1/1_COVID-19:Severe-COVID-19-patients_vs_Mild-COVID-19-patients_DOWN	NA	29465	482	1301	838
bsdb:482/1/2_COVID-19:Severe-COVID-19-patients_vs_Mild-COVID-19-patients_UP	NA	1279	561
bsdb:482/2/1_COVID-19:Severe-COVID-19-patients_vs_Mild-COVID-19-patients_UP	NA	375288
bsdb:483/2/1_COVID-19:Antibiotic-treated-COVID-19-patients_vs_Antibiotic-naive-COVID-19-patients,-pneumonia-patients,-uninfected-controls_DOWN	NA	572511	216851	1730	841	33042
bsdb:483/3/1_COVID-19:Pneumonia-controls_vs_Uninfected-controls,-COVID-19-patients_DOWN	NA	100883
bsdb:485/1/1_COVID-19:COVID-19-patients-with-fever_vs_COVID-19-patients-without-fever_UP	NA	4930	1350
bsdb:485/1/2_COVID-19:COVID-19-patients-with-fever_vs_COVID-19-patients-without-fever_DOWN	NA	207244	838	375288	33024	84111
bsdb:485/2/1_COVID-19:COVID-19-patients-with-fever_vs_COVID-19-patients-without-fever_UP	NA	1350	544	4930	724
bsdb:485/2/2_COVID-19:COVID-19-patients-with-fever_vs_COVID-19-patients-without-fever_DOWN	NA	577310	644652
bsdb:486/1/1_COVID-19:Asymptomatic-COVID-19-patients_vs_Healthy-controls_UP	NA	84111	547	1350	666060	1263	620	46255	1485
bsdb:486/1/2_COVID-19:Asymptomatic-COVID-19-patients_vs_Healthy-controls_DOWN	NA	904	207244	194	28050	906	52225	133925	841	83770
bsdb:486/2/1_COVID-19:Asymptomatic-COVID-19-patients_vs_Healthy-controls_UP	NA	469	1350	33969	620	46255	1578
bsdb:486/2/2_COVID-19:Asymptomatic-COVID-19-patients_vs_Healthy-controls_DOWN	NA	904	207244	1485	33042	39948	189330	547	216851	28050	906	52225	133925	841	1263	970	292632	83770
bsdb:486/3/1_COVID-19:Severe-COVID-19-patients_vs_Healthy-controls_UP	NA	816	1350	620	1380	33969
bsdb:486/3/2_COVID-19:Severe-COVID-19-patients_vs_Healthy-controls_DOWN	NA	904	580596	194	1485	33042	39948	189330	547	216851	28050	906	133925	841	83770
bsdb:487/2/1_COVID-19:Recovered-COVID-19-samples-(respiratory-negative)_vs_Healthy-controls_DOWN	NA	207244	33042	1407607	2039302	119852	841
bsdb:487/2/2_COVID-19:Recovered-COVID-19-samples-(respiratory-negative)_vs_Healthy-controls_UP	NA	102106	1350	1578	1301	1501226	1253	544
bsdb:487/3/1_COVID-19:Infected-COVID-19-samples-(respiratory-positive)_vs_Healthy-controls_DOWN	NA	1766253	239759	207244	816	397864	580596	574697	1980681	33042	216851	1506553	28050	2039302	283168	459786	375288	577309	838	841	1263	40544
bsdb:487/3/2_COVID-19:Infected-COVID-19-samples-(respiratory-positive)_vs_Healthy-controls_UP	NA	102106	1350	1578	1301	191303	1501226	1253	572511	620	1678	1485	1505657
bsdb:488/1/1_irritable-bowel-syndrome:IBS-D_vs_Healthy-Control_UP	NA	1283313	1678	216851	1263
bsdb:488/1/2_irritable-bowel-syndrome:IBS-D_vs_Healthy-Control_DOWN	NA	1301
bsdb:489/1/1_COVID-19:COVID-positive-patients-admitted-to-ICU-(i-COVID-19)_vs_Pneumonia-control-patients-(COVID-negative)_UP	NA	1663	909928	2737	84108	1269	1827	57493	1883	33926	1763	86331	1935176	404402	1434004	724	1926667	1696	1350	1716	66831	44249	1386	1935461	577310
bsdb:489/1/2_COVID-19:COVID-positive-patients-admitted-to-ICU-(i-COVID-19)_vs_Pneumonia-control-patients-(COVID-negative)_DOWN	NA	35829	244127	544	102106	1348911	872	1432051	216851	1686313	946234	1407607	117563	2330	1243	2093	265975	2740	1017280	638847	588605	590	292632	662	1653174	1980689	2005359	1738645	1649459	574697	1508657	1506577	207244	570
bsdb:489/2/1_COVID-19:COVID-positive-patients-admitted-to-ICU-(i-COVID-19)_vs_COVID-positive-patients-admitted-to-infectious-disease-ward-(w-COVID-19)_UP	NA	1663	84108	2737	33882	44249	1269	1827	57493	1883	33926	1763	642	86331	404402	1434004	724	1926667	1279	1716	1696	1935461	577310
bsdb:489/2/2_COVID-19:COVID-positive-patients-admitted-to-ICU-(i-COVID-19)_vs_COVID-positive-patients-admitted-to-infectious-disease-ward-(w-COVID-19)_DOWN	NA	1375	59753	544	102106	100883	1348911	413496	872	216851	1686313	946234	117563	1937007	28050	1357	1980689	1161127	133925	590	970	292632	40544	662	33024	574697	547	561	1649459	1508657	207244
bsdb:489/3/1_COVID-19:COVID-positive-patients-admitted-to-infectious-disease-ward-(w-COVID-19)_vs_Pneumonia-controls-(COVID-negative)_UP	NA	59753	1375	40544	51196	100883	133925	909928	1357	1795789	1935176	904	1931105	970	1573535	241189	119977	906	35832	561	662	66831	547
bsdb:489/3/2_COVID-19:COVID-positive-patients-admitted-to-infectious-disease-ward-(w-COVID-19)_vs_Pneumonia-controls-(COVID-negative)_DOWN	NA	583	1653174	1432051	33882	2005359	244127	1738645	2740	1407607	1017280	44249	642	588605	35829	1243	1905344	2093	1378	469	1200657	1506577	580596
bsdb:490/1/1_irritable-bowel-syndrome:IBS_vs_Healthy-Control_UP	NA	29465	1578
bsdb:490/1/2_irritable-bowel-syndrome:IBS_vs_Healthy-Control_DOWN	NA	1485
bsdb:491/1/1_irritable-bowel-syndrome:IBS_vs_Healthy-Control_UP	NA	2740
bsdb:492/1/1_type-ii-diabetes-mellitus:Individuals-having-Type-2-Diabetes-Mellitus-without-Diabetic-Retinopathy_vs_Healthy-controls_DOWN	NA	207244	572511	283	33042	724	28050	33024	841	40544	191303
bsdb:492/1/2_type-ii-diabetes-mellitus:Individuals-having-Type-2-Diabetes-Mellitus-without-Diabetic-Retinopathy_vs_Healthy-controls_UP	NA	904	574697	547	561	140625	2172	157	46255
bsdb:492/2/1_diabetic-retinopathy:Individuals-diagnosed-with-Type-2-Diabetes-and-clinically-manifest-Diabetic-Retinopathy-(DR)_vs_Healthy-controls_DOWN	NA	82373	2152	1678	572511	118747	830	1485	283	872	551	216851	724	28050	1578	52225	841	32207	1301	40544	191303
bsdb:492/2/2_diabetic-retinopathy:Individuals-diagnosed-with-Type-2-Diabetes-and-clinically-manifest-Diabetic-Retinopathy-(DR)_vs_Healthy-controls_UP	NA	904	239934	239759	508459	547	1350	561	158846	846	375288	620
bsdb:492/3/1_diabetic-retinopathy:Individuals-diagnosed-with-Type-2-Diabetes-and-clinically-manifest-Diabetic-Retinopathy-(DR)_vs_Individuals-diagnosed-with-type-2-diabetes-Mellitus_DOWN	NA	82373	2152	1678	872	551	724	570	140625	2172	52225	1301	157	46255
bsdb:492/3/2_diabetic-retinopathy:Individuals-diagnosed-with-Type-2-Diabetes-and-clinically-manifest-Diabetic-Retinopathy-(DR)_vs_Individuals-diagnosed-with-type-2-diabetes-Mellitus_UP	NA	239934	239759	508459	1350	33024	620
bsdb:493/1/1_Vitiligo:Vitiligo-patients-after-NBUVB-irradiation-on-normal-skin-(NB-group)_vs_Vitiligo-patients-before-narrowband-UV-(NBUVB)-light-irradiation-in-normal-skin-(NF-group)_UP	NA	1386	1716
bsdb:494/1/1_type-ii-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	239934	1678	375288	216851
bsdb:494/1/2_type-ii-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	189330	848	1301
bsdb:495/1/1_type-ii-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_UP	NA	1283313	906	838
bsdb:495/1/2_type-ii-diabetes-mellitus:Individuals-diagnosed-with-Type-2-Diabetes-Mellitus_vs_Healthy-controls_DOWN	NA	816	577309
bsdb:495/2/1_prediabetes-syndrome:Individuals-with-Prediabetes-(PreDM)_vs_Healthy-controls_UP	NA	906	724
bsdb:495/2/2_prediabetes-syndrome:Individuals-with-Prediabetes-(PreDM)_vs_Healthy-controls_DOWN	NA	209
bsdb:496/1/1_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	1654	174708	165779	1380	1678	118747	1485	1716	84111	1350	561	209	1578	437755	265975	583	32207	196081	177971	1301	29465
bsdb:496/1/2_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	239759	207244	32008	574697	1485	283	33042	106589	189330	216851	61170	28050	482	283168	119852	375288	838	48736	841	1263	40544	172900	629
bsdb:496/2/1_COVID-19:COVID-19-patients_vs_Seasonal-flu-patients_UP	NA	561	1678	1485	1301	375288	29465	40544	848
bsdb:496/2/2_COVID-19:COVID-19-patients_vs_Seasonal-flu-patients_DOWN	NA	1654	416916	572511	118747	32008	1485	106589	189330	1730	724	209	1243	437755	265975	119852	33024	638847	48736	177971	40323
bsdb:497/1/1_acute-myeloid-leukemia:Febrile-neutropenia_vs_Pretreatment_UP	NA	561	1350
bsdb:497/1/2_acute-myeloid-leukemia:Febrile-neutropenia_vs_Pretreatment_DOWN	NA	816	40544
bsdb:497/2/1_acute-myeloid-leukemia:Bone-marrow-recovery_vs_febrile-neutropenia_UP	NA	1350	1301	572511	29465	375288
bsdb:497/2/2_acute-myeloid-leukemia:Bone-marrow-recovery_vs_febrile-neutropenia_DOWN	NA	816	561
bsdb:497/3/1_acute-myeloid-leukemia:Bone-marrow-recovery_vs_Pre-treatment_UP	NA	1350	1301
bsdb:497/3/2_acute-myeloid-leukemia:Bone-marrow-recovery_vs_Pre-treatment_DOWN	NA	816	572511	29465
bsdb:498/1/1_COVID-19:COVID-19-patients_vs_Asymptomatic-uninfected-controls_UP	NA	1582879
bsdb:498/2/2_COVID-19:COVID-19-patients-with-high-viral-load_vs_COVID-19-patients-with-low-viral-load_DOWN	NA	40323	469
bsdb:499/1/1_irritable-bowel-syndrome:IBS-A_vs_Healthy-Control_DOWN	NA	239759	216851	283168	375288	195950
bsdb:499/1/2_irritable-bowel-syndrome:IBS-A_vs_Healthy-Control_UP	NA	572511	39948	189330	248744	100175	1263
bsdb:499/2/1_irritable-bowel-syndrome:IBS-C_vs_Healthy-Control_DOWN	NA	239759	283168	375288	195950
bsdb:499/2/2_irritable-bowel-syndrome:IBS-C_vs_Healthy-Control_UP	NA	244127	109326	55079	189330	28050	248744	100175	2740	44748
bsdb:499/3/1_irritable-bowel-syndrome:IBS-D_vs_Healthy-Control_DOWN	NA	283168	375288	195950
bsdb:499/3/2_irritable-bowel-syndrome:IBS-D_vs_Healthy-Control_UP	NA	830	189330	28050	2740	841
bsdb:499/4/1_irritable-bowel-syndrome:IBS-(All-patients)_vs_Healthy-Control_DOWN	NA	1678	239759	283168	375288	195950
bsdb:499/4/2_irritable-bowel-syndrome:IBS-(All-patients)_vs_Healthy-Control_UP	NA	55079	100175	39948	2740	109326	572511	248744	189330	28050	841
bsdb:500/1/1_COVID-19:COVID-19-patients_vs_Non-COVID-19-pneumonia-patients_UP	NA	469	28453
bsdb:500/1/2_COVID-19:COVID-19-patients_vs_Non-COVID-19-pneumonia-patients_DOWN	NA	1654	1380	194	1016	43996	1378	117563	32067	906	437755	482	265975	836	838	970	1301	195950	29465
bsdb:501/1/1_endometriosis:One-(1)-Stage-III-Endometriosis-patient_vs_Women-scheduled-for-laparoscopic-surgery-for-benign-uterine/-ovarian-conditions-as-well-as-women-with-Stage-I-or-Stage-II-endometriosis_UP	NA	35829	222	1193324	174708	244127	816	580596	100883	33042	946234	1578	375288	1743	168808	1279	191303
bsdb:502/1/1_irritable-bowel-syndrome:IBS_vs_Healthy-Control_UP	NA	194
bsdb:502/1/2_irritable-bowel-syndrome:IBS_vs_Healthy-Control_DOWN	NA	816	29465	838
bsdb:502/2/2_irritable-bowel-syndrome:IBS-C_vs_Healthy-Control_DOWN	NA	816	838
bsdb:502/3/2_irritable-bowel-syndrome:IBS-D_vs_Healthy-Control_DOWN	NA	816	838
bsdb:502/4/1_irritable-bowel-syndrome:IBS-M_vs_Healthy-Control_UP	NA	194
bsdb:503/1/1_Amoxicillin:Amoxicillin-exposed_vs_Control(Unexposed-to-Amoxicillin)_UP	NA	848
bsdb:503/2/1_Amoxicillin:Amoxicillin-exposed_vs_Control(Unexposed-to-Amoxicillin)_UP	NA	848
bsdb:504/4/1_neoplasm:TPBC-tumor-tissue_vs_TPBC-normal-tissue_UP	NA	1301
bsdb:504/5/2_ethnic-group:BNH_vs_WNH_DOWN	NA	20
bsdb:504/6/1_ethnic-group:BNH_vs_WNH_UP	NA	29465	28100
bsdb:504/6/2_ethnic-group:BNH_vs_WNH_DOWN	NA	1578	20
bsdb:505/1/2_irritable-bowel-syndrome:IBS_vs_Healthy-Control_DOWN	NA	1678
bsdb:506/1/2_irritable-bowel-syndrome:IBS-D_vs_Healthy-Control_DOWN	NA	1678
bsdb:507/1/1_antimicrobial-agent:Patients-after-Rifaximin-treatment_vs_Patients-before-Rifaximin-treatment_DOWN	NA	724	841	29465
bsdb:507/2/1_antimicrobial-agent:Patients-1-month-after-Rifaximin-treatment_vs_Patients-before-Rifaximin-treatment_UP	NA	1578
bsdb:507/2/2_antimicrobial-agent:Patients-1-month-after-Rifaximin-treatment_vs_Patients-before-Rifaximin-treatment_DOWN	NA	841
bsdb:508/1/1_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-Controls_UP	NA	239934	1678	561	119852	375288	33024
bsdb:508/1/2_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-Controls_DOWN	NA	848
bsdb:509/1/1_smoking-behavior:Smoking_vs_Non-smoking_UP	NA	1283313	1281902	120831	1357	84567	162291	836	583	475230	292632	82802
bsdb:509/1/2_smoking-behavior:Smoking_vs_Non-smoking_DOWN	NA	43668	55080	238749	547	28231	579	1578	68287	57494	33024	48736	160674
bsdb:509/2/1_smoking-behavior:Smoking_vs_Non-smoking_UP	NA	1283313	120831	1434010	1357	69965	248744	346096	84567	162291	836	583	354349	475230	292632	82802
bsdb:509/2/2_smoking-behavior:Smoking_vs_Non-smoking_DOWN	NA	43668	55080	1774107	1716	238749	547	28231	227979	579	1578	68287	248038	57494	745	157932	160674	1649510
bsdb:510/2/1_rheumatoid-arthritis:patients-with-rheumatoid-arthritis_vs_patients-with-no-rheumatoid-arthritis_UP	NA	1678	52225
bsdb:511/1/1_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	29465	194	117563	32257	44259
bsdb:511/1/2_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	482	1716	713	437755	416916	157	286
bsdb:511/2/1_COVID-19:COVID-19-patients-(severe/critical)_vs_COVID-19-patients-(mild/moderate)_DOWN	NA	157	416916	970	44259	2740
bsdb:511/3/1_COVID-19:COVID-19-patients-not-treated-with-antibiotics_vs_Healthy-controls_UP	NA	117563	29465	194	162289
bsdb:511/3/2_COVID-19:COVID-19-patients-not-treated-with-antibiotics_vs_Healthy-controls_DOWN	NA	437755	157
bsdb:511/4/1_COVID-19:COVID-19-patients_vs_Healthy-controls_UP	NA	1301	46255	1350	32207	1578	1654	117563
bsdb:511/4/2_COVID-19:COVID-19-patients_vs_Healthy-controls_DOWN	NA	572511	33042	102106
bsdb:511/5/1_COVID-19:COVID-19-patients-not-treated-with-antibiotics_vs_Healthy-controls_UP	NA	1301	165779	162289	194	1380
bsdb:511/5/2_COVID-19:COVID-19-patients-not-treated-with-antibiotics_vs_Healthy-controls_DOWN	NA	572511	33042	207244	482
bsdb:512/1/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-controls-and-healthcare-workers_UP	NA	469	1269	475	286	32207
bsdb:512/2/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-controls_UP	NA	150247	469	286
bsdb:512/3/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-healthcare-workers-(controls)_UP	NA	150247
bsdb:512/4/1_Viral-load:low-Ct-CoV+-patients_vs_high-Ct-CoV+-patients_UP	NA	1716	482	286
bsdb:512/5/1_Viral-load:mid-Ct-CoV+-patients_vs_high-Ct-CoV+-patients_UP	NA	1716	482
bsdb:512/5/2_Viral-load:mid-Ct-CoV+-patients_vs_high-Ct-CoV+-patients_DOWN	NA	1301
bsdb:512/7/1_Viral-load:high-Ct-CoV+-patients_vs_low-and-mid-Ct-CoV+-patients_UP	NA	1301
bsdb:512/7/2_Viral-load:high-Ct-CoV+-patients_vs_low-and-mid-Ct-CoV+-patients_DOWN	NA	1716	1912216	482	286
bsdb:513/1/1_COVID-19:COVID-19-positive-patients_vs_COVID-19-negative-controls_UP	NA	613	29465
bsdb:513/2/1_COVID-19:COVID-19-positive-patients-with-breathing-assistance_vs_COVID-19-positive-patients-without-breathing-assistance_UP	NA	547	838	29465	1301	32207	613
bsdb:513/3/1_COVID-19:COVID-19-positive-patients-with-antibiotic-use_vs_COVID-19-positive-patients-without-antibiotic-use_UP	NA	150022	613
bsdb:514/1/1_endometriosis:Stage-3/4-endometriosis-patients_vs_Women-scheduled-for-laparoscopic-surgery-for-benign-uterine/-ovarian-conditions_UP	NA	1301
bsdb:516/1/1_endometriosis:Mice-who-were-injected-with-endometrial-tissues_vs_Healthy-mice_UP	NA	1678	577310
bsdb:516/2/2_endometriosis:Mice-who-were-injected-with-endometrial-tissues_vs_Healthy-mice_DOWN	NA	1283313
bsdb:518/1/1_endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_UP	NA	1654	1678	572511	189330	84111	1350	1578	1357	1508657	1301	1485	1716
bsdb:518/1/2_endometriosis:Stage-3/4-endometriosis-patients_vs_Healthy-controls_DOWN	NA	28050	283168	577310	1508657	40544
bsdb:519/1/1_endometriosis:Endo-mice_vs_Non-endo-mice_UP	NA	816
bsdb:520/1/1_endometriosis:Stage-3/4-Endometriosis-patients_vs_Stage-1/2-Endometriosis-patients_UP	NA	165779
bsdb:520/2/1_endometriosis:Higher-stages-of-endometriosis_vs_Lower-stages-of-endometriosis_DOWN	NA	836	482	724
bsdb:520/2/2_endometriosis:Higher-stages-of-endometriosis_vs_Lower-stages-of-endometriosis_UP	NA	165779	12916	13687	162289	39948	28100	404402	561	1578	184869	1743
bsdb:521/1/1_endometriosis:Stage-3/4-endometriosis-patients_vs_Surgical-controls_DOWN	NA	1654	1743	32207
bsdb:521/1/2_endometriosis:Stage-3/4-endometriosis-patients_vs_Surgical-controls_UP	NA	469	212791	286	1301
bsdb:522/4/1_endometriosis:Endometriosis-patients_vs_Controls-undergoing-laparoscopic-surgery-for-benign-tumors_UP	NA	33986	1485
bsdb:522/5/1_endometriosis:Endometriosis-patients_vs_Controls-undergoing-laparoscopic-surgery-for-benign-tumors_UP	NA	1485
bsdb:523/1/1_endometriosis:Endo-mice_vs_Non-endo-mice_DOWN	NA	207244	816	572511	1432051	1573534	644652	1578	841	1506577
bsdb:523/1/2_endometriosis:Endo-mice_vs_Non-endo-mice_UP	NA	239934	174708	544	375288	577310	28138
bsdb:524/1/1_non-alcoholic-steatohepatitis:Individuals-diagnosed-with--Nonalcoholic-steatohepatitis-(without-cirrhosis)_vs_Healthy-controls_UP	NA	1654	102106	84111	1407607	1649459	1506553
bsdb:524/1/2_non-alcoholic-steatohepatitis:Individuals-diagnosed-with--Nonalcoholic-steatohepatitis-(without-cirrhosis)_vs_Healthy-controls_DOWN	NA	239759	816	397864	872	283168	375288	577309	577310	1481960	1505652
bsdb:524/2/1_non-alcoholic-steatohepatitis:Individuals-diagnosed-with-Nonalcoholic-steatohepatitis-(NASH)-with-cirrhosis_vs_Healthy-controls_UP	NA	1654	102106	84111	1649459	1506553
bsdb:524/2/2_non-alcoholic-steatohepatitis:Individuals-diagnosed-with-Nonalcoholic-steatohepatitis-(NASH)-with-cirrhosis_vs_Healthy-controls_DOWN	NA	239759	816	397864	283168	375288	1481960	1505652
bsdb:525/1/1_endometriosis:Women-with-EM-associated-CPPS_vs_Women-without-CPPS-presenting-for-routine-examinations_DOWN	NA	1578
bsdb:525/2/1_endometriosis:Women-with-EM-associated-CPPS_vs_Women-without-CPPS-presenting-for-routine-examinations_UP	NA	419014	40323	29465
bsdb:525/2/2_endometriosis:Women-with-EM-associated-CPPS_vs_Women-without-CPPS-presenting-for-routine-examinations_DOWN	NA	906	177971	168808
bsdb:525/3/1_endometriosis:Women-with-EM-associated-CPPS_vs_Women-without-CPPS-presenting-for-routine-examinations_UP	NA	419014
bsdb:526/1/1_endometriosis,Adenomyosis:Endometriosis/-adenomyosis-patients-(AMEM)_vs_Endometriosis-patients-(EM)-and-Patients-without-endometriosis(Control-CT)_UP	NA	1380	194	1582879	216851
bsdb:526/3/1_endometriosis,Adenomyosis:Endometriosis/-adenomyosis-patients-(AMEM)_vs_Adenomysis-patients_UP	NA	1380	194	1582879	216851
bsdb:527/1/1_endometriosis:Endometriosis-patients_vs_Healthy-controls-taken-from-a-larger-cohort-study_DOWN	NA	447020	28050	577309	191303
bsdb:527/1/2_endometriosis:Endometriosis-patients_vs_Healthy-controls-taken-from-a-larger-cohort-study_UP	NA	119852	816	375288	33042
bsdb:527/2/2_endometriosis:Endometriosis-patients_vs_Healthy-controls-taken-from-a-larger-cohort-study_UP	NA	28050	119852
bsdb:529/1/1_rheumatoid-arthritis,osteoarthritis:arthritis-patient_vs_healthy-controls_UP	NA	848	47670	32067	117563	1654	1301	32207	724	29465	836	482	838
bsdb:529/1/2_rheumatoid-arthritis,osteoarthritis:arthritis-patient_vs_healthy-controls_DOWN	NA	469	59732	286	212791	40323	13687	343873	816	283	13159
bsdb:529/2/1_rheumatoid-arthritis,osteoarthritis:rheumatoid-arthritis_vs_Osteoarthritis_UP	NA	713	416916	848	29465	838	724	482
bsdb:529/2/2_rheumatoid-arthritis,osteoarthritis:rheumatoid-arthritis_vs_Osteoarthritis_DOWN	NA	1301	1654	47670	32207	117563	1263	265975	46123
bsdb:530/1/1_Smoking-status-measurement:Current-Smokers_vs_Never-Smokers_UP	NA	1678	1578	1654	32207	1380	906
bsdb:530/1/2_Smoking-status-measurement:Current-Smokers_vs_Never-Smokers_DOWN	NA	2717	1350	32257	47670	482	416916	724	1378
bsdb:530/2/1_Smoking-status-measurement:Former-Smokers_vs_Never-Smokers_UP	NA	1678	32207
bsdb:530/2/2_Smoking-status-measurement:Former-Smokers_vs_Never-Smokers_DOWN	NA	2717	1350	47670	32257	838	1380	724	416916	482	1378
bsdb:530/3/1_Smoking-status-measurement:Current-Smokers_vs_Former-Smokers_UP	NA	1654	1380	1678	32207	906	1578
bsdb:530/3/2_Smoking-status-measurement:Current-Smokers_vs_Former-Smokers_DOWN	NA	416916	1350	1378	47670	482	724	32257	2717
bsdb:531/1/1_rheumatoid-arthritis:rheumatoid-arthritis-patient_vs_healthy-controls_UP	NA	1654	1380	1378	906	838	970	157
bsdb:531/1/2_rheumatoid-arthritis:rheumatoid-arthritis-patient_vs_healthy-controls_DOWN	NA	44259	724	482	836	146
bsdb:532/1/1_rheumatoid-arthritis:rheumatoid-arthritis-patients_vs_healthy-controls_UP	NA	1654	84111	551	1730	1301	191303
bsdb:532/1/2_rheumatoid-arthritis:rheumatoid-arthritis-patients_vs_healthy-controls_DOWN	NA	216851
bsdb:533/1/1_Parkinson's-disease:Patients-with-Parkinson's-disease_vs_Healthy-control_UP	NA	239934	561	1678	29465	1301	1485	613	206664	547	84108	48463	33951	207244	872	44000
bsdb:533/1/2_Parkinson's-disease:Patients-with-Parkinson's-disease_vs_Healthy-control_DOWN	NA	830	1696	283168	46205	375288	33042	748770	40544	28050	841	570	203804	572511	816
bsdb:533/2/1_Parkinson's-disease:Patients-with-Parkinson's-disease_vs_Healthy-control_UP	NA	44000	29465	1301	33951	207244
bsdb:533/2/2_Parkinson's-disease:Patients-with-Parkinson's-disease_vs_Healthy-control_DOWN	NA	572511	28050	830	841
bsdb:534/1/1_exercise:obese-subjects_vs_lean-subjects_UP	NA	816	102106
bsdb:534/1/2_exercise:obese-subjects_vs_lean-subjects_DOWN	NA	216851	28050
bsdb:534/2/1_exercise:obese-subjects_vs_lean-subjects_DOWN	NA	189330	102106
bsdb:534/2/2_exercise:obese-subjects_vs_lean-subjects_UP	NA	216851	28050
bsdb:535/1/1_antimicrobial-agent:Antibiotic-treated_vs_Antibiotic-untreated_DOWN	NA	904	830	28050
bsdb:535/1/2_antimicrobial-agent:Antibiotic-treated_vs_Antibiotic-untreated_UP	NA	165779	420345	1578	906	5073	583
bsdb:535/2/1_antimicrobial-agent:Antibiotic-treated-subjects-in-day-hospital_vs_Antibiotic-untreated-subjects-in-day-hospital_UP	NA	1578	86331	437755	162289	172900	46255
bsdb:535/2/2_antimicrobial-agent:Antibiotic-treated-subjects-in-day-hospital_vs_Antibiotic-untreated-subjects-in-day-hospital_DOWN	NA	572511	216851
bsdb:536/1/2_azithromycin:The-group-given-an-azithromycin-oral-solution_vs_The-group-given-a-placebo_UP	NA	946234
bsdb:537/1/1_Parkinson's-disease:patients-with-idiopathic-parkinson's-disease_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_UP	NA	239934	1678	561
bsdb:537/1/2_Parkinson's-disease:patients-with-idiopathic-parkinson's-disease_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_DOWN	NA	841	216851
bsdb:537/2/1_Parkinson's-disease:the-trend-over-Parkinson's-disease-progression_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_UP	NA	239934	1578
bsdb:537/3/1_Parkinson's-disease:patients-with-MSA(multiple-system-atrophy)-disease_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_UP	NA	239934	1301	1678	74107
bsdb:537/3/2_Parkinson's-disease:patients-with-MSA(multiple-system-atrophy)-disease_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_DOWN	NA	216851	841
bsdb:537/4/1_Parkinson's-disease:patients-with-PSP(progressive-supranuclear-palsy)-disease_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_UP	NA	239934	119852
bsdb:537/4/2_Parkinson's-disease:patients-with-PSP(progressive-supranuclear-palsy)-disease_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_DOWN	NA	841	1301	838	216851
bsdb:537/6/1_Parkinson's-disease:patients-with-early-Parkinson's-disease_vs_healthy-controls-without-any-form-of-Parkinson's-disease_UP	NA	239934	119852
bsdb:537/6/2_Parkinson's-disease:patients-with-early-Parkinson's-disease_vs_healthy-controls-without-any-form-of-Parkinson's-disease_DOWN	NA	216851	841
bsdb:537/7/1_Parkinson's-disease:patients-with-mid-stage-Parkinson's_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_UP	NA	239934	1678	375288
bsdb:537/7/2_Parkinson's-disease:patients-with-mid-stage-Parkinson's_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_DOWN	NA	841	216851
bsdb:537/8/1_Parkinson's-disease:patients-with-advanced-stage-Parkinson's_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_UP	NA	239934	561	1578	375288	1678
bsdb:537/8/2_Parkinson's-disease:patients-with-advanced-stage-Parkinson's_vs_healthy-controls-without-any-form-of-Parkinson's-Disease_DOWN	NA	216851	841
bsdb:538/1/1_antimicrobial-agent:ciprofloxacin-treated_vs_baseline-of-the-ciprofloxacin-treated_DOWN	NA	216851	119852	1263
bsdb:538/1/2_antimicrobial-agent:ciprofloxacin-treated_vs_baseline-of-the-ciprofloxacin-treated_UP	NA	572511	1485	1730	841
bsdb:538/2/2_antimicrobial-agent:Nitrofurantoin-treated_vs_Baseline-of-the-Nitrofurantoin-treated_UP	NA	216851
bsdb:538/6/1_urinary-tract-infection,Antimicrobial-agent:Ciprofloxacin-treated-group-(timepoint-2)_vs_control-group-(timepoint-2)_UP	NA	239759	119852	375288	841	1263
bsdb:538/7/1_urinary-tract-infection,Antimicrobial-agent:nitrofurantoin-treated-group-(timepoint-2)_vs_controls-(timepoint-2)_UP	NA	239759	216851
bsdb:540/1/1_smoking-behavior:Smokers_vs_Non-smokers_UP	NA	838	1301	29465
bsdb:540/1/2_smoking-behavior:Smokers_vs_Non-smokers_DOWN	NA	482
bsdb:540/2/1_smoking-behavior:Smokers_vs_Non-smokers_UP	NA	1654	1380	906	838	1301	29465
bsdb:540/2/2_smoking-behavior:Smokers_vs_Non-smokers_DOWN	NA	59735	848	1378	724	47670	482	195950
bsdb:541/4/1_schizophrenia:Baseline-schizophrenic-patients_vs_Healthy-controls_UP	NA	848
bsdb:541/5/1_schizophrenia:Follow-up-schizophrenic-patients_vs_Healthy-controls_UP	NA	848
bsdb:543/1/1_HIV-infection:Persons-with-HIV-(PWH)_vs_HIV-seronegative-controls_DOWN	NA	342658	459786	1501226	44748
bsdb:543/1/2_HIV-infection:Persons-with-HIV-(PWH)_vs_HIV-seronegative-controls_UP	NA	1485
bsdb:545/1/1_antimicrobial-agent:7-week-old-(young)-mice-10-days-after-antibiotic-treatments_vs_7-week-old-(young)-mice-before-antibiotic-treatment_UP	NA	1350
bsdb:545/1/2_antimicrobial-agent:7-week-old-(young)-mice-10-days-after-antibiotic-treatments_vs_7-week-old-(young)-mice-before-antibiotic-treatment_DOWN	NA	1470349	1729679	1501226
bsdb:545/2/1_antimicrobial-agent:7-week-old-(young)-mice-6-months-after-antibiotic-treatments_vs_7-week-old-(young)-mice-before-antibiotic-treatment_UP	NA	1501226	1937008
bsdb:545/2/2_antimicrobial-agent:7-week-old-(young)-mice-6-months-after-antibiotic-treatments_vs_7-week-old-(young)-mice-before-antibiotic-treatment_DOWN	NA	1470349
bsdb:545/3/2_antimicrobial-agent:40-week-old-(old)-mice-10-days-after-antibiotic-treatments_vs_40-week-old-(old)-mice-before-antibiotic-treatment_DOWN	NA	1501226	1729679
bsdb:545/4/1_antimicrobial-agent:40-week-old-(old)-mice-6-months-after-antibiotic-treatments_vs_40-week-old-(old)-mice-before-antibiotic-treatment_DOWN	NA	1729679	1918540	1501226
bsdb:545/4/2_antimicrobial-agent:40-week-old-(old)-mice-6-months-after-antibiotic-treatments_vs_40-week-old-(old)-mice-before-antibiotic-treatment_UP	NA	1937008
bsdb:546/1/2_COVID-19:COVID-19-cases_vs_Non-infected-controls_DOWN	NA	724	848	482	1301
bsdb:547/1/1_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_UP	NA	561	1505657	946234
bsdb:547/1/2_COVID-19:Recovered-COVID-19-patients_vs_Healthy-controls_DOWN	NA	35832	1392389	1501226	216851	580596	189330	1263	841	1407607
bsdb:548/1/1_COVID-19:COVID-19-cases_vs_Healthy-controls_UP	NA	2745	117563	32067	1301
bsdb:548/1/2_COVID-19:COVID-19-cases_vs_Healthy-controls_DOWN	NA	482	838	1283313	848	724
bsdb:549/1/1_Keratoconjunctivitis:Atopic-keratoconjunctivitis-(AKC)_vs_Healthy-controls_UP	NA	286	1279	724
bsdb:549/1/2_Keratoconjunctivitis:Atopic-keratoconjunctivitis-(AKC)_vs_Healthy-controls_DOWN	NA	48736	1678	583
bsdb:550/1/1_juvenile-idiopathic-arthritis:JIA-patients_vs_healthy-controls_UP	NA	123375	86331
bsdb:550/1/2_juvenile-idiopathic-arthritis:JIA-patients_vs_healthy-controls_DOWN	NA	724	1386	133925
bsdb:550/2/1_temporomandibular-joint-disorder:JIA-patients-with-TMJ_vs_JIA-patients-without-TMJ_DOWN	NA	724	265975	1380	1386	508215
bsdb:550/2/2_temporomandibular-joint-disorder:JIA-patients-with-TMJ_vs_JIA-patients-without-TMJ_UP	NA	538	724	1283313
bsdb:551/1/1_high-fat-diet:high-fiber_vs_low-fiber_UP	NA	816	1485	51514	1350	1578	1357	1301
bsdb:551/1/2_high-fat-diet:high-fiber_vs_low-fiber_DOWN	NA	1678
bsdb:552/1/1_gestational-age:Week-36_vs_Week-24_UP	NA	475	1301	1279	1350	1716	1378
bsdb:552/1/2_gestational-age:Week-36_vs_Week-24_UP	NA	1578
bsdb:552/2/1_gestational-age:Birth_vs_36_UP	NA	1716	1350	1378	475	1279	1301
bsdb:552/2/2_gestational-age:Birth_vs_36_DOWN	NA	1578
bsdb:553/2/2_spontaneous-abortion:First-trimester-miscarriage_vs_Viable-control-pregnancy_UP	NA	1301	162289	2129	39948
bsdb:554/1/1_Parkinson's-disease:patients-with-parkinson's-disease_vs_Healthy-Controls(HC)_UP	NA	838
bsdb:554/1/2_Parkinson's-disease:patients-with-parkinson's-disease_vs_Healthy-Controls(HC)_DOWN	NA	1578
bsdb:554/2/8_Parkinson's-disease:Parkinson's-Disease-subjects_vs_Healthy-Controls_UP	NA	239934	239759	33042	28050	2172	375288	33024	841	1263
bsdb:554/2/9_Parkinson's-disease:Parkinson's-Disease-subjects_vs_Healthy-Controls_DOWN	NA	1578	1301
bsdb:555/1/1_rheumatoid-arthritis:rheumatoid-arthritis-patient_vs_healthy-controls_UP	NA	572511	1301
bsdb:555/1/2_rheumatoid-arthritis:rheumatoid-arthritis-patient_vs_healthy-controls_DOWN	NA	1506553	841
bsdb:557/1/1_urinary-tract-infection:Day-5-(end-of-dosing-or-post-dose)_vs_Day-1-(pre-dose)_UP	NA	713	1654	1283313	165779	207244	816	572511	150022	946234	1940255	1434006	2701	1164882	1578	1847725	32067	906	2050	482	265975	459786	543311	1257	33024	286	1501226	841	508215	1508657	970	1301	40544
bsdb:557/1/2_urinary-tract-infection:Day-5-(end-of-dosing-or-post-dose)_vs_Day-1-(pre-dose)_DOWN	NA	39948	1350	848	375288	970	157	1506577	29465
bsdb:557/2/1_urinary-tract-infection:Follow-up-(visit-around-Day-283days)._vs_Day-1-(pre-dose)_UP	NA	1654	207244	1678	572511	194	848	1847725	32067	482	33024	1501226	841	508215	970	40544	29465
bsdb:557/2/2_urinary-tract-infection:Follow-up-(visit-around-Day-283days)._vs_Day-1-(pre-dose)_DOWN	NA	1654	816	102106	39948	1407607	2701	117563	1578	459786	375288	508215	1263	157	29465
bsdb:557/3/1_urinary-tract-infection:Day-5-(end-of-dosing-or-post-dose)_vs_Day-1-(pre-dose)_UP	NA	904	1375	216851	906	1263	177971	1578	816	194
bsdb:557/3/2_urinary-tract-infection:Day-5-(end-of-dosing-or-post-dose)_vs_Day-1-(pre-dose)_DOWN	NA	713	416916	1283313	816	194	1016	43996	39948	150022	848	117563	1164882	1578	1847725	32067	482	375288	836	838	1508657	970	1213720	1301	195950	29465
bsdb:557/4/1_urinary-tract-infection:Follow-up-(visit-around-Day-283days)._vs_Day-1-(pre-dose)_UP	NA	904	216851	906	162289	292632	29465
bsdb:557/4/2_urinary-tract-infection:Follow-up-(visit-around-Day-283days)._vs_Day-1-(pre-dose)_DOWN	NA	1766253	165779	1380	816	39948	236752	946234	375288	162289	1257	836	838	286	1508657	168808	1470353
bsdb:557/5/1_urinary-tract-infection:Day-5-(end-of-dosing-or-post-dose)_vs_Day-1-(pre-dose)_UP	NA	577309	838	286	508215	40544	1508657	216851	194	848	29465	1578	33024
bsdb:557/5/2_urinary-tract-infection:Day-5-(end-of-dosing-or-post-dose)_vs_Day-1-(pre-dose)_DOWN	NA	713	1654	1766253	1283313	419014	165779	156454	816	194	1016	1716	39948	84111	1434006	1407607	28050	1357	32067	1980693	265975	375288	543311	841	1263	1301	292632	157
bsdb:557/6/1_urinary-tract-infection:Follow-up-(visit-around-Day-283days)._vs_Day-1-(pre-dose)_UP	NA	1678	580596	1434006	28050	52225	459786	543311	286	1508657	970	157	32067	816	848	29465
bsdb:557/6/2_urinary-tract-infection:Follow-up-(visit-around-Day-283days)._vs_Day-1-(pre-dose)_DOWN	NA	904	1654	239759	1283313	1016	1716	216851	1407607	1378	117563	1164882	265975	375288	162289	1257	838	841	1506577	848
bsdb:558/1/1_antimicrobial-agent:received-oral-i.v.-administered-GSK1322322-(end-of-study)_vs_received-oral-i.v.-administered-GSK1322322-(prestudy)_UP	NA	1678	40544
bsdb:558/1/2_antimicrobial-agent:received-oral-i.v.-administered-GSK1322322-(end-of-study)_vs_received-oral-i.v.-administered-GSK1322322-(prestudy)_DOWN	NA	207244	572511	574697	216851	283168
bsdb:558/1/3_antimicrobial-agent:received-oral-i.v.-administered-GSK1322322-(end-of-study)_vs_received-oral-i.v.-administered-GSK1322322-(prestudy)_UP	NA	40323
bsdb:558/2/2_antimicrobial-agent:received-oral-i.v.-administered-GSK1322322-(end-of-study)_vs_received-oral-i.v.-administered-GSK1322322-(prestudy)_DOWN	NA	375288	283168
bsdb:561/1/1_Parkinson's-disease:Participants-with-early-stage-Parkinson's-Disease._vs_Healthy-age-sex-matched-controls-without-Parkinson's-disease._UP	NA	157920	407	1827	234	5475	1678	1573	2701	1578	196082
bsdb:561/1/2_Parkinson's-disease:Participants-with-early-stage-Parkinson's-Disease._vs_Healthy-age-sex-matched-controls-without-Parkinson's-disease._DOWN	NA	32199	511434	1518147
bsdb:562/1/1_Health-study-participation:healthy-adult-vagina-50%-up_vs_NA_NA	NA	1578
bsdb:562/2/1_Health-study-participation:healthy-adult-skin-50%-up_vs_none_NA	NA	1279	1912216	1716	1301	1269	150022	475	32207
bsdb:562/3/1_Health-study-participation:feces-from-healthy-adult_vs_none---50%-prevalence-threshold_NA	NA	447020	2048137	239934	239759	2569097	207244	816	397864	1678	35832	572511	574697	1485	102106	33042	189330	561	1730	216851	946234	1407607	204475	644652	1505657	28050	2172004	2316020	283168	459786	375288	577310	33024	909656	838	841	1263	1905344	1301
bsdb:562/4/1_Health-study-participation:nasal-cavity-from-healthy-adult_vs_none---50%-prevalence-threshold_NA	NA	1912216	1279	1716	55193
bsdb:562/5/1_Health-study-participation:oral-cavity-from-healthy-adult_vs_none---50%-prevalence-threshold_NA	NA	1301	32207	1654	29465	838	848	1378	482	724	836	194	2529408	1016	32067	1716	47670	416916	195950	1283313	117563	265976	1164882	543311	970	157	46123	32257	86331	1213720	123375	2717	906	538	1257
bsdb:562/6/1_Health-study-participation:milk-from-healthy-adult_vs_none---50%-prevalence-threshold_NA	NA	1301
bsdb:562/7/1_Health-study-participation:healthy-adult-vagina-70%-up_vs_NA_NA	NA	1578
bsdb:562/8/1_Health-study-participation:healthy-adult-skin-70%-up_vs_none_NA	NA	1716	1912216	55193	1279	1301
bsdb:562/9/1_Health-study-participation:feces-from-healthy-adult_vs_none---70%-prevalence-threshold_NA	NA	447020	2048137	239759	2569097	207244	816	1678	572511	1485	102106	33042	189330	1730	216851	946234	1407607	204475	28050	2316020	283168	459786	375288	909656	841	1263	1301	1905344
bsdb:562/10/1_Health-study-participation:feces-from-healthy-adult_vs_none---0%-prevalence-threshold_NA	NA	46123	2147	222	904	1912215	12916	469	76833	1654	1653174	447020	240233	1375	642	2048137	416916	186829	239934	507	2321111	239759	2675234	133193	114627	222991	209879	1283313	419014	2823232	2749846	2707015	13334	2569097	165779	52784	264995	156454	1924093	653683	207244	2039240	244127	55079	69278	2801844	28263	35823	5052	1903434	1380	1386	816	397864	697279	1678	35832	572511	517	85413	43668	29521	55080	1696	41275	2755	234	32008	580596	574697	830	1276290	1158982	1535326	1291539	1470349	1016	2717	2747	135858	75	158483	698776	157920	180162	28209	810	990721	59732	1573	508459	501783	1870884	1485	102106	283	2767879	100883	1348911	33042	2678534	1716	1937664	413496	69578	2675230	80865	2767880	79603	36739	82800	893	898	872	46913	39948	1472649	189330	75654	156973	635	84111	1279384	538	1432051	308865	423604	59734	212791	1472762	106591	5758	547	2719313	1350	2782229	171412	551	1647	561	1730	41201	33986	1582879	66831	216851	2005359	1573536	1573534	2767327	44259	1914234	150022	237	946234	1649295	1434006	1335631	2767881	1407607	848	2701	1378	113	204475	129337	1860	154116	1193503	13075	89583	441	1742989	2053	644652	117563	366614	724	568	1892380	31983	209	1445609	963	1573535	61170	2815774	1649459	243627	1609627	70774	89092	1937007	1934947	1505657	1392389	157226	428711	2782231	257820	32257	570	579	136099	1330547	186475	1649	57499	1506553	28050	2719231	2759736	2767842	1578	1357	420345	2767353	2767884	2767885	47670	1847725	41707	2172004	83654	110932	5658	2767893	171	32067	55968	1243	2767886	2767887	1676651	2742598	2767888	1637	2767889	745364	400634	68	69965	1637257	55193	2803850	2837505	86795	248744	149698	1926659	2316020	158846	906	65551	1649468	33969	68287	2055876	2172	1080709	2316	316612	1484898	2282523	33882	44471	29404	116071	57479	52225	2100764	2050	88138	158848	86331	2039302	475	581	212742	248038	1918540	1774128	1763	670516	1073531	1866885	2093	2767358	53460	53	909928	482	57494	1817	1839	2013	165696	283168	46254	90243	133925	265975	125287	1158	459786	219181	44249	1849828	1763521	375288	1849822	265	577309	196082	577310	745	361607	318147	2767890	2740557	122277	1253	84567	106146	2743582	1913599	2740	162289	1257	2675229	33024	909656	657	28100	447792	332100	162291	190323	702	1330546	142577	838	2800373	206375	1743	203133	583	586	1742993	2055880	53246	1504576	1017280	1742991	2755140	286	1847	113286	83618	1221880	497	2678886	638847	2260	34037	48736	160674	67575	379	75309	1827	780	28138	588605	1960084	841	2730923	120961	125216	2837508	32207	1565532	295418	42255	1263	1905344	4930	1835	45669	404432	263377	590	60919	1266	196081	2529408	2767891	970	1769710	265976	613	519427	22	177971	1649298	71	204447	84108	168808	84565	648800	413435	123375	28453	165695	13687	165697	2132	1569	1279	152053	40323	1213720	1301	1883	292632	674963	2303321	1129	2753	195950	82986	114248	203470	1505652	1418588	51668	99479	192992	141948	270	492233	1505663	111782	2847313	157	2038	1069494	2060	191303	1918598	1506577	2129	2737	184869	34072	29465	662	172900	1013	2817139	85043	2692118	338	629	158876	541
bsdb:562/11/1_Health-study-participation:feces-from-healthy-adult_vs_none---30%-prevalence-threshold_NA	NA	216851	816	841	572511	2316020	189330	1730	909656	1407607	375288	239759	207244	33042	102106	2048137	2569097	1263	1678	28050	1301	204475	1905344	459786	1485	283168	946234	447020	838	397864	644652	33024	2172004	561	35832	239934	574697	577310	1505657	1578	1505663	84108	2719313	1348911	84111	39948	29465	1472762	1392389	724	1924093	1573535	2172	61170	577309	2847313	191303	1918598	1654
bsdb:563/1/1_age:Controls-aged->-10-years_vs_Controls-aged-<=-10-years_UP	NA	1716	253183	265	1743
bsdb:563/1/2_age:Controls-aged->-10-years_vs_Controls-aged-<=-10-years_DOWN	NA	43668	57493	1269	1279	1301
bsdb:563/2/1_Seasonality-measurement:Controls-aged->-10-years-with-samples-collected-in-the-dry-season_vs_Controls-aged->-10-years-with-samples-collected-in-the-wet-season_UP	NA	1386	432330
bsdb:563/4/1_Seasonality-measurement:Cases-aged->-10-years-with-clinical-signs-of-conjunctival-scarring-sampled-during-the-dry-season_vs_Controls-aged->-10-years-with-healthy-conjunctiva-samples-collected-during-the-dry-season_UP	NA	1716	1301
bsdb:563/4/2_Seasonality-measurement:Cases-aged->-10-years-with-clinical-signs-of-conjunctival-scarring-sampled-during-the-dry-season_vs_Controls-aged->-10-years-with-healthy-conjunctiva-samples-collected-during-the-dry-season_DOWN	NA	13075
bsdb:563/6/1_Chlamydia-trachomatis:Cases-with-conjunctival-scarring-(C>0)-and-trachomatous-trichiasis-(TT),with-samples-collected-in-the-dry-season_vs_Cases-with-conjunctival-scarring-(C>0)-alone,-with-samples-collected-in-the-dry-season_UP	NA	1716	57493
bsdb:563/6/2_Chlamydia-trachomatis:Cases-with-conjunctival-scarring-(C>0)-and-trachomatous-trichiasis-(TT),with-samples-collected-in-the-dry-season_vs_Cases-with-conjunctival-scarring-(C>0)-alone,-with-samples-collected-in-the-dry-season_DOWN	NA	253183	265
bsdb:565/1/1_arthritis:dogs-with-hip-or-elbow-arthritis_vs_healthy-dogs_DOWN	NA	13334	375288	2740	33024	86331
bsdb:565/1/2_arthritis:dogs-with-hip-or-elbow-arthritis_vs_healthy-dogs_UP	NA	158846
bsdb:566/1/1_juvenile-idiopathic-arthritis:HLAB27+_vs_HLAB27-_DOWN	NA	724	84111
bsdb:566/1/2_juvenile-idiopathic-arthritis:HLAB27+_vs_HLAB27-_UP	NA	35832	39948	596767	1578	459786	543311
bsdb:566/2/1_juvenile-idiopathic-arthritis:JIA-patients-in-remission_vs_JIA-patients-with-active-disease_DOWN	NA	40544
bsdb:566/2/2_juvenile-idiopathic-arthritis:JIA-patients-in-remission_vs_JIA-patients-with-active-disease_UP	NA	577310	283168
bsdb:567/1/1_colorectal-adenoma:Advanced-colorectal-adenoma-group-(A-CRA)_vs_Healthy-control-group-(HC)_UP	NA	816	1301	1350
bsdb:568/1/1_Parkinson's-disease:NPD-group:-patients-suffering-with-suffering-with-with-PD-for-less-than-1-year-and-before-treatment._vs_healthy-controls-without-any-form-of-Parkinson's-Disease_UP	NA	191303
bsdb:568/1/2_Parkinson's-disease:NPD-group:-patients-suffering-with-suffering-with-with-PD-for-less-than-1-year-and-before-treatment._vs_healthy-controls-without-any-form-of-Parkinson's-Disease_DOWN	NA	577309	1263	1301
bsdb:568/2/1_Parkinson's-disease:NPD-group:-patients-suffering-with-PD-for-less-than-1-year-and-5-days-after-treatment._vs_healthy-controls-without-any-form-of-Parkinson's-Disease_UP	NA	191303
bsdb:568/3/1_Parkinson's-disease:NPD-group:-patients-suffering-with-PD-for-less-than-1-year-and-14-days-after-treatment._vs_healthy-controls-without-any-form-of-Parkinson's-Disease_UP	NA	191303
bsdb:568/3/2_Parkinson's-disease:NPD-group:-patients-suffering-with-PD-for-less-than-1-year-and-14-days-after-treatment._vs_healthy-controls-without-any-form-of-Parkinson's-Disease_DOWN	NA	1263
bsdb:570/1/1_rheumatoid-arthritis:female-with-early-RA_vs_female-healthy-control_DOWN	NA	102106	1730	1243
bsdb:571/1/1_osteoarthritis,-knee:Knee-osteroarthritis_vs_Normal-Vitamin-D-status_DOWN	NA	52784
bsdb:571/1/2_osteoarthritis,-knee:Knee-osteroarthritis_vs_Normal-Vitamin-D-status_UP	NA	1392389	543311	2740	1743	1335483
bsdb:571/2/1_osteoarthritis,-knee:Knee-osteroarthritis-with-vit-D-deficiency_vs_Vitamin-D-deficiency_DOWN	NA	1283313	283168	265975	838
bsdb:571/2/2_osteoarthritis,-knee:Knee-osteroarthritis-with-vit-D-deficiency_vs_Vitamin-D-deficiency_UP	NA	574697	1331051	80865	644652	375288	33024
bsdb:574/1/1_antimicrobial-agent:azithromycin-lactulose-treated-(day-18)_vs_azithromycin-lactulose-treated-(day-0)_DOWN	NA	547	838
bsdb:574/1/2_antimicrobial-agent:azithromycin-lactulose-treated-(day-18)_vs_azithromycin-lactulose-treated-(day-0)_UP	NA	207244	1350	1578	841	1263
bsdb:574/2/1_antimicrobial-agent:azithromycin-treated-(day-18)_vs_azithromycin-treated-(day-0)_DOWN	NA	547
bsdb:574/2/2_antimicrobial-agent:azithromycin-treated-(day-18)_vs_azithromycin-treated-(day-0)_UP	NA	447020	28050
bsdb:574/3/1_antimicrobial-agent:azithromycin-treated-(day-60)_vs_azithromycin-treated-(day-0)_DOWN	NA	547	283168	577309	838	40544
bsdb:574/3/2_antimicrobial-agent:azithromycin-treated-(day-60)_vs_azithromycin-treated-(day-0)_UP	NA	447020	114627	1301	29465
bsdb:574/4/1_antimicrobial-agent:azithromycin-lactulose-treated_vs_azithromycin-treated_UP	NA	207244	572511	574697	100883	156973	1647	906
bsdb:574/4/2_antimicrobial-agent:azithromycin-lactulose-treated_vs_azithromycin-treated_UP	NA	906	1569
bsdb:575/1/1_antimicrobial-agent:perinatal-antibiotics_vs_Control-group_UP	NA	1485	216851	838
bsdb:575/1/2_antimicrobial-agent:perinatal-antibiotics_vs_Control-group_DOWN	NA	816
bsdb:576/1/1_colorectal-cancer:patients-with-adenocarcinoma_vs_controls-with-no-cancer_DOWN	NA	33042
bsdb:577/2/3_asthma:Female-participants-with-asthma_vs_Female-normal-controls_UP	NA	1578
bsdb:579/1/2_major-depressive-disorder:Middle-aged-HC-(aged-30-59-years)_vs_Young-Healthy-Controls(aged-18-29-years)_DOWN	NA	102106	117563	158846	1301	29465
bsdb:579/2/1_major-depressive-disorder:Middle-aged-MDD-(aged-30-59-years)_vs_Young-MDD-(aged-18-29-years)_UP	NA	207244	84111	644652	191303
bsdb:579/2/2_major-depressive-disorder:Middle-aged-MDD-(aged-30-59-years)_vs_Young-MDD-(aged-18-29-years)_DOWN	NA	158846	33024	838
bsdb:579/3/1_major-depressive-disorder:Middle-aged-MDD-(aged-30-59-years)_vs_Middle-aged-HC-(aged-30-59-years)_UP	NA	109326	40544	459786	33024	33042	816	216851
bsdb:579/3/2_major-depressive-disorder:Middle-aged-MDD-(aged-30-59-years)_vs_Middle-aged-HC-(aged-30-59-years)_DOWN	NA	207244	29465	1301	84111	841	1730	1654
bsdb:580/1/1_HIV-infection:HIV+-individuals_vs_HIV-uninfected-individuals_DOWN	NA	194	1016	848	482	265975	838	195950
bsdb:580/1/2_HIV-infection:HIV+-individuals_vs_HIV-uninfected-individuals_UP	NA	1678	1578	32207	1301	29465
bsdb:580/2/1_nicotine-dependence,smoking-behavior:HIV+-smokers_vs_HIV+-non-smokers_DOWN	NA	1283313	59735	194	848	43994	482	838
bsdb:580/2/2_nicotine-dependence,smoking-behavior:HIV+-smokers_vs_HIV+-non-smokers_UP	NA	1380	1678	1578	1301	29465
bsdb:580/3/1_Abnormality-on-pulmonary-function-testing:HIV+-patients-with-reduced-DLCO_vs_HIV+-patients-with-normal-DLCO_UP	NA	1578	1301	29465
bsdb:580/3/2_Abnormality-on-pulmonary-function-testing:HIV+-patients-with-reduced-DLCO_vs_HIV+-patients-with-normal-DLCO_DOWN	NA	1283313	1016	848	1164882	543311	838	1213720	482
bsdb:581/1/1_epilepsy:Drug-resistant-epilepsy_vs_Drug-sensitive-epilepsy_DOWN	NA	816	397864
bsdb:581/1/2_epilepsy:Drug-resistant-epilepsy_vs_Drug-sensitive-epilepsy_UP	NA	841	33024	2172	848	33042	482	239934	204475	1263	577309	100883	80865	189330	61170	1380
bsdb:582/1/1_colorectal-cancer:CRC-patients_vs_healthy-controls_UP	NA	848	543311	1279
bsdb:582/1/2_colorectal-cancer:CRC-patients_vs_healthy-controls_DOWN	NA	572511	1485	33042	1301
bsdb:582/2/1_colorectal-cancer:CRC-patients_vs_adenoma-patients_UP	NA	543311	1279
bsdb:582/2/2_colorectal-cancer:CRC-patients_vs_adenoma-patients_DOWN	NA	189330	33042	572511	447020
bsdb:583/1/3_HIV-infection:PLWH->50-years-old-with-severe-periodontitis_vs_PLWH->50-years-old-with-no/mild-periodontitis_UP	NA	848	32257	838	1301	29465
bsdb:583/1/4_HIV-infection:PLWH->50-years-old-with-severe-periodontitis_vs_PLWH->50-years-old-with-no/mild-periodontitis_DOWN	NA	906
bsdb:583/1/5_HIV-infection:PLWH->50-years-old-with-severe-periodontitis_vs_PLWH->50-years-old-with-no/mild-periodontitis_UP	NA	1301
bsdb:583/1/6_HIV-infection:PLWH->50-years-old-with-severe-periodontitis_vs_PLWH->50-years-old-with-no/mild-periodontitis_DOWN	NA	482
bsdb:584/1/1_colorectal-adenoma:cra-patients_vs_normal-participants_UP	NA	613	620	590	53335	581	158851	561
bsdb:587/1/1_nicotine-dependence,smoking-behavior:Current-Smoker_vs_Non-smoker_UP	NA	135858	102106	32207	191303	1763
bsdb:587/1/3_nicotine-dependence,smoking-behavior:Current-Smoker_vs_Non-smoker_UP	NA	135858	102106	52225	84108
bsdb:588/1/1_colorectal-cancer:colorectal-cancer-patients_vs_healthy-subjects_UP	NA	46123	469	33870	776	1243	131079	2172	32207	100132	674963	574899
bsdb:588/1/2_colorectal-cancer:colorectal-cancer-patients_vs_healthy-subjects_DOWN	NA	119852
bsdb:588/2/1_Intestinal-polyp:polyps-patients_vs_healthy-subjects_UP	NA	244127	52225
bsdb:588/2/2_Intestinal-polyp:polyps-patients_vs_healthy-subjects_DOWN	NA	194	1350	286	978
bsdb:588/3/1_Intestinal-polyp:cancer-patients_vs_polyps-patients_UP	NA	1654	194	1350	84108	638847	33870	2172	1257	46123	776	574899	1243	46255
bsdb:588/3/2_Intestinal-polyp:cancer-patients_vs_polyps-patients_DOWN	NA	642	100132	119852	52225	34104
bsdb:589/1/1_colorectal-cancer:CRC-patients_vs_healthy-control_UP	NA	33024	65402
bsdb:590/1/1_HIV-infection:Recently-HIV-1-infected-individuals_vs_HIV-1-negative-individuals_DOWN	NA	189330
bsdb:590/1/2_HIV-infection:Recently-HIV-1-infected-individuals_vs_HIV-1-negative-individuals_UP	NA	29465
bsdb:591/1/1_HIV-infection:HIV+-individuals_vs_HIV-individuals_UP	NA	572511	118747	580596	1716	544	872	1350	561	1730	848	117563	158846	906	52225	86331	543311	1257	33024	838	1279	191303
bsdb:591/1/2_HIV-infection:HIV+-individuals_vs_HIV-individuals_DOWN	NA	1301	168808	841	1263	119852	28050	140625	61170	216851	189330	33042	1485	830	1678	816	207244	447020	357
bsdb:592/1/1_HIV-infection:HIV-Patients_vs_Healthy-controls_UP	NA	265975	123375	1578	1926663	133925	580024	86331	2082587	83770	906	1473205	84108	1573535	102106	135858	838	158846	39948
bsdb:592/1/2_HIV-infection:HIV-Patients_vs_Healthy-controls_DOWN	NA	816	207244	2039302	239759	1407607	547	117563	724
bsdb:593/1/1_polycystic-ovary-syndrome:Obese-women-with-PCOS_vs_Obese-women-without-PCOS_UP	NA	848	33042	1506553	1506577
bsdb:593/1/2_polycystic-ovary-syndrome:Obese-women-with-PCOS_vs_Obese-women-without-PCOS_DOWN	NA	61170	292632	239759	1892380	574697	33042	1508657	283
bsdb:593/2/1_polycystic-ovary-syndrome:Obese-women-with-PCOS_vs_Obese-women-without-PCOS_UP	NA	848	1506553	1506577	33042
bsdb:593/2/2_polycystic-ovary-syndrome:Obese-women-with-PCOS_vs_Obese-women-without-PCOS_DOWN	NA	292632	239759	283168	574697	1508657	1573535
bsdb:594/1/1_periodontitis:HIV+_vs_HIV_UP	NA	416916	32257	482	32207	46123
bsdb:594/1/2_periodontitis:HIV+_vs_HIV_DOWN	NA	82202	195950	32067	970	157	838
bsdb:595/1/1_colorectal-carcinoma:CRC-patients_vs_Neoplasia-free_UP	NA	816	35832	872	848	32067	543311	1257	836	1017280	970	482
bsdb:595/1/2_colorectal-carcinoma:CRC-patients_vs_Neoplasia-free_DOWN	NA	469	194	1730	1263
bsdb:595/2/1_colorectal-carcinoma:CRC-patients_vs_Adenoma-patients_UP	NA	848	133925	543311	1257	836
bsdb:595/2/2_colorectal-carcinoma:CRC-patients_vs_Adenoma-patients_DOWN	NA	1730
bsdb:595/3/1_colorectal-carcinoma:Adenoma-patients_vs_Neoplasia-free_DOWN	NA	1263
bsdb:595/4/1_colorectal-carcinoma:CRC_vs_Neoplasia-free-control_UP	NA	872	848	543311	1257	1017280	836	194
bsdb:595/4/2_colorectal-carcinoma:CRC_vs_Neoplasia-free-control_DOWN	NA	35832	2316	1263	1730
bsdb:596/1/1_HIV-infection:HIV-infected-men_vs_HIV-uninfected-men_DOWN	NA	1678	212791	1847	149698	551	110932	12916	53387	469	1386	34072	99479	89966	28065
bsdb:596/1/2_HIV-infection:HIV-infected-men_vs_HIV-uninfected-men_UP	NA	29465	402649
bsdb:598/1/1_HIV-infection:HIV-seroconverted_vs_HIV-seronegative_UP	NA	39948	2050	1257
bsdb:598/1/2_HIV-infection:HIV-seroconverted_vs_HIV-seronegative_DOWN	NA	838	1161127
bsdb:599/1/1_HIV-infection:Healthy-females-who-recieved-two-vaginal-HIV-microbicidal-gels_vs_Healthy-females-who-recieved-universal-placebo_UP	NA	1380	1350	561	2701	2050	838	168808	1301	906
bsdb:600/1/1_Parkinson's-disease:Participants-with-Parkinson's-Disease_vs_Healthy-controls_UP	NA	469	239759	92793	580596	1485	872	570	577309	13687	497726
bsdb:600/1/2_Parkinson's-disease:Participants-with-Parkinson's-Disease_vs_Healthy-controls_DOWN	NA	1578	504481
bsdb:601/2/1_Parkinson's-disease:Participants-with-idiopathic-Parkinson's-Disease_vs_Healthy-controls-without-any-form-of-Parkinson's-Disease_UP	NA	239759	547	644652	117563	61170	1578	1301	46123
bsdb:604/1/1_Parkinson's-disease:Participants-with-Parkinson's-Disease_vs_Healthy-controls-free-of-neurological-disease_UP	NA	1678	1716	1578	836	838
bsdb:604/1/2_Parkinson's-disease:Participants-with-Parkinson's-Disease_vs_Healthy-controls-free-of-neurological-disease_DOWN	NA	1766253	572511	580596	216851	1407607	28050	119852	841
bsdb:604/2/1_Parkinson's-disease:Participants-with-Parkinson's-Disease_vs_Healthy-control-free-of-neurological-disease._UP	NA	836	838	1716	572511	1678	1578
bsdb:604/2/2_Parkinson's-disease:Participants-with-Parkinson's-Disease_vs_Healthy-control-free-of-neurological-disease._DOWN	NA	216851	1766253	841	580596	1407607	28050
bsdb:605/1/1_Parkinson's-disease:Participants-with-Parkinson's-Disease_vs_Healthy-controls-without-Parkinson's-disease_UP	NA	375288	239934	574697	29465	283168	248038	35832	1350	1578
bsdb:605/1/2_Parkinson's-disease:Participants-with-Parkinson's-Disease_vs_Healthy-controls-without-Parkinson's-disease_DOWN	NA	216851	838
bsdb:605/2/1_Parkinson's-disease:Participants-with-Parkinson's-Disease-with-tremor-subtypes_vs_Participants-with-Parkinson's-Disease-with-non-tremor-subtypes_UP	NA	239934
bsdb:605/2/2_Parkinson's-disease:Participants-with-Parkinson's-Disease-with-tremor-subtypes_vs_Participants-with-Parkinson's-Disease-with-non-tremor-subtypes_DOWN	NA	106589	872	237	86331	1743	40544
bsdb:607/1/1_Parkinson's-disease:Participants-with-typical-PD_vs_Healthy-controls_UP	NA	239934	244127	35832	1578	1301	990721
bsdb:607/1/2_Parkinson's-disease:Participants-with-typical-PD_vs_Healthy-controls_DOWN	NA	191303
bsdb:607/2/1_Parkinson's-disease:Participants-with-typical-PD_vs_Healthy-controls_UP	NA	990721	244127	1578	1301	239934	35832	904
bsdb:607/2/2_Parkinson's-disease:Participants-with-typical-PD_vs_Healthy-controls_DOWN	NA	191303
bsdb:607/3/1_Parkinson's-disease:Male-patients-with-PD_vs_Female-patients-with-PD_UP	NA	577309
bsdb:608/1/1_Health-study-participation:healthy-child-oral-50%-up_vs_none_NA	NA	1301	32207	29465	838	1378	482	724
bsdb:608/2/1_Health-study-participation:healthy-child-stool-50%-up_vs_none_NA	NA	1301	1678	561	29465	816	1350	1485	2316020
bsdb:609/1/1_colorectal-cancer:CRC_vs_Healthy-Controls-(HC)_UP	NA	239934	207244	1716	84111	1350	1578	906	375288	577310	543311	1257	836	970	40544	547
bsdb:609/1/2_colorectal-cancer:CRC_vs_Healthy-Controls-(HC)_DOWN	NA	52784	553372	572511	580596	102106	216851	1407607	848	204475	1501226	841	1506577	28050
bsdb:610/1/1_irritable-bowel-syndrome:constipated-IBS_vs_Healthy-Control_DOWN	NA	1678	1730	841
bsdb:610/1/3_irritable-bowel-syndrome:constipated-IBS_vs_Healthy-Control_DOWN	NA	1578	1678
bsdb:611/1/1_colorectal-cancer:CRC-patients_vs_healthy-controls_UP	NA	239934	848	256846	543311	836
bsdb:611/1/2_colorectal-cancer:CRC-patients_vs_healthy-controls_DOWN	NA	1678	572511	216851	28050	158846	577310	33024	46205	1501226	648800	292632
bsdb:612/1/1_colorectal-cancer:CRC-cases_vs_control-subjects_DOWN	NA	33042
bsdb:613/1/1_colorectal-cancer:CRC-patients_vs_healthy-individuals_DOWN	NA	713	207244	544	1485	33042	189330	551	216851	724	28050	32067	482	265975	33024	838	841	970	1301	40544	29465
bsdb:614/1/1_colorectal-cancer:CRC_vs_Healthy-Controls_UP	NA	838	102106	283168	1257	1164882
bsdb:614/1/2_colorectal-cancer:CRC_vs_Healthy-Controls_DOWN	NA	413496	44748
bsdb:615/1/1_rheumatoid-arthritis:rheumatoid-arthritis_vs_healthy-controls_UP	NA	2701
bsdb:618/1/1_dementia:Severe-dementia_vs_Control,-mild,-and-moderate-dementia_UP	NA	244127	1432051	1649459	459786	1769710	84036
bsdb:618/2/1_dementia:Patients-with-dementia_vs_Controls-without-cognitive-impairments_UP	NA	1506553
bsdb:618/2/2_dementia:Patients-with-dementia_vs_Controls-without-cognitive-impairments_DOWN	NA	1766253
bsdb:618/3/1_dementia:moderate-dementia_vs_control,-mild,-and-severe-dementia_UP	NA	1578	1508657
bsdb:618/4/1_dementia:mild-dementia_vs_control,-moderate,-and-severe-dementia_UP	NA	216851	1407607
bsdb:620/1/1_colorectal-cancer:Invasive-cancer-group_vs_Early-cancer-group_UP	NA	848
bsdb:621/1/1_colorectal-cancer:Aspirin_vs_Placebo_UP	NA	838
bsdb:621/1/2_colorectal-cancer:Aspirin_vs_Placebo_DOWN	NA	29465
bsdb:621/2/1_colorectal-cancer:Aspirin_vs_Placebo_UP	NA	239934	838	216851
bsdb:621/2/2_colorectal-cancer:Aspirin_vs_Placebo_DOWN	NA	816	189330	375288	1263
bsdb:622/1/1_colorectal-cancer:CRA-and-CRC-groups_vs_Negative-control-group_DOWN	NA	1654	1678	572511	1485	189330	1730	1578	841
bsdb:622/1/2_colorectal-cancer:CRA-and-CRC-groups_vs_Negative-control-group_UP	NA	33042	1350	848	1301
bsdb:623/1/1_colorectal-cancer:Patients-with-CRC-recurrence_vs_Patients-without-CRC-recurrence_UP	NA	848	543311	1486725	1257	838
bsdb:623/1/2_colorectal-cancer:Patients-with-CRC-recurrence_vs_Patients-without-CRC-recurrence_DOWN	NA	40323	29465
bsdb:625/1/1_socioeconomic-status:High-SES_vs_NA_UP	NA	207244	1730	216851
bsdb:625/1/2_socioeconomic-status:High-SES_vs_NA_DOWN	NA	816
bsdb:626/1/1_ethnic-group:East-Asian-(EA)_vs_White-(W)_UP	NA	816	572511	838	1301
bsdb:626/1/2_ethnic-group:East-Asian-(EA)_vs_White-(W)_DOWN	NA	216851
bsdb:628/1/1_socioeconomic-status:Low-SES_vs_High-SES_UP	NA	838
bsdb:628/1/2_socioeconomic-status:Low-SES_vs_High-SES_DOWN	NA	816
bsdb:632/1/1_ethnic-group:African-American-neonate-by-maternal-profile_vs_Caucasian-+-other-races-neonates-by-maternal-profiles_UP	NA	239934	1678	1578	906
bsdb:632/1/2_ethnic-group:African-American-neonate-by-maternal-profile_vs_Caucasian-+-other-races-neonates-by-maternal-profiles_DOWN	NA	33042	119852	375288	838	1279	1301
bsdb:632/2/1_socioeconomic-status:Infants-in-household-income-<$80,000._vs_Infants-in-household-income-=>$80,000._UP	NA	816	1263	1301
bsdb:632/2/2_socioeconomic-status:Infants-in-household-income-<$80,000._vs_Infants-in-household-income-=>$80,000._DOWN	NA	239934	1678	33042	216851	838	1279	29465
bsdb:633/1/1_colorectal-cancer:Colorectal-Cancer-Patients_vs_Healthy-controls_UP	NA	848	1357	1257	838	1378	22	543311	39948
bsdb:633/1/2_colorectal-cancer:Colorectal-Cancer-Patients_vs_Healthy-controls_DOWN	NA	12916	469	41275	82976	75	2782229	237	29580	84567	1743	286	497	34037	28453	13687	40323	2755
bsdb:633/2/1_colorectal-cancer:cancerous-tissues_vs_adjacent-non-cancerous-tissues_UP	NA	816	1357	848	838	1301
bsdb:633/2/2_colorectal-cancer:cancerous-tissues_vs_adjacent-non-cancerous-tissues_DOWN	NA	286
bsdb:633/3/1_Sigmoid-neoplasm:Distal-Colorectal-Cancer_vs_Proximal-Colon-Cancer_UP	NA	848	32067
bsdb:633/3/2_Sigmoid-neoplasm:Distal-Colorectal-Cancer_vs_Proximal-Colon-Cancer_DOWN	NA	1257	838	970
bsdb:634/1/2_smoking-behavior:smokers_vs_non-smokers_DOWN	NA	970
bsdb:635/1/1_smoking-behavior:Less-than-High-school-diploma_vs_College-graduate-or-more_DOWN	NA	1283313
bsdb:635/1/2_smoking-behavior:Less-than-High-school-diploma_vs_College-graduate-or-more_UP	NA	836	194	838	29465	44259	196081	1301
bsdb:635/2/1_smoking-behavior:Some-college-or-associate's-degree_vs_College-graduate-or-more_DOWN	NA	1716
bsdb:635/2/2_smoking-behavior:Some-college-or-associate's-degree_vs_College-graduate-or-more_UP	NA	196081	1578	1283313	29465
bsdb:635/3/1_smoking-behavior:Alternative-smokers_vs_Cigarette-smokers_DOWN	NA	156454	286	1301	419014	1654	1213720
bsdb:635/3/2_smoking-behavior:Alternative-smokers_vs_Cigarette-smokers_UP	NA	848	482	34104	836	59735	47670	2717	1378	1283313
bsdb:635/4/1_smoking-behavior:Former-smokers_vs_Cigarette-smokers_DOWN	NA	29465	1578	1283313	194	838	286
bsdb:635/4/2_smoking-behavior:Former-smokers_vs_Cigarette-smokers_UP	NA	482	59735	47670	724	2740	1016
bsdb:635/5/1_smoking-behavior:Never-smokers_vs_Cigarette-smokers_DOWN	NA	906	1213720	838	194	32067	29465
bsdb:635/5/2_smoking-behavior:Never-smokers_vs_Cigarette-smokers_UP	NA	482	59735	1301	836	1378	1357	724	47670	1678	713
bsdb:635/6/1_smoking-behavior:Secondhand-smokers_vs_Cigarette-smokers_DOWN	NA	29465	32067	1578	508215	1301	156454	1654
bsdb:635/6/2_smoking-behavior:Secondhand-smokers_vs_Cigarette-smokers_UP	NA	59735	1257	1378	1283313	482	838
bsdb:635/7/1_smoking-behavior:Asian_vs_Non-Hispanic-white_UP	NA	1283313
bsdb:635/8/1_smoking-behavior:Hispanic_vs_Non-Hispanic-white_UP	NA	838	836	194	44259	157	848	1283313	29465
bsdb:635/9/1_smoking-behavior:Non-Hispanic-black_vs_Non-Hispanic-white_DOWN	NA	29465	2717	34104
bsdb:635/9/2_smoking-behavior:Non-Hispanic-black_vs_Non-Hispanic-white_UP	NA	838	194	1380	1578	156454	1678	44259	1283313	2147	836
bsdb:635/10/1_smoking-behavior:Females_vs_Males_DOWN	NA	713	157	836
bsdb:635/11/1_smoking-behavior:age-group-35-64_vs_age-group-20-29_DOWN	NA	836	286	1283313	1380	32067	848	713
bsdb:635/11/2_smoking-behavior:age-group-35-64_vs_age-group-20-29_UP	NA	1301	1578	32067
bsdb:635/12/1_smoking-behavior:age-group-65-and-over_vs_age-group-20-29_DOWN	NA	1283313	838	44259	32067	157	836	29465	43996	39948	1257	724	59735
bsdb:635/12/2_smoking-behavior:age-group-65-and-over_vs_age-group-20-29_UP	NA	1578	1301	508215	1357	1016	1678	196081	156454
bsdb:636/1/1_smoking-behavior:Tobacco-smokers_vs_Non-Smokers_UP	NA	836
bsdb:636/2/2_smoking-behavior:E-cigarette-smokers_vs_Non-Smokers_DOWN	NA	482	1716
bsdb:636/3/1_smoking-behavior:E-cigarette-smokers_vs_Tobacco-smokers_DOWN	NA	482
bsdb:636/5/1_smoking-behavior:Tobacco-smokers_vs_Quitting-smokers_UP	NA	836
bsdb:636/5/2_smoking-behavior:Tobacco-smokers_vs_Quitting-smokers_DOWN	NA	1716
bsdb:636/6/2_smoking-behavior:E-cigarette-smokers_vs_Quitting-smokers_DOWN	NA	1716
bsdb:637/1/1_colorectal-cancer:CRC_vs_Healthy-Individuals_UP	NA	165779	207244	43668	374	501783	1378	1269	482	53335	286	497	1301	292636
bsdb:637/1/2_colorectal-cancer:CRC_vs_Healthy-Individuals_DOWN	NA	29465	1654	838	848	68
bsdb:637/2/1_colorectal-adenoma:CRA_vs_Healthy-Individuals_UP	NA	1234	1301	1378	173479	204475	374	43668	338
bsdb:637/2/2_colorectal-adenoma:CRA_vs_Healthy-Individuals_DOWN	NA	1654	2054427	416916	1283313	156454	109326	150247	2152	1380	830	194	1016	1716	39948	238749	1279384	1730	1434006	848	1164882	32067	68	2093	482	265975	543311	2740	1257	28100	836	838	1743	123375	1213720	195950	157	29465	338
bsdb:637/3/1_colorectal-cancer:CRC_vs_CRA_DOWN	NA	836	238749	482	838	28100	283	123375	165779	1016	1257	848	416916	28219	543311	501783	194	1730	225842
bsdb:637/3/2_colorectal-cancer:CRC_vs_CRA_UP	NA	572511	173479	204475	158846	1301	338
bsdb:638/1/1_Ankylosing-spondylitis:Ankylosing-spondylitis-patients_vs_Healthy-controls_UP	NA	1654	1678	102106	1716	84111	216851	158846	906	482	838	32207	40544
bsdb:638/1/2_Ankylosing-spondylitis:Ankylosing-spondylitis-patients_vs_Healthy-controls_DOWN	NA	830	544	1485	547	1730	848	570	283168	375288	841	194	1350
bsdb:639/1/1_socioeconomic-status:underdeveloped-cities-vs-developed-cities_vs_NA_UP	NA	816	375288	1263
bsdb:639/1/2_socioeconomic-status:underdeveloped-cities-vs-developed-cities_vs_NA_DOWN	NA	838	1263
bsdb:640/1/1_rheumatoid-arthritis:Rheumatoid-Arthritis_vs_Non-Rheumatoid-Arthritis_UP	NA	1301	32207	32067
bsdb:640/1/2_rheumatoid-arthritis:Rheumatoid-Arthritis_vs_Non-Rheumatoid-Arthritis_DOWN	NA	1016	416916	836	848
bsdb:641/1/1_arthritis:Early-Rheumatoid-Arthritis_vs_healthy-control_DOWN	NA	29465	1283313	117563
bsdb:641/1/2_arthritis:Early-Rheumatoid-Arthritis_vs_healthy-control_UP	NA	1301	970
bsdb:642/2/2_socioeconomic-status:Orang-Asli-Children-(low-SES,-household-income<RM500)_vs_Chinese-Children-(High-SES,-household-income->RM500)_DOWN	NA	239759
bsdb:643/1/1_colorectal-cancer:yCRC_vs_yControl_UP	NA	1654	946234	848	283168	29465
bsdb:643/1/2_colorectal-cancer:yCRC_vs_yControl_DOWN	NA	1766253	207244	572511	580596	1485	39948	561	724	570	158846	577310	1501226	620
bsdb:643/2/1_colorectal-cancer:oCRC_vs_oControls_DOWN	NA	1766253	207244	35832	572511	580596	1485	102106	33042	216851	1407607	28050	2039302	577310	33024	1501226	841	1263	292632
bsdb:643/2/2_colorectal-cancer:oCRC_vs_oControls_UP	NA	41275	84111	1505663	561	848	1378	724	1649459	1506553	543311	1257	620	1301
bsdb:644/2/1_colorectal-cancer:colorectal-cancer-(adenocarcinoma)_vs_healthy-controls_UP	NA	119852
bsdb:644/3/1_colorectal-cancer:colorectal-cancer_vs_colorectal-adenoma_UP	NA	119852
bsdb:644/5/2_colorectal-cancer:adenocarcinoma-mucosae_vs_adenoma-adjacent_UP	NA	119852
bsdb:644/9/1_colorectal-cancer:carcinoma-adjacent-tissue_vs_colorectal-adenoma-tissue_UP	NA	119852
bsdb:645/1/1_mother's-own-milk:MOM-(Mother's-own-milk)_vs_DM-(Donor's-Milk)_UP	NA	816	1678	1350
bsdb:645/1/2_mother's-own-milk:MOM-(Mother's-own-milk)_vs_DM-(Donor's-Milk)_DOWN	NA	1279	1485	29465
bsdb:646/1/1_colorectal-adenoma:Adenoma_vs_Non-Adenoma_UP	NA	35832	86331	40544
bsdb:646/1/2_colorectal-adenoma:Adenoma_vs_Non-Adenoma_DOWN	NA	1485	724	29465
bsdb:647/1/1_ethnic-group:Black-Women_vs_White-Women_UP	NA	816
bsdb:648/1/1_ethnic-group:Gut-microbiome-of-African-American-children-(AA)_vs_Gut-microbiome-of-European-American-children-(EA)_UP	NA	244127	872	248744	846	838	1473205	84108
bsdb:648/2/1_ethnic-group:Oral-microbiota-of-African-American-children-(AA)_vs_Oral-microbiota-of-European-American-children-(EA)_UP	NA	1301
bsdb:648/2/2_ethnic-group:Oral-microbiota-of-African-American-children-(AA)_vs_Oral-microbiota-of-European-American-children-(EA)_DOWN	NA	830	1016	848	724	838
bsdb:648/3/1_Socioeconomic-status:Household-income-(EA-&-AA)-<-$50,000._vs_Household-income-(EA-&-AA)-=>$50,000._UP	NA	33024
bsdb:648/3/2_Socioeconomic-status:Household-income-(EA-&-AA)-<-$50,000._vs_Household-income-(EA-&-AA)-=>$50,000._DOWN	NA	1573534
bsdb:648/4/1_Socioeconomic-status:Household-income-(EA-&-AA)-<-$50,000._vs_Household-income-(EA-&-AA)-=>$50,000._UP	NA	1301
bsdb:649/1/1_Huntington-disease:R6/2_vs_Wild-type_UP	NA	816	100883	1578	375288
bsdb:649/1/2_Huntington-disease:R6/2_vs_Wild-type_DOWN	NA	447020	872
bsdb:650/1/1_socioeconomic-status:66-children-of-low-SES_vs_74-children-of-high-SES_UP	NA	838	135858	216851	1573535	292632	561	620
bsdb:650/1/2_socioeconomic-status:66-children-of-low-SES_vs_74-children-of-high-SES_DOWN	NA	102106	1678	572511	133925
bsdb:651/1/1_colorectal-cancer:CRC-patients-(swp)_vs_Healthy-volunteers-(swc)_DOWN	NA	207244	135858	216851	572511	2701	1678	28050
bsdb:651/1/2_colorectal-cancer:CRC-patients-(swp)_vs_Healthy-volunteers-(swc)_UP	NA	43996	848	1378	570	86331	1257	836	970	44259
bsdb:651/2/1_colorectal-cancer:cancerous-tissue-(cat)_vs_paracancerous-tissue-(pa10t)_DOWN	NA	1386	577309	33024	375288	216851	407	50709
bsdb:651/3/1_colorectal-cancer:cancerous-tissue-(cat)_vs_paracancerous-tissue-(pa2t)_DOWN	NA	528
bsdb:651/4/1_colorectal-cancer:CRC-patients-(stp)_vs_Healthy-volunteers-(stc)_UP	NA	165779	244127	102106	1730	86331	84108	577309	872	836	1257
bsdb:652/1/1_colorectal-cancer:Intramucosal-CRC_vs_Healthy_DOWN	NA	158846	165695
bsdb:652/1/2_colorectal-cancer:Intramucosal-CRC_vs_Healthy_UP	NA	713	848	543311	1257	1654
bsdb:652/2/1_colorectal-cancer:Intramucosal-CRC_vs_CRA-(colorectal-adenoma)_UP	NA	574697	102106	52225	283
bsdb:652/2/2_colorectal-cancer:Intramucosal-CRC_vs_CRA-(colorectal-adenoma)_DOWN	NA	158846	29465
bsdb:652/3/1_colorectal-adenoma:CRA-(colorectal-adenoma)_vs_Healthy_UP	NA	140625	574697	590	283
bsdb:652/3/2_colorectal-adenoma:CRA-(colorectal-adenoma)_vs_Healthy_DOWN	NA	1380	543311	848
bsdb:653/1/1_colorectal-cancer:Individuals-with-CRC_vs_Healthy-Controls_UP	NA	39948	848	1378	543311	1257	123375	1301
bsdb:653/1/2_colorectal-cancer:Individuals-with-CRC_vs_Healthy-Controls_UP	NA	1654	117563	29465	724
bsdb:654/1/1_ethnic-group:Asian-Pacific_vs_Caucasians_UP	NA	29465
bsdb:654/1/2_ethnic-group:Asian-Pacific_vs_Caucasians_DOWN	NA	283168
bsdb:654/2/1_ethnic-group:Hispanic_vs_Caucasians_UP	NA	283168	29465
bsdb:654/3/1_ethnic-group:African-Americans_vs_Caucasians_UP	NA	29465	283168
bsdb:654/4/1_ethnic-group:Asian-Pacific_vs_Caucasians_UP	NA	29465
bsdb:654/4/2_ethnic-group:Asian-Pacific_vs_Caucasians_DOWN	NA	283168
bsdb:654/5/1_ethnic-group:Hispanics_vs_Caucasians_UP	NA	29465
bsdb:654/5/2_ethnic-group:Hispanics_vs_Caucasians_DOWN	NA	283168
bsdb:654/6/1_ethnic-group:African-Americans_vs_Caucasians_UP	NA	29465	283168
bsdb:655/1/1_ethnic-group:African-Americans-(AA)_vs_European-Americans-(EA)_UP	NA	836
bsdb:655/1/2_ethnic-group:African-Americans-(AA)_vs_European-Americans-(EA)_DOWN	NA	117563	32207
bsdb:656/1/1_socioeconomic-status:Children-living-in-slum-(Low-SES)_vs_Private-school-children-(High-SES)_UP	NA	1730
bsdb:658/1/2_colorectal-cancer:Responders-(Partial-Response-or-Stable-Disease)_vs_Non-responders-(Progressive-Disease)_DOWN	NA	904	239759	35832	848	1506553
bsdb:660/1/1_smoking-behavior:Smokers_vs_Never-smokers_UP	NA	1654	1380	118747	194	906	437755	265975	838	29465
bsdb:660/1/2_smoking-behavior:Smokers_vs_Never-smokers_DOWN	NA	416916	2717	538	724	32257	47670	475	482	2740
bsdb:661/1/2_Meningeal-tuberculosis:Tuberculosis-Meningitis-(TBM)_vs_Healthy-Control-(HC)_DOWN	NA	572511	1678	1407607	375288	841	1501226
bsdb:661/2/1_Meningeal-tuberculosis:Pulmonary-tuberculosis-(PTB)_vs_Healthy-Control-(HC)_UP	NA	816
bsdb:661/2/2_Meningeal-tuberculosis:Pulmonary-tuberculosis-(PTB)_vs_Healthy-Control-(HC)_DOWN	NA	572511	1407607	189330	1501226	33042
bsdb:661/3/2_Meningeal-tuberculosis:Tuberculosis-Meningitis-(TBM)_vs_Pulmonary-tuberculosis-(PTB)_DOWN	NA	572511	816
bsdb:662/1/1_socioeconomic-status:Low-SES-(high-land-region)_vs_High-SES-(low-land-region)_UP	NA	1578
bsdb:663/1/1_ethnic-group:Malay_vs_Chinese_UP	NA	838
bsdb:663/1/2_ethnic-group:Malay_vs_Chinese_DOWN	NA	816
bsdb:663/2/1_ethnic-group:India_vs_Chinese_UP	NA	838
bsdb:663/2/2_ethnic-group:India_vs_Chinese_DOWN	NA	816
bsdb:663/3/1_ethnic-group:Jakun_vs_Chinese_UP	NA	838
bsdb:663/3/2_ethnic-group:Jakun_vs_Chinese_DOWN	NA	816
bsdb:666/1/1_socioeconomic-status:Low-income-country-(Malawi)_vs_High-Income-country-(Finland)_UP	NA	1678
bsdb:667/1/1_Response-to-immunochemotherapy:Responders_vs_Non-responders_UP	NA	216851	162289	33024	32207	1263
bsdb:667/1/2_Response-to-immunochemotherapy:Responders_vs_Non-responders_DOWN	NA	2701
bsdb:669/1/1_ethnic-group,socioeconomic-status:Rural-African-Children-in-Burkina-Faso_vs_European-Children-in-Italy_UP	NA	84111	244127	342658	228923	158846	44261	84034
bsdb:669/1/2_ethnic-group,socioeconomic-status:Rural-African-Children-in-Burkina-Faso_vs_European-Children-in-Italy_DOWN	NA	31980	216851	841	292632	239759	816
bsdb:669/2/1_Ethnic-group:Rural-African-Children-in-Burkina-Faso_vs_European-children-in-Italy_DOWN	NA	561	590	620	570
bsdb:670/1/1_ethnic-group,socioeconomic-status:Bangladesh-Children-(Household-income-<-$61)_vs_US-children_UP	NA	830
bsdb:671/1/1_seasonal-gut-microbiome-measurement:samples-taken-in-dry/cold-season_vs_samples-taken-in-dry/hot-or-rainy-season_UP	NA	838	1485	216851
bsdb:671/1/2_seasonal-gut-microbiome-measurement:samples-taken-in-dry/cold-season_vs_samples-taken-in-dry/hot-or-rainy-season_DOWN	NA	547	1485	482	1263
bsdb:674/1/1_socioeconomic-status:Low-SES_vs_High-SES_UP	NA	135858	118747	86331	838	1730	189330
bsdb:674/1/2_socioeconomic-status:Low-SES_vs_High-SES_DOWN	NA	80865	239759	816	1485	375288	283168	1263	447020
bsdb:675/1/1_socioeconomic-status:higher-monthly-household-income_vs_lower-monthly-household-income_UP	NA	61170	119852
bsdb:675/1/2_socioeconomic-status:higher-monthly-household-income_vs_lower-monthly-household-income_DOWN	NA	838
bsdb:676/1/1_Response-to-immunochemotherapy:Responders_vs_Non-responders_UP	NA	140625	620
bsdb:676/1/2_Response-to-immunochemotherapy:Responders_vs_Non-responders_DOWN	NA	1263
bsdb:677/1/1_Survival-time:Short-term-surviviors_vs_Long-term-survivors_UP	NA	194	724	1578	1506577	29465
bsdb:677/1/2_Survival-time:Short-term-surviviors_vs_Long-term-survivors_DOWN	NA	39948	836
bsdb:678/1/1_smoking-behavior:Cigarette-Smokers_vs_Nonsmokers_UP	NA	1380	1678	194	39948	212791	906	2093	346096	838	157
bsdb:678/1/2_smoking-behavior:Cigarette-Smokers_vs_Nonsmokers_DOWN	NA	836	1016	1378	2737	1257	848	32067	47670	538	482	2717	713	416916	724
bsdb:678/2/1_smoking-behavior:Dokha-Smokers_vs_Nonsmokers_UP	NA	1678
bsdb:678/2/2_smoking-behavior:Dokha-Smokers_vs_Nonsmokers_DOWN	NA	47670	836
bsdb:678/4/1_smoking-behavior:Mutiple-Smokers_vs_Nonsmokers_UP	NA	194	212791	2093	346096	157
bsdb:678/4/2_smoking-behavior:Mutiple-Smokers_vs_Nonsmokers_DOWN	NA	713	538	1378	724	47670	482	2737
bsdb:678/5/1_Cotinine-measurement:Cotinine-positive_vs_Cotinine-negative_DOWN	NA	416916	1016	2717	538	848	1378	724	47670	482	2740	1257	836	32207
bsdb:678/5/2_Cotinine-measurement:Cotinine-positive_vs_Cotinine-negative_UP	NA	1678	194	893	44259	906	2093	346096	157	577309
bsdb:678/8/1_smoking-behavior:CIigarettes_vs_Shisha_DOWN	NA	713	830	1016
bsdb:678/8/2_smoking-behavior:CIigarettes_vs_Shisha_UP	NA	346096	157	2093
bsdb:678/9/1_smoking-behavior:Dokha_vs_Shisha_DOWN	NA	713
bsdb:679/2/1_Response-to-immunochemotherapy:Responders_vs_Non-responders_UP	NA	375288
bsdb:680/1/1_Response-to-immunochemotherapy:responders-(patients-treated-with-metronomic-dose-of-capecitabine)_vs_non-responders-(patients-treated-with-conventional-dose)_UP	NA	158846	29465
bsdb:680/1/2_Response-to-immunochemotherapy:responders-(patients-treated-with-metronomic-dose-of-capecitabine)_vs_non-responders-(patients-treated-with-conventional-dose)_DOWN	NA	572511
bsdb:681/1/1_colorectal-cancer:Colorectal-cancer_vs_Healthy-Controls(HC)_UP	NA	1578	32207
bsdb:681/3/1_colorectal-cancer:Old-(-65-yrs)_vs_Young_UP	NA	1301
bsdb:681/3/2_colorectal-cancer:Old-(-65-yrs)_vs_Young_DOWN	NA	836	32207
bsdb:681/4/1_colorectal-cancer:Current-Smokers_vs_Non-Smokers_UP	NA	29465
bsdb:681/4/2_colorectal-cancer:Current-Smokers_vs_Non-Smokers_DOWN	NA	482
bsdb:682/1/1_irritable-bowel-syndrome:IBS.sibo+_vs_IBS.sibo-_UP	NA	1663	2747	1243	374	64001	1357	286
bsdb:682/1/2_irritable-bowel-syndrome:IBS.sibo+_vs_IBS.sibo-_DOWN	NA	528	44249	1743	41275	379	222	33882	1269	357	165695	1696	28453
bsdb:683/1/1_colorectal-adenoma:adenoma-group_vs_non-adenoma-group_UP	NA	574697	135858	40544
bsdb:683/1/2_colorectal-adenoma:adenoma-group_vs_non-adenoma-group_DOWN	NA	207244	1678	1573534
bsdb:683/3/1_colorectal-adenoma:adenoma-group_vs_non-adenoma-group_DOWN	NA	1678
bsdb:683/3/2_colorectal-adenoma:adenoma-group_vs_non-adenoma-group_UP	NA	40544
bsdb:683/4/1_colorectal-adenoma:adenoma-group-post-polypectomy_vs_adenoma-group-pre-polypectomy_UP	NA	1485
bsdb:683/5/1_colorectal-adenoma:control-group-post-endoscopy_vs_control-group-pre-endoscopy_UP	NA	872	39948	1301	172900	1485
bsdb:685/1/1_colorectal-cancer:CRC_vs_Control_UP	NA	848	816	572511
bsdb:686/1/1_colorectal-cancer:CRC_vs_controls_DOWN	NA	28186	1769012	91914	397864	187144	79328	1870884	79206	1730	861914	379070	158846	1184396	1849828	84567	105	278993
bsdb:686/1/2_colorectal-cancer:CRC_vs_controls_UP	NA	1955413	1654	1375	642	138	203804	1906657	568987	409304	158483	544	776	413496	872	39948	204037	635	547	551	561	848	570	1330547	32067	2742	1873	581	122277	29487	286	160674	590	613	22	620	84565	40751	629
bsdb:686/2/1_colorectal-cancer:adenomas_vs_controls_UP	NA	1654	1375	1378	65551	286
bsdb:686/2/2_colorectal-cancer:adenomas_vs_controls_DOWN	NA	1769012	1937972
bsdb:686/3/1_colorectal-cancer:CRC_vs_adenomas_UP	NA	642	32199	568987	401618	544	776	413496	872	204037	635	547	551	561	848	1217416	570	1330547	65551	581	53335	29487	160674	590	22	620	84565	13687	40751	662	629	43773
bsdb:686/3/2_colorectal-cancer:CRC_vs_adenomas_DOWN	NA	890	212790	187144	122277	84567	423349	1870884	1849828	207244	841
bsdb:687/1/1_colorectal-adenocarcinoma:colorectal-cancer-patients_vs_healthy-controls_UP	NA	816	1678	620	561
bsdb:687/1/2_colorectal-adenocarcinoma:colorectal-cancer-patients_vs_healthy-controls_DOWN	NA	102106	100883	216851	1501226	1301	1766253
bsdb:687/2/1_colorectal-adenocarcinoma:colorectal-cancer-patients-with-KRAS-mutation_vs_colorectal-cancer-patients-without-KRAS-mutation_UP	NA	580596	1738645	216851	342658	1892380	1506553	158846	165696	33024	841	2569097	33042
bsdb:687/2/2_colorectal-adenocarcinoma:colorectal-cancer-patients-with-KRAS-mutation_vs_colorectal-cancer-patients-without-KRAS-mutation_DOWN	NA	1678
bsdb:687/4/1_colorectal-adenocarcinoma:colorectal-cancer-patients-with-APC-mutation_vs_colorectal-cancer-patients-without-APC-mutation_UP	NA	1654
bsdb:687/5/1_colorectal-adenocarcinoma:colorectal-cancer-patients-with-PIK3CA-mutation_vs_colorectal-cancer-patients-without-PIK3CA-mutation_DOWN	NA	1654
bsdb:687/5/2_colorectal-adenocarcinoma:colorectal-cancer-patients-with-PIK3CA-mutation_vs_colorectal-cancer-patients-without-PIK3CA-mutation_UP	NA	239759	1578	906	48736
bsdb:688/2/1_Response-to-immunochemotherapy:Responders_vs_Non-responders_UP	NA	216851	1263	33024	162289	32207
bsdb:688/2/2_Response-to-immunochemotherapy:Responders_vs_Non-responders_DOWN	NA	2701
bsdb:689/1/2_Response-to-immunochemotherapy:Responders_vs_Non-responders-(Progressive-disease)_DOWN	NA	162289
bsdb:690/1/1_Response-to-immunochemotherapy:Responders_vs_Non-responders_UP	NA	1485	1578	84036
bsdb:690/1/2_Response-to-immunochemotherapy:Responders_vs_Non-responders_DOWN	NA	35832	375288	40544
bsdb:691/1/1_Response-to-immunochemotherapy:Responders_vs_Non-responders_UP	NA	35832	561	39948	33024
bsdb:691/1/2_Response-to-immunochemotherapy:Responders_vs_Non-responders_DOWN	NA	84111	133925	29465	1301	838
bsdb:692/1/1_nutraceutical,colorectal-cancer:colorectal-cancer-patients-who-took-prebiotics-(preoperative-fecal-sample)_vs_colorectal-cancer-patients-who-didn't-take-prebiotics-(preoperative-fecal-sample)_DOWN	NA	816	1350
bsdb:692/1/2_nutraceutical,colorectal-cancer:colorectal-cancer-patients-who-took-prebiotics-(preoperative-fecal-sample)_vs_colorectal-cancer-patients-who-didn't-take-prebiotics-(preoperative-fecal-sample)_UP	NA	1678
bsdb:692/2/1_nutraceutical,colorectal-cancer:colorectal-cancer-patients-non-prebiotic-(postoperative)_vs_colorectal-cancer-patients-non-prebiotic-(preoperative)_DOWN	NA	816
bsdb:692/2/2_nutraceutical,colorectal-cancer:colorectal-cancer-patients-non-prebiotic-(postoperative)_vs_colorectal-cancer-patients-non-prebiotic-(preoperative)_UP	NA	1386	1350	1357	1301
bsdb:692/3/1_nutraceutical,colorectal-cancer:colorectal-cancer-patients-who-took-prebiotics-(postoperative-fecal-sample)_vs_colorectal-cancer-patients-who-took-prebiotics-(preoperative-fecal-sample)_UP	NA	1386	1678	1350
bsdb:692/3/2_nutraceutical,colorectal-cancer:colorectal-cancer-patients-who-took-prebiotics-(postoperative-fecal-sample)_vs_colorectal-cancer-patients-who-took-prebiotics-(preoperative-fecal-sample)_DOWN	NA	816
bsdb:693/1/1_Response-to-immunochemotherapy:Responders_vs_Non-responders_UP	NA	146918	292632	1578	1678	1263	239934	39948	196081
bsdb:693/1/2_Response-to-immunochemotherapy:Responders_vs_Non-responders_DOWN	NA	773	517	191303	10
bsdb:694/1/1_colorectal-cancer:low-dose-GQD-(300-mg/kg)_vs_non-GQD_UP	NA	1470349	1578	577310	841	1331051
bsdb:694/1/2_colorectal-cancer:low-dose-GQD-(300-mg/kg)_vs_non-GQD_DOWN	NA	1331051	191303	1506577
bsdb:694/2/1_colorectal-cancer:low-dose-GQD-(300-mg/kg)_vs_non-GQD_UP	NA	1470349	583	577310
bsdb:694/2/2_colorectal-cancer:low-dose-GQD-(300-mg/kg)_vs_non-GQD_DOWN	NA	1279	1331051	191303	1506577
bsdb:694/3/1_colorectal-cancer:low-dose-GQD-(300-mg/kg)-+-PD-1_vs_control_UP	NA	239759	1470349	1508657
bsdb:694/3/2_colorectal-cancer:low-dose-GQD-(300-mg/kg)-+-PD-1_vs_control_DOWN	NA	1331051
bsdb:694/4/1_colorectal-cancer:low-dose-GQD-(300-mg/kg)_vs_control_UP	NA	816	1649459	375288
bsdb:694/4/2_colorectal-cancer:low-dose-GQD-(300-mg/kg)_vs_control_DOWN	NA	2086	1678	572511	33042	872	580024	1506577
bsdb:694/5/1_colorectal-cancer:PD-1-group_vs_control_UP	NA	447020	2086	1505663	1649459
bsdb:694/5/2_colorectal-cancer:PD-1-group_vs_control_DOWN	NA	459786
bsdb:694/6/1_colorectal-cancer:low-dose-300-mg/kg-GQD-+-PD-1-group_vs_control_UP	NA	239759	816	1470349	1508657
bsdb:694/6/2_colorectal-cancer:low-dose-300-mg/kg-GQD-+-PD-1-group_vs_control_DOWN	NA	244127	1678
bsdb:695/1/1_antimicrobial-agent:Coli_vs_control_UP	NA	816	1508657	375288
bsdb:695/1/2_antimicrobial-agent:Coli_vs_control_DOWN	NA	872	577310
bsdb:695/2/1_antimicrobial-agent:Vanc_vs_control_UP	NA	239934	1578	375288	577310	841
bsdb:695/2/2_antimicrobial-agent:Vanc_vs_control_DOWN	NA	872
bsdb:695/3/1_antimicrobial-agent:Vanc_vs_Coli_UP	NA	239934	1578	375288	577310	841	1508657
bsdb:695/3/2_antimicrobial-agent:Vanc_vs_Coli_DOWN	NA	816	1508657	872
bsdb:695/5/1_antimicrobial-agent:Vanc_vs_control_UP	NA	816	375288
bsdb:695/6/1_antimicrobial-agent:Vanc_vs_coli_UP	NA	375288
bsdb:696/1/1_Nutraceutical:colorectal-cancer-patients-perioperative-probiotics_vs_colorectal-cancer-patients-perioperative-placebo_UP	NA	12916	469	41275	82976	75	212791	1350	29580	57494	286	497	34037	379	28453	40323	64001
bsdb:696/1/2_Nutraceutical:colorectal-cancer-patients-perioperative-probiotics_vs_colorectal-cancer-patients-perioperative-placebo_DOWN	NA	33042	13687	283
bsdb:696/2/1_Nutraceutical:colorectal-cancer-patients-perioperative-probiotics_vs_Healthy-controls_UP	NA	1386	2747	1350	379	64001	1827
bsdb:696/2/2_Nutraceutical:colorectal-cancer-patients-perioperative-probiotics_vs_Healthy-controls_DOWN	NA	12916	469	41275	82976	75	212791	2782229	237	29580	57494	84567	1743	286	497	34037	28453	13687
bsdb:696/3/1_Nutraceutical:colorectal-cancer-patients-perioperative-placebo_vs_Healthy-controls_UP	NA	1350	1257	848
bsdb:696/3/2_Nutraceutical:colorectal-cancer-patients-perioperative-placebo_vs_Healthy-controls_DOWN	NA	12916	469	41275	82976	75	212791	2782229	237	29580	57494	64001	84567	1743	286	497	34037	1827	28453	13687	40323
bsdb:696/4/1_Nutraceutical:colorectal-cancer-patients-perioperative-probiotics_vs_colorectal-cancer-patients-perioperative-placebo_UP	NA	379	1350
bsdb:696/4/2_Nutraceutical:colorectal-cancer-patients-perioperative-probiotics_vs_colorectal-cancer-patients-perioperative-placebo_DOWN	NA	848	1378	1257	653683
bsdb:696/6/1_Nutraceutical:colorectal-cancer-patients-perioperative-placebo_vs_Healthy-controls_UP	NA	653683	848	1378	1257
bsdb:696/6/2_Nutraceutical:colorectal-cancer-patients-perioperative-placebo_vs_Healthy-controls_DOWN	NA	286
bsdb:697/1/1_hepatocellular-carcinoma:Responders-to-Immune-checkpoint-inhibitors_vs_Non-responders-to-Immune-checkpoint-inhibitors_UP	NA	83770	1506577
bsdb:697/1/2_hepatocellular-carcinoma:Responders-to-Immune-checkpoint-inhibitors_vs_Non-responders-to-Immune-checkpoint-inhibitors_DOWN	NA	239934
bsdb:697/2/1_hepatocellular-carcinoma:Disease-control-with-Immune-checkpoint-inhibitors_vs_Non-Disease-control-with-Immune-checkpoint-inhibitors_UP	NA	904	1283313	1678	572511	33042	28050	906	674963	1506577
bsdb:697/2/2_hepatocellular-carcinoma:Disease-control-with-Immune-checkpoint-inhibitors_vs_Non-Disease-control-with-Immune-checkpoint-inhibitors_DOWN	NA	216851
bsdb:697/3/1_hepatocellular-carcinoma:Responders-to-Immune-checkpoint-inhibitors_vs_Non-responders-to-Immune-checkpoint-inhibitors_DOWN	NA	1283313
bsdb:698/2/1_ulcerative-colitis:Patients-with-ulcerative-colitis_vs_Healthy-controls_UP	NA	117563	1257	55506	1016	561	29580	194	1654	84111	1716
bsdb:698/2/2_ulcerative-colitis:Patients-with-ulcerative-colitis_vs_Healthy-controls_DOWN	NA	239759	574697	872	61170	140625	158846	52225	846	838	638847	2753	172900
bsdb:698/3/1_Crohn's-disease:Patients-with-Crohn's-disease_vs_Patients-with-ulcerative-colitis_UP	NA	872	113286	84108
bsdb:698/3/2_Crohn's-disease:Patients-with-Crohn's-disease_vs_Patients-with-ulcerative-colitis_DOWN	NA	580596	437755	1279	1016	724	29580	2717	47670	22	1716
bsdb:699/1/1_ulcerative-colitis:Patients-with-ulcerative-colitis_vs_Healthy-controls_DOWN	NA	447020	239934	1263	244127	397864	1870884	2172	84108	195950
bsdb:699/1/2_ulcerative-colitis:Patients-with-ulcerative-colitis_vs_Healthy-controls_UP	NA	836	1301	1506553	1870884	1257	165779	29465	848	538	724
bsdb:700/1/1_ulcerative-colitis:children-with-ulcerative-colitis_vs_healthy-controls_DOWN	NA	256846
bsdb:701/1/1_Crohn's-disease:CD_vs_Non-IBD_UP	NA	713	180162	1485	1350	561	1164882
bsdb:701/1/2_Crohn's-disease:CD_vs_Non-IBD_DOWN	NA	239759	33042	216851	204475	838	841	286
bsdb:701/2/1_ulcerative-colitis:UC_vs_NON-IBD-controls_UP	NA	1678	572511	544	1578	29465
bsdb:701/2/2_ulcerative-colitis:UC_vs_NON-IBD-controls_DOWN	NA	29521	209	283168	239759	204475	286	33042	838
bsdb:701/3/1_Crohn's-disease:CD_vs_UC_UP	NA	180162	1485	561	581	1257
bsdb:701/3/2_Crohn's-disease:CD_vs_UC_DOWN	NA	84111	580596	28050	204475	544	841	1678	572511	216851
bsdb:702/1/1_rheumatoid-arthritis:Rheumatoid-Arthritis_vs_Arthritis-Remission_UP	NA	1716	1654	29465	1301	838
bsdb:702/1/2_rheumatoid-arthritis:Rheumatoid-Arthritis_vs_Arthritis-Remission_DOWN	NA	1380	848	265975	838	970
bsdb:703/1/1_rheumatoid-arthritis:All-Matched-(AM)-Rheumatoid-Arthritis_vs_Healthy-Controls_UP	NA	848
bsdb:703/2/1_rheumatoid-arthritis:Periodontally-diseased-(PD)-Rheumatoid-Arthritis_vs_Healthy-Controls_UP	NA	1654	848	543311
bsdb:704/1/1_arthritis:Rheumatoid-Arthritis_vs_healthy-shallow_DOWN	NA	32067
bsdb:705/1/1_arthritis:Rheumatoid-Arthritis-with-periodontitis_vs_Osteoarthritis-with-periodontitis_DOWN	NA	43996	836	970
bsdb:707/1/1_arthritis:Rheumatoid-Arthritis_vs_healthy-controls_UP	NA	156454	1016	1716	32067	838	970
bsdb:707/1/2_arthritis:Rheumatoid-Arthritis_vs_healthy-controls_DOWN	NA	1716
bsdb:708/1/1_rheumatoid-arthritis:rheumatoid-arthritis-patients_vs_healthy-controls_UP	NA	157	836	838
bsdb:708/1/2_rheumatoid-arthritis:rheumatoid-arthritis-patients_vs_healthy-controls_DOWN	NA	1301	195950
bsdb:708/2/1_periodontitis:periodontal-disease-patients_vs_rheumatoid-arthritis-patients_UP	NA	1301
bsdb:708/2/2_periodontitis:periodontal-disease-patients_vs_rheumatoid-arthritis-patients_DOWN	NA	838	157	195950	836
bsdb:709/1/2_arthritis:Early-Rheumatoid-Arthritis_vs_Healthy-Controls_UP	NA	1213720
bsdb:710/2/2_psoriasis:Psoriasis_vs_periodntitis_DOWN	NA	848
bsdb:710/3/1_periodontitis:Periodontitis-patients_vs_orally-healthy-individuals_UP	NA	32207
bsdb:711/1/1_Systemic-lupus-erythematosus:SLE_vs_HC_UP	NA	1649459	570	579	1506553	886360	13687	1301	3025755
bsdb:711/1/2_Systemic-lupus-erythematosus:SLE_vs_HC_DOWN	NA	1766253	239934	39948	189330	216851	1407607	283168	292632
bsdb:712/1/1_rheumatoid-arthritis:Rheumatoid-Arthritis_vs_healthy-controls_UP	NA	893	872	43994	906	52225	437755	133925
bsdb:713/1/1_arthritis:Juvenile-Idiopathic-Arthritis_vs_healthy-controls_DOWN	NA	1654	1716	32067
bsdb:713/1/2_arthritis:Juvenile-Idiopathic-Arthritis_vs_healthy-controls_UP	NA	1301	32067	724	32257
bsdb:715/1/1_Acute-respiratory-distress-syndrome:acute-respiratory-distress-syndrome_vs_healthy-controls_UP	NA	1279	40323	1301
bsdb:715/1/2_Acute-respiratory-distress-syndrome:acute-respiratory-distress-syndrome_vs_healthy-controls_DOWN	NA	1378	724
bsdb:715/2/1_Acute-respiratory-failure:Non-survivors_vs_Survivors_UP	NA	1279	561
bsdb:715/2/2_Acute-respiratory-failure:Non-survivors_vs_Survivors_DOWN	NA	838
bsdb:715/3/1_Acute-respiratory-failure:Patients-with-more-VFDs_vs_Patients-with-fewer-VFDs_UP	NA	1301
bsdb:715/3/2_Acute-respiratory-failure:Patients-with-more-VFDs_vs_Patients-with-fewer-VFDs_DOWN	NA	1279	561
bsdb:715/4/1_Acute-respiratory-failure:Non-survivors_vs_Survivors_DOWN	NA	838
bsdb:715/5/1_Acute-respiratory-failure:Patients-with-more-VFDs_vs_Patients-with-fewer-VFDs_UP	NA	838	508215	1301	482	29465	117563
bsdb:715/6/1_Acute-respiratory-failure:Mortality_vs_Hyper-inflammatory-subphenotype_UP	NA	838
bsdb:715/6/2_Acute-respiratory-failure:Mortality_vs_Hyper-inflammatory-subphenotype_DOWN	NA	848	1279
bsdb:715/7/1_Acute-respiratory-failure:VFD-(Ventilator-free-days)_vs_Hyper-inflammatory-subphenotype_UP	NA	838	724	1301
bsdb:715/7/2_Acute-respiratory-failure:VFD-(Ventilator-free-days)_vs_Hyper-inflammatory-subphenotype_DOWN	NA	848
bsdb:716/2/1_Parkinson's-disease:PD-duration-more-than-5-years_vs_PD-duration-less-than-5-years_UP	NA	416916	248038
bsdb:716/2/2_Parkinson's-disease:PD-duration-more-than-5-years_vs_PD-duration-less-than-5-years_DOWN	NA	28100
bsdb:716/3/1_Parkinson's-disease:Early-onset-PD_vs_Late-onset-PD_UP	NA	66831	216851	724	1357	40544	1485
bsdb:716/3/2_Parkinson's-disease:Early-onset-PD_vs_Late-onset-PD_DOWN	NA	244127	283
bsdb:716/4/1_Parkinson's-disease:Tremor-dominant-PD_vs_Non-tremor-dominant-PD_UP	NA	244127
bsdb:716/4/2_Parkinson's-disease:Tremor-dominant-PD_vs_Non-tremor-dominant-PD_DOWN	NA	841
bsdb:717/1/1_Parkinson's-disease:Participants-with-Parkinson's-Disease-at-baseline_vs_Healthy-controls-at-baseline_UP	NA	239759	1678
bsdb:717/2/1_Parkinson's-disease:Progressed-PD-patients-at-follow-up_vs_Stable-PD-patients-at-follow-up_UP	NA	1678
bsdb:717/3/1_Parkinson's-disease:Participants-with-Parkinson's-Disease-at-time-of-follow-up_vs_Healthy-controls-at-time-of-follow-up_UP	NA	1678
bsdb:717/3/2_Parkinson's-disease:Participants-with-Parkinson's-Disease-at-time-of-follow-up_vs_Healthy-controls-at-time-of-follow-up_DOWN	NA	816	838	841	1263
bsdb:717/4/1_Parkinson's-disease:Postural-instability-and-gait-difficulty-(PIGD)-phenotype-at-baseline_vs_Tremor-dominant-phenotype-(TD)-at-baseline_DOWN	NA	1678	1485	1432051	1357	838
bsdb:717/4/2_Parkinson's-disease:Postural-instability-and-gait-difficulty-(PIGD)-phenotype-at-baseline_vs_Tremor-dominant-phenotype-(TD)-at-baseline_UP	NA	830	204475	816
bsdb:717/5/1_Parkinson's-disease:Postural-instability-and-gait-difficulty-(PIGD)-phenotype-at-follow-up_vs_Tremor-dominant-phenotype-(TD)-at-follow-up_DOWN	NA	397864	1357
bsdb:717/5/2_Parkinson's-disease:Postural-instability-and-gait-difficulty-(PIGD)-phenotype-at-follow-up_vs_Tremor-dominant-phenotype-(TD)-at-follow-up_UP	NA	239934
bsdb:718/1/1_polycystic-ovary-syndrome:Letrozole-treated_vs_Placebo-treated_UP	NA	174708	572511	33042	841
bsdb:718/1/2_polycystic-ovary-syndrome:Letrozole-treated_vs_Placebo-treated_DOWN	NA	239759	51514
bsdb:719/3/1_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-Controls_UP	NA	239934	244127	946234	133925	577310	838
bsdb:719/3/2_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-Controls_DOWN	NA	816	574697	1578	133925	841	1263	40544
bsdb:719/4/1_REM-sleep-behavior-disorder:idiopathic-rapid-eye-movement-sleep-behavior-disorder_vs_Healthy-Controls_UP	NA	244127	946234	644652
bsdb:719/4/2_REM-sleep-behavior-disorder:idiopathic-rapid-eye-movement-sleep-behavior-disorder_vs_Healthy-Controls_DOWN	NA	816	574697	135858	33042	906	52225	133925	838	40544	2316
bsdb:720/1/1_Chlamydia-trachomatis-infectious-disease:Chlamydia-trachomatis_vs_Healthy-Controls_UP	NA	1375	419014	1380	572511	1485	39948	561	216851	906	841	168808	1301	2129	1678
bsdb:720/2/1_Vulvovaginal-candidiasis:Vulvovaginal-candidiasis_vs_Healthy-Controls_DOWN	NA	1578
bsdb:720/2/2_Vulvovaginal-candidiasis:Vulvovaginal-candidiasis_vs_Healthy-Controls_UP	NA	419014	1380	572511	39948	561	216851	150022	2701	906	1257	838	841	1301	29465	338
bsdb:720/3/1_Bacterial-vaginosis:bacterial-vaginosis_vs_Healthy-Controls_DOWN	NA	1578
bsdb:720/3/2_Bacterial-vaginosis:bacterial-vaginosis_vs_Healthy-Controls_UP	NA	1375	1380	1485	39948	2701	1378	906	2050	1257	838	841	168808	2129
bsdb:721/1/1_HIV-mother-to-child-transmission:HIV-exposed-uninfected-infants-(HEU)_vs_HIV-unexposed-infants-(HUU)_UP	NA	397864	572511	84111	283168	168808
bsdb:721/1/2_HIV-mother-to-child-transmission:HIV-exposed-uninfected-infants-(HEU)_vs_HIV-unexposed-infants-(HUU)_DOWN	NA	135858	547	158846
bsdb:721/2/1_HIV-mother-to-child-transmission:HIV-exposed-uninfected-infants-(HEU)_vs_HIV-unexposed-infants-(HUU)_UP	NA	570	1357	158846	577310
bsdb:721/2/2_HIV-mother-to-child-transmission:HIV-exposed-uninfected-infants-(HEU)_vs_HIV-unexposed-infants-(HUU)_DOWN	NA	1380	2701	1378	2050	543311	168808
bsdb:721/2/4_HIV-mother-to-child-transmission:HIV-exposed-uninfected-infants-(HEU)_vs_HIV-unexposed-infants-(HUU)_DOWN	NA	168808
bsdb:721/2/6_HIV-mother-to-child-transmission:HIV-exposed-uninfected-infants-(HEU)_vs_HIV-unexposed-infants-(HUU)_DOWN	NA	2701	2050	239759	135858	39948	150022	1378	2740	1257	123375	168808
bsdb:721/3/1_HIV-mother-to-child-transmission:HIV-exposed-uninfected-infants-(HEU)_vs_HIV-unexposed-infants-(HUU)_DOWN	NA	583
bsdb:721/4/1_HIV-mother-to-child-transmission:HIV-infected-mothers_vs_Healthy-controls_UP	NA	904	165779	816	35832	572511	1716	946234	848	117563	570	2093	1279	40544
bsdb:721/4/2_HIV-mother-to-child-transmission:HIV-infected-mothers_vs_Healthy-controls_DOWN	NA	2152	423604	216851	724
bsdb:721/5/1_HIV-mother-to-child-transmission:HIV-infected--mothers_vs_Healthy-controls_UP	NA	904	207244	572511	102106	189330	216851	946234	158846	375288	292632	168934
bsdb:721/5/2_HIV-mother-to-child-transmission:HIV-infected--mothers_vs_Healthy-controls_DOWN	NA	469	423604	1378	838	1279	29465
bsdb:721/6/2_HIV-mother-to-child-transmission:HIV-infected-mothers_vs_Healthy-controls_UP	NA	165779	1663	1380	1386	38501	1696	59732	1716	1350	33986	216851	150022	2701	963	89966	1357	149698	407	1269	186650	475	482	1839	162289	838	1743	46205	1847	295418	42255	1279
bsdb:722/1/1_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-Controls_UP	NA	239934	574697	1432051	61170	596767	1392389	283168	577310	292632
bsdb:722/1/2_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-Controls_DOWN	NA	209879	816	1485	102106	1573535	1506577
bsdb:723/1/2_Parkinson's-disease:Idiopathic-Parkinson's-Disease-Patients_vs_Healthy-Controls_DOWN	NA	1380	1562	117563	841
bsdb:723/3/1_Parkinson's-disease:Idiopathic-Parkinson's-Disease-Patients-with-Weight-Loss_vs_Healthy-Controls_UP	NA	283168	35832
bsdb:723/3/2_Parkinson's-disease:Idiopathic-Parkinson's-Disease-Patients-with-Weight-Loss_vs_Healthy-Controls_DOWN	NA	109326	117563	1654	1380	165779
bsdb:723/4/1_Parkinson's-disease:Idiopathic-Parkinson's-Disease-Patients-without-Weight-Loss_vs_Healthy-Controls_UP	NA	1350	2383
bsdb:723/4/2_Parkinson's-disease:Idiopathic-Parkinson's-Disease-Patients-without-Weight-Loss_vs_Healthy-Controls_DOWN	NA	572511	1485	51514	841
bsdb:723/5/1_Parkinson's-disease:Idiopathic-Parkinson's-Disease-Patients-with-Weight-Loss_vs_Idiopathic-Parkinson's-Disease-Patients-without-Weight-Loss_UP	NA	28050	102106	841
bsdb:723/5/2_Parkinson's-disease:Idiopathic-Parkinson's-Disease-Patients-with-Weight-Loss_vs_Idiopathic-Parkinson's-Disease-Patients-without-Weight-Loss_DOWN	NA	1350
bsdb:724/1/1_Parkinson's-disease:Parkinson's-disease-patients-with-normal-cognition_vs_Healthy-spouses-and-Parkinson's-disease-patients-with-mild-cognitive-impairment_UP	NA	1263	572511
bsdb:724/2/1_Parkinson's-disease:Parkinson's-disease-patients-with-mild-cognitive-impairment_vs_Healthy-spouses-and-Parkinson's-disease-patients-with-normal-cognition_UP	NA	239759	570	397864	574697	244127	283168
bsdb:724/3/1_Parkinson's-disease:Parkinson's-disease-patients-with-mild-cognitive-impairment-and-Parkinson's-disease-patients-with-normal-cognition_vs_Healthy-spouses_DOWN	NA	29465
bsdb:725/1/1_Eczema:Atopic-dermatitis-case-group_vs_Healthy-controls_DOWN	NA	1378	724	1301	29465
bsdb:725/1/2_Eczema:Atopic-dermatitis-case-group_vs_Healthy-controls_UP	NA	57495	407	1298
bsdb:725/2/1_Eczema:Females-(cases)_vs_Females-(controls)_DOWN	NA	57495	407
bsdb:725/3/1_Eczema:Males-(case)_vs_Males-(control)_DOWN	NA	1298	57495
bsdb:725/3/2_Eczema:Males-(case)_vs_Males-(control)_UP	NA	1301	1378	29465	724
bsdb:725/4/1_Eczema:AD-cases-with-no-reported-cream-usage_vs_Normal-control_DOWN	NA	57495	407
bsdb:725/4/2_Eczema:AD-cases-with-no-reported-cream-usage_vs_Normal-control_UP	NA	1301	1378	29465	724
bsdb:726/1/1_Aging:Group-2_vs_Group-1-(1835-years-old)_DOWN	NA	32207	1654	117563
bsdb:726/2/1_Aging:Group-3_vs_Group-1-(1835-years-old)_DOWN	NA	1654	1301	117563
bsdb:726/2/2_Aging:Group-3_vs_Group-1-(1835-years-old)_UP	NA	32207	29465
bsdb:726/3/1_Aging:Group-4_vs_Group-1-(1835-years-old)_DOWN	NA	1654	117563
bsdb:726/3/2_Aging:Group-4_vs_Group-1-(1835-years-old)_UP	NA	32207	29465
bsdb:726/4/1_Aging:Group-3_vs_Group-2-(36-to-50-years-old)_DOWN	NA	117563	1301
bsdb:726/4/2_Aging:Group-3_vs_Group-2-(36-to-50-years-old)_UP	NA	32207	29465
bsdb:726/5/1_Aging:Group-4_vs_Group-2-(36-to-50-years-old)_DOWN	NA	117563	1654
bsdb:726/5/2_Aging:Group-4_vs_Group-2-(36-to-50-years-old)_UP	NA	32207	29465
bsdb:726/6/1_Aging:Group-4_vs_Group-3-(51-to-65-years-old)_DOWN	NA	29465	1654
bsdb:726/6/2_Aging:Group-4_vs_Group-3-(51-to-65-years-old)_UP	NA	117563	1301
bsdb:727/1/1_Tobacco-smoke-exposure-measurement:Current-cigarette-smokers_vs_Never-smokers_DOWN	NA	713	59735	1678	1378	1164882	1357	47670	836	1301	482	2717	724
bsdb:727/1/2_Tobacco-smoke-exposure-measurement:Current-cigarette-smokers_vs_Never-smokers_UP	NA	1283313	156454	194	1434006	1578	32067	906	838	286	32207	157	29465
bsdb:728/1/1_Diarrhea:Diarrhea-Group_vs_Controls-(No-Diarrhea-Group)_DOWN	NA	207244	816	1678	572511	100883	189330	1730	216851	1407607	459786	1501226	1508657	1263	33042
bsdb:728/1/2_Diarrhea:Diarrhea-Group_vs_Controls-(No-Diarrhea-Group)_UP	NA	1350	561	1506553
bsdb:728/2/1_Diarrhea:Antibiotic-excluded-Diarrhea-Group_vs_Antibiotic-excluded-Controls-(No-Diarrhea-Group)_DOWN	NA	1730	33042	207244	1501226	189330	216851	1263	1407607	1678	459786	1508657	816	204475	100883
bsdb:728/2/2_Diarrhea:Antibiotic-excluded-Diarrhea-Group_vs_Antibiotic-excluded-Controls-(No-Diarrhea-Group)_UP	NA	1506553	561	3025755	572511	1301
bsdb:728/3/1_Diarrhea:2000-mg/day-MMF-Dosage-No-Diarrhea-Group_vs_1000-mg/day-MMF-Dosage-No-Diarrhea-Group_DOWN	NA	1501226	33042	1407607	189330	1505657	1730	1301	207244
bsdb:728/3/2_Diarrhea:2000-mg/day-MMF-Dosage-No-Diarrhea-Group_vs_1000-mg/day-MMF-Dosage-No-Diarrhea-Group_UP	NA	1263	1508657	572511	816	1678	216851	1506553	204475
bsdb:728/4/1_Diarrhea:1000-mg/day-MMF-Dosage-Diarrhea-Group_vs_1000-mg/day-MMF-Dosage-No-Diarrhea-Group_DOWN	NA	816	1730	459786	189330	1263	207244	216851	1501226	1407607	1508657	204475	33042	3025755	572511	1505657
bsdb:728/4/2_Diarrhea:1000-mg/day-MMF-Dosage-Diarrhea-Group_vs_1000-mg/day-MMF-Dosage-No-Diarrhea-Group_UP	NA	1350	561	1301	1506553	100883
bsdb:728/5/1_Diarrhea:2000-mg/day-MMF-Dosage-Diarrhea-Group_vs_2000-mg/day-MMF-Dosage-No-Diarrhea-Group_DOWN	NA	1730	33042	207244	1263	216851	1501226	1508657	189330	459786	1678	1407607	572511	816	204475	100883	3025755
bsdb:728/5/2_Diarrhea:2000-mg/day-MMF-Dosage-Diarrhea-Group_vs_2000-mg/day-MMF-Dosage-No-Diarrhea-Group_UP	NA	1350	1506553	1301	1505657
bsdb:728/6/1_Diarrhea:Diarrheal-specimens_vs_Pre-Diarrheal-specimens_DOWN	NA	204475	1263	1730	207244	3025755	100883	459786	1508657	1678	33042	561	816	189330
bsdb:728/6/2_Diarrhea:Diarrheal-specimens_vs_Pre-Diarrheal-specimens_UP	NA	1301	1506553
bsdb:728/7/1_Diarrhea:First-Diarrheal-Specimens-in-the-Diarrhea-group_vs_First-Diarrheal-Specimens-Time-Matched-Fecal-Specimens-from-the-No-Diarrhea-Group_DOWN	NA	1730	33042	207244	1501226	216851	1407607	189330	1263	572511	459786	1508657	1678	816	100883	204475	3025755	1301
bsdb:728/7/2_Diarrhea:First-Diarrheal-Specimens-in-the-Diarrhea-group_vs_First-Diarrheal-Specimens-Time-Matched-Fecal-Specimens-from-the-No-Diarrhea-Group_UP	NA	1350	561	1506553	1505657
bsdb:729/1/1_schizophrenia:Elderly-Schizophrenia-Patients_vs_healthy-control_UP	NA	239934	1283313	1678	35832	135858	872	848	1573535	158846	52225	1501226	1473205	84108	1301	83770	40544
bsdb:729/1/2_schizophrenia:Elderly-Schizophrenia-Patients_vs_healthy-control_DOWN	NA	207244	580596	544	33042	1432051	216851	1407607	204475	570	577310	841	1263	191303
bsdb:729/2/1_schizophrenia:Schizophrenia_vs_healthy-control_UP	NA	904	1654	239934	1283313	1380	35832	135858	102106	1716	872	189330	724	2745	1573535	158846	906	133925	543311	1082930	33024	838	1501226	1473205	1301	83770	40544
bsdb:729/2/2_schizophrenia:Schizophrenia_vs_healthy-control_DOWN	NA	580596	33042	216851	1407607	204475	841
bsdb:730/1/1_Spinal-cord-injury:SCI-(spinal-cord-injury)_vs_healthy-control-(without-SCI)_DOWN	NA	1766253	397864	572511	580596	102106	33042	189330	216851	1686313	1407607	1573535	248744	577310	841	1263	84108	40544
bsdb:730/1/2_Spinal-cord-injury:SCI-(spinal-cord-injury)_vs_healthy-control-(without-SCI)_UP	NA	52784	2383	990721	156973	84111	1350	946234	1505657	1578	459786	1769710	3025755
bsdb:730/2/1_Spinal-cord-injury:SCI-(spinal-cord-injury)_vs_healthy-control-(without-SCI)_DOWN	NA	572511	216851	1766253	102106	189330	841	1407607	1573535	1263
bsdb:730/2/2_Spinal-cord-injury:SCI-(spinal-cord-injury)_vs_healthy-control-(without-SCI)_UP	NA	84111
bsdb:731/1/2_Parkinson's-disease:Parkinson's-Disease-subjects_vs_Healthy-controls_DOWN	NA	1506553	841
bsdb:731/2/2_Parkinson's-disease:Parkinson's-Disease-subjects_vs_Healthy-controls_DOWN	NA	1980681	841
bsdb:731/4/2_Parkinson's-disease:Parkinson's-Disease-subjects_vs_Healthy-controls_DOWN	NA	580596
bsdb:732/1/1_obesity:Obese-individuals_vs_Individuals-with-a-healthy-body-mass-index_DOWN	NA	508459	1263	244127	119852	84111	572511	239934
bsdb:732/1/2_obesity:Obese-individuals_vs_Individuals-with-a-healthy-body-mass-index_UP	NA	904	906	135858	838	1301
bsdb:732/2/1_age:Later-age_vs_Early-age_UP	NA	574697	724	33024	283168	216851	570	838	577309	28050	140625	872
bsdb:732/2/2_age:Later-age_vs_Early-age_DOWN	NA	100883	816	904	40544	61170	1678	102106	119852	906	572511	375288	189330	244127	447020	1730
bsdb:732/4/1_Ethnic-group:LAB_vs_USB-(US-born)_DOWN	NA	604195	5635	264095
bsdb:732/4/2_Ethnic-group:LAB_vs_USB-(US-born)_UP	NA	5410
bsdb:732/6/2_age:Later-age_vs_Early-age_UP	NA	5475
bsdb:733/1/1_Sampling-site:duodenal-microbiota_vs_biliary-microbiota_UP	NA	1301
bsdb:735/1/1_Crohn's-disease:Crohn's-disease_vs_Healthy-control_UP	NA	482	713	416916	724
bsdb:735/1/2_Crohn's-disease:Crohn's-disease_vs_Healthy-control_DOWN	NA	216851	375288	841	33042	572511	1263	1730	1678	1485
bsdb:735/2/1_Crohn's-disease:Crohn's-disease_vs_Healthy-control_UP	NA	1263	189330
bsdb:735/3/1_Crohn's-disease:Crohn's-disease_vs_Healthy-control_UP	NA	1578	1730	1263	1485	84111	189330	1301	33042	1678	572511
bsdb:735/3/2_Crohn's-disease:Crohn's-disease_vs_Healthy-control_DOWN	NA	816	416916	469	1279	482	508215	1716	836
bsdb:736/1/1_Alzheimer's-disease:Alzheimers-disease-patients_vs_healthy-controls_UP	NA	239934	1678	1716	1350	1730	1578	292632	2735
bsdb:736/1/2_Alzheimer's-disease:Alzheimers-disease-patients_vs_healthy-controls_DOWN	NA	207244	580596	33042	39948	216851	1407607	204475	838	1501226	841	29465
bsdb:737/1/1_smoking-behavior:Healthy-current-smokers_vs_Healthy-non-smokers_DOWN	NA	1301	838	482	836	1378	724	117563
bsdb:737/1/2_smoking-behavior:Healthy-current-smokers_vs_Healthy-non-smokers_UP	NA	1654	29465	848
bsdb:737/2/1_smoking-behavior:Healthy-current-smokers_vs_Healthy-non-smokers_DOWN	NA	1301	838	848	482	836	117563	1378	724
bsdb:737/2/2_smoking-behavior:Healthy-current-smokers_vs_Healthy-non-smokers_UP	NA	1654
bsdb:737/3/1_smoking-behavior:Healthy-current-smokers_vs_Healthy-non-smokers_DOWN	NA	838	1301	482	29465	836	508215	265975
bsdb:737/3/2_smoking-behavior:Healthy-current-smokers_vs_Healthy-non-smokers_UP	NA	848	1654
bsdb:737/4/1_smoking-behavior:Healthy-current-smokers_vs_Healthy-non-smokers_DOWN	NA	838	1301	29465	482	848	836	1654	1378
bsdb:737/4/2_smoking-behavior:Healthy-current-smokers_vs_Healthy-non-smokers_UP	NA	265975	2038
bsdb:738/1/1_Crohn's-disease:pediatric-crohn's-disease_vs_healthy-adults_DOWN	NA	158846
bsdb:738/2/1_Crohn's-disease:pediatric-crohn's-disease_vs_healthy-adults_UP	NA	146	244127
bsdb:738/2/2_Crohn's-disease:pediatric-crohn's-disease_vs_healthy-adults_DOWN	NA	189330	1301	3025755
bsdb:738/3/1_Crohn's-disease:pediatric-crohn's-disease_vs_healthy-adults_UP	NA	1263
bsdb:738/4/1_Gut-microbiome-measurement:Lysine-acetylome-aliquot-of-human-gut_vs_Metaproteome-aliquot-of-human-gut_UP	NA	1407607	283168	1506553	580596
bsdb:738/4/2_Gut-microbiome-measurement:Lysine-acetylome-aliquot-of-human-gut_vs_Metaproteome-aliquot-of-human-gut_DOWN	NA	816	830	577310	102106	204475	9605
bsdb:739/1/1_inflammatory-bowel-disease:Bacillus-clausii-UBBC-07-group-after-intervention/treatment_vs_Placebo-group-before-intervention/treatment_UP	NA	1578	1678	216851
bsdb:740/1/1_Alzheimer's-disease:Alzheimers-disease_vs_healthy-controls_DOWN	NA	572511	1263
bsdb:740/2/1_Alzheimer's-disease:aMCI-patients_vs_healthy-controls_DOWN	NA	572511
bsdb:740/2/2_Alzheimer's-disease:aMCI-patients_vs_healthy-controls_UP	NA	816
bsdb:740/3/2_Alzheimer's-disease:aMCI-patients_vs_Alzheimers-patients-in-dementia-stage_UP	NA	1263	816
bsdb:741/2/1_Parkinson's-disease:Parkinson's-Disease-patients-without-constipation-and-Parkinson's-Disease-patients-with-constipation_vs_Healthy-Controls_DOWN	NA	28050	1407607
bsdb:741/3/1_Parkinson's-disease:Parkinson's-Disease-patients-with-constipation_vs_Healthy-Controls-and-Parkinson's-Disease-patients-without-constipation_UP	NA	102106	1649459
bsdb:741/4/1_Parkinson's-disease:Parkinson's-Disease-patients-with-constipation_vs_Parkinson's-Disease-patients-without-constipation_DOWN	NA	1573535	158846
bsdb:741/4/2_Parkinson's-disease:Parkinson's-Disease-patients-with-constipation_vs_Parkinson's-Disease-patients-without-constipation_UP	NA	244127	1649459	1301
bsdb:742/1/1_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-spouses_UP	NA	239759	244127	35832	574697	830	872	846	196081	292632	133925
bsdb:742/1/2_Parkinson's-disease:Parkinson's-Disease-Patients_vs_Healthy-spouses_DOWN	NA	816	1279384
bsdb:743/1/1_Parkinson's-disease:Parkinson's-Disease-subjects_vs_Healthy-control-volunteers_UP	NA	239934	816	119852
bsdb:743/1/2_Parkinson's-disease:Parkinson's-Disease-subjects_vs_Healthy-control-volunteers_DOWN	NA	572511	33042	189330	841
bsdb:743/2/1_Parkinson's-disease:Parkinson's-Disease-subjects_vs_Healthy-control-volunteers_UP	NA	48736
bsdb:743/2/2_Parkinson's-disease:Parkinson's-Disease-subjects_vs_Healthy-control-volunteers_DOWN	NA	189330	216851
bsdb:744/1/1_Parkinson's-disease:Parkinson's-Disease-subjects._vs_Healthy-controls._UP	NA	239934	1350	1649459
bsdb:745/1/1_Fasting:Adults-after-fasting_vs_Adults-before-fasting_UP	NA	239934	174708	816	580596	39948	1730	216851	906	841
bsdb:745/1/2_Fasting:Adults-after-fasting_vs_Adults-before-fasting_DOWN	NA	1350	561
bsdb:750/1/1_sex-design:Females_vs_Males_DOWN	NA	59735	195950
bsdb:750/1/2_sex-design:Females_vs_Males_UP	NA	157	2093	1716
bsdb:750/2/1_Aging:Elderly_vs_Adults_UP	NA	838	146	157
bsdb:750/2/2_Aging:Elderly_vs_Adults_DOWN	NA	46123	1654	416916	156454	194	43996	39948	538	1378	117563	724	32257	1164882	47670	32067	906	86331	32207	970	1213720	1301	29465
bsdb:750/3/1_Gingival-bleeding:Participants-with-gingival-bleeding_vs_Participants-without-gingivitis-bleeding_UP	NA	1016	838
bsdb:750/3/2_Gingival-bleeding:Participants-with-gingival-bleeding_vs_Participants-without-gingivitis-bleeding_DOWN	NA	1283313	1378	117563	724	47670	32067	906	482	1301	29465
bsdb:750/4/1_Oral-ulcer:Participants-with-oral-ulcers_vs_Participants-without-oral-ulcers_UP	NA	1016	838
bsdb:750/4/2_Oral-ulcer:Participants-with-oral-ulcers_vs_Participants-without-oral-ulcers_DOWN	NA	1378	117563	724	32067	906	482	1301	29465
bsdb:750/5/1_Dentures:Participants-with-dentures_vs_Participants-without-dentures_UP	NA	482	1301	113286
bsdb:750/5/2_Dentures:Participants-with-dentures_vs_Participants-without-dentures_DOWN	NA	194
bsdb:750/6/1_smoking-behavior:Smokers_vs_Non-smokers_UP	NA	838
bsdb:750/6/2_smoking-behavior:Smokers_vs_Non-smokers_DOWN	NA	1357	1716	1378	1016	1301
bsdb:750/7/1_Coffee-consumption:Coffee-drinkers_vs_Non-coffee-drinkers_UP	NA	47670	117563	724	29465	1301
bsdb:750/7/2_Coffee-consumption:Coffee-drinkers_vs_Non-coffee-drinkers_DOWN	NA	838
bsdb:750/8/1_Tea-consumption-measurement:Tea-drinkers_vs_Non-tea-drinkers_DOWN	NA	1016
bsdb:751/1/1_alcohol-drinking:Moderate-drinkers_vs_Non-drinkers_UP	NA	1301	838	59735	1716	848	32067	416916	2717	538	32257	482
bsdb:751/2/1_alcohol-drinking:Heavy-drinkers_vs_Non-drinkers_UP	NA	1654	416916	59735	1164882	32067	482	1301	195950
bsdb:751/3/1_alcohol-drinking:Wine-drinkers_vs_Non-drinkers_UP	NA	416916	1716	538
bsdb:751/3/2_alcohol-drinking:Wine-drinkers_vs_Non-drinkers_DOWN	NA	2740	838	86331
bsdb:751/4/1_alcohol-drinking:Beer-drinkers_vs_Non-drinkers_UP	NA	416916	196082
bsdb:751/4/2_alcohol-drinking:Beer-drinkers_vs_Non-drinkers_DOWN	NA	265975	836	838	1213720
bsdb:751/5/1_alcohol-drinking:Liquor-drinkers_vs_Non-drinkers_DOWN	NA	838
bsdb:751/5/2_alcohol-drinking:Liquor-drinkers_vs_Non-drinkers_DOWN	NA	86331	265975	196082	838	1213720
bsdb:752/1/1_smoking-behavior:Smokers_vs_Non-smokers_UP	NA	713	1651	118747	59732	1647	848	1378	82980	908284	613	40544
bsdb:752/1/2_smoking-behavior:Smokers_vs_Non-smokers_DOWN	NA	46123	1654	1016	1716	44259	117563	32067	86331	53370	970	1279	1301	195950	469
bsdb:753/1/1_smoking-behavior:Smokers_vs_Nonsmokers_UP	NA	970	157
bsdb:753/1/2_smoking-behavior:Smokers_vs_Nonsmokers_DOWN	NA	1016	2717
bsdb:753/2/1_smoking-behavior:Smokers_vs_Nonsmokers_UP	NA	1380	39948
bsdb:753/2/2_smoking-behavior:Smokers_vs_Nonsmokers_DOWN	NA	43996	1378	117563	724	1257
bsdb:754/1/1_smoking-behavior:Smokers_vs_Non-smokers_UP	NA	816	1716	893	1730	44259	1434006	848	1378	117563	47670	86331	543311	32207	1301	195950	29465	43996	32067	157
bsdb:754/1/2_smoking-behavior:Smokers_vs_Non-smokers_DOWN	NA	416916	194	2717	724	838	1434006	482	836	970	157
bsdb:756/1/1_smoking-behavior:Smokers-(S)_vs_Controls-(C)_DOWN	NA	46123	416916	292480	1386	59735	28219	1378	117563	32257	86331	437755	482	196079	265975	162289	1257	67572	75309	42255	1279	265570	933
bsdb:756/1/2_smoking-behavior:Smokers-(S)_vs_Controls-(C)_UP	NA	222	110934	507	28263	1663	1016	308865	848	32636	110932	33882	838	48736	13687	40323	195950	34072	84567	46466
bsdb:756/2/1_Alcohol-drinking,Smoking-behavior:Smokers/Drinkers-(SD)_vs_Controls-(C)_DOWN	NA	46123	416916	28263	1663	1386	59735	28219	237	848	46466	32257	110932	33882	86331	437755	482	196079	265975	84567	1257	67572	48736	75309	42255	13687	1279	265570	195950	933	34072
bsdb:756/2/2_Alcohol-drinking,Smoking-behavior:Smokers/Drinkers-(SD)_vs_Controls-(C)_UP	NA	222	110934	507	1016	1378	117563	32636	196079	162289	838	40323
bsdb:758/1/1_Nasopharyngeal-neoplasm:Nasopharyngeal-carcinoma-patients-at-baseline_vs_Healthy-controls-at-Baseline_UP	NA	32067	482	286
bsdb:758/1/2_Nasopharyngeal-neoplasm:Nasopharyngeal-carcinoma-patients-at-baseline_vs_Healthy-controls-at-Baseline_DOWN	NA	1301
bsdb:758/2/1_Nasopharyngeal-neoplasm:Nasopharyngeal-carcinoma-patients-after-treatment_vs_Nasopharyngeal-carcinoma-patients-at-baseline_UP	NA	1301	29465
bsdb:758/2/2_Nasopharyngeal-neoplasm:Nasopharyngeal-carcinoma-patients-after-treatment_vs_Nasopharyngeal-carcinoma-patients-at-baseline_DOWN	NA	482	838
bsdb:759/1/1_Dry-eye-syndrome:Dry-Eye_vs_control_DOWN	NA	1716	237	848	724	149698	33882	219181	32207	13687	270	29465
bsdb:759/2/1_Dry-eye-syndrome:OGVHD_vs_control_DOWN	NA	2747	501783	1637	33882	286
bsdb:759/2/2_Dry-eye-syndrome:OGVHD_vs_control_UP	NA	1386
bsdb:759/3/1_Dry-eye-syndrome:ADDE_vs_control_UP	NA	1696	212791
bsdb:759/3/2_Dry-eye-syndrome:ADDE_vs_control_DOWN	NA	286	2747
bsdb:760/1/1_Surgical-resection,Chemotherapy-induced-nausea-and-vomiting:Placebo-control-group_vs_CRC-(colorectal-cancer-patients)-before-surgery-and-chemotherapy_UP	NA	239934
bsdb:760/1/2_Surgical-resection,Chemotherapy-induced-nausea-and-vomiting:Placebo-control-group_vs_CRC-(colorectal-cancer-patients)-before-surgery-and-chemotherapy_DOWN	NA	1578	838	841
bsdb:760/2/1_Surgical-resection,Chemotherapy-induced-nausea-and-vomiting:Probiotic-treatment-group_vs_CRC-(colorectal-cancer-patients)-before-surgery-and-chemotherapy_DOWN	NA	1578
bsdb:760/3/1_Treatment:Probiotic-treatment-group_vs_Placebo-control-group_UP	NA	572511	1578	841
bsdb:760/4/1_Treatment:Probiotic-treatment-group_vs_Placebo-control-group_UP	NA	572511	724	239759	204475	1485
bsdb:761/1/1_Metabolic-disease-associated-with-ocular-features:SJS-(Steven's-Johnson-Syndrome)-disease_vs_healthy-controls_UP	NA	1716	1279	1301
bsdb:761/1/2_Metabolic-disease-associated-with-ocular-features:SJS-(Steven's-Johnson-Syndrome)-disease_vs_healthy-controls_DOWN	NA	848	1578	838
bsdb:761/2/1_Metabolic-disease-associated-with-ocular-features:Patients_vs_Healthy-control_UP	NA	1654	1716	838	1301	508215
bsdb:761/2/2_Metabolic-disease-associated-with-ocular-features:Patients_vs_Healthy-control_DOWN	NA	469	1654	1716	1578	286	1279	1301
bsdb:761/2/3_Metabolic-disease-associated-with-ocular-features:Patients_vs_Healthy-control_UP	NA	469	1485	1716	848	1004300	1578	838	48736	970	1279	1301	508215
bsdb:761/3/1_Metabolic-disease-associated-with-ocular-features:GVHD-patients_vs_Healthy-control_UP	NA	970
bsdb:761/3/2_Metabolic-disease-associated-with-ocular-features:GVHD-patients_vs_Healthy-control_DOWN	NA	1578	1301
bsdb:761/4/1_Metabolic-disease-associated-with-ocular-features:FES-patients_vs_Healthy-control_UP	NA	1716	1004300	48736	508215	1279
bsdb:761/5/1_Metabolic-disease-associated-with-ocular-features:DED-patients_vs_Healthy-control_UP	NA	1716	1279	469
bsdb:762/1/2_Dry-eye-syndrome:Dry-Eye_vs_healthy-controls_UP	NA	286
bsdb:762/2/2_Dry-eye-syndrome:MGD_vs_Non-MGD_DOWN	NA	1283313	141948
bsdb:763/1/2_Age-at-assessment:Old_vs_Young_DOWN	NA	336809
bsdb:764/1/1_type-ii-diabetes-mellitus:diabetic_vs_healthy-controls_UP	NA	469	32008	67575	1060	1269	2745	1663	235888	1562	13159	28100	76890	2742	1835	1696	357	57494	191	1375
bsdb:764/1/2_type-ii-diabetes-mellitus:diabetic_vs_healthy-controls_DOWN	NA	165696	1279
bsdb:765/1/1_Adenomyosis:adenomyosis-patients_vs_Healthy-controls_UP	NA	419014	212791	216851	158846	119852	292632
bsdb:765/1/2_Adenomyosis:adenomyosis-patients_vs_Healthy-controls_DOWN	NA	236752	906
bsdb:766/1/1_Stevens-Johnson-syndrome:Stevens-Johnson-Syndrome_vs_healthy-controls_UP	NA	816	216851	51366	239934	838	33042	1301	1578	848	1678	572511	1386	33024	577309	469	1263	158846	283168	1279	53246	551	286	102106	2172	29465	141948	841	191303
bsdb:766/1/2_Stevens-Johnson-syndrome:Stevens-Johnson-Syndrome_vs_healthy-controls_DOWN	NA	22	655352	1485	76008	104267	40222	180162	28196	662
bsdb:767/1/1_Alzheimer's-disease:Alzheimer's-disease-patients_vs_Non-demented-Controls_UP	NA	102106	283168	375288	577309	838
bsdb:767/1/2_Alzheimer's-disease:Alzheimer's-disease-patients_vs_Non-demented-Controls_DOWN	NA	580596	577310
bsdb:767/2/1_Alzheimer's-disease:Mild-Cognitive-Impairment-group_vs_Non-demented-Controls_UP	NA	1774107	375288	838
bsdb:767/2/2_Alzheimer's-disease:Mild-Cognitive-Impairment-group_vs_Non-demented-Controls_DOWN	NA	580596	577310
bsdb:771/1/2_Health-study-participation:Bejing-healthy-volunteers_vs_Guangzhou-healthy-volunteers_DOWN	NA	336809
bsdb:772/1/1_obesity:OW-cats-at-T1_vs_LN-cats-at-T1_UP	NA	830	118747	39948	904	29465	86331	52225	102106	906	265975	1678	836	61170	155493	745	2740	194	397864	239759	33042	283168	158846	209	841	119852	1301	580596	1350
bsdb:772/1/2_obesity:OW-cats-at-T1_vs_LN-cats-at-T1_DOWN	NA	848	174708	13334	33024	189330	838	1730	40544	191303	1578	216851	1654	872	702	375288	447020	816	1257	577309	1485	135858	49082	561	1263	84108	244127	572511	574697	620	83770
bsdb:772/2/1_diet:CON-fed-OW-cats-at-T2-(end-of-intervention)_vs_OW-cats-at-T1(end-of-baseline-feeding)_UP	NA	239759	13334	244127	816	572511	118747	580596	830	135858	1485	102106	33042	872	39948	189330	1730	216851	61170	283168	119852	375288	2740	1257	836	841	1263	84108	83770	577309	447020
bsdb:772/2/2_diet:CON-fed-OW-cats-at-T2-(end-of-intervention)_vs_OW-cats-at-T1(end-of-baseline-feeding)_DOWN	NA	906	848	29465	1678	40544	158846	1578	86331	838	265975	33024	1350	904	191303	49082	561	209	1301	194
bsdb:772/3/1_diet:HPLC-fed-OW-cats-at-T2-(end-of-intervention)_vs_OW-cats-at-T1(end-of-baseline-feeding)_UP	NA	216851	848	1485	572511	2740	375288	40544	580596	1263	84108	816	119852	447020	189330	1730	836	838	265975	33024	1257	577309	61170	561	830
bsdb:772/3/2_diet:HPLC-fed-OW-cats-at-T2-(end-of-intervention)_vs_OW-cats-at-T1(end-of-baseline-feeding)_DOWN	NA	906	29465	1678	239759	244127	283168	135858	841	158846	118747	1578	33042	86331	83770	1350	904	39948	191303	102106	49082	872	209	1301	194	13334
bsdb:772/4/1_diet:HPLC-fed-OW-cats-at-T2-(end-of-intervention)_vs_CON-fed-OW-cats-at-T2-(end-of-intervention)_UP	NA	572511	580596	830	1485	1350	561	1730	216851	848	265975	2740	1257	33024	838	1263	1301	40544	49082
bsdb:772/4/2_diet:HPLC-fed-OW-cats-at-T2-(end-of-intervention)_vs_CON-fed-OW-cats-at-T2-(end-of-intervention)_DOWN	NA	906	29465	1678	239759	244127	375288	283168	135858	841	158846	84108	816	118747	1578	119852	33042	189330	86331	836	83770	904	577309	39948	191303	102106	872	209	194	13334
bsdb:774/1/1_irritable-bowel-syndrome:IBS-C-(IBS-Constipation)_vs_Non-IBS1-(Non-irritable-bowel-syndrome-1)_DOWN	NA	1766253	653683	207244	1678	572511	580596	33042	1716	189330	216851	1407607	724	28050	2039302	838	841	1263	292632	83770	40544	29465
bsdb:774/1/2_irritable-bowel-syndrome:IBS-C-(IBS-Constipation)_vs_Non-IBS1-(Non-irritable-bowel-syndrome-1)_UP	NA	239934	397864	990721	80865	872	1472649	1432051	1730	1573534	150022	946234	1918511	1649459	596767	1392389	1980693	459786	119852	375288	1508657
bsdb:774/2/1_irritable-bowel-syndrome:IBS-D-(IBS-Diarrhea)_vs_Non-IBS2-(Non-irritable-bowel-syndrome-2)_DOWN	NA	222	239934	239759	207244	397864	1678	574697	830	194	33042	73029	872	216851	1686313	596767	283168	846	577310	162289	836	838	1263	40544	184869	29465	172900
bsdb:774/2/2_irritable-bowel-syndrome:IBS-D-(IBS-Diarrhea)_vs_Non-IBS2-(Non-irritable-bowel-syndrome-2)_UP	NA	46123	189330	946234	724	292632
bsdb:774/3/1_irritable-bowel-syndrome:IBS-U-(IBS-Unclassified)_vs_Non-IBS3-(Non-irritable-bowel-syndrome-3)_DOWN	NA	1766253	207244	1678	572511	194	135858	102106	189330	216851	1686313	150022	1407607	1378	1573535	162289	838	1263	292632	40544	191303	184869
bsdb:774/3/2_irritable-bowel-syndrome:IBS-U-(IBS-Unclassified)_vs_Non-IBS3-(Non-irritable-bowel-syndrome-3)_UP	NA	286	40840
bsdb:774/4/1_Depressive-disorder:IBS-patients-with-depression-in-all-three-subtypes-(IBS-D,-IBS-C-and-IBS-U)_vs_IBS-patients-without-depression_DOWN	NA	1678	574697	40544
bsdb:774/4/2_Depressive-disorder:IBS-patients-with-depression-in-all-three-subtypes-(IBS-D,-IBS-C-and-IBS-U)_vs_IBS-patients-without-depression_UP	NA	583
bsdb:775/1/1_breast-cancer:breast-cancer-(BC)_vs_healthy-controls-(HC)_UP	NA	1654	572511	84111	1573534
bsdb:776/1/1_Overactive-bladder:Overactive-Bladder-(OAB)_vs_Asymptomatic-controls_UP	NA	1279	168808	583	31983	1378	2093	1375
bsdb:776/1/2_Overactive-bladder:Overactive-Bladder-(OAB)_vs_Asymptomatic-controls_DOWN	NA	165779	194	39948	1350	150022	848	428711	1578	1357	165696	838	638847	2129
bsdb:776/2/1_Overactive-bladder:Overactive-Bladder-(OAB)-with-anxiety_vs_Overactive-Bladder-(OAB)-without-anxiety_UP	NA	76833	29330	162290	31983	836	168808	47251
bsdb:776/2/2_Overactive-bladder:Overactive-Bladder-(OAB)-with-anxiety_vs_Overactive-Bladder-(OAB)-without-anxiety_DOWN	NA	357	32008	102106	2172	497	205841
bsdb:777/2/2_Crohn's-disease:Crohn's-disease-(CD)_vs_healthy-controls_UP	NA	29465	1506553
bsdb:777/3/1_Crohn's-disease:Crohn's-disease-(CD)_vs_ulcerative-colitis-(UC)_UP	NA	191303
bsdb:777/3/2_Crohn's-disease:Crohn's-disease-(CD)_vs_ulcerative-colitis-(UC)_DOWN	NA	239934	653683	574697	848	1892380	158846	33024	40544
bsdb:778/1/1_gastric-cancer:Gastric-cancer_vs_Superficial-gastritis_DOWN	NA	39948	1578	642	1827	1301	838	504481	886360	194	209
bsdb:778/1/2_gastric-cancer:Gastric-cancer_vs_Superficial-gastritis_UP	NA	1654	1283313	1663	374	41275	194	848	724	32067	482	28100	836	838	508215	29465
bsdb:778/2/1_gastric-cancer:GC(gastric-cancer)_vs_HC-(healthy-controls)_DOWN	NA	68287	374
bsdb:778/2/2_gastric-cancer:GC(gastric-cancer)_vs_HC-(healthy-controls)_UP	NA	848
bsdb:779/1/2_Post-COVID-19-disorder:long-COVID-19_vs_healthy-controls_DOWN	NA	838	1301	29465	724	482	1283313
bsdb:779/2/1_Post-COVID-19-disorder:long-COVID-19_vs_healthy-controls_UP	NA	848	47670	482	2740557	836	1301	29465	724
bsdb:780/1/1_exercise:Meditation-group_vs_Control-group_UP	NA	216851	158846	838	816
bsdb:780/1/2_exercise:Meditation-group_vs_Control-group_DOWN	NA	841	39948	216851	906	1678	102106
bsdb:782/1/1_COVID-19:Pharyngeal-samples-from-COVID-19-patients_vs_samples-from-Healthy-patients_DOWN	NA	32008	194	561	848	724	1269	482	970	195950	157
bsdb:782/1/2_COVID-19:Pharyngeal-samples-from-COVID-19-patients_vs_samples-from-Healthy-patients_UP	NA	508215	1301	1654	46123
bsdb:782/2/1_COVID-19:Sputum-samples-from-COVID-19-patients_vs_samples-from-Healthy-patients_UP	NA	1016	1301
bsdb:782/2/2_COVID-19:Sputum-samples-from-COVID-19-patients_vs_samples-from-Healthy-patients_DOWN	NA	157	80865	836	195950	724	482
bsdb:782/3/1_COVID-19:Feces-samples-from-COVID-19-patients_vs_samples-from-Healthy-patients_UP	NA	2745	286
bsdb:782/3/2_COVID-19:Feces-samples-from-COVID-19-patients_vs_samples-from-Healthy-patients_DOWN	NA	1506553	84111	207244	28050	2719313	841	946234	1678	375288	216851
bsdb:785/1/1_ulcerative-colitis:ulcerative-colitis-patient_vs_healthy-control-individual_UP	NA	375288
bsdb:785/3/2_Illness-severity-status:patients-with-moderate-to-severe-ulcerative-colitis_vs_patients-with-mild-ulcerative-colitis_DOWN	NA	239759
bsdb:785/4/2_Illness-severity-status:patients-with-moderate-to-severe-ulcerative-colitis_vs_patients-with-remission-ulcerative-colitis-(symptoms-of-UC-are-reduced-or-inapparent)_DOWN	NA	239759	40544
bsdb:785/5/2_Distal-colitis,Pancolitis:patients-with-left-sided-or-extensive-ulcerative-colitis_vs_patients-with-proctitis-ulcerative-colitis_DOWN	NA	838	44748
bsdb:786/1/1_type-ii-diabetes-mellitus:Pre-Type-2-Diabetes_vs_Healthy-controls_UP	NA	1432051	1301	1924105
bsdb:786/2/1_type-ii-diabetes-mellitus:Treatment-naive-Type-2-Diabetes_vs_Healthy-controls_UP	NA	189330	191303
bsdb:786/2/2_type-ii-diabetes-mellitus:Treatment-naive-Type-2-Diabetes_vs_Healthy-controls_DOWN	NA	2039240
bsdb:786/3/1_type-ii-diabetes-mellitus:Pre-Type-2-Diabetes_vs_Healthy-controls_UP	NA	189330	620	561
bsdb:786/3/2_type-ii-diabetes-mellitus:Pre-Type-2-Diabetes_vs_Healthy-controls_DOWN	NA	841	29465
bsdb:788/2/1_Ruminative-stress-response:Jersey-cows-under-heat-stress-condition_vs_Jersey-cows-under-normal-condition_UP	NA	1279	1485	1386
bsdb:788/2/2_Ruminative-stress-response:Jersey-cows-under-heat-stress-condition_vs_Jersey-cows-under-normal-condition_DOWN	NA	1883	286
bsdb:789/1/1_breast-cancer:Prediagnostic-(PD)_vs_Health-(H)_UP	NA	196013	848	53335	1501226	13687	1279
bsdb:789/1/2_breast-cancer:Prediagnostic-(PD)_vs_Health-(H)_DOWN	NA	1716
bsdb:789/2/1_breast-cancer:Adjacent-normal-(AN)_vs_Health-(H)_UP	NA	165779	1716	75654	570	583	1494958
bsdb:789/2/2_breast-cancer:Adjacent-normal-(AN)_vs_Health-(H)_DOWN	NA	1663	816	374	1912216	32014	1357	657	1263
bsdb:789/3/1_breast-cancer:Tumor-(T)_vs_Health-(H)_UP	NA	165779	1494958	1827
bsdb:789/3/2_breast-cancer:Tumor-(T)_vs_Health-(H)_DOWN	NA	469	1663	816	35832	1357	1847725	657	295418	613	270	2737
bsdb:792/1/1_Root:Test-group-(Roots)_vs_Control-group-(Leaves)_UP	NA	237	149698	1865
bsdb:792/1/2_Root:Test-group-(Roots)_vs_Control-group-(Leaves)_DOWN	NA	286	29580	13687
bsdb:794/1/1_colorectal-cancer:EOCRC-(Early-onset-Colorectal-cancer)-patients_vs_Healthy-controls_UP	NA	848	158846	543311	1257	836
bsdb:794/3/1_colorectal-cancer:LOCRC-(Late-onset-colorectal-cancer)_vs_Healthy-controls_UP	NA	239759	375288	33024
bsdb:796/1/1_Aging:group-4-(-66-to-80-years-old.-elderly-people)_vs_group-1-(-18-to-35-years-old.-young-adults)_UP	NA	570	1578	1350
bsdb:797/1/1_Smoking-status-measurement:Active-smokers_vs_Never-smokers_UP	NA	1301	848	407	724
bsdb:797/1/2_Smoking-status-measurement:Active-smokers_vs_Never-smokers_DOWN	NA	335058	40323
bsdb:797/2/2_Smoking-status-measurement:former-smokers_vs_Never-smokers_UP	NA	47670	32067
bsdb:797/3/1_Smoking-status-measurement:active-smokers_vs_former-smokers_UP	NA	482	848
bsdb:797/3/2_Smoking-status-measurement:active-smokers_vs_former-smokers_DOWN	NA	1213720	838
bsdb:797/4/1_Smoking-status-measurement:Active-smokers-&-former-smokers_vs_Never-smokers_UP	NA	1730	724	47670	906	407	86331	838	29465
bsdb:797/5/1_Smoking-status-measurement:Active-smokers_vs_never-smokers-&-former-smokers_DOWN	NA	80865
bsdb:798/1/1_urinary-tract-infection:Recurrent-Urinary-Tract-Infection-(RUTI)-patients_vs_Asymptomatic-controls_UP	NA	165779	1716	39948	906	836	838	48736	1653174	162289	194	848	212791
bsdb:798/1/2_urinary-tract-infection:Recurrent-Urinary-Tract-Infection-(RUTI)-patients_vs_Asymptomatic-controls_DOWN	NA	469	239759	1582879	2701	1578	168808	1301
bsdb:799/1/1_chronic-obstructive-pulmonary-disease:HIV-positive-individuals-diagnosed-with-COPD_vs_HIV-negative-individuals-with-COPD_UP	NA	416916	2801844	1386	2717	1716	1730	44259	848	1378	1840214	32067	2742598	475	543311	838	1743	508215	970	1301	195950
bsdb:799/1/2_chronic-obstructive-pulmonary-disease:HIV-positive-individuals-diagnosed-with-COPD_vs_HIV-negative-individuals-with-COPD_DOWN	NA	46123	2147	713	1654	1283313	156454	1380	59735	194	1331051	1016	39948	1434006	117563	724	1164882	47670	482	265975	2740	1257	836	71	123375	1213720	34104	195950	157	29465
bsdb:799/2/1_chronic-obstructive-pulmonary-disease:HIV-positive-individuals-(without-COPD)_vs_HIV-negative-individuals-(without-COPD)_UP	NA	713	1654	1283313	2060094	1380	1386	830	194	1331051	1016	43996	1716	1730	1378	117563	724	1164882	475	265975	1913599	836	1743	970	123375	1213720	34104	157	29465
bsdb:799/2/2_chronic-obstructive-pulmonary-disease:HIV-positive-individuals-(without-COPD)_vs_HIV-negative-individuals-(without-COPD)_DOWN	NA	46123	416916	2801844	44259	1434006	848	47670	32067	482	543311	1257	838	508215	1301
bsdb:800/1/1_Health-study-participation:pandemic-group-with-covariates-controlled-for_vs_pre-pandemic-group-with-covariates-controlled-for_DOWN	NA	724
bsdb:800/3/2_Health-study-participation:pandemic-group-according-to-the-number-of-days_vs_pandemic-group-(without-covariates)_UP	NA	46123
bsdb:801/1/1_Respiratory-system-disease:Diseased-individuals-(D)_vs_Non-diseased/-healthy-individuals-(ND)_UP	NA	2801844	1678	1716	561	724	570	44249	286	497	195950
bsdb:801/1/2_Respiratory-system-disease:Diseased-individuals-(D)_vs_Non-diseased/-healthy-individuals-(ND)_DOWN	NA	543311	2093	970	39948	32067	86331	1380	416916	123375	133925	43996	47670	76833	194	1164882	1257	1283313	1485	898	848	157	838
bsdb:802/1/1_Cachexia:cachexia-induced-mice_vs_Healthy-controls_UP	NA	1501226	1357	191303	1678	1263	1980681
bsdb:802/1/2_Cachexia:cachexia-induced-mice_vs_Healthy-controls_DOWN	NA	49082	1485	248744	1926677	1301
bsdb:803/1/2_colorectal-cancer:Samples-with-Colorectal-Cancer_vs_Normal-samples-free-from-Colorectal-Cancer_DOWN	NA	33986	1269	482
bsdb:803/2/1_colorectal-cancer:Samples-with-Colorectal-Cancer_vs_Normal-samples-free-from-Colorectal-Cancer_UP	NA	2701	117563	1060
bsdb:803/2/2_colorectal-cancer:Samples-with-Colorectal-Cancer_vs_Normal-samples-free-from-Colorectal-Cancer_DOWN	NA	374
bsdb:803/3/1_colorectal-cancer:Samples-with-Colorectal-Cancer_vs_Normal-samples-free-from-Colorectal-Cancer_UP	NA	149698
bsdb:803/3/2_colorectal-cancer:Samples-with-Colorectal-Cancer_vs_Normal-samples-free-from-Colorectal-Cancer_DOWN	NA	28231
bsdb:803/4/1_Population:Tumor-samples-of-European-American_vs_Patients--in-keyan,-African-American-and-Egyptians_UP	NA	2086	2353	2093	1301
bsdb:803/5/1_Population:Tumor-samples-of-kenyans_vs_Patients--in-egypt,-African-American-and-European-Africans_UP	NA	171673	838	59507
bsdb:803/6/1_Population:Tumor-samples-of-African-Americans_vs_Patients--in-egypt,-Kenya-and-European-Africans_UP	NA	1716	212791	66831	1578	1357	32067	162289	286	1060
bsdb:803/7/1_Population:Tumor-samples-of-Egyptians_vs_Patients--in-African-American,-Kenya-and-European-Africans_UP	NA	469	374	963	70774	68	65551	1269	44249	28100	583	13687	1279	32067
bsdb:804/1/1_Response-to-transplant:CON-FMT:-receiving-control-microbiota-FMT-mice_vs_SD-FMT-AND-SD+MEL-FMT_UP	NA	1918598	1508657	248038
bsdb:804/1/2_Response-to-transplant:CON-FMT:-receiving-control-microbiota-FMT-mice_vs_SD-FMT-AND-SD+MEL-FMT_DOWN	NA	1263
bsdb:804/2/1_Response-to-transplant:SD-FMT:-receiving-Sleep-deprivation--FMT-mice_vs_CON-FMT:(-receiving-control-microbiota-FMT-mice)-and-SD+Mel-FMT:(-receiving-SD+Mel-(20-mg/kg)-microbiota--FMT-mice)_UP	NA	1283313	577310	1918598
bsdb:804/3/1_Response-to-transplant:SD+Mel-FMT:(-receiving-SD+Mel-(20-mg/kg)-microbiota-FMT-mice)_vs_CON-FMT-and-SD-FMT_UP	NA	239759	1331051	1263	2086	1730
bsdb:806/1/1_Mood-disorder:bipolar-disorder-(BD)_vs_healthy-controls-(HCs)_UP	NA	816	102106	84111	848	1506553	1578	286	1301	292632	3025755
bsdb:806/2/1_Mood-disorder:Major-depressive-disorder-(MDD)_vs_healthy-controls-(HCs)_UP	NA	816	544	848
bsdb:806/2/2_Mood-disorder:Major-depressive-disorder-(MDD)_vs_healthy-controls-(HCs)_DOWN	NA	816
bsdb:806/3/1_Mood-disorder:Major-depressive-disorder-(MDD)_vs_bipolar-disorder-(BD)_UP	NA	816	1678	572511	84111	216851	1301	3025755
bsdb:806/3/2_Mood-disorder:Major-depressive-disorder-(MDD)_vs_bipolar-disorder-(BD)_DOWN	NA	207244	816	572511	580596	39948	1350	216851	1506553	33024	286	1501226	1301
bsdb:807/1/1_Nasopharyngitis:Nasopharyngeal-swab-samples-from-workplaces_vs_Indoor-dust-samples_UP	NA	1716	1279
bsdb:808/1/1_Response-to-diet:mice-on-ketogenic-diet_vs_mice-on-American-diet_UP	NA	35832	28138	1508657
bsdb:808/1/2_Response-to-diet:mice-on-ketogenic-diet_vs_mice-on-American-diet_DOWN	NA	375288
bsdb:809/1/1_Retinopathy:diabetes-mellitus-(DM)_vs_healthy-controls-(HC)_UP	NA	724	906	375288	29465
bsdb:809/3/1_Retinopathy:diabetes-retinopathy-(DR)_vs_healthy-controls-(HC)_UP	NA	904	1730	46255
bsdb:811/1/1_psoriasis:Psoriasis-patients_vs_Healthy-controls_UP	NA	135858	39948
bsdb:811/1/2_psoriasis:Psoriasis-patients_vs_Healthy-controls_DOWN	NA	264995	572511	990721	28050	1263
bsdb:812/1/1_urinary-tract-infection:rUTI-History,-UTI-(-),-rUTI-History,-UTI(+)_vs_No-UTI-History_UP	NA	1375	1578
bsdb:812/1/2_urinary-tract-infection:rUTI-History,-UTI-(-),-rUTI-History,-UTI(+)_vs_No-UTI-History_UP	NA	816	84111	561	1378	570	1301	2129
bsdb:812/2/1_urinary-tract-infection:EHT+-Premenopausal-women-with-no-UTI-History-and-rUTI-History(-UTI()-groups)-with-estrogen-hormone-therapy-(EHT)_vs_Premenopausal-women-with-no-UTI-History-and-rUTI-History(-UTI()-groups)-without-estrogen-hormone-therapy-(EHT)_UP	NA	1578
bsdb:812/2/3_urinary-tract-infection:EHT+-Premenopausal-women-with-no-UTI-History-and-rUTI-History(-UTI()-groups)-with-estrogen-hormone-therapy-(EHT)_vs_Premenopausal-women-with-no-UTI-History-and-rUTI-History(-UTI()-groups)-without-estrogen-hormone-therapy-(EHT)_UP	NA	1578
bsdb:812/2/4_urinary-tract-infection:EHT+-Premenopausal-women-with-no-UTI-History-and-rUTI-History(-UTI()-groups)-with-estrogen-hormone-therapy-(EHT)_vs_Premenopausal-women-with-no-UTI-History-and-rUTI-History(-UTI()-groups)-without-estrogen-hormone-therapy-(EHT)_UP	NA	1301
bsdb:812/2/5_urinary-tract-infection:EHT+-Premenopausal-women-with-no-UTI-History-and-rUTI-History(-UTI()-groups)-with-estrogen-hormone-therapy-(EHT)_vs_Premenopausal-women-with-no-UTI-History-and-rUTI-History(-UTI()-groups)-without-estrogen-hormone-therapy-(EHT)_NA	NA	1578	1375	570	561	1350	1678	1301	2701	1279	76833	150022	1716	1743	66831	165779	838	162289	419014	184869	1654	1380	1263
bsdb:814/1/1_Systemic-scleroderma:Adult-Systemic-Sclerosis-patients-on-a-non-low-fermentable-oligosaccharides,-disaccharides,-monosaccharides,-and-polyols-(FODMAP)-diet._vs_Adult-Systemic-Sclerosis-patients-on-a-low-fermentable-oligosaccharides,-disaccharides,-monosaccharides,-and-polyols-(FODMAP)-diet._UP	NA	1350	570	906
bsdb:814/1/2_Systemic-scleroderma:Adult-Systemic-Sclerosis-patients-on-a-non-low-fermentable-oligosaccharides,-disaccharides,-monosaccharides,-and-polyols-(FODMAP)-diet._vs_Adult-Systemic-Sclerosis-patients-on-a-low-fermentable-oligosaccharides,-disaccharides,-monosaccharides,-and-polyols-(FODMAP)-diet._DOWN	NA	1649459	265975	1481960	1505652
bsdb:814/2/1_Systemic-scleroderma:Systemic-Sclerosis-patients-with-increased-GIT-2.0-score_vs_Not-Applicable_UP	NA	1350	570	1578	165695
bsdb:814/2/2_Systemic-scleroderma:Systemic-Sclerosis-patients-with-increased-GIT-2.0-score_vs_Not-Applicable_DOWN	NA	135858	33042	1918450	1937008	2172	838	1501226	292632	191303	1506577
bsdb:814/3/1_Systemic-scleroderma:Systemic-Sclerosis-patients-with-more-severe-diarrhoea_vs_NA_UP	NA	1350	29465	1578	165695
bsdb:814/3/2_Systemic-scleroderma:Systemic-Sclerosis-patients-with-more-severe-diarrhoea_vs_NA_DOWN	NA	191303	292632	1678	1505657	33042	1508657	2172	1470353	1263	838	244127	1501226	61170	447020	1506577
bsdb:814/4/1_Systemic-scleroderma:Systemic-Sclerosis-patients-with--worsened-social-functioning_vs_NA_UP	NA	1357	906	1350	1649459	561	620	84111	1578	1506553	165695
bsdb:814/4/2_Systemic-scleroderma:Systemic-Sclerosis-patients-with--worsened-social-functioning_vs_NA_DOWN	NA	191303	1263	33042	1501226	292632	2172
bsdb:815/1/1_Ulcerative-proctosigmoiditis:Infants-diagnosed-with-food-protein-induced-allergic-proctocolitis-(FPIAP)_vs_Infants-diagnosed-without-food-protein-induced-allergic-proctocolitis-(FPIAP)_UP	NA	816	1678	572511	1485	724	1578	375288	1263	1301	29465
bsdb:816/2/1_Postcholecystectomy-syndrome:post-cholecystectomy-diarrhea-(PCD)_vs_post-cholecystectomy-non-diarrhea-(PCND)_DOWN	NA	1678	1357	1266	160674	544
bsdb:816/2/2_Postcholecystectomy-syndrome:post-cholecystectomy-diarrhea-(PCD)_vs_post-cholecystectomy-non-diarrhea-(PCND)_UP	NA	838	40544
bsdb:818/1/2_Dermatitis,Asthma,Food-allergy,Allergic-rhinitis:Allergic-Children_vs_Healthy-controls_UP	NA	1506577
bsdb:820/1/1_Antimicrobial-agent,Amoxicillin:mouse--after-antibiotic-treatment_vs_mouse-before-antibiotic-treatment_DOWN	NA	5052	5498	83174
bsdb:820/1/2_Antimicrobial-agent,Amoxicillin:mouse--after-antibiotic-treatment_vs_mouse-before-antibiotic-treatment_UP	NA	5052	5498	83174
bsdb:822/1/1_azithromycin:azithromycin(AZM)_vs_placebo_UP	NA	1654	47670	2740	508215	34104	157	29465
bsdb:822/1/2_azithromycin:azithromycin(AZM)_vs_placebo_DOWN	NA	416916	265975	475	724
bsdb:822/2/1_azithromycin:Participants-on-azithromycin-at-48-weeks-of-treatment_vs_Participants-on-azithromycin-at-baseline-(prior-to-treatment)_UP	NA	47670	2740	508215	34104	157	29465
bsdb:822/2/2_azithromycin:Participants-on-azithromycin-at-48-weeks-of-treatment_vs_Participants-on-azithromycin-at-baseline-(prior-to-treatment)_DOWN	NA	416916	724	475	265975
bsdb:822/3/1_azithromycin:Participants-on-azithromycin-at-72-weeks-(24-weeks-post-treatment)_vs_Participants-on-azithromycin-at-baseline-(prior-to-treatment)_UP	NA	47670	265975	2740	508215	157
bsdb:822/3/2_azithromycin:Participants-on-azithromycin-at-72-weeks-(24-weeks-post-treatment)_vs_Participants-on-azithromycin-at-baseline-(prior-to-treatment)_DOWN	NA	416916	724	475	34104	29465
bsdb:823/1/1_Dry-eye-syndrome:Mild-Meibomian-Gland-Dysfunction-(MGD)-Group_vs_Healthy-controls_UP	NA	1279	1743	13687
bsdb:823/1/2_Dry-eye-syndrome:Mild-Meibomian-Gland-Dysfunction-(MGD)-Group_vs_Healthy-controls_DOWN	NA	1716	1193515	1301
bsdb:823/2/1_Dry-eye-syndrome:Moderate-Meibomian-Gland-Dysfunction-(MGD)-Group_vs_Healthy-Controls_UP	NA	13687	1279	1743	1193515
bsdb:823/2/2_Dry-eye-syndrome:Moderate-Meibomian-Gland-Dysfunction-(MGD)-Group_vs_Healthy-Controls_DOWN	NA	1716	1301
bsdb:823/3/1_Dry-eye-syndrome:Severe-Melbomian-Gland-dysfunctions-[MGD]-Group_vs_Healthy-Controls_UP	NA	1279	1301
bsdb:823/3/2_Dry-eye-syndrome:Severe-Melbomian-Gland-dysfunctions-[MGD]-Group_vs_Healthy-Controls_DOWN	NA	1716	1743	1193515	13687
bsdb:824/1/1_gastric-cancer:Gastric-cancer-patients-(Post-gastrectomy)_vs_Gastric-cancer-patients-(Pre-gastrectomy)_UP	NA	404402	1578
bsdb:824/1/2_gastric-cancer:Gastric-cancer-patients-(Post-gastrectomy)_vs_Gastric-cancer-patients-(Pre-gastrectomy)_DOWN	NA	1654	1766253	239759	2060094	207244	2801844	830	1331051	848	2740	40544
bsdb:824/2/1_gastric-cancer:Gastric-cancer-patients-(Post-gastrectomy)_vs_Gastric-cancer-patients-(Pre-gastrectomy)_UP	NA	59735	1678	570	1578	1481960
bsdb:824/2/2_gastric-cancer:Gastric-cancer-patients-(Post-gastrectomy)_vs_Gastric-cancer-patients-(Pre-gastrectomy)_DOWN	NA	1283313	830	1331051	43996	100883	189330	1573534	848	209	1573535	86795	482	577310	1257	836	196081
bsdb:825/1/1_Urolithiasis:urinary-stone-disease-patients_vs_healthy-controls_UP	NA	1654	239759	209879	1283313	244127	816	1678	572511	574697	135858	1980681	102106	1348911	1716	872	39948	848	596767	1392389	1506553	1578	248744	158846	906	52225	86331	2039302	283168	459786	375288	577310	838	1263	1301	40544	157	191303	29465
bsdb:825/2/1_Urolithiasis:urinary-stone-disease-patients_vs_healthy-controls_UP	NA	469	1654	165779	1380	816	572511	374	1696	59732	1716	308865	66831	236752	237	1407607	848	162290	31983	57493	1578	1847725	407	1161127	133925	2740	162289	836	838	286	1263	13687	1301	292632	29465	43947	401469	332102	149698	1931224	508215
bsdb:826/1/1_colorectal-adenoma:HRA-(high-risk-adenoma)_vs_Healthy-controls_DOWN	NA	620
bsdb:826/2/1_colorectal-cancer:CRC-(participants-diagnosed-with-colorectal-cancer)_vs_Healthy-controls_UP	NA	33024
bsdb:826/4/2_colorectal-adenoma:HRA-(high-risk-adenoma)_vs_Healthy-controls_DOWN	NA	577310
bsdb:826/5/1_colorectal-cancer:CRC-(participants-diagnosed-with-colorectal-cancer)_vs_Healthy-controls_UP	NA	904
bsdb:826/7/1_Time:Colorectal-cancer-diagnosed-during-17-year-follow-up/post-screening_vs_Colorectal-cancer-diagnosed-at-time-of-screening_UP	NA	1678
bsdb:827/1/1_Disease-progression-measurement:Advanced-cholangiocarcinoma_vs_Early-cholangiocarcinoma_UP	NA	194	544	32067
bsdb:827/2/1_Disease-progression-measurement:Advanced-pancreatic-ductal-adenocarcinoma_vs_Early-pancreatic-ductal-adenocarcinoma_UP	NA	28100	13687
bsdb:827/2/2_Disease-progression-measurement:Advanced-pancreatic-ductal-adenocarcinoma_vs_Early-pancreatic-ductal-adenocarcinoma_DOWN	NA	547	1649459	1763
bsdb:827/3/1_Disease-progression-measurement:Intraductal-papillary-mucinous-carcinoma-(IPMC)_vs_intraductal-papillary-mucinous-neoplasm-(IPMN)_UP	NA	1654	1283313	35832	39948	84111	970	1301
bsdb:827/4/1_Disease-prognosis-measurement:Good-prognosis-in-bile-duct-lesion-cases_vs_Poor-prognosis-in-bile-duct-lesion-cases_UP	NA	1301	848	29465
bsdb:827/4/2_Disease-prognosis-measurement:Good-prognosis-in-bile-duct-lesion-cases_vs_Poor-prognosis-in-bile-duct-lesion-cases_DOWN	NA	1350	1716	724	1847725	1279	475	816	1649459
bsdb:827/5/1_Disease-prognosis-measurement:Good-prognosis-in-pancreatic-lesion-cases_vs_Poor-prognosis-in-pancreatic-lesion-cases_UP	NA	1350	1279	816	160674	1301
bsdb:827/5/2_Disease-prognosis-measurement:Good-prognosis-in-pancreatic-lesion-cases_vs_Poor-prognosis-in-pancreatic-lesion-cases_DOWN	NA	570	29465	469	970	265
bsdb:828/1/1_COVID-19:Symptomatic-patients_vs_Asymptomatic-patients_DOWN	NA	292632
bsdb:828/2/1_Pneumonia,COVID-19:COVID-19-patients-with-severe-pneumonia_vs_Healthy-controls_UP	NA	1386	1678	1350	428711	475	125287	165697	1279
bsdb:828/2/2_Pneumonia,COVID-19:COVID-19-patients-with-severe-pneumonia_vs_Healthy-controls_DOWN	NA	1654	724	265975	836	838	970	285107	551208
bsdb:829/1/1_Breastfeeding-duration:Low-Total-Time-Breastfeeding_vs_Medium-Total-Time-Breastfeeding_DOWN	NA	110934	1678	84567	40323	212744
bsdb:829/2/1_Breastfeeding-duration:High-Total-Time-Breastfeeding_vs_Medium-Total-Time-Breastfeeding_DOWN	NA	110934	1678	84567	40323	212744
bsdb:829/3/1_Breastfeeding-duration:Low-Breastfeeding-Bouts_vs_Medium-Breastfeeding-Bouts_UP	NA	1678	1269
bsdb:829/3/2_Breastfeeding-duration:Low-Breastfeeding-Bouts_vs_Medium-Breastfeeding-Bouts_DOWN	NA	84567	50709	222
bsdb:829/4/1_Breastfeeding-duration:High-Breastfeeding-Bouts_vs_Medium-Breastfeeding-Bouts_UP	NA	1678
bsdb:829/4/2_Breastfeeding-duration:High-Breastfeeding-Bouts_vs_Medium-Breastfeeding-Bouts_DOWN	NA	1269	84567	50709	222
bsdb:830/6/1_Dry-eye-syndrome:Dry-Eye_vs_healthy-controls_DOWN	NA	1716
bsdb:831/1/1_COVID-19:COVID-19-Patients_vs_ventilator-associated-pneumonia-(pneumonia-group)_UP	NA	816	1905344	1017280
bsdb:831/1/2_COVID-19:COVID-19-Patients_vs_ventilator-associated-pneumonia-(pneumonia-group)_UP	NA	838	150022	1686313	162289	836
bsdb:831/2/1_COVID-19:COVID-19-patients-with-ventilation_vs_COVID-19-patients-without-ventilation_DOWN	NA	216851	841	1301
bsdb:831/2/2_COVID-19:COVID-19-patients-with-ventilation_vs_COVID-19-patients-without-ventilation_UP	NA	194	1485	1263
bsdb:832/1/1_Atrial-fibrillation:Individuals-with-Atrial-Fibrillation-(AF)_vs_Individuals-without-Atrial-Fibrillation-(AF)_UP	NA	872	1432051	1472762	547	579
bsdb:832/1/2_Atrial-fibrillation:Individuals-with-Atrial-Fibrillation-(AF)_vs_Individuals-without-Atrial-Fibrillation-(AF)_DOWN	NA	816	1678	1573535	375288	191303
bsdb:832/2/1_Atrial-fibrillation:Individuals-with-Incident-Atrial-Fibrillation-(AF)_vs_Individuals-without-Atrial-Fibrillation-(AF)_UP	NA	1678	1472762	1578	1357	52225	1769710
bsdb:832/2/2_Atrial-fibrillation:Individuals-with-Incident-Atrial-Fibrillation-(AF)_vs_Individuals-without-Atrial-Fibrillation-(AF)_DOWN	NA	1432051	1649459	60919	1506577
bsdb:832/3/1_Atrial-fibrillation:Individuals-with-Incident-Atrial-Fibrillation-(AF)_vs_NA_DOWN	NA	239759	397864	1350	283168	577309	60919
bsdb:832/3/2_Atrial-fibrillation:Individuals-with-Incident-Atrial-Fibrillation-(AF)_vs_NA_UP	NA	1485	102106	1472762	123375
bsdb:833/1/1_irritable-bowel-syndrome:Irritable-Bowel-Syndrome_vs_Healthy-controls_UP	NA	1654
bsdb:835/1/1_Response-to-vaccine,Timepoint:Mothers-at-post-vaccination-timepoints_vs_Mothers-at-pre-vaccination-timepoint_UP	NA	41275	2053
bsdb:835/1/2_Response-to-vaccine,Timepoint:Mothers-at-post-vaccination-timepoints_vs_Mothers-at-pre-vaccination-timepoint_DOWN	NA	174708	48736	191303
bsdb:835/2/1_Response-to-vaccine:High-IgA-mothers-at-one-week-post-second-dose_vs_mothers-at-pre-vaccination_UP	NA	848	416916	482	40544	359336	2039302	2801844	1213720	713	1505652	111142
bsdb:835/3/1_Response-to-vaccine:low-IgA-mothers-at-one-week-post-second-dose_vs_pre-vaccination-(baseline)_UP	NA	41275	469
bsdb:835/4/1_Response-to-vaccine:Mothers-at-one-week-post-first-dose_vs_Mothers-at-pre-vaccination-timepoint_UP	NA	713	41275	33882	150247	1386	59735	75654	59734	212791	237	29580	586	1742993	22	13687
bsdb:835/5/1_Response-to-vaccine:Mothers-at-one-week-post-second-dose_vs_Mothers-at-pre-vaccination-timepoint-(baseline)_UP	NA	469	713	41275	204456	2053	570	32067	158846	481445	75687	528	162289	1742993	1200657	613	57739
bsdb:835/6/1_Response-to-vaccine:Mothers-at-one-month-post-second-dose_vs_Mothers-at-pre-vaccination-timepoint_UP	NA	12916	2040	1380	41275	225842	2053	1164882	186650	475	165696	1253	2321113	613	204447	13687	114248
bsdb:836/1/1_food-allergy:food-allergy-(FA)-group_vs_non-allergy-(NA)-group_UP	NA	469	286	1696
bsdb:836/1/2_food-allergy:food-allergy-(FA)-group_vs_non-allergy-(NA)-group_DOWN	NA	239934	239759	1283313	1678	1485	158846	33024	838	1501226	841	1263	29465	204475	572511	459786	1380	848	397864	577309	191303	66831	499551	336260	1017280	580596	43773	53457	423604	906	580024	1184396	283168	2172	2740	1860
bsdb:837/1/1_food-allergy:Healthy-pregnant-women_vs_Mother-infant_UP	NA	286	469
bsdb:837/1/2_food-allergy:Healthy-pregnant-women_vs_Mother-infant_DOWN	NA	239934	1678	572511	561	838	841	1263	620	29465	1485
bsdb:839/1/3_epilepsy:pre-treatment-(focal-epilepsy)_vs_healthy-control-(HC)_UP	NA	102106	1378
bsdb:839/2/1_epilepsy:post-treatment-(focal-epilepsy)_vs_healthy-control-(HC)_UP	NA	574697	102106	1730	459786	375288
bsdb:839/3/1_epilepsy:post-treatment-(focal-epilepsy)_vs_pre-treatment-(focal-epilepsy)_UP	NA	459786	172900
bsdb:839/3/2_epilepsy:post-treatment-(focal-epilepsy)_vs_pre-treatment-(focal-epilepsy)_DOWN	NA	1378	1501226	1301
bsdb:840/1/1_COVID-19:COVID-19-positive-participants-with-severe-disease._vs_COVID-19-positive-participants-with-mild-or-moderate-disease._UP	NA	1654	1678	1485	848	1578	816
bsdb:840/1/2_COVID-19:COVID-19-positive-participants-with-severe-disease._vs_COVID-19-positive-participants-with-mild-or-moderate-disease._DOWN	NA	838	1301	1654	836	29465	32067	1016	1378	482
bsdb:841/1/1_Breastfeeding-duration:Calves-without-dam-on-day-35_vs_Calves-with-dam-on-day-35_UP	NA	76831	651554	1257
bsdb:841/1/2_Breastfeeding-duration:Calves-without-dam-on-day-35_vs_Calves-with-dam-on-day-35_DOWN	NA	816	375288
bsdb:841/2/1_Breastfeeding-duration:Calves-without-dam-on-day-65_vs_Calves-with-dam-on-day-65_UP	NA	816	1578
bsdb:841/2/2_Breastfeeding-duration:Calves-without-dam-on-day-65_vs_Calves-with-dam-on-day-65_DOWN	NA	157
bsdb:841/3/1_Breastfeeding-duration:Calves-without-dam-on-day-95_vs_Calves-with-dam-on-day-95_UP	NA	157
bsdb:842/1/1_food-allergy:Food-Allergy_vs_Control-group_UP	NA	816
bsdb:842/2/1_Dermatitis:Atopic-dermatitis_vs_Control-group_UP	NA	375288
bsdb:842/3/1_Food-allergy,Dermatitis:Atopic-dermatitis-and-Food-Allergy-(ADFA)_vs_Control-group_UP	NA	816	375288
bsdb:842/4/1_Food-allergy,Dermatitis:Infants-with-Allergy-Symptoms_vs_Control-group_UP	NA	1378
bsdb:844/1/1_Response-to-metformin:metformin-treated-T2D-patients_vs_metformin-naive-type-2-diabetes-(T2D)-patients_DOWN	NA	1506553
bsdb:844/3/1_Population:Denmark-(normoglycaemic-controls-and-T2D-patients)_vs_Indians-(normoglycaemic-controls-and-T2D-patients)_UP	NA	447020	239934	239759	52784	244127	1935176	816	397864	35832	374	574697	990721	1348911	872	1432051	216851	946234	61170	1649459	1506553	28050	1935200	3028852	1980693	283168	459786	119852	846	375288	577309	577310	2740	33024	1017280	1827	1508657	1635148	292632	40544
bsdb:844/3/2_Population:Denmark-(normoglycaemic-controls-and-T2D-patients)_vs_Indians-(normoglycaemic-controls-and-T2D-patients)_DOWN	NA	222	1654	1766253	1283313	156454	207244	1678	135858	102106	189330	1407607	117563	1573535	404402	257820	1578	248744	906	52225	133925	265975	2082587	1501226	1473205	613	123375	1505652	46255
bsdb:844/4/1_Metformin:metformin-treated-T2D-patients_vs_metformin-naive-type-2-diabetes-(T2D)-patients_UP	NA	216851
bsdb:844/5/1_type-ii-diabetes-mellitus:Type-2-diabetes-(T2D)-patients_vs_Normoglycemic-(NG)-controls_UP	NA	653683	580596	39948	216851	1578	1501226	841	292632
bsdb:844/5/2_type-ii-diabetes-mellitus:Type-2-diabetes-(T2D)-patients_vs_Normoglycemic-(NG)-controls_DOWN	NA	816	189330	1506553	906	459786
bsdb:844/6/1_type-ii-diabetes-mellitus:Type-2-diabetes-(T2D)-patients_vs_Normoglycemic-(NG)-controls_UP	NA	292632	580596	653683
bsdb:844/6/2_type-ii-diabetes-mellitus:Type-2-diabetes-(T2D)-patients_vs_Normoglycemic-(NG)-controls_DOWN	NA	1506553
bsdb:844/7/1_type-ii-diabetes-mellitus:Type-2-diabetes-(T2D)-patients_vs_Normoglycemic-(NG)-controls_DOWN	NA	1506553
bsdb:845/1/1_Smoking-status-measurement:Current-smokers_vs_Never-smokers_UP	NA	1654	419014	1380	1678	118747	84162	39948	44259	1434006	1578	906	52225	2093	508215	1213720	157	29465
bsdb:845/1/2_Smoking-status-measurement:Current-smokers_vs_Never-smokers_DOWN	NA	46123	416916	1283313	59735	1016	2717	43996	848	724	32257	47670	32067	482	219181	2740	1257	836
bsdb:845/2/1_Smoking-status-measurement:Former-smokers-(0-1--year)_vs_Never-smokers_UP	NA	46123	416916	118747	84162	39948	1434006	32257	2093
bsdb:845/2/2_Smoking-status-measurement:Former-smokers-(0-1--year)_vs_Never-smokers_DOWN	NA	419014	1016	43996	724	47670	482	219181	2740	1257	1213720
bsdb:845/3/1_Smoking-status-measurement:Former-smokers-(2-3--year)_vs_Never-smokers_UP	NA	59735	2717	724
bsdb:845/3/2_Smoking-status-measurement:Former-smokers-(2-3--year)_vs_Never-smokers_DOWN	NA	1654	416916	419014	1678	118747	84162	39948	44259	1434006	1578	32067	52225	2093	482	219181	836	508215	1213720	29465
bsdb:845/4/1_Smoking-status-measurement:Former-smokers-(4-5-year)_vs_Never-smokers_UP	NA	1654	1380	1678	43996	32067	906	52225	29465
bsdb:845/4/2_Smoking-status-measurement:Former-smokers-(4-5-year)_vs_Never-smokers_DOWN	NA	46123	416916	59735	1016	2717	848	32257	47670	482	836
bsdb:845/5/1_Smoking-status-measurement:Former-smokers-(5-10-years)_vs_Never-smokers_UP	NA	219181	47670	1257	1578	419014	1213720	44259	157	2093
bsdb:845/5/2_Smoking-status-measurement:Former-smokers-(5-10-years)_vs_Never-smokers_DOWN	NA	84162	39948	2740	1283313	32067	52225	59735	848	46123	416916	1016
bsdb:845/6/1_Smoking-status-measurement:Former-smokers-(11-62--year)_vs_Never-smokers_UP	NA	836	1016	482
bsdb:845/6/2_Smoking-status-measurement:Former-smokers-(11-62--year)_vs_Never-smokers_DOWN	NA	84162	39948	906	157	1434006	32257	1257	1380	1678	29465	2717	724
bsdb:847/1/1_obesity:Obese-Volunteers-(O)_vs_Normal-weight-volunteers-(N)_UP	NA	102106	135858	123375	46123	84108	100883
bsdb:847/1/2_obesity:Obese-Volunteers-(O)_vs_Normal-weight-volunteers-(N)_DOWN	NA	239759	244127	397864	194	1485	1582879	596767	459786	577310	162289	836	1501226	44748	292632	191303
bsdb:848/1/1_Autism-spectrum-disorder:Constipated-autism-spectrum-disorder-(C-ASD)-group_vs_Typically-developing-(TD)-group_UP	NA	397864	1470349	283	1348911	33042	872	1472762	848	158846	283168	375288	577309	1481960	2740	33024	1508657	172900
bsdb:848/1/2_Autism-spectrum-disorder:Constipated-autism-spectrum-disorder-(C-ASD)-group_vs_Typically-developing-(TD)-group_DOWN	NA	1375	207244	1716	1506553	1578	1637	475961	248744	407	33882	838	286	48736	1263	399320	1279	3025755	157	1506577
bsdb:849/1/1_age:type-2-diabetes-(T2D)_vs_Non-T2D(prediabetes)_UP	NA	816	1578	29465
bsdb:849/1/2_age:type-2-diabetes-(T2D)_vs_Non-T2D(prediabetes)_DOWN	NA	1485	216851
bsdb:849/2/1_Cytokine:Type-2-Diabetes_vs_Non-Type-2-Diabetes-(Prediabetes)_UP	NA	816	375288
bsdb:849/2/2_Cytokine:Type-2-Diabetes_vs_Non-Type-2-Diabetes-(Prediabetes)_DOWN	NA	838
bsdb:849/3/1_diet:Type-2-Diabetes_vs_Non-Type-2-Diabetes-(Prediabetes)_UP	NA	816	1485	1578
bsdb:849/4/1_HbA1c-measurement:Type-2-Diabetes_vs_Non-Type-2-Diabetes-(Prediabetes)_UP	NA	33024
bsdb:849/4/2_HbA1c-measurement:Type-2-Diabetes_vs_Non-Type-2-Diabetes-(Prediabetes)_DOWN	NA	1485
bsdb:850/10/1_Breastfeeding-duration,Transport:weaning+short-transportation_vs_suckling-calves-(control)_UP	NA	75984
bsdb:850/10/2_Breastfeeding-duration,Transport:weaning+short-transportation_vs_suckling-calves-(control)_DOWN	NA	475
bsdb:851/1/1_Crohn's-disease:non-inflamed-crohn's-disease_vs_non-inflammatory-bowel-disease-who-were-undergoing-colonoscopy-either-for-screening-or-for-other-gastrointestinal-complaints-unrelated-to-IBD_DOWN	NA	33042	459786
bsdb:851/2/1_ulcerative-colitis:non-inflamed-ulcerative-colitis_vs_non-inflammatory-bowel-disease-patients-who-were-undergoing-colonoscopy-either-for-screening-or-for-other-gastrointestinal-complaints-unrelated-to-IBD_UP	NA	1654	2742	286
bsdb:851/2/2_ulcerative-colitis:non-inflamed-ulcerative-colitis_vs_non-inflammatory-bowel-disease-patients-who-were-undergoing-colonoscopy-either-for-screening-or-for-other-gastrointestinal-complaints-unrelated-to-IBD_DOWN	NA	239759	816	189330	459786	375288	33024	838
bsdb:851/3/1_ulcerative-colitis:inflamed-ulcerative-colitis_vs_non-inflammatory-bowel-disease-patients-who-were-undergoing-colonoscopy-either-for-screening-or-for-other-gastrointestinal-complaints-unrelated-to-IBD_UP	NA	286
bsdb:851/3/2_ulcerative-colitis:inflamed-ulcerative-colitis_vs_non-inflammatory-bowel-disease-patients-who-were-undergoing-colonoscopy-either-for-screening-or-for-other-gastrointestinal-complaints-unrelated-to-IBD_DOWN	NA	239759	375288
bsdb:852/1/1_Acne:Acne-group_vs_Healthy-group_UP	NA	1716	40323
bsdb:852/1/2_Acne:Acne-group_vs_Healthy-group_DOWN	NA	1654	37914	150022	32067	437755	836	838
bsdb:852/2/1_Acne:Acne-group_vs_Healthy-group_DOWN	NA	1716	836
bsdb:852/3/1_Acne:Acne-group_vs_Healthy-group_UP	NA	2570834
bsdb:854/1/1_Dry-eye-syndrome:Sjogrens-Syndrome-Dry-Eye-(SSDE)_vs_Normal-Control-(NC)_UP	NA	469	1485	1716
bsdb:854/1/2_Dry-eye-syndrome:Sjogrens-Syndrome-Dry-Eye-(SSDE)_vs_Normal-Control-(NC)_DOWN	NA	1386
bsdb:854/2/1_Dry-eye-syndrome:Non-Sjogrens-Syndrome-Dry-Eye-(NSSDE)_vs_Normal-Control-(NC)_UP	NA	469	1485
bsdb:854/2/2_Dry-eye-syndrome:Non-Sjogrens-Syndrome-Dry-Eye-(NSSDE)_vs_Normal-Control-(NC)_DOWN	NA	1386
bsdb:854/3/2_Dry-eye-syndrome:Sjogrens-Syndrome-Dry-Eye-(SSDE)_vs_Non-Sjogrens-Syndrome-Dry-Eye-(NSSDE)_DOWN	NA	1485
bsdb:855/1/1_Dry-eye-syndrome:Dry-Eye-Disease-patients_vs_Healthy-Controls_UP	NA	547	1350	1582879	236752	2701	724	47670	83614	1370	1817	543311	1632780	286	1060	84108	165695	34104	1883	2060	349
bsdb:855/1/2_Dry-eye-syndrome:Dry-Eye-Disease-patients_vs_Healthy-Controls_DOWN	NA	12916	469	642	111142	1283313	1663	414371	1386	59735	1678	43668	1696	10	59732	1716	1912216	80865	82800	37914	1433999	59734	212791	2053	117563	366614	2745	53457	570	57493	57499	1578	1847725	32067	68	149698	407	33882	1269	1763	44249	265	28100	985001	1085622	83618	1855416	32207	613	22	204447	40323
bsdb:855/2/1_Dry-eye-syndrome:Sjogren's-patients-with-Dry-Eye-Disease_vs_Healthy-Controls_UP	NA	59735	547	1350	1582879	724	1578	47670	1370	543311	1632780	28100	286	1060	590	165695	1883	2060
bsdb:855/2/2_Dry-eye-syndrome:Sjogren's-patients-with-Dry-Eye-Disease_vs_Healthy-Controls_DOWN	NA	12916	111142	1283313	165779	1663	43668	1696	10	59732	1716	1912216	80865	82800	37914	1433999	212791	33986	1378	2053	117563	366614	2745	57499	1847725	32067	83614	68	149698	407	33882	1269	1763	265	985001	1085622	1855416	32207	613	22	204447	40323	662	46255	349
bsdb:855/3/1_Dry-eye-syndrome:Non-Sjogren's-Syndrome-patients-with-Dry-Eye-Disease_vs_Healthy-Controls_UP	NA	59735	547	1350	1582879	236752	2701	47670	83614	1370	33882	1817	543311	28100	286	1060	32207	613	165695	34104	1883	292632	2060	349
bsdb:855/3/2_Dry-eye-syndrome:Non-Sjogren's-Syndrome-patients-with-Dry-Eye-Disease_vs_Healthy-Controls_DOWN	NA	12916	469	642	111142	1283313	150247	1386	1678	43668	1696	41275	10	59732	1716	1912216	80865	82800	37914	1433999	59734	212791	2053	366614	724	2745	53457	570	57493	57499	1847725	32067	68	451512	149698	407	1269	1763	44249	265	985001	1085622	83618	1855416	22	204447	84108	40323
bsdb:856/2/1_Dry-eye-syndrome:Diabetic-children-with-Dry-Eye-Disease-(DM-DE)_vs_Normal-healthy-(NDM)-children_UP	NA	547	662
bsdb:858/1/1_Social-anxiety-disorder:Patients-with-Social-Anxiety-Disorder-(SAD)_vs_Healthy-controls_UP	NA	1924093	644652
bsdb:858/1/2_Social-anxiety-disorder:Patients-with-Social-Anxiety-Disorder-(SAD)_vs_Healthy-controls_DOWN	NA	577310
bsdb:865/1/1_Colorectal-cancer-cell-line:azoxymethane/dextran-sodiumsulfate-(AOM/DSS)-group-at-week-10_vs_control-group-at-week-10_UP	NA	239759	283168	1485	872
bsdb:865/1/2_Colorectal-cancer-cell-line:azoxymethane/dextran-sodiumsulfate-(AOM/DSS)-group-at-week-10_vs_control-group-at-week-10_DOWN	NA	375288	1730	1392389	1301	209	816
bsdb:866/1/2_Intestinal-polyp:low-grade-colorectal-polyps-cohort_vs_polyp-free-control-cohort_DOWN	NA	1386
bsdb:867/1/1_breast-cancer:Breast-cancer-patients_vs_Healthy-controls_UP	NA	904	1649459	1506577
bsdb:867/1/2_breast-cancer:Breast-cancer-patients_vs_Healthy-controls_DOWN	NA	52784	2840511	39948	1501226
bsdb:868/1/1_ulcerative-colitis:ulcerative-colitis_vs_healthy-controls_UP	NA	724	133925	838	158483	1257	216851	28050	1980693	830
bsdb:868/1/2_ulcerative-colitis:ulcerative-colitis_vs_healthy-controls_DOWN	NA	1243	629	41275	1649292	1912216	1348911	1432051	1357	574697	1407607
bsdb:869/1/1_ulcerative-colitis:quiescent-ulcerative-colitis-patients_vs_healthy-controls_UP	NA	1678
bsdb:869/2/1_Disease-progression-measurement:relapsed-ulcerative-colitis-group_vs_sustained-remission-of-ulcerative-colitis-group_UP	NA	216851	1678
bsdb:869/2/2_Disease-progression-measurement:relapsed-ulcerative-colitis-group_vs_sustained-remission-of-ulcerative-colitis-group_DOWN	NA	838
bsdb:870/1/1_Postmenopausal-osteoporosis:Postmenopausal-osteoporosis-(PMOP)-patients_vs_Healthy-controls_UP	NA	1578
